2002 SCIENTIFIC PROGRAM COMMITTEE

Seated (left to right): Drs. McDowell, Muskin, Ordorica. 1st Row Standing (left to right): Drs. Judge, Blake, Worley, Pandurangi, LeMelle, Shafii, Anderson, Jayaram, Casey, Dawkins, Foulks. 2nd Row Standing (left to right): Drs. Blinder, Choeng, Taylor, Crone, Baker, Hilty, Kanefield, Groves, Goldfinger, Yeung, MacKenzie, Pandya, Alessi, D'Alli. Not pictured: Drs. Kales, Stabinsky

May 18, 2002

Dear Colleagues and Guests:

Welcome to the 155th Annual Meeting of the American Psychiatric Association. The coming week will highlight the best in our profession in the largest psychiatric meeting in the world. Our meeting has become an outstanding international forum to discuss the latest scientific advances and traditional humane values in psychiatry and how we will continue to integrate these bodies of knowledge to provide excellent patient care into the future.

This year's Annual Meeting theme is "The 21st Century Psychiatrist." Many sessions throughout the week will highlight an important aspect of the theme. Please make a special effort to attend the Monday afternoon Presidential Symposium, from 2:00 p.m.-5:00 p.m., entitled, "What Will the 21st Century Bring to the Training of Psychiatrists?"

I join our colleagues from North America in greeting the thousands of colleagues from other parts of the world who have joined us in Philadelphia. At the Opening Session, from 5:00 p.m.-6:30 p.m., on Sunday, we will officially welcome the leaders from psychiatric societies in the U.S. and around the world. I will present my Presidential Address, and I look forward to seeing you there.

Please also make sure to attend the Convocation on Monday night at 6:00 p.m., where we will honor all those being inducted as fellows and many receiving awards from the APA.

Organizing a meeting like ours represents the best in collaboration between our members and our staff. Special congratulations go to Dr. Philip R. Muskin and the members of the Scientific Program Committee, Marvin Kanefield, D.O., and the members of the Local Arrangements Committee, and to the APA staff who work on the Annual Meeting.

Welcome to Philadelphia 2002.

Sincerely,

Richard K. Harding, M.D. President American Osychiatric Association

1400 K Street, N.W. Washington, D.C. 20005 Telephone 202.682.6237 Fax 202.682.6345 E-mail [email protected] May 18, 2002 155th Annual Meeting Philadelphia, PA May 18-23, 2002

President Richard K. Harding, M.D. Dear APA Members and Guests:

Scientific Program Committee 2001-2002 Welcome to Philadelphia, PA, and the 155th Annual Meeting of the American Psychiatric Association. Philip R. Muskin, M.D., Chairperson David M. McDowell, M.D. This historic city, with its vibrancy, cultural diversity, and excitement, provides a perfect setting for the Vice-Chairperson scientific presentations we have planned. As you read through the Program Book, you will notice a number of Patricia I. Ordorica, M.D. sessions related to the theme "The 21st Century Psychiatrist," chosen by our President, Dr. Richard K. Vice-Chairperson Robert W. Baker, M.D. Harding. Let me draw your attention to just a few of the many exciting sessions presented this week. On David A. Casey, M.D. Monday we will present the Presidential Symposium entitled, "What Will the 21st Century Bring to the Josepha Cheong, M.D. Training of Psychiatrists?" Throughout the week we will feature sessions presented in collaboration with the Catherine C. Crane, M.D. Karon Dawkins, M.D. Substance Abuse and Mental Health Service Administration. David Satcher, MD, will present the APA's Geetha Jayaram, M.D. Patient Advocacy Award Lecture on Wednesday, at 9:00 a.m. Sheila Judge, M.D. Helen Kales, M.D. Stephanie LeMelle, M.D. The Local Arrangements Committee, under the excellent guidance of its Chairperson, Marvin Kanefield, Anand Pandya, M.D. DO., has developed a wide array of activities that will help you take advantage of Philadelphia. You will Mohammad Shafii, M.D. Harvey Stabinsky, M.D. notice that a number of activities are designed especially for families and children. David H. Taylor, M.D. Linda Worley, M.D. The Business Meeting will be held on Sunday, from 12:30 p.m. to 1:30 p.m.; all voting members are Paul Yeung, M.D. encouraged to attend. The Opening Session will be held on Sunday, from 5:00 p.m. to 6:30 p.m. Exhibits Consultants Lesley M. Blake, M.D. will be open 11:00 a.m. to 4:30 p.m. on Sunday, 10:00 a.m. to 6:00 p.m. on Monday and Tuesday, and Barton J. Blinder, M.D. 10:00 a.m. to 3:00 p.m. on Wednesday. Please note that the Convocation will begin at 6:00 p.m., a new time, Edward Foulks, M.D. on Monday, May 20. Rodger McFarlane, recipient of APA's Patient Advocacy Award, will present the William Donald Hilty, M.D. K. Roy MacKenzie, M.D. C. Menninger Memorial Lecture during the Convocation. Randall Marshall, M.D. Ananda Pandurangi, M.D. The Advances in Research session will be held on Monday at 10:30 a.m. This session highlights the latest Tanya Royster-Anderson, M.D. research findings in psychiatry and summarizes their relevance to clinical practice. This session has become Media Subcommittee Richard E. D'Alli, M.D. an excellent way to start off the Annual Meeting's research programs, in conjunction with the Young Chairperson Investigators' Poster and Oral/Slide Sessions also on Monday. You will find an expanded number of small Telecommunications group sessions, including Discussion Groups; Research Consultations with selected experts in the field; and Subcommittee Master Educator Clinical Consultations, a series of clinically-based seminars with outstanding clinician Norman E. Alessi, M.D. Chairperson educators, offered to APA members only.

Committee on Commercial Support You will note in the Program Book that we are continuing with an expanded series of noon Forums. This Stephen M. Goldfinger, M.D. format allows us to schedule sessions that may not fit in the usual formats or that focus on late-breaking Chairperson topics of importance to the field. Several forums, as well as numerous other sessions, will focus on aspects Annual Meetings Department Cathy L. Nash, Director of the terrorist attacks, terrorists, and the response efforts to deal with the psychological sequelae of the (202) 682-6237 events. Hope Ball-Mann Registrar (202) 682-6082 It is extremely important that you fill out and return the evaluation forms for this meeting. The members Frank Berry of the Scientific Program Committee are interested in your opinion regarding the quality of the content of Administrator, Commercially- the Annual Meeting. The information we obtain will be used to plan next year's Annual Meeting. Supported Activities (202)682-6172 Renee Brown Once again, welcome to Philadelphia. I look forward to sharing a week of exciting and professionally Administrative Assistant rewarding activities with you. (202) 682-6365 Vernetta V. Copeland CME Course Coordinator Sincerely, (202) 682-6836 Tonya Frazier Administrative Assistant (202) 682-6849 Kendra W. Grant Scientific Program Coordinator (202) 682-6191 Sheena L. Majette Philip R. Muskin, M.D. Scientific Program Coordinator Chairperson (202) 682-6170 Scientific Program Committee Celeste M. Mele Operations Manager (202) 682-6237 Robbie J. Morsette Administrative Assistant (202) 682-6313 APA 155th ANNUAL MEETING

Philadelphia, PA • May 18-23, 2002

KEY LOCATIONS - CONVENTION CENTER MESSAGE CENTER American Journal of Psychiatry APA Resource Center Located on the Bridge, Level 200, Convention Center and staffed Annual Meetings Office Room 304, Level 300 during registration hours. Messages can be left and picked up at the (formerly the Scientific Program Office & Meetings Management) Message Center. Message monitors will be strategically located in the APA Communications Center Room 105 A/B, Street Level Exhibit Hall and elsewhere at the Convention Center. Registrants APA Resource Center Exhibit Halls A-C, Level 200 whose names appear on these monitors should pick up their messages A/V Preview Room Room 303 B, Level 300 at the Message Center. CME Course Enrollment Exhibit Halls A-C, Level 200 Computerized Evaluation APA Resource Center APA RESOURCE CENTER Daily Bulletin Room 310, Level 300 Located in Exhibit Halls A-C, Level 200, Convention Center. Hours Education Office Room 309, Level 300 of operation will be: Saturday, May 18,10:00 a.m.-5:00 p.m.; Sunday, Exhibit Office Level 200 May 19, 8:00 a.m.-4:30 p.m.; Monday and Tuesday, May 20-21,10:00 Exhibits/Publishers' Bookfair Exhibit Halls A-C, Level 200 a.m.-6:00 p.m.; and Wednesday, May 22, 10:00 a.m.-3:00 p.m. A few Information/Locator Center Street Level of the many APA activities exhibited include: membership, APA's Lost & Found Room 304, Level 300 internet-based programs, continuing medical education, quality Message Center Bridge, Level 200 improvement, psychiatric services, managed care services, and APA On-Site Job Bank and Job Bank. Placement Center APA Resource Center Psychiatric Services APPI Bookstore, Exhibit Halls A-C APA JOB BANK Registration Exhibit Halls A-C, Level 200 Located in the APA Resource Center and open during the Center's hours of operation. The on-line APA Job Bank will power the popular on-site Job Bank providing tools for both employers and FIRST AID candidates at the APA's Annual Meeting. With new features such as Located in Room BF2, Exhibit Hall B, Level 200, Convention Center. resume posting, enhanced job searching, and response tracking, the Hours of operation: Tuesday, May 14, through Thursday, May 23, Job Bank provides the best opportunity available for career research opens one hour prior to show opening and closes one hour after the last and on-site interviews. Candidates and employers are encouraged to event of the evening. This station will be operated by Registered Nurses. activate their resume and jobs postings in advance of the meeting for Information on emergency services may be found on page 1 of the best results. For more information on the Job Bank go to the APA Leisure Time Activities Brochure. web site, www.psych.org, and click on the Job Bank icon. You may also contact us by phone (888-884-8242) or e-mail COURTESY SHUTTLE BUS SERVICE ([email protected]) prior to the meeting, or stop by the Service will begin on Saturday, May 18, at approximately 7:30 a.m., Job Bank booth on-site. and will operate daily throughout the meeting commensurate with the scientific program schedule, including nighttime activities, and will APA COMMUNICATIONS OFFICE/PRESS OFFICE conclude on Thursday, May 23, at 6:00 p.m. The Convention Center Located in Rooms 105 A/B, Street Level, Convention Center. will serve as the "hub" for all shuttle bus routes. A detailed Shuttle Bus Hours of operation: Saturday, May 18, 12 noon-5:00 p.m.; Sunday- Services Schedule will be included in each registration packet and posted Wednesday, May 19-22, 8:00 a.m.-6:00 p.m.; and Thursday, May 23, in the lobbies of participating hotels. Refer to the city map on page XII 8:00 a.m.-12 noon. for the location of hotels in relation to the Convention Center. . The Press Office is for the use of registered press only. All Annual Meeting sessions are open to the press except CME Courses, the Business Meeting, Clinical and Continuous Clinical Case EXHIBITS Conferences, and Master Educator Clinical Consultations. Commercial and educational exhibits are located in Exhibit Halls A-C, Level 200, Convention Center, along with the Publishers' Bookfair and DAILY BULLETIN the APA Resource Center. As a convenience to registrants, the APA The Daily Bulletin accepts written requests from APA members for Resource Center will open on Saturday, May 18, 10:00 a.m.-5:00 p.m., publicity of component, committee, and allied group events as space and the Publishers' Bookfair will open on Saturday, May 18, 11:00 a.m.- allows. Four issues are published. The issue for Saturday/Sunday is 5:00 p.m. Hours for commercial and educational exhibits: Sunday, May printed in advance. Copy for the Monday, Tuesday, and 19,11:00 a.m.-4:30 p.m.; Monday and Tuesday, May 20-21,10:00 Wednesday/Thursday issues can be dropped off in Room 310, Level a.m.-6:00 p.m., and Wednesday, May 22, 10:00 a.m.-3:00 p.m. All 300, by 12 noon prior to the date of publication. exhibits will close on Wednesday, May 22 at 3:00 p.m. Please refer to the APA Exhibits Guide for additional information on participating CENTER FOR INTERNATIONAL GUESTS companies. APA periodicals will be located in the APPI Bookstore. Bienvenidos, Wilkommen, Bienvenue, Welcome! Located in the Commonwealth Hall, Second Floor, Loews. Hours INFORMATION/LOCATOR CENTER of operation: Saturday, May 18, through Wednesday, May 22, 8:00 a.m.- Located in the Lobby, Street Level, Convention Center and staffed 6:00 p.m.; and Thursday, May 23, from 8:00 a.m.-3:00 p.m. All during registration hours. Up-to-date general information about the international visitors are invited. These activities are supported by program, component meetings, the local area, and the locations of Pfizer Pharmaceuticals Group. various activities and events can be obtained there. Meeting participants also can find out where colleagues who are registered for the meeting are staying. II WOMEN'S RESOURCE CENTER One-Day Exhibit Hall Only Pass (18 and older) 10.00 Located in Room 303A, Level 300, Convention Center. Hours of On-site fees can be paid by cash, check, money order, American operation: Sunday, May 19, through Monday, May 20,7:00 a.m.-5:00 p.m. Express, VISA or MasterCard. Registration fees are waived only for Meet and network with other women psychiatrists and peruse materials CME Course Faculty, APA Honorary or Distinguished Fellows (does not on women's programs offered by APA and other organizations. Special include APA Life Fellows or Fellows), medical students (with proper events will include an informal session for women on passing the identification), District Branch Executive Staff (who are not APA boards, a meeting of the women's mentoring network, and a networking members), active members of the Association of Mental Health Clergy meeting for District Branch committees on women. The Center is (with proper identification), and nonmember program participants (only funded by an unrestricted educational grant from Wyeth for the day(s) they present). Pharmaceuticals. NONMEMBER PSYCHIATRIC RESIDENTS AND OTHER FULL-TIME STUDENTS must present documentation of their IMG HOSPITALITY CENTER qualifications to register in their respective category and qualify for Located in Room 303A, Level 300, Convention Center. Hours of the reduced fee. (Examples include: a valid full-time [12 + hours per operation: Tuesday, May 21, through Wednesday, May 22, 8:00 a.m.-6:00 semester] student ID; a letter from your instructor or director of p.m. Stop by the Center to meet and network with your colleagues. training verifying your status as a psychiatric resident; or similar From 12 noon-l:30 p.m. both days, there will be informal sessions on documentation.) "Acculturation, Language: Problems and Solutions for IMGs and Note: There are no exemptions or reduced fees available for ECFMGs: Friend or Foe?" CME courses. The registration fee covers admission to all sessions (except courses), shuttle buses, and includes a badge and copy of the BUSINESS CENTERS Program Book, APA Exhibits Guide, and New Research Program and Convention Center Abstracts Books, and for most categories, a copy of the Syllabus. Location: Between Exhibit Halls B & C NAME BADGES Times of operation: Monday-Sunday, 8:00 a.m.-6:00 p.m. Badges are required for all sessions including the Opening Session and exhibit area. Only an APA member badge will admit you to the Loews Business Meeting. Location: 3rd Floor Badge Color Codes: Blue-Members, Yellow-Nonmembers, Times of operation: Monday-Friday, 6:30 a.m.-9:00 p.m. Silver-Press, Red-Exhibitors, Green-APA Staff, and Black-Temporary Saturday-Sunday, 8:00 a.m.-5:00 p.m. Convention Personnel.

Marriott - Kinkos CME COURSE ENROLLMENT Location: Main Level, Market Street Exit Times of operation: open 24 hours TICKET PURCHASE REQUIRED FOR CME COURSES REGISTRATION Located in Exhibit Halls A-C, Level 200, Convention Center. Hours of operation: Saturday, May 18, 10:00 a.m.-5:00 p.m.; Sunday, May 19, ADMISSION TO ALL SESSIONS BY REGISTRATION BADGE Located in Exhibit Halls A-C, Level 200, Convention Center. Hours 7:30 a.m.-5:00 p.m.; Monday through Tuesday, May 20-21, 7:30 of operation: Saturday, May 18,10:00 a.m.-5:00 p.m.; Sunday, May 19, a.m.-6:00 p.m.; Wednesday, May 22, 7:30 a.m.-5:00 p.m.; and 7:30 a.m.-5:00 p.m.; Monday-Tuesday, May 20-21, 7:30 a.m.-6:00 p.m.; Thursday, May 23, 7:30 a.m.-2:00 p.m. Tickets for CME Courses not Wednesday, May 22, 7:30 a.m.-5:00 p.m.; and Thursday, May 23, 7:30 sold by April 13 will be on sale to all registrants beginning at 10:00 a.m.-2:00 p.m. a.m. on Saturday, May 18. You must show your registration badge before you can enroll in courses. On-Site Registration Fee Schedule: APA ART ASSOCIATION APA MEMBERS Located in the APA Resource Center and staffed during the Resource Center's hours. The exhibit includes paintings, Full-Time Registration (North American Members) ...... $235.00 photography, ceramics, and crafts done by APA members and/or Full-Time Registration (International Members) ...... $500.00 Members-in-Training (Member Class MT) ...... $ 70.00 their significant others. Please stop by the exhibit for information on Daily Registration (North American Members) ...... $120.00 joining the APA Art Association. Daily Registration (International Members) ...... $255.00 APA AUXILIARY BOOTH Medical Students no charge Located on the Bridge, Level 200, Convention Center. Hours of operation: Saturday, May 18, through Wednesday, May 22, 9:00 a.m.- NONMEMBERS 5:00 p.m. Stop by the booth to obtain information on the Auxiliary's Full-Time Registration ...... $710.00 program schedule and information on membership. Nonmember Residents, Students, Advocacy Group Members or Mental Health Chaplains ...... 90.00 APA PERIODICALS Daily Registration (all "Nonmember"categories) ...... 360.00 Complimentary copies of the latest issues of American Journal of Medical Students no charge Psychiatry, Psychiatric Services, Psychiatric News, Academic Psychiatry, the American Journal of Geriatric Psychiatry, the Journal of GUEST REGISTRA TION Neuropsychiatry, and Psychosomatics may be obtained at the One only per full-time registrant ...... 95.00 APA/APPI Periodicals Exhibit in the APA Resource Center. Staff Only one guest is allowed to register with each full-time meeting will sell discounted subscriptions to all APA/APPI journals and registrant. The guest must reside in the same household and be able to demonstrate online access for subscribers. They will also show authors receive mail at the same address. APA members cannot register as a and reviewers how to use Manuscript Central, the new Web-based "guest"; they must register as an APA member. (Continued on next page) III manuscript submission and review system. Staff of the American Journal receive a parchment Certificate of Attendance at the Annual Meeting of Psychiatry and Psychiatric Services will be available to answer authors' by returning your completed form (to the Annual Meetings Office, questions. Persons who wish to contact editors or reporters of Information/Locator Center, or APA Resource Center, all located in Psychiatric News are asked to leave a message on the message board in the the Convention Center) or by completing the computerized general Annual Meetings Office, Room 304, Level 300, Convention Center. evaluation in the APA Resource Center. Written announcements, suggestions for articles, letters to the editor, or other material for the newspaper's consideration may be left with staff SESSION CAPACITY at the Periodicals Exhibit. We expect "sell out" attendance for many of the scientific sessions. So that all in attendance may benefit, we ask your assistance when AUDIOTAPES overcrowding occurs: * Please find seating as far forward as possible. Audiotapes of most sessions are available shortly after each session * Move to the center of the row and fill all seats so that chairs are concludes and may be purchased at the Mobiltape Booth located-on the available on aisles for additional attendees. Bridge, Level 200, in the Convention Center. * Store materials under chairs to maximize seating capacity. * Overcrowding of meeting rooms may subject the session to CONTINUING MEDICAL EDUCATION shutdown by the Fire Marshal; therefore, we urge all attendees to The APA is accredited by the Accreditation Council for Continuing locate seating rather than stand in aisles or against walls. Medical Education (ACCME) to provide continuing medical education * If space does not permit you to attend a session, an audiotape of for physicians. that session may be available. Please check the order form The APA designates this educational activity for up to 66 hours in included in your registration packet. Category 1 credit towards the AMA Physician's Recognition Award Thank you for your cooperation. and for the CME requirement of the APA. Each physician should claim only those hours of credit that he/she actually spent in the educational TAPE RECORDING AND VISUAL activity. Please note: Most portions of the scientific program, as outlined REPRODUCTION POLICIES below, have been approved for CME credit. The scientific sessions of Audiotape recording is only permitted for personal use and by the official Annual Meeting program, with some exceptions, meet the members of the media. Registrants are welcome to use their own criteria for Category 1 CME credit. Sessions in the following program small, portable audiotape recorders to record any session except the formats are designated as Category 1: Advances in Psychopharmacology, Master Educator Clinical Consultations, Clinical Case Advances in Research, Clinical Case and Continuous Clinical Case Conferences, and the Continuous Clinical Case Conference, or Conferences, CME Courses, Forums, Industry-Supported Symposia, unless prohibited by the presenters. Larger professional tape most Lectures, some Media Sessions, Medical Updates, New Research recorders, however, are not permitted other than those utilized by Oral/Slide Sessions, Research Advances in Medicine, the Presidential members of the media and personnel representing the professional Symposium, Review of Psychiatry, Scientific and Clinical Reports, taping firm authorized by APA to audiotape sessions. The badges of Symposia, Telecommunication sessions, and Workshops. Other program personnel representing this firm and members of the media will activities may be considered Category 2: Debate, Discussion Groups, clearly identify them. Non-media registrants are not permitted to Master Educator Clinical Consultations, New Research Poster Sessions, Research Consultations With, Round Table Discussion, and some Media videotape any session because the intrusive nature of the recording Sessions, and Lectures. Scientific sessions are open to all Annual may disrupt the session. More detailed guidelines for media Meeting registrants, except for the Clinical Case and Continuous representatives may be obtained in the Press Office. Clinical Case Conferences and the Master Educator Clinical Consultations, which are open to APA members only. SMOKING POLICY Please note: APA members are required to maintain their own There will be NO SMOKING in scientific records of CME hours. Reporting of CME credit is on an honor sessions or in the exhibit hall. Smoking will only be basis. permitted in designated areas. To document CME credit earned at the Annual Meeting, participants should record the sessions they attended on the Certificate of Attendance log sheet found in the front of the 2002 Annual Meeting CHILD CARE SERVICE CME Syllabus & Proceedings Summary Book. Credit is earned on an ACCENT in Children's Arrangements, Inc., the official youth program hour-for-hour basis. A parchment Certificate of Attendance is also provider for APA, has planned an exciting on-site children's activity available. program called Camp APA. Camp APA offers both parents and their The Certificate of Attendance (or copy) may be forwarded to other children a safe, nurturing, and positive experience. ACCENT'S organizations requiring verification of participation in the APA Annual professional, specially-trained supervisors are certified in both CPR Meeting. and pediatric first aid. The ACCENT staff is comprised of teachers, The APA requires members to participate in a total of 150 hours of professional childcare providers, and mothers who simply love working CME activities within a three-year reporting period. At least 60 hours with children and have completed ACCENT'S specialized training must be in Category 1 activities. program. Camp APA is headquartered at the Loews Philadelphia CME report forms may be obtained from the Department of CME at Hotel for the exclusive use of APA registrants and their families. the APA. Staff will be available in the APA Resource Center to answer Children aged six months to 17 years are welcome and will be any of your questions about CME. provided with developmentally appropriate programs designed specifically for their age group. Activities will take place on site for all ANNUAL MEETING EVALUATION children younger than six years old. The older children will enjoy arts The Annual Meeting Scientific Program Committee needs your and crafts projects, active games, and much more. Field Trips will recommendations and evaluations to plan next year's Annual Meeting. depart and return to the on-site Camp APA Activity Center each day. A participant evaluation form is enclosed with your registration packet ACCENT provides an exceptional caregiver to child ratio: 1:2 for and includes instructions for completing the form. BEFORE YOU children 6-12 months; 1:3 for children 13-36 months; 1:5 for children LEAVE THE MEETING, PLEASE COMPLETE YOUR FORM 3-12 years; and 1:8 for children 12 years and older. Please complete AND DROP IT IN ONE OF THE EVALUATION BOXES the Registration Form to participate in this great opportunity. If you LOCATED THROUGHOUT THE MEETING SITES. You can have any questions, please e-mail us at [email protected].

IV GUIDE TO THE PROGRAM BOOK FUTURE APA MEETINGS Below, you will find the table of contents for ease in locating APA ANNUAL MEETINGS information about this meeting. A topic index is included to assist you 2003 May 17-22 San Francisco, CA with finding sessions of interest. The individual program for each day's 2004 May 1-6 New York, NY sessions is listed by start time with the formats listed alphabetically 2005 May 21-26 Atlanta, GA under those times. NOTE: To make it easier for you to plan your day, we have prepared a separate "Days-at-a-Glance," which is included in your registration packet. APA CLINICAL MEETINGS If you have any questions about this book or the scientific sessions, THE INSTITUTE ON PSYCHIATRIC SERVICES please feel free to stop by the Annual Meetings Office in the 2002 October 9-13 Chicago, IL Convention Center, and we will be glad to help you. Also, all central 2003 October 29-Nov. 2 Boston, MA office APA staff members will be wearing green ribbons on their 2004 October 6-10 Atlanta, GA badges. Please feel free to direct your questions to them. 2005 October 5-9 San Diego, CA

Tentative program schedules and hotel information for the 2002 Institute on Psychiatric Services are available at the Information/Locator Center, located on the Street Level, Convention Center.

TABLE OF CONTENTS Moor Plans for Convention Center, Loews, Marriott, and NVyndham VJ-XII City Map Xin Special Acitnou'ledgmenis ...XIV-XV Format Descriptions XVI-XVII Disclosure Inlornution XVIE-XXX Saturday Sessions 1-3 A'.idiot ape Sales Information 4 Sunday Sessions 5-12 N'onday Sessions 13-36 Tuesday Sessions 37-64 Wednesday Sessions 65-86 Thursday Sessions 87-98 Topic Index 99-112 Participant Index 113-123 American Psychiatric Publishing Inc. 124-125 Call for 2C03 Annual Meeting Papers 126 Industry-Supported Symposia... 127-151 2 DO 2 Institute on Psychiatric Services !52 APA Resource Center Back Cover

Refer lo the APA Exhibits Guide for information on: Inhibits, Publishers' Bookfair. Hospitality Lounge, and Dining I'-ici-iiies in the Convention Center.

j JL* .rEtvrr. ir. ->r pr"-. .4(?.i *:.J v—wi rxijrr^v.i ^L. fV'Lwr.lr:t .>r. [:r:> pri'^r^n". irc> rii'> nr^ '. iu.nl V :b.(Mt of :hf Ar'.mL-an ?WL hiA::^ A vie-; nt ion. nor dort ',[:: Arrrr mr, :V . :i.;'.;>/ ,*,^r. ^•jri;n' • h.' .I.VI.T-. ^ :-' iT'.y .r]onr.4i-^ rrpc.".jM

EAmr:iCin PiychuiriL Asso<:i.u:on.

V Convention Center One Convention Place, 1101 Arch Street 215-418-4700

Street Level

VI Convention Center Level 200

VII Loews 1200 Market Street 215-627-1200

VIII Loews

IX Marriott 1201 Market Street 215-62572900-1200 Level 3

X Marriott Level 4

33,000-SQUARE-FOOT FRANKLIN HALL ACCOMMODATES 165-8' X 10' OR 10' X 10' BOOTHS; 9.5'-!4,5* CEILING HEIGHT. Level 5

XI Wyndham 17th & Race Streets 215-448-2000

XII Philadelphia City Map

XIII SPECIAL ACKNOWLEDGMENTS

The American Psychiatric Association expresies us deep appreciation :or the following:

Abbott Laboratories: support of the Industry-Sup ported Symposia. Ccphalon Inc.: support o: the Industry-Supported Symposium, "Diagnosis and Treatment Issues in Cbild and Adolescent B:polir "Identiticaticn and Management o; Daytime hatigue and Sleepiness in Disorders," Sunday, May 19, 8:30 a.m ; "New Developments in the Pivchutry," Wednesday, Mav 22, 7:M p.m. Treatment of Bipolar Disorder," Sunday, May 19, 7:30 p.m.; and suppon oi the In dun ry-Supported Breakfast Svmposia. "Tke Cyheromci, Inc.: support of the Industry-Supported Symposium, Pathophysiology and Treatment of Impulsiviiv and Aggression in "Long-Term MAnageraeat of Mood Disorders." Sundav, May 19, I:HC 1 Psychiatric Disorders," Wednesday. May 22 and Thursday, May 2>T 7:00 p.m. a.m Eisai Inc., Pfizer Inc.: support o: the InduHrv-Supported Symposia, American Academy of Psychiatry and the Law: co-support of the "Psychiatry PractiL-e Par.idigm: The Emerging Role c>l the Psychiaiim Manfred S. Gumnacher Award Lecture, Sunday, May 19, 2;30 p.m. in Trca'ing Alzheimer's Disease," Saturdav, Mav IK, ^:K' p m ; ^nd "F.xplo rat ions in Dementia: New and Current Perspectives," American Association of Psychiatric Administrators: co-suppcrt o:" Wednesday, Mav 22, 7:K p.m. the Administrative Psychiatry Award Lecture, Thursday, May 23, 9:00 a.m. Eli Lilly and Company: suppon ol the Industrv-Suppartea Symposia, "New Approaches for Treating ADHD: The Whole-Lite Perspcaive," Amerittn Psychiatric Foundation: co-support of the APA Award for SiturdiV, May 18, 7:OC p.m.; "Treating Psychotic Illness Across the Life Research m Psychiatry; support of the Disaster Psychiatry Fellowship; Span: Are Dmgi Enough?" Sundav. May 19. S K a.m.; "Primary Mood and support of the APIRE Practice Research Network (PR.V). Stabilizers as the Cornerstone ot Treatment for Bipolar Disordfr," Sunday. MJV 19, 7:00 p.m.; "Clinical Differences in Serotonin and Association of Mental Health Clergy: co-support of the Oskar Pfi'ie.- Norepineprirme Antidepressanl Lltecls." Tuesdav. Mav 21, 7:00 p.m ; Aw*rd Lecture, Wednesday, May 22, 9:00 a.m. support of the Industry-Supported Breakiasi Symposia, "One Size Doein t Fit All: Depression Thr:jpi« tor the 21sl-Centu.-v." Mondjy, Association of Women Psychiatrists: support of the joint AWTVAPA M.iy 20 and Tuesday, May 21. ~:C-C a.m., "TherapcuLi: Challenges, Women's Career reception and meeting. Novel Approaches: AntipsvtLotics in the Minigcment ot Mood and Anxiety Disorders," Wednesday, May 22 and Thursday, May 2?, ?:OC AstraZeneca Pharmaceuticals: support of the Industry-Supported am.; the APA/I-Jiy Resideni Research Awards; pan.ial support oi the Symposia, "Customizing Care for Patients with Bipolar Disorder." .Vfif RtfejrchAifs:riic[i and .Yen1 Rruarch Progrun Bcok< \ and suppon Sundav, May 19, 1:33 p.m.; "Molecules of the Mind. The Science of or the Daniel Freedman Congreisional Fellowship Schizophrenia," Sunday, May 19, 7:00 p.m.; "The Burden oi Schizophrenia: Why Patients Don't Get Beticr," Wednesday, May 22. Lsiate of Kun-Po Soo, M.D., Ph.D.: supper, of the K.un-Po Soo 7:00 p.m.; the Industry-Supponed Breakfast Symposia, * AnlipiychotfC Award Lecture, Wedncidav, Mav 22: ll:OCa.m Phannacotherapy and tic HippooMtic Oath; Above All Do No Harm," Monday, May 2C and Tuesday. May 21, 7:00 a.m.; the George Tanan Estate of Agnes Purcell McGavin: suppon ci the- Agnes Purceil Award Lecture. Monday, May 20, 9:00 a.m.: the A PA/AstraZeneca McGivin Awards in child arid jdcilescen: p?VLh:air,r Fellowship and reception, Tuesday, May 21, 7;OQ p.m., and support ot the American Psychiatric Foundation "Conversations" event, Tuesdav, Forest Laboratories, Inc.: suppon of ihr Industry-Supported May 21, 5:30 p.m. Svmpoiia, "Molecules and Mood Disorders: Drug Discovery and ihe 'I realm em of Depression," Saturday, May 18. 7:CC p m.; "Lite-Life Aventis: suppon of the Travel Fellowship for Women Resident Leaders Depression: Old Myths and New Dili." Sundav, Mav 19, 8.K a.m.; ind in Psychiatry and Leadership Luncheon, Sunday, May 19. 12:CC p m. "Noncliolinergic Treatments :or Alzheimer i Disease: Present Knowledge. Future Hope," Wednesday. Mav 22, 7;K p.m Bristol-Myers Squibb: support of the Industry-Supported Symposia. "Advances in the Treatment of Psychosis: Minimizing ihe Burden of GlaxoSmithKline: suppon ol the Industry-Supponed Syraposu, Disease," Sunday, May 19, 8:K a.m.; "Challenges and Opportunities in "Bipolar Disorder: New Nat:onwide Dst.i on Mitdiagnosis and the Management of Psychotic Disorders." Sunday, May 19, IJO p.m.; Community Cosvts," Saturday. May IS 7:00 p.m ; "Recent the Indus try-Supported Breakfast Symposia, "Novel Antipsythotic Devrlopmenti in the Science and Treatment (>! P'i'SD," Sunday, May Drugs: Advances in the Treatment of Psychotic Spectrum Disorders," 19, 1:10 p.m.. "BipoLr Depression ind Rapid CvL-'lirig; Current Monday, May 2C and Tuesday, May 21, 7;OC a.m.; ihf Solomon Carter Management S-.rategies," Tuesdar. Mav 2i. 7:OC p.m.: "The New Fuller Award Reception; and the shuttle bus system. N euro biology ol Mood and Aruti^tv Disorders." Tuesday. Mav 21, 7:00 p.m.; the Industry-Supported Breakfast Symposia, "Clmical Challenges Center for Mental Health Services: sponsorship of the APA/CMI IS in Depression," Monday, ^[iv 2C and Ti;csday, May 21. 7-00 a.m.; Minority Fellowship Program; support of the APIRE Practice Research "CChronic Fpisodic Disorders: Comorbiditv and Comprelieniivr Network (PRN); suppon of the special Annual Meeting series "Access Integr.ited Treatment," Wednesday, May 22 and Thursdav, Mav 23, 7:00 ID Quality Care: What Really Works?" and training activities of ihe a.m.: die APA/Gla\oSrnnhKJine Fellowship Program: the annual AIDS Kducation Proiect, contribution to ihe APA Presidential Fund, the APA-'GlaxoSmitliKline Young Faruhy Award ;or Research Devclopmen; in Biological Center far Abuse Prevention: support of the special Annual Meeting PiVchiairv; and the rcgiilrilion poitlolios series "Access to Quality Care: What Really Works?" Harding Foundalion: co-support o: the Oskar Pfirter A^ard Lea tire. Center for SubiUncc Abuse Treatment: suppon of tiie APIRE Wediu-jdjv. Ma\' 22. 9:00 a.m". Practite Research Network (PRN); and suppon oi the ipr^al Annui! Meeting series "Access to Quality Care: What Rrailv Works" XIV SPECIAL ACKNOWLEDGMENTS

Ittleson Foundation, Inc.: support of the Blanche F. Ittleson Award Pfizer Inc.: support of the Industry-Supported Symposia, "Improving for Research in Child Psychiatry. Patient Outcomes Across the Spectrum of Bipolar Disorder," Saturday, May 18, 7:00 p.m.; "Treatment of Anxiety Disorders: Where Are We, Janssen Pharmaceutica and Research Foundation: support of the and Where Are We Going?" Sunday, May 19, 7:00.p.m.; "Raising Industry-Supported Symposia, "Antipsychotic Therapy and Expectations in Schizophrenia: Enhancing Long-Term Outcomes," Cardiovascular Disease: The Unfolding Story," Saturday, May 18, 7:00 Tuesday, May 21, 7:00 p.m.; the Industry-Supported Breakfast p.m.; "The Adherence Challenge: Chronic Issues and Emerging Symposia, "Age, Gender, and Diagnosis: Influences on Drug Response," Solutions with Antipsychotic Therapy," Sunday, May 19, 1:30 p.m.; Wednesday, May 22 and Thursday, May 23, 7:00.a.m.; the Residents' "Managing Aggression Across the Life Span: From the Pediatric to the Session, "Meet the Experts: Sunny-Side Up," Monday, May 20, 7:00 Geriatric Patient," Tuesday, May 21,7:00 p.m.; the Industry-Supported a.m.; the "Abstracts-On-Disk" Program; and the APA Daily Bulletin Breakfast Symposia, "Breaking the Silence of Children's Mental Illness: newspaper. National Initiatives, Early Detection, and New Pharmacotherapies," Monday, May 20 and Tuesday, May 21, 7:00 a.m.; "New Perspectives The Pfizer Pharmaceuticals Group: support of the International on Schizophrenia Spectrum Disorders and Their Treatment," Hospitality Suite, a daily visitor center for international delegates. Wednesday, May 22 and Thursday, May 23,7:00 a.m.; the reception for Kun-Po Soo Award recipients, Wednesday, May 22; and the American The Psychiatrist's Program, The APA-Endorsed Professional Psychiatric Institute for Research and Education/Janssen Research Liability Insurance Program: support of the ECP luncheon, Tuesday, Scholars on Severe Mental Illness Program. May 21,12:00 p.m.

Johnson & Johnson: support of the International Leadership Dinner, Roche Laboratories, a member of the Roche Group: support of the Wednesday, May 22, 7:00 p.m. Benjamin Rush Award Lecture, Tuesday, May 21, 9:00 a.m.

Lilly Research Laboratories, a division of Eli Lilly & Company: Sanofi-Synthelabo, Inc.: support of the Residents, Medical Student, support of the APA/Lilly Psychiatric Research Fellowship. and Training Directors Luncheon, Tuesday, May 21,12:00 p.m.

Merck & Co., Inc.: support of the William C. Menninger Memorial Sepracor, Inc: support of the Industry-Supported Symposium, "Sleep Convocation Lecture, Monday, May 20, 6:00 p.m.; and an unrestricted Disorders and Psychiatric Illnesses: Scientific Foundations," Wednesday, educational grant in support of various scientific sessions. May 22, 7:00 p.m.

National Institute of Mental Health: co-support of the AP A/NIMH Shire US, Inc.: support of the Industry-Supported Symposium, "Adult Vestermark Psychiatry Educator Award Lecture, Tuesday, May 21, ADHD: From Research to Clinical Practice," Wednesday, May 22,7:00 11:00 a.m.; American Psychiatric Institute for Research and Education p.m. Annual Meeting activities for research trainees; and the Program for Minority Research Training in Psychiatry (PMRTP). Solvay Pharmaceuticals, Inc.: "Treating Fear: Perspectives on the Biology and Therapy of Anxiety Disorders," Tuesday, May 21, 7:00 National Institute on Drug Abuse: support of the American p.m.; and the beverage service in the exhibit hall. Psychiatric Institute for Research and Education/Research Training activities and the Drug Abuse Research Scholars in Psychiatry Program Somerset Pharmaceuticals, Inc.: support of the Industry-Supported (DARSPP). Symposium, "Atypical Depression: Overview and New Developments," Sunday, May 19, 7:00 p.m. Novartis Pharmaceuticals Corporation: support of the Industry- Supported Symposium, "Behavioral Disturbances in Dementia: Substance Abuse and Mental Health Services Administration: Diagnostic and Treatment Guidelines," Tuesday, May 21, 7:00 p.m. support of the special Annual Meeting series "Access to Quality Care: What Really Works?" Organon Inc.: support of the Industry-Supported Symposia, "Depressive Subtypes: The Multiple Faces of Depression," Sunday, May Wyeth Pharmaceuticals: support of the Industry-Supported Symposia, 19, 8:00 a.m.; and "The Aging Brain and Vulnerability to Depression," "Recovery from Depression: New Perspectives to Improve Outcomes," Sunday, May 19, 1:30 p.m. Sunday, May 19, 8:00 a.m.; "Treatment of Mood and Anxiety Disorders in Women: What Is Evidence and What Is Art?" Sunday, May 19,7:00 Ortho-McNeil Pharmaceuticals: support of the Industry-Supported p.m.; the Industry-Supported Breakfast Symposia, "Understanding Sleep Symposium, "Advances in the Understanding and Treatment of Binge- Medicine: What the Psychiatrist Needs to Know," Monday, May 20 and Eating Disorder," Wednesday, May 22, 7:00 p.m. Tuesday, May 21, 7:00 a.m.; the APA/Wyeth Pharmaceuticals M.D./Ph.D. Psychiatric Research Fellowship; the Women's Resource Professional Risk Management Services, Inc.: co-support of the Center and Display; the IMG Hospitality Suite; the Alexandra Symonds Manfred S. Guttmacher Award Lecture, Sunday, May 19, 2:30 p.m. Award Lecture, Tuesday, May 21,2:00 p.m.; the Jeanne Spurlock, M.D. Congressional Fellowship; and the daily in-house TV program, "APA News Network."

XV FORMAT DESCRIPTIONS

ADVANCES IN PSYCHOPHARMACOLOGY FORUMS This three-and-one-half hour session will summarize important These are flexible presentations that afford an opportunity to high- new clinical and research findings in the field of psychopharma- light and select topics that are of timely interest to psychiatrists. cology, based in part, on material contained in the American Psy- Speakers and panel members are chosen for their expertise and chiatric Publishing Textbook of Psychopharmacology, Second Edition. leadership in the field. Authors of selected chapters from the textbook will present mate- rial from the chapters. The topics were selected by the editors to LECTURES represent areas of clinical psychopharmacology of greatest impor- Lectures feature a small number of distinguished speakers discuss- tance to APA members. ing scientific and cultural topics, many of which will extend our understanding beyond the usual limits of clinical psychiatry. The ADVANCES IN RESEARCH Scientific Program Committee invites the lecturers. This two-hour session is traditionally chaired by the Chairperson of the Council on Research and co-chaired by the Chairperson of MASTER EDUCATOR CLINICAL the Scientific Program Committee. After a brief overview of ma- CONSULTATIONS jor advances in research in psychiatry and a preview of selected These 90-minute, clinically-based seminars are presented by out- research presentations scheduled at the Annual Meeting, leading standing educators. Formats and subject matter will vary, but all clinical researchers present the latest developments in four differ- will utilize clinical material offered by participants. These sessions ent, clinically-relevant areas of research. are limited to 25 participants on a first-come, first-served basis. THESE SESSIONS ARE OPEN TO APA MEMBERS ONLY. CLINICAL CASE CONFERENCES BLUE REGISTRATION BADGE OR APA MEMBERSHIP During these 90-minute sessions, clinical material is presented by CARD REQUIRED FOR ADMITTANCE. videotape or the treating therapist. One or more experts then discuss the case. THESE SESSIONS ARE OPEN TO APA MEDIA SESSIONS MEMBERS ONLY. BLUE REGISTRATION BADGE OR In these sessions, a videotape of educational value is shown. Video- APA MEMBERSHIP CARD REQUIRED FOR tapes may illustrate innovation in: patient assessment, diagnosis, ADMITTANCE. treatment, and education; practice management, medical records, information systems, and research; professional education; public CONTINUOUS CLINICAL CASE CONFERENCES awareness and education; psychiatric interpretations of meaning in The presenters will review the progress of psychotherapy in two media; assessment of the biopsychosocial effects of media on indi- successive three-hour sessions on consecutive days (Monday- viduals; social/cultural issues and mental health/illness; and the Tuesday and Wednesday-Thursday, beginning at 9:00 a.m.). Audi- human spirit as seen in the arts and humanities. ence participation will be encouraged throughout. Participants are requested to attend both sessions in their entirety. THESE MEDICAL UPDATES SESSIONS ARE OPEN TO APA MEMBERS ONLY. BLUE These 90-minute sessions are designed to provide psychiatrists with REGISTRATION BADGE OR APA MEMBERSHIP CARD the latest clinical developments in other areas of medicine. Topics REQUIRED FOR ADMITTANCE. may range from subspecialty areas of adult or pediatric medicine (infectious disease, cardiology, gastroenterology, etc.) to new tech- COURSES niques or procedures in surgery or radiology. The interface be- Courses are designed to emphasize learning experiences that ac- tween psychiatry and these areas is not necessarily emphasized. tively involve participants and include the opportunity for infor- The intent is to give participants an update from a physician in a mal exchange with the faculty. Offered in four-hour (half-day) and particular specialty. six-hour (full-day) sessions, courses either review basic concepts in a special subject area or present advanced material on a circum- NEW RESEARCH scribed topic. Enrollment is limited, and participants must pur- This format allows for presentation of the very recent findings chase tickets to attend. obtained from ongoing research. The three types of presentations include: Posters, which are visual, self-explanatory presentations; DEBATE and Young Investigators' Posters, with presentations from young Experts in the field, including psychiatrists and nonpsychiatrists, investigators, residents, medical students, and research or clinical will debate a controversial topic in psychiatry. The debate format fellows; and Young Investigators' Oral/Slide which are fifteen- allows for members to hear both pro and con views about impor- minute presentations with three minutes for discussion. tant, interesting and timely concerns for our members. Someone who has expertise in the topic area moderates the debate. A por- RESEARCH ADVANCES IN MEDICINE tion of the time is allocated for questions from the audience to the This two-hour format presents an overview of cutting-edge research presenters with active participation by participants. in various aspects of medicine. In contrast to the Medical Update series, which is more clinically focused, this session will help par- DISCUSSION GROUPS ticipants keep pace with the rapidly expanding knowledge base and This 90-minute format allows small groups to meet informally technology in various branches of medicine. Several speakers, with selected experts in psychiatry to discuss topics chosen by the authorities in their fields, will present on their topics. experts. Some of these are reserved for residents only. These ses- sions are limited to 25 participants on a first-come, first-served basis.

XVI FORMAT DESCRIPTIONS

RESEARCH CONSULTATIONS WITH TELECOMMUNICATION SESSIONS This 90-minute format provides an opportunity, in a small group These three-hour sessions are presented in a computer software setting, for participants to obtain consultations around problems demonstration format (i.e., on computer and LCD projector pro- in research from outstanding senior researchers. Participants vided for projection on a large screen). Topic areas include telepsy- should come prepared to present a specific problem in research, chiatry, virtual reality, internet, electronic medical records, and whether it's one of research design, methodology, subject selection information technology. or data analysis, etc., which could be presented briefly to the con- sultant. These sessions are limited to 25 participants on a first- SYMPOSIA come, first-served basis. Symposia are three-hour sessions consisting of four to six presenta- tions that are thematically linked and focus on a specific topic rele- REVIEW OF PSYCHIATRY vant to clinical psychiatry. They are designed to provide compre- There will be four, three-and-one-half hour sessions presented, hensive treatment of a topic or discussion of the topic from several based on the annual American Psychiatric Press Review of Psy- points of view by the participants and stimulate discussion with the chiatry Series. Each session includes an abridged presentation by audience. Some symposia are supported by industry and are desig- the senior author from each of the chapters in each volume. The nated as "Industry-Supported Symposium" in this Program Book. topics were selected by the overall editors of the series to represent current areas of new research, new developments in clinical care, WORKSHOPS and special issues of importance to APA members. Workshops are 90-minute sessions, which typically involve brief ROUNDTABLE presentations from individual panel members, followed by the op- This 90-minute format is designed to establish a dialogue between portunity for lively and informative discussion. This format pro- psychiatrists and other citizens about controversial issues of special vides for substantial audience participation and should be highly interest to our profession. The moderator presents a panel of ex- interactive. perts with hypothetical scenarios that highlight controversial and problematic situations with which psychiatrists interface.

SCIENTIFIC AND CLINICAL REPORT SESSIONS Scientific and Clinical Reports are oral presentations of papers prepared for submission before publication. In this 90-minute format, reports are grouped by topic, with floor discussion from the audience following the presentation of each paper. There is no formal discussant.

XVII AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE

The American Psychiatric Association requires disclosure by presenters at CME activities of any significant financial or other affiliation with commercial goods/organization(s) that may have a direct or indirect interest in the subject matter of the scientific program. A "financial interest" may include, but is not limited to, being a shareholder in the organization; being on retainer with the organization; or having research or honoraria paid by the organization. An "affiliation" may include holding a position on an advisory committee or some other role or benefit to a supporting organization. The existence of such relationships does not necessarily constitute a conflict of interest, but the prospective audience must be informed of the presenter's affiliation with every commercial supporter by an acknowledgement in the printed program and oral or visual disclosure to participants at the session (disclosure by slide or overhead is required if audiovisual equipment is used for the presentation). This policy is intended to openly identify any potential conflicts) so that members of the audience in an educational activity are able to form their own judgments about the presentation. The APA also requires oral disclosure of discussion of unapproved uses of a commercial product or investigational use of a product not yet approved for this purpose.

The following presenters have indicated a significant financial interest or other affiliation with a commercial supporter of the session and/or with the manufacturer(s) of a commercial product(s) and/or provider of commercial service(s). The presenter's name, the manufacturer's name, and the page number(s) the presenter appears on in this Program Book are listed below:

Presenter Manufacturer(s) Program Page #

Gene G. Abel, M.D. Abel Screening, Inc. 67 Lenard A.Adler,M.D. Eli Lilly and Company; Alza Pharmaceuticals; GlaxoSmithKline 3 Hagop S. Akiskal, M.D. Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Abbott Laboratories 33, 56 George S. Alexopoulos, M.D. Forest Laboratories, Inc.; National Institute of Mental Health; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; GlaxoSmithKline; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation 5, 30 Albert J. Allen, M.D. Eli Lilly and Company (employer) 3 Anne Alonso, Ph.D. Eli Lilly and Company 6 Jonathan E. Alpert, M.D. Abbott Laboratories; Bristol-Myers Squibb; Cyberonics; Eli Lilly and Company; GlaxoSmithKline; Lichtwer Pharma; Novartis Pharmaceuticals Corporation; Organon Inc.; Pfizer Inc.; Pharmacia Corporation; Roche Laboratories, a member of the Roche Group; Sanofi Pharmaceuticals, Inc.; Solvay Pharmaceuticals, Inc.; Synthelabo; Wyeth Pharmaceuticals 61 Jay D. Amsterdam, M.D. Eli Lilly and Company; Somerset Pharmaceuticals, Inc.; Pfizer Inc.; Organon Inc.; Forest Laboratories, Inc.; Merck & Co., Inc.; Wyeth Pharmaceuticals; GlaxoSmithKline; Biopharm; Organon Inc. 96 Jose C. Appolinario, M.D. Knoll Pharmaceutical Company 32 Ralph Aquila, M.D. Eli Lilly and Company 6 Kimberry A. Arlinghaus, M.D. Pfizer Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Forest Laboratories, Inc.; Wyeth Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb; AstraZeneca Pharmaceuticals; Abbott Laboratories; Cephalon, Inc. 5 Jorge L. Armenteros, M.D. Janssen Pharmaceutica and Research Foundation 63 Peter M. Aupperle, M.D. Pfizer Inc.; Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation 7 Robert W. Baker, M.D. Eli Lilly and Company 24, 75 Benjamin H. K. Balderson, Ph.D. Group Health Cooperative (employer) 59 Richard Balon, M.D. Bristol-Myers Squibb; GlaxoSmithKline; Pfizer Inc.; Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, a division of Eli Lilly and Company; Forest Laboratories, Inc.; Parke-Davis, Division of Warner-Lambert Company; Organon Inc.; Solvay Pharmaceuticals, Inc.; Wyeth Pharmaceuticals; Merck & Co., Inc. 97 PaulJ.Barreira,M.D. Eli Lilly and Company 6 Gail M. Barton, M.D. Wyeth Pharmaceuticals 19 Mark S. Bauer, M.D. Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Solvay Pharmaceuticals, Inc. 59 Philip M. Becker, M.D. Cephalon, Inc. 49 Bernard D. Beitman, M.D. Pfizer Inc.; GlaxoSmithKline 8, 29 RuthM.Benca,M.D. Wyeth Pharmaceuticals; Cephalon, Inc.; Sanofi Pharmaceuticals, Inc.; National Institute of Mental Health; Merck & Co., Inc.; Sepracor, Inc. 85 Joseph Biederman, M.D. Shire U.S., Inc.; Gliatec, Inc.; Cephalon, Inc.; GlaxoSmithKline; Eh Lilly and Company; Alza Pharmaceuticals; Pfizer Inc.; Wyeth Pharmaceuticals 86 Bradley F. Boeve, M.D. Pfizer Inc.; Eisai Inc. 86 Howard E. Book, M.D. American Psychiatric Press Inc. 27, 50 Soo Borson, M.D. Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Forest Laboratories, Inc.; Wyeth Pharmaceuticals 63

XVIII DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Charles L. Bowden, M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; National Institute of Mental Health; Parke-Davis, Division of Warner-Lambert Company; Pfizer Inc.; R.W. Johnson Pharmaceutical Institute; Sanofi Pharmaceuticals, Inc.; Stanley Foundation; UCB Pharma, Inc. 8,11 Kathleen T. Brady, M.D. Pfizer Inc.; Abbott Laboratories; Lilly Research Laboratories, a division of Eli Lilly and Company; GlaxoSmithKline; Bristol-Myers Squibb 37, 55, 87 George Brainard, Ph.D. Bio-Brite, Inc; Philips 8 Olga Brawman-Mintzer, M.D. AstraZeneca Pharmaceuticals; Eli Lilly and Company; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation 87 Alan F. Breier, M.D. Eli Lilly and Company 95 William Breitbart, M.D. Janssen Pharmaceutica and Research Foundation; Johnson and Johnson; Ortho- Biotech; Bristol-Myers Squibb; Eli Lilly and Company 29 Lawrence Brown, M.D. GlaxoSmithKline; AGVRON 44 Thomas E. Brown, Ph.D. Alza Pharmaceuticals; American Psychiatric Press Inc.; Cephalon, Inc.; Eli Lilly and Company; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Shire U.S., Inc.; The Psychological Corporation; Yale University Press 1, 3, 78 Peter F. Buckley, M.D. AstraZeneca Pharmaceuticals; Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation 86, 96 Kathryn A. Burns, M.D. Eli Lilly and Company 69 George Bush, M.D. Pfizer Inc.; Eli Lilly and Company; Shire U.S., Inc. 86 Ira R. Byock, M.D. Purdue; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Knoll 70 Joseph R. Calabrese, M.D. National Institute of Mental Health; Abbott Laboratories; Ciba Geigy Corporation, Pharmaceutical Division; Merck & Co., Inc.; Forest Laboratories, Inc.; GlaxoSmithKline; Lilly Research Laboratories, a division of Eli Lilly and Company; MacArthur Foundation; National Alliance for Research in Schizophrenia and Affective Disorders; Parke-Davis, Division of Warner-Lambert Company; Robert Wood Johnson Pharmaceutical Research Institute; Sandoz Pharmaceuticals Corporation; Stanley Foundation; TAP Pharmaceuticals; UCB Pharma; Wyeth Pharmaceuticals; AstraZeneca Pharmaceuticals; Elan Pharmaceuticals; Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation; Shire U.S., Inc.; Teva Pharmaceuticals 3, 5, 63 Lori Calabrese, M.D. GlaxoSmithKline; Lilly Research Laboratories, a division of Eli Lilly and Company; Wyeth Pharmaceuticals; Pfizer Inc.; Abbott Laboratories; Bristol-Myers Squibb 37 Joshua W. Calhoun, M.D. Novartis Pharmaceuticals Corporation; Eli Lilly and Company; Bristol-Myers Squibb; Organon Inc.; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; AstraZeneca Pharmaceuticals 80 Linda L. Carpenter, M.D. Corcept; Pfizer Inc.; Forest Laboratories, Inc.; Merck & Co., Inc.; Cyberonics; Organon Inc.; Abbott Laboratories; Parke-Davis, Division of Warner-Lambert Company; GlaxoSmithKline 6,11,52 Diana Carter, M.B. GlaxoSmithKline 8 William P. Carter, M.D. Eli Lilly and Company; Wyeth Pharmaceuticals; Ortho-McNeil Pharmaceuticals 86 Daniel E. Casey, M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation 64, 65 David Castle, M.D. Eli Lilly and Company 55 Patrizia A. Cavazzoni, M.D. Eli Lilly and Company (employer) 47 Carlyle H. Chan, M.D. Medscape 38, 52 Kiki D. Chang, M.D. Abbott Laboratories; Eli Lilly and Company; Solvay Pharmaceuticals, Inc. 5 Kyong-Mi Chang, M.D. Wyeth Pharmaceuticals; Vivopharma 44 Dennis S. Charney, M.D. AstraZeneca Pharmaceuticals; Abbott Laboratories; Bristol-Myers Squibb; Cyberonics; Dov Pharmaceuticals; Eli Lilly and Company; Forest Laboratories, Inc.; Infoscriber; Janssen Pharmaceutica and Research Foundation; Merck & Co., Inc.; Mindsense; Mitsubishi Chemical; Novartis Pharmaceuticals Corporation; Organon Inc.; Pfizer Inc.; Pharmacia Corporation; R.W. Johnson Pharmaceutical Research Institute; Sepracor, Inc.; Skila; GlaxoSmithKline; Somerset Pharmaceuticals, Inc.; Solvay Pharmaceuticals, Inc.; Velva Pharmaceuticals 34, 97 Josepha A. Cheong, M.D. Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Wyeth Pharmaceuticals 25, 51 James C.Y. Chou Pass the Boards, Inc. 15 Leslie L. Citrome, M.D. Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; AstraZeneca Pharmaceuticals; Abbott Laboratories; Pfizer Inc. 30 Anita H. Clayton, M.D. Corcept; Forest Laboratories, Inc.; GlaxoSmithKline; Organon Inc.; Pfizer Inc.; Pharmacia Corporation; Eli Lilly and Company; Bristol-Myers Squibb; Organon, Inc. 65 Judith A. Cohen, M.D. Pfizer Inc. 71, 94,95 Lee S. Cohen, M.D. Forest Laboratories, Inc.; Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; Organon Inc.; Pfizer Inc.; GlaxoSmithKline; Wyeth Pharmaceuticals; Solvay Pharmaceuticals, Inc. 11, 23, 57 XIX DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Steven A. Cole, M.D. Eli Lilly and Company; Pfizer Inc. 60 Robert R. Conley, M.D. AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; IVAX Pharmaceuticals; Novartis Pharmaceuticals Corporation; Eli Lilly and Company 63, 96 Kathryn M. Connor, M.D. Pfizer Inc.; Eli Lilly and Company; PureWorld Botanicals; Ancile Pharmaceuticals; GlaxoSmithKline 8 Barbara Cornblatt, Ph.D. Otsuka Pharmaceuticals; Janssen Pharmaceutica and Research Foundation 65, 87 PaulT. Costa, Jr., Ph.D. Neo Five-Factor Inventory 82 Andrew J. Cutler, M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; Novartis Pharmaceuticals Corporation; Forest Laboratories, Inc.; Shire U.S., Inc.; Otsuka Pharmaceuticals; Sumitomo; Wyeth Pharmaceuticals; GlaxoSmithKline 6 Daniella David, M.D. Janssen Pharmaceutica and Research Foundation 55 Jonathan R.T. Davidson, M.D. Pfizer Inc.; American Home Products; GlaxoSmithKline; Proctor and Gamble; Triangle Pharmaceuticals; Solvay Pharmaceuticals, Inc.; Forest Laboratories, Inc.; Eli Lilly and Company; Ancile; Roche Laboratories, a member of the Roche Group; Novartis Pharmaceuticals Corporation; Wyeth Pharmaceuticals; Organon Inc.; PureWorld; Schwabe; MultiHealth Systems, Inc., Guilford Publications; American Psychiatric Association 8, 64 Jonathan S. Davine, M.D. Solvay Pharmaceuticals, Inc.; GlaxoSmithKline; Pfizer Inc.; Lundbeck; Janssen Pharmaceutica and Research Foundation; AstraZeneca Pharmaceuticals; Eli Lilly and Company; Wyeth Pharmaceuticals 71 Kenneth L. Davis, M.D. Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Abbott Laboratories; Mitsubishi; Scirex 12 Denise De Guzman, M.D. Pharmacia Corporation 77 Deborah Deas, M.D. Bristol-Myers Squibb; Pfizer Inc. 58 Pedro L. Delgado, M.D. National Institute of Mental Health; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Organon Inc.; Otsuka Pharmaceuticals; Pharmacia Corporation; Solvay Pharmaceuticals, Inc.; Wyeth Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Boehringer Ingelheim; Forest Laboratories, Inc.; Parke-Davis, Division of Warner-Lambert Company; Pfizer Inc.; Novartis Pharmaceuticals Corporation; AstraZeneca Pharmaceuticals 64 Davangere P. Devanand, M.D. Pfizer Inc.; Eli Lilly and Company; Wyeth Pharmaceuticals; Pfizer Inc. 30 C. Lindsay DeVane, Pharm.D. Eli Lilly and Company; Wyeth Pharmaceuticals; AstraZeneca Pharmaceuticals; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb; Forest Laboratories, Inc. 2 Mantosh J. Dewan, M.D. Pfizer Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation 38 David F. Dinges, Ph.D. Cephalon, Inc. 86 Karl Doghramji, M.D. Sanofi Pharmaceuticals, Inc.; Eli Lilly and Company; Wyeth Pharmaceuticals; Cephalon, Inc. 13, 23, 27, 86 Rachelle S. Doody, M.D. Eisai Inc.; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Merz; Forest Laboratories, Inc.; Fujisawa; Elan Pharmaceuticals 85 P. Murali Doraiswamy, M.D. Eisai Inc.; Pfizer Inc.; Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation; GlaxoSmithKline; Elan Pharmaceuticals; Wyeth Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company; Merck & Co., Inc.; National Institutes of Health; Forest Laboratories, Inc.; Lundbeck 64 Robert T. Dunn, M.D. Novartis Pharmaceuticals Corporation 90 David L. Dunner, M.D. Eli Lilly and Company; Pfizer Inc.; GlaxoSmithKline; Wyeth Pharmaceuticals; Bristol-Myers Squibb; Forest Laboratories, Inc.; Mitsubishi; Cyberonics; Pharmacia Corporation; Organon Inc. 13, 33, 37, 47 Steven A. Epstein, M.D. Pfizer Inc.; AstraZeneca Pharmaceuticals 49 Milton K. Erman, M.D. Searle; Pharmacia Corporation; Wyeth Pharmaceuticals; Pfizer Inc.; Takeda Pharmaceuticals; Neurocrine Diosciences; Orphan Medical; Sepracor, Inc.; Resmed Sanofi Pharmaceuticals, Inc.; Cephalon, Inc.; Forest Laboratories, Inc. 13, 37 Javier I. Escobar, M.D. Pfizer Inc.; Bristol-Myers Squibb; Wyeth Pharmaceuticals; Johnson and Johnson 1 Raymond A. Faber, M.D. Janssen Pharmaceutica and Research Foundation; Pfizer Inc. 1, 5 Stephen V. Faraone, Ph.D. Alza Pharmaceuticals; Shire U.S., Inc.; Wyeth Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; GlaxoSmithKline; SG Cowan 86 Martin K. Farlow, M.D. Novartis Pharmaceuticals Corporation 64 Maurizio Fava, M.D. Eli Lilly and Company; GlaxoSmithKline; Pfizer Inc.; Wyeth Pharmaceuticals; Organon Inc.; Bristol-Myers Squibb; Pharmacia Corporation; Solvay Pharmaceuticals, Inc.; Forest Laboratories, Inc.; Sanofi Pharmaceuticals, Inc.; Janssen Pharmaceutica and Research Foundation; Lundbeck; Knoll Pharmaceuticals; Parke-Davis, Division of Warner-Lambert Company; Somerset Pharmaceuticals, Inc.; Pharmavite; Abbott Laboratories; Roche Laboratories, a member of the Roche Group; Novartis Pharmaceuticals Corporation; Lorex Pharmaceuticals; Lichtwer Pharma 6,13 Jan A. Fawcett, M.D. National Institute of Mental Health; Abbott Laboratories; Bristol-Myers Squibb; GlaxoSmithKline; Eli Lilly and Company; Pfizer Inc.; Theodore and Vada Stanley Foundation; Wyeth Pharmaceuticals; Forest Laboratories, Inc.; Merck & Co., Inc.; Parke-Davis, Division of Warner-Lambert Company; Pharmacia Corporation; Solvay Pharmaceuticals, Inc. 29, 96 Joel S. Feiner, M.D. Eli Lilly and Company; Telecare 32

XX DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Stephen J. Ferrando, M.D. Merck & Co., Inc.; Pfizer Inc. 29, 61 Howard Fillit, M.D. Pfizer Inc.; Novartis Pharmaceuticals Corporation 92 Robert L. Findling, M.D. Abbott Laboratories; Solvay Pharmaceuticals, Inc.; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Pfizer Inc.; Somerset Pharmaceuticals, Inc.; Shire U.S., Inc.; GlaxoSmithKline; Wyeth Pharmaceuticals; Organon Inc.; Forest Laboratories, Inc. 5,14, 38 Mara J. Fiorentino, M.D. Eli Lilly and Company 71 Kathleen M. Fisher, Ph.D. Pfizer Inc.; Organon Inc.; Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Wyeth Pharmaceuticals; Manor Health Care; Abbott Laboratories; Bristol-Myers Squibb; Organon Inc. 80 Marc Fishman, M.D. Potomac Healthcare Foundation; Mortain Manor Treatment Center 84 Lois T. Flaherty, M.D. Merck & Co., Inc.; Pfizer Inc. 39, 89 Lyle B. Forehand, Jr., M.D. GlaxoSmithKline 25 Richard J. Frances, M.D. Abbott Laboratories; Forest Laboratories, Inc.; Schering Plough; Merck & Co., Inc.; Organon Inc.; Pfizer Inc.; Pharmacia Corporation; Suburban Hill Hospital 44 Ellen Frank, Ph.D. Pfizer Inc.; Forest Laboratories, Inc.; Eli Lilly and Company; National Institute of Mental Health 3,13, 96 W. Gordon Frankle, M.D. Janssen Pharmaceutica and Research Foundation; AstraZeneca Pharmaceuticals 8 Jean A. Frazier, M.D. Eli Lilly and Company 6 Robert Freedman, M.D. AstraZeneca Pharmaceuticals 12 Matthew J. Friedman, M.D. Pfizer Inc.; GlaxoSmithKline 71 Mark A. Frye, M.D. Abbott Laboratories; Eli Lilly and Company; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Ortho-McNeil Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Cephalon, Inc. 2, 3, 5, 34, 63 Glen O. Gabbard, M.D. Merck & Co., Inc. 33, 56 Joseph Gal, Ph.D. Forest Laboratories, Inc. 2 David R. Gastfriend, M.D. Dupont Pharma; Purdue Pharma; Bristol-Myers Squibb; CSAT; State of Oklahoma; Earley Corporation 33 Alan J. Gelenberg, M.D. Cyberonics; Bristol-Myers Squibb; Pfizer Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Wyeth Pharmaceuticals; Hoechst Marion Roussel; Vela Pharmaceuticals; Best Practice; Novartis Pharmaceuticals Corporation; AstraZeneca Pharmaceuticals; GlaxoSmithKline 60, 81 Mark S. George, M.D. Cyberonics; MagStim; Netonics; Dontec; Medtronic 9, 15, 81 S. Nassir Ghaemi, M.D. Janssen Pharmaceutica and Research Foundation; AstraZeneca Pharmaceuticals; Novartis Pharmaceuticals Corporation; Abbott Laboratories; GlaxoSmithKline; Forest Laboratories, Inc.; Eli Lilly and Company 33, 62, 65, 88 Leslie H. Gise, M.D. Merck Medco Managed Care 23, 70 Michael J.Gitlin, M.D. Wyeth Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; Forest Laboratories, Inc.; Janssen Pharmaceutica and Research Foundation; GlaxoSmithKline 90 Alexander H. Glassman, M.D. Pfizer Inc.; GlaxoSmithKline; Lilly Research Laboratories, a division of Eli Lilly and Company; Sanofi Pharmaceuticals, Inc.; Organon Inc. 65, 87 Donald C. Goff, M.D. Eli Lilly and Company; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Cortex Pharmaceuticals; AstraZeneca Pharmaceuticals 3 R. Rao Gogineni, M.D. Devereux Foundation 31,84 Joseph F. Goldberg, M.D. AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; Abbott Laboratories; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation; R.W. Johnson; Shire U.S., Inc.; Pharmacia Corporation 11, 33, 62, 63 Stephen M. Goldfinger, M.D. IVAX Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; Mallingkrodt; AstraZeneca Pharmaceuticals 35, 71, 89 Karl Goodkin, M.D. Advanced Immunity, Inc.; GlaxoSmithKline; Pharmacia Corporation; Merck & Co., Inc.; Cambridge University Press 29,61,89 Marianne Goodman, M.D. Janssen Pharmaceutica and Research Foundation 84, 87 Paul J. Goodnick, M.D. Lilly Research Laboratories, a division of EH Lilly and Company; Pfizer Inc.; AstraZeneca Pharmaceuticals; GlaxoSmithKline 47 Frederick K. Goodwin, M.D. Abbott Laboratories; GlaxoSmithKline; Solvay Pharmaceuticals, Inc.; Pfizer Inc.; Eli Lilly and Company; Scios Nova Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; AstraZeneca Pharmaceuticals 33, 62, 90 Guy M. Goodwin, M.D. AstraZeneca Pharmaceuticals 8,11

XXI DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Jack M. Gorman, M.D. Eli Lilly and Company; National Institute of Mental Health; NARSAD; Pfizer Inc.; Eli Lilly and Company; Bristol-Myers Squibb; Wyeth Pharmaceuticals; GlaxoSmithKline; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Organon Inc.; Forest Laboratories, Inc.; Lundbeck; Solvay Pharmaceuticals, Inc.; Merck & Co., Inc.; Sanofi Pharmaceuticals, Inc.; UCB Pharma; Purdue; Aventis; Xenova 3, 63 Elizabeth Gould, Ph.D. GlaxoSmithKline 63 Tana A. Grady-Weliky, M.D. Pfizer Inc.; Eli Lilly and Company; GlaxoSmithKline 65 Kevin F. Gray, M.D. Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation 5 Laurence L. Greenhill, M.D. Alza Pharmaceuticals; Johnson and Johnson; Celltech; Noven Pharmaceuticals; Novartis Pharmaceuticals Corporation; Shire U.S., Inc.; Somerset Pharmaceuticals, Inc. 83, 98 John H. Greist, M.D. Abbott Laboratories; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Organon Inc.; Pfizer Inc.; Sanofi Pharmaceuticals, Inc.; Solvay Pharmaceuticals, Inc.; Pharmacia Corporation; Wyeth Pharmaceuticals; Bristol-Myers Squibb; Forest Laboratories, Inc.; Hoffman-LaRoche; Novartis Pharmaceuticals Corporation 64 Nichole D. Grier, M.D. Bristol-Myers Squibb 70 Mark S. Groves, M.D. GlaxoSmithKline 22 Robert E. Hales, M.D. Bristol-Myers Squibb; Forest Laboratories, Inc.; GlaxoSmithKline 13, 37 Ellen Haller, M.D. Pfizer Inc.; Bristol-Myers Squibb 52, 76 Mark B. Hamner, M.D. AstraZeneca Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb 55 Roger F. Haskett, M.D. Eli Lilly and Company; GlaxoSmithKline; Forest Laboratories, Inc.; Pfizer Inc.; Wyeth Pharmaceuticals 23 Keith A. Hawkins, Psy.D. Eli Lilly and Company 95 Stephen H. Heidel, M.D. Integrated Insights (employer) 7 Howard A. Heit, M.D. Purdue Pharma; McNeil Pharmaceutical; Abbott Laboratories 62 David J. Hellerstein, M.D. Pfizer Inc.; Eli Lilly and Company; GlaxoSmithKline; Bristol-Myers Squibb; Forest Laboratories, Inc.; Dista Products; Wyeth Pharmaceuticals; Merck & Co., Inc.; National Institute of Mental Health; National Institute on Drug Abuse 92 David C. Henderson, M.D. Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; AstraZeneca Pharmaceuticals 37, 64 John P. Hendrick, M.D. AstraZeneca Pharmaceuticals; Forest Laboratories, Inc.; GlaxoSmithKline; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; Organon Inc.; Wyeth Pharmaceuticals 48 Scott W. Henggeler, Ph.D. MST Services, Inc. 95 Charles H. Hennekens, M.D. Pfizer Inc. 64 Paula L. Hensley, M.D. Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Eli Lilly and Company; Forest Laboratories, Inc.; Wyeth Pharmaceuticals; Abbott Laboratories; Novartis Pharmaceuticals Corporation; Parke-Davis, Division of Warner-Lambert Company 77 Jerrold W. Hill, Ph.D. Pfizer Inc. 92 Robert M.A. Hirschfeld, M.D. Abbott Laboratories; Bristol-Myers Squibb; GlaxoSmithKline; Organon Inc.; Wyeth Pharmaceuticals; Forest Laboratories, Inc.; Eli Lilly and Company; Pfizer Inc.; Pharmacia Corporation; Janssen Pharmaceutica and Research Foundation; Sepracor, Inc.; Novartis Pharmaceuticals Corporation 3,11 Max Hirshkowitz, Ph.D. Wyeth Pharmaceuticals; Searle; Lorex Bertek; Pharmacia Corporation; Cephalon, Inc.; Merck & Co., Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Sepracor, Inc.; Takeda Pharmaceuticals 78 Eric Hollander, M.D. Solvay Pharmaceuticals, Inc.; Abbott Laboratories; Wyeth Pharmaceuticals 34, 64, 84, 87 Michael A. Hollifield, M.D. Eli Lilly and Company 77 Rory P. Houghtalen, M.D. Wyeth Pharmaceuticals 89 Robert H. Howland, M.D. Cyberonics, Inc. 52 Rona Hu, M.D. Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; AstraZeneca Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company; Bristol-Myers Squibb 13 James I. Hudson, M.D. Eli Lilly and Company; Pfizer Inc.; Ortho-McNeil Pharmaceuticals; Elan Pharmaceuticals; Merck & Co., Inc.; Knoll 86 James J. Hudziak, M.D. Pfizer Inc.; GlaxoSmithKline; Eli Lilly and Company 64 Douglas H. Hughes, M.D. Janssen Pharmaceutica and Research Foundation 63 Thomas D. Hurwitz, M.D. Searle; Wyeth Pharmaceuticals 27, 78 Mustafa M. Husain National Institute of Mental Health; Eli Lilly and Company; Bristol-Myers Squibb; Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation; GlaxoSmithKline; Pfizer Inc. 52, 64 Michael Y. Hwang, M.D. Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation 19, 30 Steven E. Hyler, M.D. Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company 14, 56

XXII DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Naveed Iqbal, M.D. Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; GlaxoSmithKline; Pfizer Inc.; AstraZeneca Pharmaceuticals; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb 19 Richard S. Jackson, M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company; Forest Laboratories, Inc.; Pfizer Inc.; Bristol-Myers Squibb; Janssen Pharmaceutica and Research Foundation 7 Richard L. Jaffe, M.D. Pfizer Inc. 38 Philip G. Janicak, M.D. Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb; Genentech; National Institutes of Health; Pfizer Inc.; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Sepracor, Inc.; Abbott Laboratories; Lilly Research Laboratories, a division of Eli Lilly and Company 24,38 Kathleen Jarboe, R.N. Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Eli Lilly and Company 9 Robin B.Jarrett, Ph.D. Cyberonics, Inc. 9 Dilip V. Jeste, M.D. AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; EU Lilly and Company; Janssen Pharmaceutica and Research Foundation; Pfizer Inc. 37 Michael D. Jibson, M.D. AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc. 85 David C. Jimerson, M.D. Abbott Laboratories 7 David E. Joranson, M.S.W. Ortho-McNeil Products; Janssen Pharmaceutica and Research Foundation; Purdue Pharma 62 Ned H. Kalin, M.D. GlaxoSmithKline; Wyeth Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Forest Laboratories, Inc.; Neurocrine 11 John M. Kane, M.D. Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation; Abbott Laboratories; Bristol-Myers Squibb; Lundbeck; Lilly Research Laboratories, a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals 9,13 Shitij Kapur, M.D. Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Neuromolecular, Inc.; Pfizer Inc.; Wyeth Pharmaceuticals; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; GlaxoSmithKline; Solvay Pharmaceuticals, Inc. 82, 96 David J. Katzelnick, M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; GlaxoSmithKline; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Solvay Pharmaceuticals, Inc.; MacArthur Foundation; Organon Inc.; Robert Wood Johnson Foundation; Wyeth Pharmaceuticals; Forest Laboratories, Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Pharmacia Corporation; Johnson and Johnson; Healthcare Technology Systems, Inc. 60 Paul E. Keck, Jr., M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; GlaxoSmithKline; Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Wyeth Pharmaceuticals; Merck & Co., Inc. 11, 81, 93 Samuel J.Keith, M.D. Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb; Pfizer Inc.; Novartis Pharmaceuticals Corporation 9 Martin B. Keller, M.D. Pfizer Inc.; Bristol-Myers Squibb; Forest Laboratories, Inc.; Wyeth Pharmaceuticals; Merck & Co., Inc.; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Organon Inc.; Pharmacia Corporation; Wyeth Pharmaceuticals; GlaxoSmithKline; AstraZeneca Pharmaceuticals; Mitsubishi Pharmaceuticals; Scirex; Vela Pharmaceuticals; Sepracor, Inc.; Somerset Pharmaceuticals, Inc.; Sanofi Pharmaceuticals, Inc.; Cypress Bioscience 11, 60 Charles H. Kellner, M.D. Somatics, Inc. 1,38 Justine M. Kent, M.D. Solvay Pharmaceuticals, Inc. 63 Ronald C. Kessler, Ph.D. Pfizer Inc. 10 Terence A. Ketter, M.D. Abbott Laboratories; Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Bristol-Myers Squibb; Elan Pharmaceuticals; AstraZeneca Pharmaceuticals; Shire U.S., Inc.; Cephalon, Inc. 5, 63 Paul A. Kettl, M.D. Pfizer Inc.; Organon Inc.; Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Wyeth Pharmaceuticals; Manor HealthCare; Abbott Laboratories; Bristol- Myers Squibb 42,80 Clinton D. Kilts, Ph.D. Bristol-Myers Squibb; Janssen Pharmaceutica and Research Foundation; Forest Laboratories, Inc.; AstraZeneca Pharmaceuticals; GlaxoSmithKline 63 Steven A. King, M.D. Wyeth Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Purdue; Endo 2 Ellen Kingsley, M.A. Additude Magazine; Alza Pharmaceuticals; Shire U.S., Inc.; Abbott Laboratories; Bristol-Myers Squibb; GlaxoSmithKline; Organon Inc.; Wyeth Pharmaceuticals; Forest Laboratories, Inc.; Eli Lilly and Company; Pharmacia Corporation; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation 38 Herbert D. Kleber, M.D. Schering Plough 34, 43, 66 Mitchel A. Kling, M.D. Cyberonics, Inc. 52 Harold W. Koenigsberg, M.D. Janssen Pharmaceutica and Research Foundation 74, 84 Anthony L. Komaroff, M.D. Cephalon, Inc. 86

XXIII DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Lilli Kopala, M.D. AstraZeneca Pharmaceuticals; Abbott Laboratories; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb; Eli Lilly and Company; Lundbeck; Novartis Pharmaceuticals Corporation; Pfizer Inc. 13 Susan G. Kornstein, M.D. Pfizer Inc.; Bristol-Myers Squibb; Lilly Research Laboratories, a division of Eli Lilly and Company; GlaxoSmithKline; Forest Laboratories, Inc.; Wyeth Pharmaceuticals; Pharmacia Corporation; Mitsubishi; Biovail; Berlex Laboratories; Novartis Pharmaceuticals Corporation; Merck & Co., Inc. Cyberonics, Inc. 6, 9 Thomas R. Kosten, M.D. Abbott Laboratories; Schering Pharmaceuticals 66, 95 Robert A. Kowatch, M.D. Abbott Laboratories; Solvay Pharmaceuticals, Inc. 5 Diana M. Koziupa, M.D. GlaxoSmithKline; Organon Inc.; Wyeth Pharmaceuticals; Eli Lilly and Company 97 Lois Krarin, M.D. Wyeth Pharmaceuticals 8,13, 78 Henry R. Kranzler, M.D. Best Practice/Drug Abuse Sciences; Central Pharma 55 Christopher J. Kratochvil, M.D. Eli Lilly and Company; Alza Pharmaceuticals; Novartis Pharmaceuticals Corporation 3, 83 Ranga K. Krishnan, M.D. Eisai Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Forest Laboratories, Inc.; Abbott Laboratories; Bristol-Myers Squibb; Dupont Pharma; GlaxoSmithKline; Janssen Pharmaceutica And Research Foundation; Merck & Co., Inc.; Organon Inc.; Pharmacia Corporation; Somerset Pharmaceuticals, Inc. 6,11 Elisabeth J.S. Kunkel, M.D. Forest Laboratories, Inc.; Parke-Davis, Division of Warner-Lambert Company; Wyeth Pharmaceuticals; Pfizer Inc. 75 David J.Kupfer, M.D. Pfizer Inc.; Eli Lilly and Company; Forest Laboratories, Inc. 3, 34, 63 Raymond W. Lam, M.D. Pfizer Inc.; Eli Lilly and Company; Pharmacia Corporation; Lundbeck; Servier; Litebook; Organon Inc.; Wyeth Pharmaceuticals 2 William B. Lawson, M.D. AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company 17, 58,70, 94 Arthur L. Lazarus, M.D. Pfizer Inc. 25, 93 Ellen Leibenluft, M.D. Pfizer Inc.; Wyeth Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company; Abbott Laboratories; Johnson and Johnson 3 Alan I. Levenson, M.D. Psychiatrists' Purchasing Group, Inc. 18 Frances R. Levin, M.D. Eli Lilly and Company; GlaxoSmithKline 34, 44, 55 Saul M. Levin, M.D. SAMHSA/CSAT 90,93 Jeffrey M. Levine, M.D. Wyeth Pharmaceuticals; GlaxoSmithKline; Pfizer Inc. 44 David A. Lewis, M.D. AstraZeneca Pharmaceuticals 12 Jeffrey A. Lieberman, M.D. Bristol-Myers Squibb; Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; AstraZeneca Pharmaceuticals; Hoechst Marion Roussel; Pharmacia Corporation 9, 10, 12 Barry D. Liebowitz, Ph.D. Forest Laboratories, Inc. 85 Walter Ling, M.D. Roxane Laboratories; Schering Plough 50 Paul S. Links, M.D. Eli Lilly and Company, Canada, Inc. 81 Sarah H. Lisanby, M.D. MagStim Company 14 Maria D. Llorente, M.D. Abbott Laboratories 32 Miklos F. Losonczy, M.D. Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; AstraZeneca Pharmaceuticals 19 Joe Lovelace, J.D. Janssen Pharmaceutica and Research Foundation 9 R. Bruce Lydiard, M.D. Bristol-Myers Squibb; GlaxoSmithKline; Parke-Davis, Division of Warner-Lambert Company; Pfizer Inc.; Eli Lilly and Company; Pharmacia Corporation; Forest Laboratories, Inc.; Roche Laboratories, a member of the Roche Group; AstraZeneca Pharmaceuticals 10, 61, 87 Constanine G. Lyketsos, M.D. Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a Division of Eli Lilly and Company; Dupont Pharma; Abbott Laboratories; Eisai Inc.; Bristol-Myers Squibb 7 Gerald A. Maguire, M.D. Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Pfizer Inc. 6 Husseini K. Manji, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Oxford Glycosciences; Chiron; AstraZeneca Pharmaceuticals; Abbott Laboratories; Pharmacia Corporation 12 Lauren B. Marangell, M.D. National Institutes of Health; Stanley Foundation; Eli Lilly and Company; Martek Biosciences; Cyberonics; Abbott Laboratories; Pfizer Inc.; Parke-Davis, Division of Warner-Lambert Company; Forest Laboratories, Inc.; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Wyeth Pharmaceuticals; Novartis Pharmaceuticals Corporation 9, 11, 81 John S. March, M.D. Solvay Pharmaceuticals, Inc.; Pfizer Inc.; GlaxoSmithKline; Wyeth Pharmaceuticals; Shke U.S., Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Alza Pharmaceuticals; Somerset Pharmaceuticals, Inc.; Medeva; Celgene; Bristol-Myers Squibb 87 Stephen R. Marder, M.D. Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; Pfizer Inc.; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb 9, 38

XXIV DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

John C. Markowitz, M.D. National Institute of Mental Health; Pfizer Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Bristol-Myers Squibb; Forest Laboratories, Inc.; Organon Inc.; American Psychiatric Press Inc.; Basic Books; Wyeth Pharmaceuticals 6, 48, 66, 96 Robert C. Marks, M.D. Pfizer Inc.; Janssen Pharmaceutica and Research Foundation 24 Prakash S. Masand, M.D. AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; GlaxoSmithKline; Forest Laboratories, Inc.; Wyeth Pharmaceuticals; Health Care Technology; Pfizer Inc.; Abbott Laboratories; Bristol-Myers Squibb; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Searle; Solvay Pharmaceuticals, Inc. 3, 37, 63, 96 Donna Masterman, M.D. Pfizer Inc.; Eisai Inc.; Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation; Bayer Corporation, Pharmaceutical Division; Eli Lilly and Company; Fugisawa; Neotherapeutica; Sanofi Pharmaceuticals, Inc.; Pharmacia Corporation 86 Matig R. Mavissakalian, M.D. Pfizer Inc.; Forest Laboratories, Inc. 22 Una D. McCann, M.D. Pfizer Inc.; Bristol-Myers Squibb 81 Richard H. McCarthy, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation; Parke-Davis, Division of Warner-Lambert Company 71 Christopher J. McDougle, M.D. Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Eli Lilly and Company 14 Susan L. McElroy, M.D. Abbott Laboratories; Eli Lilly and Company; Forest Laboratories, Inc.; Elan Pharmaceuticals; GlaxoSmithKline; Bristol-Myers Squibb; Janssen Pharmaceutica and Research Foundation; Ortho-McNeil Pharmaceuticals 86 Joseph P. McEvoy, M.D. Bristol-Myers Squibb 9,10 Patrick D. McGorry, Ph.D. Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; Pfizer Inc.; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb 9 Alan J. Mendelowitz, M.D. Pfizer Inc.; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company 64, 85 Ricardo P. Mendoza, M.D. Pfizer Inc.; Forest Laboratories, Inc.; Janssen Pharmaceutica and Research Foundation 70 Matthew A. Menza, M.D. Cephalon, Inc. 92 David Michelson, M.D. Eli Lilly and Company (employer) 47 Frederick E. Miller, M.D. Pfizer Inc. 74 Matthew S. Miller, Ph.D. Cephalon, Inc. (employer) 49 Jacobo E. Mintzer, M.D. Abbott Laboratories; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; Janssen Pharmaceutica and Research Foundation; Pfizer Inc. 7, 25, 85 Shaila Misri, M.D. GlaxoSmithKline; Wyeth Pharmaceuticals 8 James E. Mitchell, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Abbott Laboratories 7, 30 Gary S. Moak, M.D. Eisai Inc.; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company 2 Francisco A. Moreno, M.D. Solvay Pharmaceuticals, Inc. 18,64 Philip Morris, Ph.D. Dupont Pharma 83 Greer M. Murphy, M.D. Organon Inc. 9 Dominique L. Musselman, M.D. DANA Foundation; GlaxoSmithKline; National Institutes of Health; Schering Plough; Forest Laboratories, Inc.; Parke-Davis, Division of Warner-Lambert Company; Pfizer Inc.; Wyeth Pharmaceuticals 13 Ziad H. Nahas, M.D. Cyberonics, Inc.; Neotonus, Inc. 14, 52 Henry A. Nasrallah, M.D. AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation: Pfizer Inc.; Wyeth Pharmaceuticals; Forest Laboratories, Inc.; National Institutes of Health; Bristol-Myers Squibb 13,37 Rebecca R. Neal, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation 19 J. Craig Nelson, M.D. Abbott Laboratories; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Organon Inc.; Pfizer Inc.; Pharmacia Corporation; Wyeth Pharmaceuticals 6, 64 Charles B. Nemeroff, M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Forest Laboratories, Inc.; Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; Organon Inc.; Pfizer Inc.; Pharmacia Corporation; GlaxoSmithKline; Solvay Pharmaceuticals, Inc.; Wyeth Pharmaceuticals; Acadia Pharmaceuticals; Cypress Biosciences; Otsuka Pharmaceuticals; Merck & Co., Inc.; Neurocrine Biosciences; Sanofi Pharmaceuticals, Inc.; Vela 11, 63 John W. Newcomer, M.D. Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; Pfizer Inc.; AstraZeneca Pharmaceuticals 3 Thomas Newton, M.D. Cypress Bioscience 52 Andrew A. Nierenberg, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Wyeth Pharmaceuticals; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Innapharma; Bristol-Myers Squibb; Cyberonics; Lichtner; Pfizer Inc.; Forest Laboratories, Inc. 2, 6 Carol S. North, M.D. GlaxoSmithKline; Bristol-Myers Squibb 8, 97 Andrei Novae, M.D. Pfizer Inc.; GlaxoSmithKline; Forest Laboratories, Inc. 71 H. George Nurnberg, M.D. Pfizer Inc.; Eli Lilly and Company; GlaxoSmithKline 75 Charles P. O'Brien, M.D. Dupont Pharma 18, 83, 94 XXV DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Mary B. O'Malley, M.D. Cephalon, Inc. 49, 86 N. Kalaya Okereke, M.D. AstraZeneca Pharmaceuticals 47 Lewis A. Opler, M.D. Multi-Health Systems 5,19, 25, 30 Michael W. Otto, Ph.D. Pharmacia Corporation; Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Ancile Pharma; GlaxoSmithKline; Eli Lilly and Company; Psychological Corporation; Abbott Laboratories 11,57 Michael J. Owens, Ph.D. Forest Laboratories, Inc.; GlaxoSmithKline; Abbott Laboratories; Eli Lilly and Company 2, 63, 65 Michelle T. Pato, M.D. Solvay Pharmaceuticals, Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Forest Laboratories, Inc.; Pfizer Inc. 38 Diana O. Perkins, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb 9,13, 95 Frederick Petty, M.D. Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc. 87 Edmond H.T. Pi, M.D. Eli Lilly and Company 70 Debra A. Pinals, M.D. Janssen Pharmaceutica and Research Foundation 90 Daniel Pine, M.D. Solvay Pharmaceuticals, Inc.; Bristol-Myers Squibb; Wyeth Pharmaceuticals 35, 63 Mark H. Pollack, M.D. Bristol-Myers Squibb; Forest Laboratories, Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Parke-Davis, Division of Warner-Lambert Company; Pfizer Inc.; GlaxoSmithKline; Solvay Pharmaceuticals, Inc.; Wyeth Pharmaceuticals 10 Robert M. Post, M.D. Abbott Laboratories; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, a division of Eli Lilly and Company; Parke-Davis, Division of Warner-Lambert Company; Pfizer Inc.; Pharmacia Corporation; UCB Pharma 62, 63 Marc N. Potenza, M.D. GlaxoSmithKline; Forest Laboratories, Inc. 83 Steven G. Potkin, M.D. Novartis Pharmaceuticals Corporation 64 David W. Preven, M.D. Forest Laboratories, Inc.; Pfizer Inc. 26 Annelle B. Primm, M.D. Pfizer Inc. 43 Jefferson B. Prince, M.D. GlaxoSmithKline; Forest Laboratories, Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; Alza Pharmaceuticals 1,78 Andres J. Pumariega, M.D. Center for Mental Health Services 90 Arturo G. Quiason, M.D. Wyeth Pharmaceuticals; Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation; Pfizer Inc. 25 Ljiljana Radulovic, M.D. Abbott Laboratories 92 Paul M. Ramirez, Ph.D. Multi-Health Systems 5 Mark H. Rapaport, M.D. Abbott Laboratories; Forest Laboratories, Inc.; GlaxoSmithKline; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Sanofi Pharmaceuticals, Inc.; Pharmacia Corporation; Robert Wood Johnson; UBC Pharma; Wyeth Pharmaceuticals 33 Natalie L. Rasgon, M.D. Forest Laboratories, Inc. 2, 34 Scott L. Rauch, M.D. GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; Solvay Pharmaceuticals, Inc. 8 William T. Regenold, M.D. Pfizer Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals; Novartis Pharmaceuticals Corporation 43 William E. Reichman, M.D. Eisai Inc.; Pfizer Inc.; Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb; Organon Inc.; Forest Laboratories, Inc. 2, 7 Roy O. Resnikoff, M.D. Pfizer Inc.; Bristol-Myers Squibb; Forest Laboratories, Inc.; AstraZeneca Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company 66, 93 Kerry J. Ressler, M.D. Pfizer Inc.; GlaxoSmithKline 63 Charles F. Reynolds III, M.D. GlaxoSmithKline; Forest Laboratories, Inc.; Organon Inc. 5, 9 Mary Ann Richardson, Ph.D. Scientific Hospital Supplies, Ltd. 75 Mark A. Riddle, M.D. Best Practice; Excerpta Medical; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb; Shire U.S., Inc.; Solvay Pharmaceuticals, Inc.; National Institute of Mental Health 98 Gustavo C. Roman, M.D. Eisai Inc. 86 Steven P. Roose, M.D. Forest Laboratories, Inc.; GlaxoSmithKline; Wyeth Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; Organon Inc.; Pharmacia Corporation 5, 9 Mark R. Rosekind, Ph.D. Wyeth Pharmaceuticals 13 Jerrold F. Rosenbaum, M.D. Cyberonics; Eli Lilly and Company; Forest Laboratories, Inc.; Lichtwer Pharma; Organon Inc.; Wyeth Pharmaceuticals 2 Thomas Roth, Ph.D. Wyeth Pharmaceuticals; Sanofi Pharmaceuticals, Inc.; Aventis; Sepracor, Inc.; Neurocrine; Merck & Co., Inc.; Proctor and Gamble; Takeda Pharmaceuticals; Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, a division of Eli Lilly and Company; Bristol-Myers Squibb; Forest Laboratories, Inc. 37, 85 Barbara O. Rothbaum, Ph.D. Pfizer Inc.; Bristol-Myers Squibb; Wyeth Pharmaceuticals; Virtually Better; Somerset Pharmaceuticals, Inc. 8. 11

XXVI DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

A. John Rush, M.D. Cyberonics; Robert Wood Johnson Foundation; National Institute of Mental Health; Stanley Foundation; Wyeth Pharmaceuticals; Abbott Laboratories; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Merck & Co., Inc.; Pfizer Inc.; Pharmacia Corporation 9, 60 Donna H. Ryan, M.D. Wyeth Pharmaceuticals; Abbott Laboratories; Boots Pharmaceuticals; Roche Laboratories, a member of the Roche Group; Amgen; Bristol-Myers Squibb; Ergo; GlaxoSmithKline; Parke- Davis, Division of Warner-Lambert Company; Warner Lambert; Regeneron Pharmaceuticals; Schering Plough; Proctor and Gamble; TAP Pharmaceuticals; Wyeth Pharmaceuticals 65 J. Michael Ryan, M.D. Eisai Inc.; Pfizer Inc.; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation; Eli Lilly and Company; Abbott Laboratories 2, 86 Neal D. Ryan, M.D. Pfizer Inc.; Abbott Laboratories; Hoffman-LaRoche; AstraZeneca Pharmaceuticals; GlaxoSmithKline; Wyeth Pharmaceuticals 13 Gary S. Sachs, M.D. Abbott Laboratories; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; Bristol-Myers Squibb; Novartis Pharmaceuticals Corporation; Elan; Sanofi Pharmaceuticals, Inc.; Scios Nova Pharmaceuticals; Solvay Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals 8,11,92 Harold A. Sackeim, Ph.D. Pfizer Inc.; Forest Laboratories, Inc.; Cyberonics 5, 9, 81 Mary Sano, Ph.D. Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation; Forest Laboratories, Inc.; Merck & Co., Inc.; Fujisawa; Pfizer Inc. 85 Norman Sartorius, M.D. Bristol-Myers Squibb 6, 60 Seddon R. Savage, M.D. Muro Asta Medica; Ortho-McNeil Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Purdue Pharma 62 Franklin R. Schneier, M.D. Forest Laboratories, Inc.; Solvay Pharmaceuticals, Inc.; Somerset Pharmaceuticals, Inc.; GlaxoSmithKline 61 Nina R. Schooler, Ph.D. Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Novartis Pharmaceuticals Corporation 30,64 S. Charles Schulz, M.D. Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals; Pfizer Inc. 13, 87 Dean Schuyler, M.D. Wyeth Pharmaceuticals; Pfizer Inc. 27 Marcia Scott, M.D. Prudential 7 Yvette Sealy, Ph.D. Bedford Community Health Center 44 Larry J. Seidman, Ph.D. Forest Laboratories, Inc.; GlaxoSmithKline; Shire U.S., Inc. 86 Stuart N. Seidman, M.D. Forest Laboratories, Inc.; GlaxoSmithKline 2, 34, 47 Shawn C. Shea, M.D. GlaxoSmithKline 15 M. Katherine Shear, M.D. Wyeth Pharmaceuticals 11 David V. Sheehan, M.D. Abbott Laboratories; Alza Pharmaceuticals; Forest Laboratories, Inc.; GlaxoSmithKline; Layton Bioscience; Lilly Research Laboratories, a division of Eli Lilly and Company; Lundbeck; Organon Inc.; Pharmacia Corporation; Pfizer Inc.; Pierre Fabre; Wyeth Pharmaceuticals; American Medical Association; Anclote Foundation; Bristol-Myers Squibb; Eisai Inc.; International Clinical Research; Janssen Pharmaceutica and Research Foundation; Kali Duphar Laboratories; Mead Johnson Laboratories; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Parke-Davis, Division of Warner-Lambert Company; Quintiles; Sandoz Pharmaceuticals Corporation; Synthelabo; Tampa General Hospital-University Psychiatry Center; TAP Pharmaceuticals; Warner Chilcott Pharmaceutical Company; Worldwide Clinical Trials; AstraZeneca Pharmaceuticals; Boehringer Ingelheim; Boots Pharmaceuticals; Charter Hospitals; Ciba Geigy Corporation, Pharmaceutical Division; Dista Products; Excerpta Medica Asia; Humana; ICI; Marion Merrill Dow; McNeil Pharmaceuticals; Organon Inc.; Novo Nordisk Pharmaceuticals Inc., Rhone-Poulenc Rorer Pharmaceuticals; Roerig; Schering Plough; Corporation; Solvay Pharmaceuticals, Inc.; Layton Bioscience; Medical Outcome Systems 8, 13 Richard C. Shelton, M.D. Eli Lilly and Company; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; Rhone-Poulenc Rorer Pharmaceuticals; Sanofi Pharmaceuticals, Inc.; Wyeth Pharmaceuticals; AstraZeneca Pharmaceuticals; Abbott Laboratories; Bristol-Myers Squibb; Solvay Pharmaceuticals, Inc. 65, 87, 96 Larry J. Siever, M.D. Janssen Pharmaceutica and Research Foundation 65, 84, 87 Linmarie Sikich, M.D. Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company 48 Deborah R. Simkin, M.D. Pfizer Inc.; Alza Pharmaceuticals; GlaxoSmithKline 83, 84 Gregory E. Simon, M.D. Group Health Cooperative; Eli Lilly and Company 59 Naomi M. Simon, M.D. Bristol-Myers Squibb; Forest Laboratories, Inc.; GlaxoSmithKline; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; Wyeth Pharmaceuticals 10 Samuel G. Siris, M.D. Pfizer Inc.; Eli Lilly and Company; Merck & Co., Inc. 30 Gary W. Small, M.D. Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Abbott Laboratories; Lilly Research Laboratories, a division of Eli Lilly and Company; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Organon Inc.; Forest Laboratories, Inc.; Eisai Inc. 86

XXVII DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Michael W. Smith, M.D. Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; GlaxoSmithKline; AstraZeneca Pharmaceuticals; Kaiser; Bristol- Myers Squibb; Pfizer Inc.; Upsher-Smith; National Institute of Mental Health 5 Thomas J. Spencer, M.D. Abbott Laboratories; Alza Pharmaceuticals; Boston Life Sciences; Bristol-Myers Squibb; Eisai Inc.; GlaxoSmithKline; Gliatech; Lilly Research Laboratories, a division of Eli Lilly and Company; Medeva; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Shire U.S., Inc.; Solvay Pharmaceuticals, Inc.; Wyeth Pharmaceuticals 3, 86 Stephen M. Stahl, M.D. Bayer Corporation, Pharmaceutical Division; Boehringer-Ingelheim; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Lundbeck; Organon Inc.; Parke-Davis, Division of Warner-Lambert Company; Pfizer Inc.; Pharmacia Corporation; Sanofi Pharmaceuticals, Inc.; Solvay Pharmaceuticals, Inc.; Watson; Wyeth Pharmaceuticals; Yamanouchi; AstraZeneca Pharmaceuticals; Abbott Laboratories; Aventis; Fabre Kramer; Lorex; Lundbeck; Neurocrine; Novartis Pharmaceuticals Corporation; Pierre Fabre; Sanao; Roche; Sumimoto 37, 57 Judy L. Stange, Ph.D. SAMHSA (employer) 90 Dan J. Stein, M.D. MRC Unit on Anxiety Disorders (employer) 57 Murray B. Stein, M.D. Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; GlaxoSmithKline; Solvay Pharmaceuticals, Inc.; Wyeth Pharmaceuticals; Allergan; Alza Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Hoffman-LaRoche; Pharmacia Corporation 61 Hans Steiner, M.D. Abbott Laboratories; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation 14, 65 Jonathan W. Stewart, M.D. Organon Inc. 6 Nada L. Stodand, M.D. Eli Lilly and Company; Solvay Pharmaceuticals, Inc.; Pfizer Inc. 49 Eric C. Strain, M.D. Schering-Plough Corp. 55, 66 David L. Sultzer, M.D. Pfizer Inc.; Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation 7 Patricia Suppes, M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Pharmaceutical Research Institute 8,11 Alan C. Swann, M.D. Abbott Laboratories; GlaxoSmithKline; UCB; Bristol-Myers Squibb; Shire U.S., Inc.; Novartis Pharmaceuticals Corporation; Shire U.S., Inc.; Robert Wood Johnson 65, 87 Holly A. Swartz, M.D. GlaxoSmithKline; Eli Lilly and Company 3, 37 Carol A. Tamminga, M.D. AstraZeneca Pharmaceuticals 12 Rajiv Tandon, M.D. AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation; Pfizer Inc. 38, 85, 93 Steven D. Targum, M.D. AstraZeneca Pharmaceuticals 14 Pierre N. Tariot, M.D. Abbott Laboratories; AstraZeneca Pharmaceuticals; Bayer Corporation, Pharmaceutical Division; Eisai Inc.; Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Lundbeck; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Sanofi Pharmaceuticals, Inc. Berlex; Pharmacia Corporation; Schwabe 2, 7, 86 Michael E. Thase, M.D. Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Merck & Co., Inc.; Organon Inc.; Pfizer Inc.; Pharmacia Corporation; Wyeth Pharmaceuticals; Parke- Davis, Division of Warner-Lambert Company; Solvay Pharmaceuticals, Inc. 6,11, 59, 66 Diane S. Thompson, M.D. Eli Lilly and Company; GlaxoSmithKline; Organon Inc.; Wyeth Pharmaceuticals; Pfizer Inc. 87 Joyce A. Tinsley, M.D. Pfizer Inc. 76 Mauricio F. Tohen, M.D. Eli Lilly and Company (employer) 24, 48 Martin G. Tracy, J.D. Professional Risk Management Services, Inc. 18, 42, 72 Madhukar H. Trivedi, M.D. Abbott Laboratories; Akzo; Bayer Corporation, Pharmaceutical Division; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Organon Inc.; Pharmacia Corporation; Solvay Pharmaceuticals, Inc.; Janssen Pharmaceutica and Research Foundation; Johnson and Johnson; National Institute of Mental Health; Mead Johnson; Parke- Davis, Division of Warner-Lambert Company; Pfizer Inc.; Wyeth Pharmaceuticals 9, 60 John W. Tsuang, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation 52 Phebe M. Tucker, M.D. Eli Lilly and Company; GlaxoSmithKline; Pfizer Inc.; Solvay Pharmaceuticals, Inc.; Ortho-McNeil 8 Atilla Turgay, M.D. Janssen Pharmaceutica and Research Foundation; Purdue Pharmaceuticals; Eli Lilly and Company; Nestle 74,91 Michael A. Van Ameringen, M.D. GlaxoSmithKline; Pfizer Inc.; Eli Lilly and Company; Wyeth Pharmaceuticals; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb 22 Meera Vaswani, Ph.D. All India Institute of Medical Sciences (employer) 74 Sanjeev Venkataraman, M.D. Organon Inc.; Forest Laboratories, Inc.; Janssen Pharmaceutica and Research Foundation 7 Sumer Verma, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc.; Abbott Laboratories; GlaxoSmithKline; Searle; Janssen Pharmaceutica and Research Foundation; Neotherapeutics 6

XXVIII DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Garry M. Vickar, M.D. Eli Lilly and Company; Johnson and Johnson; Merck & Co., Inc.; GlaxoSmithKline; Pfizer Inc.; Elan; Wyeth Pharmaceuticals 33 Bruce S. Victor, M.D. Eli Lilly and Company; Pfizer Inc.; Wyeth Pharmaceuticals; Bristol-Myers Squibb; Abbott Laboratories 15 Walter V. Vieweg, M.D. Janssen Pharmaceutica and Research Foundation 3 Adele C. Viguera, M.D. Wyeth Pharmaceuticals; Eli Lilly and Company 11,32 Joseph R. Volpicelli, M.D. Mallinckrodt, Inc. 83 Karen D. Wagner, M.D. GlaxoSmithKline; Pfizer Inc.; Abbott Laboratories; Lilly Research Laboratories, a division of Eli Lilly and Company; Bristol-Myers Squibb; Organon Inc.; Forest Laboratories, Inc.; Wyeth Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; Celexa; Lamictal 3, 5 B.Timothy Walsh, M.D. Knoll Pharmaceuticals; Eli Lilly and Company; Ortho-McNeil Pharmaceuticals 59, 86 James K. Walsh, Ph.D. Pharmacia Corporation; Lorex Pharmaceuticals; Searle; Pfizer Inc.; Abbott Laboratories; Amerian Cyanamid; Hoffman-LaRoche; Merck & Co., Inc.; Bristol-Myers Squibb; Wyeth Pharmaceuticals; Takeda Pharmaceuticals; Ancile Pharmaceuticals; Neurocrine Biosciences; Cephalon, Inc.; Sepracor, Inc.; Whitehall-Robbins; Eli Lilly and Company; Sanofi Pharmaceuticals, Inc.; CoCensys Pharmaceuticals; Proctor and Gamble 85 Khakasa H. Wapenyi, M.D. AstraZeneca Pharmaceuticals 29, 75 Julia K. Warnock, M.D. Pfizer Inc.; GlaxoSmithKline; Forest Laboratories, Inc.; Pherin; Solvay Pharmaceuticals, Inc. 65, 87 Deborah Wasilchak Community Care Behavior Health (employer) 43 Peter J. Weiden, M.D. AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc. 9, 86, 92 Daniel R. Weinberger, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb 6,12, 86 Robert M. Weinrieb, M.D. Dupont Pharma 44 Risa B. Weisberg, Ph.D. Pfizer Inc. 22 Myrna M. Weissman, Ph.D. GlaxoSmithKline 3,97 Elizabeth B. Weller, M.D. GlaxoSmithKline; Wyeth Pharmaceuticals; Forest Laboratories, Inc.; Organon Inc.; Johnson and Johnson 97 Gary L. Wenk, Ph.D. Forest Laboratories, Inc. 85 Joyce C. West, Ph.D. APIRE 60 Mark D. Wiederhold, M.D. The Virtual Reality Medical Center; VR Health; Interactive Media Institute 98 Timothy E. Wilens, M.D. Alza Pharmaceuticals; Abbott Laboratories; Meckva; Shire U.S., Inc.; Lilly Research Laboratories, a division of Eli Lilly and Company; GlaxoSmithKline; National Institute of Mental Health; National Institute on Drug Abuse; Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation; Pfizer Inc.; NICMH 5, 47 Denise E. Wilfley, Ph.D. Abbott Laboratories; Ortho-McNeil Pharmaceuticals 86 Martin S. Willick, M.D. Bristol-Myers Squibb 6 John W. Winkelman, M.D. Eli Lilly and Company; Pfizer Inc.; Cephalon, Inc.; Wyeth Pharmaceuticals; Parke-Davis, Division of Warner-Lambert Company; Searle 10, 27, 86 Donna A. Wirshing, M.D. Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals; Organon Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; PPD Pharmaco 3 Scott W. Woods, M.D. Eli Lilly and Company 95 Mary R. Worthen Eli Lilly and Company 11 Janet Wozniak, M.D. Alza Pharmaceuticals; Pharmacia Corporation; Eli Lilly and Company 3, 38 Jesse H. Wright, M.D. Mindstreet 18, 26, 30, 66, 78 Kevan R. Wylie, M.D. Pfizer; Abbott Laboratories; Lilly Research Laboratories, a division of Eli Lilly and Company 49 Joel Yager, M.D. Eli Lilly and Company 7, 26, 30, 77 Rachel Yehuda, Ph.D. GlaxoSmithKline; Pfizer Inc.; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb 8,71 Kimberly A. Yonkers, M.D. Eli Lilly and Company; GlaxoSmithKline; Berlex; Pfizer Inc.; American Home Products; Wyeth Pharmaceuticals 11, 87 Stuart Yudofsky, M.D. Bristol-Myers Squibb 13,37 John M. Zajecka, M.D. Bristol-Myers Squibb; Eli Lilly and Company; Cephalon, Inc.; Cyberonics; GlaxoSmithKline; Lichtwer Pharma; MIICRO, Inc.; Otsuka Pharmaceuticals; Parke-Davis, Division of Warner- Lambert Company; Pfizer Inc.; Wyeth Pharmaceuticals; Abbott Laboratories; Pharmacia Corporation 37 Douglas M. Ziedonis, M.D. Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Pfizer Inc. 33

XXIX DISCLOSURE INDEX

The following presenters on this year's scientific program failed to return the APA disclosure form. The presenter's name and the page number(s) the presenter appears on in this Program Book are listed below:

Nancy C. Andreasen, M.D. 82 Marvis Frazier 80 Earl C. Lawrence, M.A. 41 William Arroyo, M.D. 89 Amarsingh M. Ghorpade, M.D. 48 Alexandra MacLean, M.D. 59 Gregory L. Barker 41 Jodi Goldstein, J.D. 76 Cesare Maffei, M.D. 31 Guido Belsasso, M.D. 89 Norma Hatot 77 Farris Tuma, Sc.D. 71 Eric G. Bing, M.D. 94 Ruben J. Hernandez-Serrano, M.D. 84 Mike Ward 41 Herve Bokobza, M.D. 59 Michael J. Kittay, M.D. 90 Wendy Williams 80 Gary Cobb 80 Louis J. Kraus, M.D. 89 Lishan Workeneh, M.D. 42

XXX SATURDAY, MAY 18, 2002 155TH ANNUAL MEETING

8:00 a.m. Sessions 9:00 a.m. Sessions

COURSES 1-5 COURSES 6-11 Course descriptions are available in the CME Course descriptions are available in the CME Course Brochure included in your registration Course Brochure included in your registration packet. Admission by ticket only. packet. Admission by ticket only.

COURSE 1 8:00a.m.-12 noon COURSE 6 9:00 a.m.-4:00 p.m. Room 102 B, Street Level, Convention Center Room 102 A, Street Level, Convention Center

COMPUTER-ASSISTED DIAGNOSTIC INTERVIEW BASIC CONCEPTS IN ADMINISTRATIVE PSYCHIATRY: THEORY, HUMAN RESOURCES, AND Co-Directors: Paul R, Miller, M.D., Charles Chiu, M.D. FISCAL MAN AGE MINT

COURSE 2 8:00 a.m.-12 noon Co-Directois: Christopher G. Fichtner, M.D., Thomas A. Room 104 A, Street Level, Convention Center Simpatico, M.D. Faculty: L. Mark Russakoff, M.D., Stuart B. Silver, M.D., ANTIPSYCHOTIC-INDUCED MOVEMENT S. Atezaz Saeed, M.D., Shivkumar Hatti, M.D. DISORDERS: ASSESSMENT AND TREATMENT COURSE 7 9:00 a.m.-4:00 p.m. Director Leonardo Cortese, M.D. Room 106 A, Street Level, Convention Center Faculty: Richard Williams, M.D., Michael Caligiuri, Ph.D. INTERPERSONAL PSYCHOTHERAPY COURSE 3 8:00 a.m.-12 noon Room 104 B, Street Level, Convention Center Director Scott P. Stuart, M.D. Faculty: Michael Robertson, M.D. ADD IN CHILDREN AND ADOLESCENTS COURSE 8 £:00a.m.-4:00 p.m. Director Thomas E. Brown, Ph.D. Room 111 A, Street Level, Convention Center Faculty: Jefferson B. Prince, M.D. PERSON ALITY AND POLITICAL BEHAVIOR COURSE 4 8:00 a.m.-12 noon Room 109 A, Street Level, Convention Center Director Jerrold M. Post, M.D.

WRITING ABOUT CLINICAL EXPERIENCES COURSE 9 9:00 a.m.-4:00 p.m. Room 112 A, Street Level, Convention Center Director John S. Strauss, M.D. PSYCHIATRY UPDATE FOR THE INTERNATIONAL COURSE 5 8:00 a.m.-12 noon SPANISH-SPEAKING COLLEAGUE (IN SPANISH) Room 203 B, Level 200, Convention Center Director Gabriel Kaplan, M.D. ECT IN NEUROLOGICAL DISORDERS Faculty: Javier I. Escobar, M.D., Jorge R. Petit, M.D., Eduardo Dunayevich, M.D., Rodrigo A. Pizarro, M.D., Dario F. Mirski, M.D., Co-Directors: Georgios Petrides, M.D., Charles H. Kellner, M.D. Ana Kaplan, M.D. Faculty: C. Edward Coffey, M.D., Raymond A. Faber, M.D., Max Fink, M.D., Chitra Malur, M.D.

1 SATURDAY

COURSE 10 9:00 a.m.-4:00 p.m. 7:00 p.m. Sessions Room 112 B, Street Level, Convention Center

MULTIMODAL TREATMENT OF EATING INDUSTRY-SUPPORTED SYMPOSIA 1-6 DISORDERS INDUSTRY-SUPPORTED SYMPOSIUM 1 Co-Directors: Kathryn J. Zerbe, M.D., Mae S. Sokol, M.D. 7:00 p.m.-10:00 p.m. Millennium Hall, Second Floor, Loews COURSE 11 9:00 a.m.-4:00 p.m. PSYCHIATRY PRACTICE PARADIGM: THE Room 203 A, Level 200, Convention Center EMERGING ROLE OF THE PSYCHIATRIST IN TREATING ALZHEIMER'S DISEASE OUTCOMES: USE OF RATING SCALES Supported by Eisai Inc., Pfizer Inc. Co-Directors: Luis F. Ramirez, M.D., Martha Sajatovic, M.D. Chp: Pierre N. Tariot, M.D.

A Mild Cognitive Impairment Versus Early Alzheimer's 1:00 p.m. Sessions Disease J. Michael Ryan, M.D.

COURSES 12-16 B Mild to Moderate Alzheimer's Disease Course descriptions are available in the CME Pierre N. Tariot, M.D. Course Brochure included in your registration packet. Admission by ticket only. C Depression in Alzheimer's Disease William E. Reichman, M.D.

D Dementia with Abnormal Neurological Features COURSE 12 1:00 p.m.-5:00 p.m. J.Michael Ryan, M.D. Room 104 A, Street Level, Convention Center E Severe Dementia with Agitation and Nursing Home EVIDENCE-BASED MANAGEMENT OF SAD: FOCUS Issues ON LIGHT THERAPY William E. Reichman, M.D. Co-Directors: Raymond W. Lam, M.D., Anthony J. Levitt, M.D. F Psychosis in Alzheimer's Disease William E. Reichman, M.D. COURSE 13 1:00 p.m.-5:00 p.m. Room 104 B, Street Level, Convention Center G Practice Management Gary S. Moak, M.D. NEUROENDOCRINOkOqYmMOOD DISORDER: DYSREGULATION AND TREATMENT INDUSTRY-SUPPORTED SYMPOSIUM 2 7:00 p.m.-10:00 p.m. Co-Directors: JMtark A. Ftye, M.D., Natalie L. Rasgon, M.D. Regency Ballrooms A-C, Second Floor, Loews Faculty: D. Jeffrey Newport, M.D., Stuart N. Seidman, M.D. MOLECULES AND MOOD DISORDERS: DRUG COURSE 14 - WITHDRAWN DISCOVERY AND THE TREATMENT OF DEPRESSION COURSE 15 1:00 p.m.-5:00 p.m. Supported by Forest Laboratories, Inc. Room 108 B, Street Level, Convention Center Chp: Jerrold F. Rosenbaum, M.D. THE EVALUATION AND MANAGEMENT OF PAIN A Antidepressant Drug Discovery: The Ways, Means, and Director: Steven A. King, M.D. Needs Michael]. Owens, Ph.D. COURSE 16 1:00 »,m.-5:00 p.m. Room 109 A, Street Level, Convention Center B The Phenomenon of Single Isomer Drugs Joseph Gal, Ph.D. DREAM TRANSLATION! ONE EMPIRICALLY-BASED APPROACH C Refining Current Therapies: Clinical Implications to the Treatment of Depression Director: Milton Kramer, M.D. C. Lindsay DeVane, Pharm.D. D The State-of-the-Art in Treating Depression: 2002 Andrew A. Nierenberg, M.D.

2 SATURDAY

INDUSTRY-SUPPORTED SYMPOSIUM 3 INDUSTRY-SUPPORTED SYMPOSIUM 5 7:00 p.m.-10:00 p.m. 7:00 p.m.-10:00 p.m. Grand Ballroom Salons E/F, Level 5, Marriott Wyndham Ballrooms A/B, First Floor, Wyndham

BIPOLAR DISORDER: NEW NATIONWIDE DATA NEW APPROACHES FOR TREATING ADHD: THE ON MISDIAGNOSIS AND COMMUNITY COSTS WHOLE-LIFE PERSPECTIVE Supported by GlaxoSmtihKline Supported by Eli LiUy and Company Chp: Mark A. Fiye, M.D. Chp: Christopher J. Kratochvil, M.D. A Prevalence and Burden of Depression in the Co-Chp: Janet Wozniak, M.D. Community and Primary Care Myma M. Weissman, Ph.D. A ADHD: DSM-IV and Beyond Thomas E. Brown, Ph.D. B The True Prevalence of Bipolar Spectrum Disorder Robert MA. Hirschfeld, M.D. B ADHD: Phenotypes and Pathophysiologies Albert J. Allen, M.D., David Michelson, M.D. C Human Suffering and Economic Burden in a Large Community Sample C New ADHD Treatment Options on the Horizon Joseph R. Calabrese, M.D. Christopher J. Kratochvil, M.D. D New Developments in the Treatment of Bipolar D From Childhood to Adolescence: Diagnosis and Depression Comorbidity Issues MarkA.Frye,M.D. Thomas J. Spencer, M.D. E The Challenge of Bipolar Disorder in Children and Adolescents E Issues in Diagnosing and Treating the Adult ADHD Karen D. Wagner, M.D. Patient Lenard A. Adler, M.D. INDUSTRY-SUPPORTED SYMPOSIUM 4 7:00 p.m.-10:00 p.m. Discussant: Janet Wozniak, M J). Grand Ballroom Salons G/H, Level 5, Marriott INDUSTRY-SUPPORTED SYMPOSIUM 6 IMPROVING PATIENT OUTCOMES ACROSS THE 7:00 p.m.-10:00 p.m. SPECTRUM OF BIPOLAR DISORDER Wyndham Ballrooms C/D, First Floor, Wyndham Supported by Pftzer Inc. ANTIPSYCHOTIC THERAPY AND Chp: David J. Kupfer, M.D. CARDIOVASCULAR DISEASE: THE UNFOLDING STORY A Managing the Pendulum of Mood in Bipolar Disorder Supported byjanssen Phrnnacadica Jack M. Gorman, M.D. B Acute Mania: Pharmacologic Treatment Strategies Chp: Donald C. Goff, M.D. David J. Kupfer, M.D. A Antipsychotic Therapy in Patients with Comorbidities: C Phase-Specific Psychotherapy for Bipolar Disorder Issues and Polypharmacy Holly A. Swartz,M.D. Donald C. Goff, M.D.

D Gender Variation in Bipolar Disorder B Torsade de Pointes, QT, and Antipsychotic Drugs Ellen Leibenluft, M.D. Walter V. Vieweg, M.D.

E The Longitudinal Course of Bipolar Disorder Across the C A Focus on Health: Metabolic Consequences of Life Cycle Antipsychotic Therapy Ellen Frank, Ph.D. Donna A. Wirshing, M.D.

D Antipsychotics and Diabetes: A Current Perspective on Epidemiology Michael J. Sernyak, M.D.

E Mechanisms of Antipsychotic-Induced Glucose Dysregulation and Insulin Resistance John W. Newcomer, M.D.

3 American psychiatric Association Audiotapes Recorded Live!

High Quality Continues for the 2002 Annual Meeting...

Live recordings will be available for most of the following:

• Lectures • Advances in Research ? Presidential Symposium ? Medical Updates ? Scientific and Clinical Reports ? Symposia • Debate • Resetrch Avarices in Medicine

Tapes may be purchased on site at Mobiltape's booth in the Convention Center, Level II Lobby.

Mobiltape Company, Incorporated 24730 Avenue Tibbitts, Suite 170 Valencia, CA 91355 Phone: (661) 295-0504 4> (800) 369-5718 Fax: (661)295-8474 Webside: www.mobiltape.com

4 SUNDAY, MAY 19, 2002 155TH ANNUAL MEETING 8:00 a.m. Sessions INDUSTRY-SUPPORTED SYMPOSIA 7-12 INDUSTRY-SUPPORTED SYMPOSIUM 7 COURSES 17-22 8:00 a.m.-ll:00 a.m. Course descriptions are available in the CME Millennium Hall, Second Floor, Loews Course Brochure included in your registration packet. Admission by ticket only. DIAGNOSIS AND TREATMENT ISSUES IN CHILD AND ADOLESCENT BIPOLAR DISORDERS COURSE 17 8:00 a.m.-12 noon Supported by Abbott Laboratories Room 107 A, Street Level, Convention Center Chp.: Karen D. Wagner, M.D. DSM-IV-TR CULTURAL FORMULATIONS: DIAGNOSIS AND THERAPY A Diagnosis and Course of Bipolar Disorder in Children and Adolescents Director: Russell F. Lim, M.D. Karen D. Wagner, M.D. Faculty: J. Charles Ndlela, M.D., Candace M. Fleming, Ph.D., Frances G. Lu, M.D., Michael W. Smith, M.D. B Genetic and Environmental Effects of Bipolar Disorder on Families and Offspring COURSE 18 8:00 a.m.-12 noon Kiki D. Chang, M.D. Room 108 B, Street Level, Convention Center C Pharmacologic Treatment of Children and Adolescents THE PSYCHIATRIST AS EXPERT WITNESS with Bipolar Disorders Director: Phillip J. Resnick, M.D. Robert A. Kowatch, M.D.

COURSE 19 8:00 a.m.-12 noon D Novel and Maintenance Treatment Approaches in Pediatric Bipolarity Room 112 A, Street Level, Convention Center Robert L. Findling, M.D. TRAINING IN THE USE OF THE POSITIVE AND NEGATIVE SYNDROME SCALE E Diagnostic and Treatment Implications of Psychiatric Comorbidity in Juvenile Bipolar Disorder Co-Directors: Lewis A. Opler, M.D., Paul M. Ramirez, Ph.D. Timothy E. Wilens, M.D.

COURSE 20 8:00 a.m.-12 noon INDUSTRY-SUPPORTED SYMPOSIUM 8 Room 113 B, Street Level, Convention Center 8:00 a.m.-ll:00 a.m. Regency Ballrooms A-C, Second Floor, Loews THE EVALUATION AND IDENTIFICATION OF THE MAJOR DEMENTIAS LATE-LIFE DEPRESSION: OLD MYTHS AND NEW DATA Director: Raymond A. Faber, M.D. Supported by Forest Laboratories, Inc. Faculty: Kevin F. Gray, M.D., Randolph B. Schiffer, M.D. Chp.: Steven P. Roose, M.D. COURSE 21 8:00 a.m.-12 noon Lecture Hall 114, Street Level, Convention Center A Late-Life Depression: Neuroanatomy and Medical Comorbidity ANTICONVULSANTS IN BIPOLAR DISORDER Anand Kumar, M.D.

Co-Directors: Joseph R. Calabrese, M.D., Mark A. Frye, M.D. B Depression: Pseudodementia and Executive Dysfunction Faculty: Terence A. Ketter, M.D. George S. Alexopoulos, M.D.

COURSE 22 8:00 a.m.-12 noon C How Long Should Antidepressant Trials Be in Geriatric Room 203 B, Level 200, Convention Center Depression? Harold A. Sackeim, Ph.D., Steven P. Roose, M.D., Tal Burt, M.D. APPRECIATING AND ALLEVIATING SPOUSAL CAREGIVER BURDEN IN DEMENTIA D Treatment of Depression in the Old and the Old-Old Steven P. Roose, M.D. Co-Directors: Sheila M. Loboprabhu, M.D., Kimberly A. Arlinghaus, M.D. E Interpersonal Psychotherapy Therapy in Late-Life Faculty: Ellen F. Barr, M.S.W., James W. Lomax II, M.D. Depression: Who Benefits? Charles F. Reynolds III, M.D.

5 SUNDAY

INDUSTRY-SUPPORTED SYMPOSIUM 9 A Psychotic Illness in Children 8:00 a.m.-ll:00 a.m. Jean A. Frazier, M.D. Grand Ballroom Salons E/F, Level 5, Marriott B From Getting by to Getting Better DEPRESSIVE SUBTYPES: THE MULTIPLE FACES OF Gerald A. Maguire, M.D. DEPRESSION C Raising the Bar of Expectations Supported by Organon Inc. Ralph Aquila, M.D. Chp.: Maurizio Fava, M.D. D Madness and the Rest of a Life Anne Alonso, Ph.D. A Atypical Depression: An Often Under-Recognized Condition E Best Practices in Psychosocial Rehabilitation for Jonathan W. Stewart, M.D. Psychotic Illnesses Paul J. Barreira, M.D. B Treatment Challenges in Anxious Depression Maurizio Fava, M.D. F Is the Cheapest Alternative the Most Economical? Sumer Verma, M.D. C Melancholic Depression: Are Dual-Action Antidepressants Superior to Selective Agents? INDUSTRY-SUPPORTED SYMPOSIUM 12 J. Craig Nelson, M.D. 8:00 a.m.-ll:00 a.m. Wyndham Ballrooms C/D, First Floor, Wyndham D Vascular Depression ADVANCES IN THE TREATMENT OF PSYCHOSIS: Ranga K. Krishnan, M.D. MINIMIZING THE BURDEN OF DISEASE Supported by Bristol-Myers Squibb Company E Practical Approach to Psychotic Depression Linda L. Carpenter, M.D. Chp.: Daniel R. Weinberger, M.D.

INDUSTRY-SUPPORTED SYMPOSIUM 10 A The Public Health Impact of Schizophrenia 8:00 a.m.-ll:00 a.m. Norman Sartorius, M.D. Grand Ballroom Salons G/H, Level 5, Marriott B Evolution of Antipsychotic Therapies: Overcoming RECOVERY FROM DEPRESSION: NEW Treatment Barriers PERSPECTIVES TO IMPROVE OUTCOMES Daniel R. Weinberger, M.D. Supported by Wyeth Pharmaceuticals C Optimizing Management of Schizophrenia: Bridging the Chp.: Michael E. Thase, M.D. Gap Between Clinical Research and Real Worl Clinical Practice A Recovery from Depression: Conceptual Underpinnings Andrew J. Cutler, M.D. Michael E. Thase, M.D. D Caring for a Family Member with Schizophrenia: A B Augmentation and Combination Strategies for the Newer Personal Account Antidepressants Martin S. Willick, M.D. Andrew A. Nierenberg, M.D.

C Combining Psychotherapy and Medication for Depression 9:00 a.m. Sessions John C. Markowitz, M.D. COURSES 23-29 D Maximizing Efficacy in the Treatment of Chronic Course descriptions are available in the CME Depression Course Brochure included in your registration Susan G. Kornstein, M.D. packet. Admission by ticket only. INDUSTRY-SUPPORTED SYMPOSIUM 11 8:00 a.m.-ll:00 a.m. COURSE 23 9:00 a.m.-4:00 p.m. Wyndham Ballrooms A/B, First Floor, Wyndham Room 102 A, Street Level, Convention Center TREATING PSYCHOTIC ILLNESS ACROSS THE LIFE BASIC CONCEPTS IN ADMINISTRATIVE PSYCIATRY: SPAN: ARE DRUGS ENOUGH? CARE MANAGEMENT, LAW, AND ETHICS Supported by E/i Lilly and Company Co-Directors: Christopher G. Fichtner, M.D., Wesley Sowers, M.D. Chp.: Paul J. Barreira, M.D. Faculty: Stephen H. Dinwiddie, M.D., William G. Wood, M.D., Co-Chp.: Sumer Verma, M.D. Steven Moffic, M.D., John A. Talbott, M.D.

6 SUNDAY

COURSE 24 9:00 a.m.-4:00 p.m. MEMORIAL TO DECEASED MEMBERS Room 102 B, Street Level, Convention Center ANNOUNCEMENT OF ELECTION RESULTS THE SUBJECTIVE EXPERIENCE: CRUCIAL KEYS TO Catherine S. May , M.D., Chairperson, THERAPY AND TO THE HUMAN MIND Committee of Tellers Director: Vincenzo R. Sanguined, M.D. REPORTS TO THE MEMBERSHIP Faculty: Donatella Marazziti, M.D. Secretary: Pedro Ruiz, M.D. COURSE 25 9:00 a.m.-4:00 p.m. Treasurer: Curol A. Bernstein, M.D. Room 104 A, Street Level, Convention Center Speaker, Assembly: Nada L. Stotland, M.D. Speaker-Elect, Assembly: Albert C. Gaw, M.D. THERAPEUTIC INTERVENTIONS IN EATING Chairperson, By-Laws Committee: DISORDERS: BASIC PRINCIPLES Jo-Ellyn M. Ryall, M.D. Chairperson, Elections Committee: Director: David C. Jimerson, M.D. Yvonne B. Ferguson, M.D. Faculty: Michael J. Devlin, M.D., Katherine A. Halmi, M.D., Chariperson, Membership Committee: James E. Mitchell, M.D.Joel Yager, M.D. Bernard A. Katx, M.D. Medical Director: Steven M. Mirin, M.D. COURSE 26 9:00 a.m.-4:00 p.m. Room 106 A, Street Level, Convention Center ANNUAL FORUM MONEY MATTERS: USING THEORY IN CLINICAL ADJOURNMENT PRACTICE *Members-in-Training, General Members, Fellows, Life Director: Cecilia M. Mikalac, M.D. Fellows, and Life Members. Badge or APA membership card necessary for admission. No cameras or tape recorders will be COURSE 27 9:00 a.m.-4:00 p.m. permitted. Room 108 A, Street Level, Convention Center ALZHEIMER'S DISEASE: ADVANCED APPROACHES 1:00 p.m. Sessions TO TREATMENT Director: William E. Reichman, M.D. COURSES 30-38 Faculty: Constanine G. Lyketsos, M.D., David L. Sultzer, M.D., Course descriptions are available in the CME Course Brochure included in your registration Peter M. Aupperle, M.D., Jacobo E. Mintzer, M.D., Pierre N. packet. Admission by ticket only. Tariot, M.D.

COURSE 28 9:00 a.m.-4:00 p.m. Room 111 A, Street Level, Convention Center COURSE 30 1:00 p.m.-5;00 p.m. Room 104 B, Street Level, Convention Center MEDICAL ETHICS 101 INTRODUCTION TO CORRECTIONAL PSYCHIATRY Director: Edmund G. Howe, M.D. Co-Directors: James E. Dillon, M.D., Lee H. Rome, M.D. COURSE 29 9:00 a.m.-4:00 p.m. Faculty: Richard S. Jackson, M.D., Sanjeev Venkataraman, M.D. Room 113 C, Street Level, Convention Center COURSE 31 1:00 p.m.-5;00 p.m. BUILD YOUR OWN RELATIONAL DATABASE Room 107 A, Street Level, Convention Center ELECTRONIC MEDICAL RECORD INTEGRATIVE PSYCHOTHERAPY SUPERVISION: BASIC TOOLS Director: Daniel A. Deutschman, M.D. Director: Paul Rodenhauser, M.D. Faculty: Ramona Dvorak, M.D., Albert F. Painter, Psy.D., 12:30 p.m. Session John R. Rudisill, Ph.D.

BUSINESSMEETING COURSE 32 1:00 p.m.-5:00 p.m. Room 107 B, Street Level, Convention Center (Voting Members Only*) CORE COMPETENCIES IN WORKPLACE PSYCHIATRY 12:30 p.m.-1:30 p.m. APA. Committee on Psychiatry in the Workplace, Academy of Rooms 201 A.C, Level 200, Convention Center Organisational and Occupational Psychiatry Director: Ronald Schouten, M.D. CALL TO ORDER Faculty: Stephen H. Heidel, M.D., Steven E. Pflanz, M.D., Richard K. Harding, M.D., President Marcia Scott, M.D.

7 SUNDAY

COURSE 33 1:00 p.m.-5:00 p.m. Room 108 B, Street Level, Convention Center 1:30 p.m. Sessions

PSYCHIATRIC DISORDERS IN PREGNANCY AND INDUSTRY-SUPPORTED SYMPOSIA 13-18 POSTPARTUM INDUSTRY-SUPPORTED SYMPOSIUM 13 Co-Directors: Shaila Misri, M.D., Kristin S. Sivertz, M.D. 1:30 p.m.-4:30 p.m. Faculty: Diana Carter, MB., Maria R. Corral, M.D., Deirdre M. Millennium Hall, Second Floor, Loews Ryan, M.B. RECENT DEVELOPMENTS IN THE SCIENCE AND COURSE 34 1:00 p.m.-5;00 p.m. TREATMENT OF PTSD Room 109 A, Street Level, Convention Center Supported by GlaxoSmithKline

EVIDENCE-GUIDED DUAL DIAGNOSIS TREATMENT Chp.: Jonathan R.T. Davidson, MD. Co-Chp.: Rachel Yehuda, Ph.D. Director: Andrew P. Ho, M.D. Faculty: Robert Chang, M.D., Davin A. Agustines, MD., Carol A Risk and Resilience Factors in PTSD Giannini, M.PJi., James Smith, M.D., David Haponski, M.S.W. Rachel Yehuda, Ph.D.

COURSE 35 1:00 p.m.-5;00 p.m. B What Can Neuroimaging Teach Us About PTSD? Scott L. Rauch, M.D. Room 112 A, Street Level, Convention Center C Medication Strategies in PTSD IRRESISTIBLE SLEEP: NARCOLEPSY UPDATE David V. Sheehan, M.D. Director: Lois Krahn, M.D. D Treatment of PTSD with Exposure Therapy Faculty: Mark R. Hansen, M.D., Steven I. Altchuler, M.D., Barbara O. Rothbaum, Ph.D. Jarrett W. Richardson, M.D. E Using Assessment Tools in Clinical Practice: When, Why, 1:00 p.m.-5;00 p.m. COURSE 36 and How? Room 112 B, Street Level, Convention Center Kathryn M. Connor, M.D.

INTEGRATING PHARMACOTHERAPY AND INDUSTRY-SUPPORTED SYMPOSIUM 14 PSYCHOTHERAPY 1:30 p.m.-4:30 p.m. Regency Ballrooms A-C, Second Floor, Loews Co-Directors: Barton J. Blinder, M.D., Bernard D. Beitman, MD. Faculty: Mark G. Barad, M.D. CUSTOMIZING CARE FOR PATIENTS WITH BIPOLAR DISORDER COURSE 37 1:00 p.m.-5:00 p.m. Supported by AstraZeneca Pharmaceuticals Room 113 B, Street Level, Convention Center Chp.: Gary S. Sachs, M.D. PSYCHIATRIC INTERVENTIONS IN DISASTERS: LESSONS FROM EXPERIENCE A Intervention for Refractory Patients Patricia Suppes, M.D. Director: Carol S. North, M.D. Faculty: Betty Pfefferbaum, M.D., Phebe M. Tucker, M.D. B Significance of Psychosis Charles L. Bowden, M.D. COURSE 38 1:00 p.m.-5;00 p.m. Room 203 B, Level 200, Convention Center C Choosing Initial Mood Stabilizer After Acute Mania Guy M. Goodwin, M.D. MELATONIN AND LIGHT TREATMENT OF SAD, SLEEP, AND OTHER BODY CLOCK DISORDERS D Selection of an Acute Treatment Strategy: Sequential Versus Stratified Approach Director: Alfred]. Lewy, M.D. Gary S. Sachs, M.D. Faculty: George Brainard, Ph.D. E Dealing with Common Problems During Ongoing Treatment in Bipolar Disorder W. Gordon Frankle, M.D.

8 SUNDAY

INDUSTRY-SUPPORTED SYMPOSIUM 15 INDUSTRY-SUPPORTED SYMPOSIUM 17 1:30 p.m.-4:30 p.m. 1:30 p.m.-4:30 p.m. Grand Ballroom Salons E/F, Level 5, Marriott Wyndham Ballrooms A/B, First Floor, Wyndham

THE AGING BRAIN AND VULNERABILITY TO THE ADHERENCE CHALLENGE: CHRONIC ISSUES DEPRESSION AND EMERGING SOLUTIONS WITH Supported by Orginan Inc. ANTIPSYCHOTIC THERAPY Supported byjanssen PharmtceutJca, Chp.: Charles F. Reynolds III, MD. Chp.: John M Kane, MD. A Age, Neurobiology, and Treatment Response Co-Chp.: Stephen R Marder, MD. Madhukar H. Trivedi, MD. A Approaching the Adherence Challenge B The Impact on Cognition of Pharmacological Treatment Stephen R. Marder, MD., Donna A Wirshing, MD., for Late-Life Depression William G Wirshing, MD. Ruth O'Hara, Ph.D., Alan F. Schatzberg, MD., Greer M Murphy, M.D. B Pharmacologic Options for Schizophrenia: Implications for Compliance C Pharmacogenetics in Geriatric Depression John M Kane, MD. Greer M. Murphy, MD. C Research Experience with Long-Acting Atypical D Treatment of the Depressed: Old-Old in Outpatient and Antipsychotic Medication Long-Term Care Settings Samuel J. Keith, MD. Steven P. Roose, MD. D Views from the Nursing Perspective: Problems and INDUSTRY-SUPPORTED SYMPOSIUM 16 Solutions 1:30 p.m.-4:30 p.m. Kathleen Jarboe, RN. Grand Ballroom Salons G/H, Level 5, Marriott Discussant: Joe Lovelace, J.D. LONG-TERM MANAGEMENT OF MOOD DISORDERS Supported by Cybenvncs, Inc. INDUSTRY-SUPPORTED SYMPOSIUM 18 1:30 p.m.-4:30 p.m. Chp.: A John Rush, MD. Wyndham Ballrooms C/D, First Floor, Wyndham Co-Chp.: Harold A Sackeim, Ph.D. CHALLENGES AND OPPORTUNITIES IN THE A Does Medication Change the Long-Term Course of Mood MANAGEMENT OF PSYCHOTIC DISORDERS Disorders? Supported by Bristol-Myers Squibb Company Susan G. Kornstein, M.D. Chp.: Diana O. Perkins, MD. B Does Psychotherapy Change the Long-Term Course of Co-Chps.: Jeffrey A Lieberman, MD., Joseph P. McEvoy, MD. Mood Disorders? Robin B.Jarrett,Ph.D. A Intervening Early in the Evolution of Schizophrenia: Need for Novel Approaches During the Prodromal Phase C Does ECT Alter the Long-Term Course of Mood Disorders? Patrick D. McGorry, Ph.D., Lisa Phillips, MS.C, Alison R Harold A Sackeim, Ph.D. Yung, MD., Paul Amminger, MB., John Koutsogiannis, MD., Jannine Ward, B.A, Phillipe Conus, MD. D Vagus Nerve Stimulation for Depression: Methods and Mechanisms B New Advances in Schizophrenia Pharmacotherapy: Mark S. George, MD. Management of Acute Episodes Diana O. Perkins, MD. E Does Vagus Stimulation Change the Long-Term Course of Mood Disorders? C Improving Long-Term Outcomes in Patients with Lauren B. Marangell, MD. Schizophrenia Peter J.Weiden,MD.

(Continued on next page)

9 SUNDAY

D The Impact of Safety and Tolerability on Patients' INTRODUCTION OF STAGE GUESTS Satisfaction with Therapy Joseph P. McEvoy, MID. INTRODUCTION OF CHAIRPERSONS OF THE SCIENTIFIC PROGRAM COMMITTEE E Mechanism of Action as Predictor for Clinical Utility: AND THE TASK FORCE ON LOCAL Lessons from Schizophrenia Research ARRANGEMENTS Jeffrey A. Lieberman, M.D. Philip R. Muskin, M.D. 2;30 p.m. Sessions Chairperson, Annual Meeting Scientific Png>&n C&rtmttee Marvin Kane field, D.O. LECTURE 1 Chairperson, Task Fonx on Local Arr&ifpnBTts 2:30 p.m.-4:00 p.m. INTRODUCTION OF VISITING DIGNITARIES Lecture Hall 114, Street Level, Convention Center PRESIDENTIAL ADDRESS AAPL/APA'S MANFRED S. GUTTMACHER Richard K. Harding, MD. AWARD LECTURE TbfertrofaBttyR. Dale Walker, MD. John Monahan, Ph.D. RESPONSE OF THE PRESIDENT-ELECT Paul S. Appdbaum, MD. Rethinking Risk Assessment: The MacArthur To be w&xbadby Alan A Stone, MD. Study of Mental Disorder and Violence ADJOURNMENT Chp.: Brian Crowiey, M.D. Co-Chp,: Michael A. Norko, M.D. Legislatures, courts, and the public bive come to expect 7:00 p.m. Sessions that menial health professionals can provide accurate assessment of the risk for violence in mentally ill persons. John Monahan, Ph.D., one of the authors of Redrnhng INDUSTRY-SUPPORTED SYMPOSIA 19-24 Risk Assesffnex: The M&Antxfr StiidyofMaxaJ Disoinerand Vtoiax?) reviews the study's decision-tree approach for INDUSTRY-SUPPORTED SYMPOSIUM 19 identifying patients at risk for violence and discusses ihe 7:00 p.m.-10:00 p.m. implications of the approach for the everyday clinical Millennium Hall, Second Floor, Loews practice of nsk assessment and nsk managemeni. Dr. Monahan, a clinical psychologist, is the Henry L. and TREATMENT OF ANXIETY DISORDERS: WHERE Grace Doherty Charitable Foundation Professor of Law ARE WE, AND WHERE ARE WE GOING? at the University of Virginia in Charlonesviile, where he Supported by Pfizer Inc. is also Professor of Psychology and Legal Medicine. He directed the MacArthur Foundation's Research Network on Mental Health and the Law from 1988 to 1998 and Chp.: R. Bruce Lydiard, M.D. now directs the Foundation's initiative on mandated community treatment. Dr, Monahan formerly received A Comorbidities and Issues to Consider in the Management APA's \Ianfred Gunmacher award tor his book Ttx of Anxiety Disorders dncol Pndxtxfi cf Vtokni Betxtwr and .APA's Isaac Ray Ronald C. Kessler, Ph.D. Award for his contributions to forensic psychiatry. He has been elected to the Institute of Medicine of the B Management of Depression and Demoralization in National Academy of Sciences. He received his doctoral Anxiety Disorders degree from Indiana University. Naomi M. Simon, M.D. THIS SESSION WILL BE AUDIO TAPED. C Managing the Disordered Sleep Associated with Anxiety and Mood Disorders 5;00 p.m. Session John W. Winkelman, M.D. D GAD: Long-Term Treatment to Improve Outcome OFFICIAL OPENING SESSION Mark H. Pollack, M.D.

5:00 p.m.-6:3Q p.m. E Current and Future Treatments for Anxiety: Efficacy and Ballrooms A/B, Ballroom Level, Convention Center Tolerability CALL TO ORDER R. Bruce Lydiard, M.D. Rjchard K. Harding, M.D. PfBxfalt

10 SUNDAY

INDUSTRY-SUPPORTED SYMPOSIUM 20 INDUSTRY-SUPPORTED SYMPOSIUM 22 7:00 p.m.-10:00 p.m. 7:00 p.m.-10:00 p.m. Regency Ballrooms A-C, Second Floor, Loews Grand Ballroom Salons G/H, Level 5, Marriott

ATYPICAL DEPRESSION: OVERVIEW AND NEW TREATMENT OF MOOD AND ANXIETY DISORDERS DEVELOPMENTS IN WOMEN: WHAT IS EVIDENCE AND WHAT IS ART? Supported by Somerset Pharmaceuticals, Inc. Supported by Wyeth Pharmaceuticals

Chp.: Ranga K. Krishnan, M.D. Chp.: Kimberly A. Yonkers, M.D. Co-Chp.: Charles B. Nemeroff, M.D. A Treatment of Mood Disorders in Pregnancy and the A The Biology of Atypical Depression Postpartum Period Ranga K. Krishnan, M.D. Lee S. Cohen, M.D.

B The Biology of PTSD and Atypical Depression: The Role B Course and Treatment of Bipolar Illness During of Early-Life Trauma Pregnancy and the Postpartum Period Linda L. Carpenter, M.D. Adele C. Viguera, M.D.

C Diagnostic Issues in Atypical Depression C New Strategies in Managing PMDD NedH.Kalin,M.D. Kimberly A. Yonkers, M.D.

D Psychotherapy in the Treatment of Major Depression D Gender as a Factor Barbara O. Rothbaum, Ph.D. M. Katherine Shear, M.D.

E New Treatments for Atypical Depression INDUSTRY-SUPPORTED SYMPOSIUM 23 Charles B. Nemeroff, M.D. 7:00 p.m.-10:00 p.m. Wyndham Ballrooms A/B, First Floor, Wyndham Discussant: Martin B. Keller, M.D. PRIMARY MOOD STABILIZERS AS THE CORNER- INDUSTRY-SUPPORTED SYMPOSIUM 21 STONE OF TREATMENT FOR BIPOLAR DISORDER 7:00 p.m.-10:00 p.m. Supported by Eli Lilly and Company Grand Ballroom Salons E/F, Level 5, Marriott Chp.: Paul E. Keck, Jr., M.D. NEW DEVELOPMENTS IN THE TREATMENT OF BIPOLAR DISORDER A Mania and Mood Stabilization: What's New? Supported by A bbott Laboratories Lauren B. Marangell, M.D.

Chp.: Robert MA. Hirschfeld, M.D. B Practical Approaches to Recognizing and Managing Side Effects A Advances in the Treatment of Mania Paul E. Keck Jr., M.D. Gary S. Sachs, M.D. C Treating Depression and Suicidality B Update on the Treatment of Bipolar Depression Michael E. Thase, M.D. Robert MA. Hirschfeld, M.D. D Update on the Treatment of Rapid-Cycling Bipolar C Stabilizing the Course of Refractory Bipolar Illness: Disorder Meeting the Challenges of Dysphoric States and Mixed Joseph F. Goldberg, M.D. Mania Patricia Suppes, M.D. E Compliance and Optimizing Function Guy M. Goodwin, M.D. D Update on Psychosocial Treatments of Bipolar Disorder Michael W. Otto, Ph.D. F The Doctor/Patient Relationship: How to Get Help for the One You Love E The Multiple Goals of Maintenance Treatment MaryKWorthen Charles L. Bowden, M.D.

11 SUNDAY

INDUSTRY-SUPPORTED SYMPOSIUM 24 MEDIA SESSION 2 7:00 p.m.-10:00 p.m. 7:00 p.m.-10:00 p.m. Congress Rooms A-C, Fourth Floor, Loews Wyndham Ballrooms C/D, First Floor, Wyndham

MOLECULES OF THE MIND: THE SCIENCE OF PSYCHIATRY GOES TO THE MOVIES SCHIZOPHRENIA Supported by A straTjeneca Pharmaceuticals Co-Chps.: Steven E. Hyler, M.D., Harvey R. Greenberg, M.D. Clip.: Jeffrey A. Lieberman, M.D. 2 Memento (120 minutes) A The Neurobiology of Cognitive Dysfunction in Schizophrenia Distributor: Facets Multimedia David A. Lewis, M.D. 1517 West Fullerton B Nicotinic Receptors and the Genetics of Schizophrenia Chicago, IL 60614 and Bipolar Disorder Robert Freedman, M.D. Memento is a film about the quest of Leonard Shelby. Although he wears expensive, tailored suits, and drives a late-model C Glutamatergic Transmission in Schizophrenia Jaguar sedan, he lives in cheap anonymous motels, paying his Carol A. Tamminga, M.D. way with thick wads of cash. Shelby looks like a successful D White-Matter Abnormalities in Schizophrenia businessman; however, his only work is the pursuit of Kenneth L. Davis, M.D. vengeance. He spends all his time tracking and punishing the man who raped and murdered his wife. The difficulty of E Molecular Biology and Genetics of Cortical Function in locating his wife's killer is compounded by the fact that he Schizophrenia suffers from a rare unbeatable form of memory loss. Although Daniel R. Weinberger, M.D. he can recall details from his life before the "accident," Leonard F Neuroplasticity and Cellular Resilience in Mood cannot remember what happened within 15 minutes of the Disorders event. The police dismiss his suspicions; therefore, Leonard's Husseini K. Manji, M.D. complex life has become an all consuming quest for justice.

Discussant: Steven E. Hyler, MD. MEDIA SESSIONS 1-2

MEDIA SESSION 1 7:00 p.m.-10;00 p.m. Washington Rooms A-C, Third Floor, Loews HOLOCAUST MEMORIES Chp.: Maurice Preter, M.D. 1 Our Children (68 minutes) Distributor: MimiKrant NCJF-Brandeis University Lown 102 MS053 Waltham, MA 02454 Our Children illustrates the impact of massive psychological trauma on childhood and adult development. In this Yiddish- language feature made in Poland, part docudrama, part melancholic comedy, famous Yiddish comedians Dzigan and Shumacher visit an orphanage near the city of Lodz to perform for an audience of Jewish orphans who survived the Holocaust. Their performance, although well intentioned, stirs up painful memories of recent events, but also offends the children by the senti- mentalized and naive depiction of wartime conditions. Having all lived through the reality of separation and loss, the children take over the stage, outdo the performers, and tell their stories.

Discussants: Maurice Preter, M.D., Yehuda Mr, M.D., Don Laub, M.D., Harold J. Bursztajn, M.D.

12 MONDAY, MAY 20, 2002 155TH ANNUAL MEETING

A Medical Morbidity and Mortality in Patients with 7:00 a.m. Sessions Schizophrenia S. Charles Schulz, M.D. PART 1 OF INDUSTRY-SUPPORTED BREAKFAST SYMPOSIA 25-30 B Minimizing Acute and Long-Term Movement Disorders with Atypical Antipsychotics INDUSTRY-SUPPORTED BREAKFAST Lilli Kopala, M.D., David Whitehorn, Ph.D., Hazel SYMPOSIUM 25, PART 1 Woodley, R.N., Connie Hault, M.D., Heather Milliken, M.D., 7:00 a.m.-8:30 a.m. S. Devarajan, M.D., Uttam J. Wadhwa, M.D. Millennium Hall, Second Floor, Loews C Weight Gain and Obesity Secondary to Atypicals: CLINICAL CHALLENGES IN DEPRESSION Immediate and Long-Term Health Threats Supported by GlaxoSmithKline Diana O. Perkins, M.D. Chp.: Prakash S. Masand, M.D. INDUSTRY-SUPPORTED BREAKFAST A Special Challenges in Treating Bipolar Depression and SYMPOSIUM 28, PART 1 Psychotic Depression 7:00 a.m.-8:30 a.m. David V. Sheehan, M.D. Grand Ballroom Salons G/H, Level 5, Marriott

B Growing Up Depressed: The Underserved Child and UNDERSTANDING SLEEP MEDICINE: WHAT THE Adolescent PSYCHIATRIST NEEDS TO KNOW Neal D. Ryan, M.D. Supported by Wyeth Pharmaceuticals

C Cardiovascular Disease and Depression: A Deadly Chp.: Milton K. Erman, M.D. Comorbidity Dominique L. Musselman, M.D. A Sleep, Safety, and Public Policy Mark R. Rosekind, Ph.D. INDUSTRY-SUPPORTED BREAKFAST SYMPOSIUM 26, PART 1 B Sleep Disorders: What the Psychiatrist Needs to Know 7:00 a.m.-8:30 a.m. Lois Krahn, M.D. Regency Ballrooms A-C, Second Floor, Loews C Innovative Strategies in the Management of Insomnia NOVEL ANTIPSYCHOTIC DRUGS: ADVANCES IN Karl Doghramgi, M.D. THE TREATMENT OF PSYCHOTIC SPECTRUM DISORDERS INDUSTRY-SUPPORTED BREAKFAST Supported by Bristol-Myers Squibb Company SYMPOSIUM 29, PART 1 Chp.: Robert E. Hales, M.D. 7:00 a.m.-8:30 a.m. Co-Chp.: Stuart C. Yudofsky, M.D. Wyndham Ballrooms A/B, First Floor, Wyndham

A Bench to Bedside: Rational Selection of Medications in ONE SIZE DOESN'T FIT ALL: DEPRESSION Treating Schizophrenia THERAPIES FOR THE 21ST CENTURY Rona Hu, M.D. Supported by Eli Ully and Company

B What We Have Learned About the Long-Term Chp.: David L. Dunner, M.D. Management of Schizophrenia: What Constitutes Treatment Refractoriness? A The Physical Manifestations of Depression John M. Kane, M.D. John H. Greist, M.D.

INDUSTRY-SUPPORTED BREAKFAST B Improving Outcomes in the Long-Term Treatment of SYMPOSIUM 27, PART 1 Depression: Giving Patients a Choice 7:00 a.m.-8:30 a.m. Maurizio Fava, M.D. Grand Ballroom Salons E/F, Level 5, Marriott C Adapting Psychotherapies to a Patient's Individual Needs ANTIPSYCHOTIC PHARMACOTHERAPY AND THE Ellen Frank, Ph.D. HIPPOCRATIC OATH: ABOVE ALL DO NO HARM Supported by s4.straZeneca Pharmaceuticals

Chp.: Henry A. Nasrallah, M.D.

13 MONDAY

INDUSTRY-SUPPORTED BREAKFAST COURSE 40 8:00 a.m.-12 noon SYMPOSIUM 30, PART 1 Concerto B, Third Floor, DoubleTree 7:00 a.m.-8:30 a.m. Wyndham Ballrooms C/D, First Floor, Wyndham PSYCHIATRIC CONSULTATIONS IN MEDICAL SETTINGS: THE BASICS BREAKING THE SILENCE OF CHILDREN'S MENTAL ILLNESS: NATIONAL INITIATIVES, EARLY Director: Richard L. Elliott, M.D. DETECTION, AND NEW PHARMACOTHERAPIES Supported byjanssen Pharmaceutica COURSE 41 8:00 a.m.-12 noon Overture, Third Floor, DoubleTree Chp.: Robert L. Findling, M.D. RISK ASSESSMENT FOR VIOLENCE A Mental Illness in Children: Diagnosing Outside the Box Hans Steiner, M.D. Director: Phillip J. Resnick, M.D.

B Atypical Antipsychotics in Pediatric Psychiatry: Efficacy COURSE 42 8:00 a.m.-12 noon in Well-Designed Trials Minuet, Fourth Floor, DoubleTree Christopher J. McDougle, M.D. TEACHING PSYCHIATRY? LET HOOLYWOOD RESIDENT'S SESSION HELP! 7:00 a.m.-8:30 a.m. Salon II, First Floor, Courtyard by Marriott Director: Steven E.Hyler, M.D. Faculty: Carol A. Bernstein, M.D., Michael B. First, M.D. MEET THE EXPERTS: SUNNY-SIDE UP COURSE 43 8:00 a.m.-12 noon Chp.: Richard K. Harding, M.D. Rhapsody, Fourth Floor, DoubleTree At this breakfast, nationally recognized "experts" will sit at tables FAMILIES AND MEDICAL ILLNESS: AN with small groups of residents and discuss a variety of career INTEGRATIVE TREATMENT APPROACH issues and opportunities in psychiatry. Topic areas include addiction/substance abuse, administrative psychiatry, child/adolescent Director: John S. Rolland, M.D. psychiatry, consultation-liaison, cultural competency, emergency/ disaster psychiatry, "how to be an expert witness: forensic COURSE 44 8:00 a.m.-12 noon psychiatry," geriatric psychiatry, leadership development, public/ community psychiatry, psychiatry, law and ethics, psycho- Sonata 5, Fifth Floor, DoubleTree dynamic psychotherapy, research, and women's mental health, among others. USING HUMANITIES TO UNDERSTAND MOOD DISORDERS

Director: Emilie S. Passow, Ph.D. 8:00 a.m. Sessions Faculty: Jerome S. Gans, M.D., Steven D. Targum, M.D.

COURSES 39-44 Course descriptions are available in the CME 9:00 a.m. Sessions Course Brochure included in your registration packet. Admission by ticket only. CLINICAL CASE CONFERENCE 1 9:00 a.m.-10:30 a.m. Room 103 B, Street Level, Convention Center COURSE 39 8:00 a.m.-12 noon Ormandy East, Street Level, DoubleTree CONTRASTING PSYCHOPATHOLOGY IN ADOLESCENTS AND ADULTS INTRODUCTION TO TRANSCRANIAL MAGNETIC STIMULATION Moderator: Lynda A. Tenhundfeld, M.D.

Co-Directors: Ziad H. Nahas, M.D., Leon J. Grunhaus, M.D. THIS SESSION IS OPEN TO APA MEMBERS ONLY. Faculty: Sarah H. Lisanby, M.D., Martin P. Szuba, M.D. BLUE REGISTRATION BADGE OR APA MEMBER- SHIP CARD REQUIRED FOR

14 MONDAY

CONTINUOUS CLINICAL CASE CONFERENCE 1: COURSE 50 9:00 a.m.-4:00 p.m. PARTI Sonata 4, Fifth Floor, DoubleTree 9:00 a.m.-12 noon Rooms 106 A/B, Street Level, Convention Center ISSUES IN TRANSPERSONAL PSYCHIATRY

LIVES AND TREATMENTS: TWO PATIENTS, TWO Director: Bruce W. Scotton, M.D. THERAPISTS Faculty: Allan B. Chinen, M.D.John R. Battista, M.D., William W. Foote, M.D, John F. Hiatt, M.D., Francis G. Lu, M.D, Moderator: James W. Lomax II, M.D. Bruce S. Victor, M.D. Presenters: Glen O. Gabbard, M.D., Irma J. Bland, M.D.

THIS SESSION IS OPEN TO APA MEMBERS ONLY. DISCUSSION GROUPS 1-4 BLUE REGISTRATION BADGE OR APA MEMBER- SHIP CARD REQUIRED FOR 9:00 a.m.-10:30 a.m.

These sessions are limited to 25 participants on a first- COURSES 45-50 come, first-served basis. Course descriptions are available in the CME Course Brochure included in your registration 1 Leslie H. Gise, M.D., on Save Time, Make Money, Have packet. Admission by ticket only. Fun! Outpatient Group Therapy for the Seriously Mentally 111 Room 410, Level 4, Marriott

COURSE 45 9:00 a.m.-4:00 p.m. 2 Lenore C. Terr, M.D., on What Makes People Change? Ormandy West, Street Level, DoubleTree Room 413, Level 4, Marriott

PASS THE BOARDS! THE PART II ORAL EXAM 3 Kelly L. Cozza, M.D., and Scott C. Armstrong, M.D., on Quickie Guide to the Cytochrome P450 System (Meet the Director: James C.Y. Chou, M.D. Authors) Faculty: Gregory C. Bunt, M.D. Room 501, Level 5, Marriott

COURSE 46 9:00 a.m.-4:00 p.m. 4 Nehama Dresner, M.D., on Postpartum Depression: Orchestra Room, Second Floor, DoubleTree Prevention and Intervention Room 502, Level 5, Marriott ADVANCED INTERVIEWING TECHNIQUES

Director: Shawn C. Shea, M.D. LECTURES 2-3

COURSE 47 9:00 a.m.-4:00 p.m. LECTURE 2 Aria A, Third Floor, DoubleTree 9:00 a.m.-10:30 a.m. TRAUMATIC BRAIN INJURY: NEUROPSYCHIATRIC Rooms 108 A/B, Street Level, Convention Center ASSESSMENT John M. Oldham, M.D. Director: Robert P. Granacher, M.D. Personality Disorders: New Findings and Current controversies COURSE 48 9:00 a.m.-4:00 p.m. Concerto A, Third Floor, DoubleTree Chp.: John G. Gunderson, M.D. DISORDERS OF THE SELF: DIFFERENTIAL Co-Chp.: Andrew R. Skodol II, M.D. DIAGNOSIS AND TREATMENT Patterns of adaptive and maladaptive behavior have Director: James F. Masterson, M.D. been described for centuries, and broad personality types have been identified, yet whether maladaptive behavior fits within, familiar medical models of path- COURSE 49 9:00 a.m.-4:00 p.m. Symphony Ballroom, Third Floor, DoubleTree ology remains controversial. John M. Oldham, M.D., draws on recent neurobiological research and clinical, longtudinal studies of DSM-IV personality disorders to ADVANCES IN NEUROPSYCHIATRY examine current debate about the relationship between personality and personality disorder. Dr. Oldham is Director: C. Edward Coffey, M.D. Director of the New York State Psychiatric Institute Faculty: Michael R. Trimble, M.D., Mark S. George, M.D. (Continued on next page) 15 MONDAY

and Chief Medico] Officer o! iht- New York Slate MASTER EDUCATOR CLINICAL Orfice of Menial Health. He is also the K'izjbeth K. CONSULTATIONS 1-2 [\>lhrd Professor ol Clinical Psychuirv. Mediant1, .ma LJW And Acting Chairman of the Department ai Psycliijuy 9:00 a.m.-10:30 a.m. at Columbia University Collie ot Physicians and Surgeons. In addition, heis a I raining .ind Supervising These sessions are limited to 25 participants on a first- Psychoanalyst at (.olumbia University Center for Psychoanalytic Training and Research and maintains a come, first-served private practice ot adult ind torensic psychiatry. An APA Fellow, Dr. Oldhim chaired the APA work group 1 Elissa P. Benedek, M.D., on Child Forensic Psychiatry that developed the Prxctx? duxidoie fur M I^iDooii $ Contemporary Issues Bo^fftiffK Pmu>ulu\ Dixmkr and currently chain the Room 111 A, Street Level, Convention Center APA Committee on Quality indicators. Dr. Oldhom graduated from Baylor C College ot Medic;ne m Houston 2 Francine Cournos, M.D., on the Aftermath of Childhood and received his psychiaini; training Jl New York State Parental Loss P^'chiatnc Insuiuif and hus ps>vhoAnalytic training at Room 301, Level 3, Marriott Columbia Univeriiiy. Distinguished Psychiatrist Lecture Series THESE SESSIONS ARE OPEN TO APA MEMBERS THIS SESSION WILL BF. ALIDLOTAPED. ONLY. BLUE REGISTRATION BADGE OR APA MEMBERSHIP CARD REQUIRED FOR LEC1XIRE 3

9:00 a.m.-10:30 a.m. MEDIA SESSIONS 3-4 Rooms 109 A/B, Street Level, Convention Center

AP.VSGEORGE. I'ARJAN AWARD LECTURE MEDIA SESSION 3 9:00 a.m.-10:30 a.m. Washington Rooms A-C, Third Floor, Loews Pedro Ruiz, M.D. AMERICAN FRENZY Accessing Care: A Challenge to the Poor and Dis advantaged Chp.: Jonathan M. Metzl, M.D.

Chp.: Gop.ilaknshna D. L'p,i

Despite overall improvement in ;he soaoivonomK Distributor: University of California Extension jonditioni of thi: United States dunng the last decade, Center for Media and Independent Learning major gaps remain in the health and mental health 2000 Center Street, 4th Floor delivery' system. Pedro Ruiz, MJX disoissrt ihi- dispro- Berkeley, CA 94704 ponionate repres«ntation ot the poor and disadvan- laged among Americans who lack health insurance Time Frenzy, produced by Bob Gliner, a multi-award-winning and suggests ways of improving access to health and mental health care for this group. Dr. Ruiz is Professor documentarian and Professor of Sociology at San Jose State ind Vice-Chair ior CEnical Attairs and Medical University, is a thought-provoking documentary that explores Director of the Mental Sciences Institute .11 the the psychological, sociological, philosophical, and cultural rami- University of Texas Health Science Center in ! lousion. fications of our increasingly fast-paced lives. Time Frenzy Dr, Ruiz, has held senior leadership positions in several examines this new "24-7" reality, compares the American "work rofessional organizations, including the APA, where and consume" lifestyle with that of other countries, and probes Ee currently serves as Secretary as well as Chairperson the impact of technology on personal relationships, education, of the Ethics Appeal Board, Vice-Chairperson 01 the health, and the environment. Council on Addiction Psychiatry, and a member ot the Commission on Global Psychiatry. He has received the MEDIA SESSION 4 9:00 a.m.-10:30 a.m. Simon Bolivar Award, the Administrative Psychiatry Congress Rooms A-C, Fourth Floor, Loews Aivard, and a Special Presidential Commentiation from APA, and the Fjiemplary Psychiatrist Award trom '.he PUPPETRY OF PERSONALITY National Alliance for the Mentally fll. The author of more than J50 publications, he is the co-editor ot Chp.: Ian E. Alger, M.D. Substance Abuse: A Carip^xnsiu; 'fexilvak. Bom in Co-Chp.: Ferruccio A. DiCori, M.D. Cuba, Dr, Ruiz graduated from the University ol Paris, France, and trained in psychiatry at the University of Miami Medical School. 4 The Puppets of Di Cori: New Psychodrama Approach THIS SESSION WILL BE AUDIOTAPED. (70 minutes)

16 MONDAY

Distributor: Ian E. Alger, M.D. B The Analytic Process Scales 500 East 77th Street, #132 Anna M. Burton, M.D. New York, NY 10162 C An Outcome Study for Psychodynamic Psychotherapy Ferruccio A. di Cori, M.D., is an innovator of many therapeutic of Panic Disorder techniques that combine the arts and various theoretical Barbara L. Milrod, M.D., Fredric N. Busch, M.D. approaches to handling problems in relationships throughout the THIS SESSION WILL BE AUDIOTAPED. life cycle. In this demonstration, two adolescent students from the "therapeutic theater course," which Dr. di Cori gives to an audience of over 100 students at the University of Rome, WORKSHOPS volunteer to participate. They are invited to throw to the floor two loosely articulated, amorphous rag doll figures that land in COMPONENTS Ml unanticipated positions vis-a-vis each other on the floor. He then directs the students in pairs and small groups in an COMPONENT WORKSHOP 1 9:00 a.m.-10:30 a.m. imaginative discourse as they project themselves into the lives of Rooms 102 A/B, Street Level, Convention Center the rag doll figures on the floor. This involvement leads to an emerging recognition by them of their personalities, ambitions, HOW TO CONVINCE CORPORATE CEOS THAT and conflicts. MENTAL HEALTH IS A GOOD INVESTMENT APA Committee on APA/Business Relationships

NEW RESEARCH YOUNG INVESTIGATORS' Co-Chps.: Norman A. Clemens, M.D., Lloyd I. Sederer, M.D. POSTER SESSION 1 Participants: Leonard T. Sperry, MD., Paul W. Heck 9:00 a.m.-10:30 a.m. Exhibit Hall D, Street Level, Convention Center COMPONENT WORKSHOP 2 9:00 a.m.-10:30 a.m. Room 103 A, Street Level, Convention Center For further information on New Research Sessions, please refer to the New Research Program and Abstracts Book included in your JUSTICE AND HEALTH EQUITY IN GLOBAL registration packet. PSYCHIATRY APA Commission on Global Psychiatry

ROUNDTABLE DISCUSSION Chp.: Arthur M. Kleinman, M.D. 9:00 a.m.-10:30 a.m. Participants: Benedetto Saraceno, M.D, Ahmed M.F. Rooms 107 A/B, Street Level, Convention Center Okasha, M.D., Carl C. Bell, M.D., Vikram Patel, PhD.

GOVERNMENT RESPONSE TO TERRORISM COMPONENT WORKSHOP 3 9:00 a.m.-10:30 a.m. Room 104 A, Street Level, Convention Center Moderator: Randall D. Marshall, M.D. Participants: John J. Worthington III, M.D., Mary Jane THE AMERICAN PSYCHIATRIC ASSOCIATION AND England, M.D., Sharon E. Carpinello, Ph.D., Regina Dolan- ITS ALLIANCE GO TO AMERICA'S SCHOOLS Sewell, Ph.D., Chip J. Felton, MS.W., Peter S. Jensen, M.D., APA Alliance Matthew J. Friedman, M.D., Robert S. Pynoos, M.D., Jane D. Plapinger, M.P.H., Arieh Y. Shalev, M.D. Chp.: Alicia A. Munoz, B.S.C. Participants: Carol Skiljan, Jorge A. Zapatel, M.D.

SYMPOSIUM 1 COMPONENT WORKSHOP 4 9:00 a.m.-10:30 a.m. 9:00 a.m.-12 noon Room 104 B, Street Level, Convention Center Room 113 B, Street Level, Convention Center WHEN YOUR PHYSICIAN PATIENT IS FROM AN EVIDENCE-BASED PSYCHODYNAMIC THERAPY ETHNIC MINORITY: A CROSS-CULTURAL PART I: STUDYING CLINICAL WORK APPROACH TO TREATMENT American Academy of Psychoanalysis and American Psychoanalytic A PA Committee on Physician Health, Illness, and Impairment Association Co-Chps.: Carmen T. Webb, MD., Patti Tighe, M.D. Chp.: Sheila Hafter-Gray, M.D. Participants: William B. Lawson, MD., Raymond M Reyes, MD., Co-Chp.: Ann-Louise S. Silver, M.D. Hagit Bat-Avi, M.D., Jimmie C. Holland, M.D. A The Analytic Process Scales II: Intervention Quality and Patient Productivity Sherwood Waldron, Jr., M.D.

17 MONDAY

COMPONENT WORKSHOP 5 9:00 a.m.-10:30 a.m. Chp.: Carl B. Greiner, M.D. Room 111 B, Street Level, Convention Center Participants: Jonathan Polan, M.D., Linda F. Pessar, M.D., Surender P. Punia, M.D., Michael J. Vergare, M.D. THE PSYCHIATRIST AND MIGRATION IN THE 21ST CENTURY COMPONENT WORKSHOP 11 9:00 a.m.-10:30 a.m. APA Rhode IslandPsychiatric Society Rooms 407-409, Level 4, Marriott

Co-Clips.: Shahbaz A. Khan, M.D., Thomas O. Osinowo, M.D. THE ROLE OF THE GERIATRIC PSYCHIATRIST IN Participants: Alison M. Hem, M.D., Kazi M. Salahuddin, M.D., PALLIATIVE CARE Madelyn H. Hicks, M.D., Deji Ayonrinde, M.D. APA Committeeon Access and Effectiveness ofPsychiatric Services for the Elderly COMPONENT WORKSHOP 6 9:00 a.m.-10:30 a.m. Rooms 112 A/B, Street Level, Convention Center Chp.: Judith H. W. Crossett, M.D. Participants: Julian Offsay, M.D., Colleen J. Northcott, M.D., RISK MANAGEMENT ISSUES IN PSYCHIATRIC Jaime M. Benitez, M.D. PRACTICE APA Psychiatrists' Purchasing Group, Inc.

Chp.: Alan I. Levenson, M.D. ISSUES 1-18 Participants: Ellen R. Fischbein, M.D., Martin G. Tracy, J.D., Jacqueline M. Melonas, J.D. ISSUE WORKSHOP 1 9:00 a.m.-10:30 a.m. Room 113 A, Street Level, Convention Center COMPONENT WORKSHOP 7 9:00 a.m.-10:30 a.m. Rooms 302/303, Level 3, Marriott HOW TO GET THE MOST OUT OF SUPERVISION: WHAT RESIDENTS NEED TO KNOW THE PHILADELPHIA STORY: A VA UNIVERSITY OF ADDICTION RESEARCH COLLABORATION Chp.: Sarah M. Whitman, M.D. APA Consortium on Orgxnized Service Systems ISSUE WORKSHOP 2 9:00 a.m.-10:30 a.m. Chp.: Laurent S. Lehmann, M.D. Room 113 C, Street Level, Convention Center Participants: George E. Woody, M.D., Charles P. O'Brien, M.D., Laura F. McNicholas, M.D., A. Thomas McLellan, Ph.D. NURSING HOME PSYCHIATRY: PROBLEMS AND SOLUTIONS COMPONENT WORKSHOP 8 9:00 a.m.-10:30 a.m. Room 307, Level 3, Marriott Chp.: Marc I. Rothman, M.D. Participants: Istvan J.E. Boksay, M.D., David L. Snyder, M.D., SUBSTANCE ABUSE IN SPECIAL POPULATIONS APA Council on Addiction Psychiatry Nancy O'Dowd Chp.: Ramon Solhkhah, M.D. ISSUE WORKSHOP 3 9:00 a.m.-10:30 a.m. Participants: Richard T. Suchinsky, M.D., Seeth Vivek, M.D. Room 202 A, Level 200, Convention Center

COMPONENT WORKSHOP 9 9:00 a.m.-10:30 a.m. COGNITIVE-BEHAVIORAL THERAPY TRAINING Independence Ballrooms II/III, Level 3, Marriott FOR RESIDENTS: HOW TO TEACH, MEASURE, AND ATTAIN RESIDENT AGING AND MOURNING IN THE GAY AND LESBIAN COMMUNITY Chp.: Donna M. Sudak, M.D. APA New York CountyDistrict Branch's Committee onGayand Participants: Judith S. Beck, Ph.D., Jesse H. Wright, M.D., Lesbitm Issues HindaF. Dubin,M.D.

Co-Chps.: Benjamin H. McCommon, Jr., M.D., Jordan F. ISSUE WORKSHOP 4 9:00 a.m.-10:30 a.m. Karp, M.D. Room 202 B, Level 200, Convention Center Participants: Alan Schwartz, M.D., Duane D. Shubert, M.D., Jennifer I. Downey, M.D. SUPERVISION 101: SEX, LIES, AND VIDEOTAPE?

COMPONENT WORKSHOP 10 9:00 a.m.-10:30 a.m. Chp.: Chelsea L. Chesen, M.D. Rooms 401-403, Level 4, Marriott Participants: Francisco A. Moreno, MD., Gayle Masterson, MJ3., John C. Racy, M.D. PSYCHIATRY IN THE NEUROSCIENCE CURRICULUM: PROMISE AND PERIL APA Committee on Medical Student Education

18 MONDAY

ISSUE WORKSHOP 5 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 11 9:00 a.m.-10:30 a.m. Room 203 A, Level 200, Convention Center Rooms 414/415, Level 4, Marriott

CHILDREN OF PSYCHIATRISTS: 21ST-CENTURY ACCESS TO PSYCHOTHERAPY TRAINING IN INSIGHTS RESIDENCY: A CURRENT PERSPECTIVE

Co-Chps.: Leah J. Dickstein, MD., Michelle B. Riba, M.D. Chp.: Robert W. Guynn, M.D. Participants: Gail M. Barton, M.D., Zachary Myers, Elizabeth Participants: Sandra Sexson, MD., Anu A. Matorin, M.D., Bakalar Vinay Kapoor, M.D. ISSUE WORKSHOP 6 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 12 9:00 a.m.-10:30 a.m. Room 203 B, Level 200, Convention Center Grand Ballroom Salon A, Level 5, Marriott THE POLICING OF PHYSICIAN-PATIENT BOUNDARIES: SOME INTERNATIONAL USE OF THE PERSONAL DIGITAL ASSISTANT IN PERSPECTIVES PSYCHIATRY Psychiatric Society of Informatics Chp.: Gail E. Robinson, M.D. Participants: Werner Tschan, MD., Carolyn Quadrio, M.D., Chp.: John Luo, M.D. Linda M. Jorgenson, J.D. Participants: Daniel A. Deutschman, M.D., Sol Herman, M.D.

ISSUE WORKSHOP 7 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 13 9:00 a.m.-10:30 a.m. Room 204 A, Level 200, Convention Center Grand Ballroom Salon B, Level 5, Marriott

PERSONALITY DISORDERS IN THE MENTAL SCHIZOPHRENIA WITH COMORBID CONDITIONS: RETARDATION AND DEVELOPMENT DISORDERS CLINICAL AND RESEARCH ISSUES POPULATION Co-Chps.: Michael Y. Hwang, MD., Miklos F. Losonczy, M.D. Co-Chps.: Harvey Stabinsky, MD., Susan Stabinsky, M.D. Participants: Lewis A. Opler, MD., Naveed Iqbal, M.D. Participant: Michael M. Scimeca, M.D.

ISSUE WORKSHOP 8 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 14 9:00 a.m.-10:30 a.m. Rooms 304-306, Level 3, Marriott Grand Ballroom Salon C, Level 5, Marriott

THE IMPACT ON CLINICIANS OF SUICIDE PSYCHOTHERAPY TRAINING FOR THE 21ST- CENTURY PSYCHIATRIST Co-Chps.: Eric M. Plakun, M.D., Jane G. Tillman, Ph.D. Participants: Edward R. Shapiro, M.D., Edward K. Co-Chps.: Diane M. Roston, MD., Rebecca R. Neal, M.D. Rynearson, M.D. ISSUE WORKSHOP 15 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 9 9:00 a.m.-10;30 a.m. Grand Ballroom Salon D, Level 5, Marriott Liberty Ballroom B, Level 3, Marriott TRAINING A CULTURALLY COMPETENT CAREER DEVELOPMENT FOR INTERNATIONAL PSYCHIATRIC WORKFORCE MEDICAL GRADUATES Co-Chps.: Janet E. Osterman, MD., Albert C. Gaw, M.D. Chp.: Renato D. Alarcon, M.D. Participant: Joop De Jong, M.D. Participants: Nyapati R. Rao, MD., Norma C. Panahon, M.D., Gabrielle F. Beaubrun, M.D. ISSUE WORKSHOP 16 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 10 9:00 a.m.-10:30 a.m. Grand Ballroom Salon I, Level 5, Marriott Rooms 411/412, Level 4, Marriott TRANSGENDER CARE: NEW PERSPECTIVES EVALUATION OF TELEPSYCHIATRY SERVICES IN AN INTEGRATED HOSPITAL SYSTEM IN THE Chp.: Dan H. Karasic, M.D. VETERANS ADMINISTRATION AND DEPARTMENT Participants: Daniel Garza, M.D., Vernon A. Rosario, M.D., OF DEFENSE Melanie E. Spritz, D.O.

Co-Chps.: Paul E. Ruskin, M.D., Stephen]. Cozza, M.D. Participants: Brian J. Grady, MD., Stephen I. Deutsch, M.D., James J. Nocks, M.D.

19 MONDAY

ISSUE WORKSHOP 17 9:00 a.m.-10:30 a.m. 5 Glen O. Gabbard, M.D., on Psychodynamic Psychiatry in Grand Ballroom Salon J, Level 5, Marriott Clinical Practice: Third Edition (Meet the Authors) Room 308, Level 3, Marriott HOW TO EFFECTIVELY INTEGRATE MENTAL HEALTH SERVICES IN GENERAL CARE SYSTEMS 6 William Breitbart, M.D., on Psychiatry and Palliative Medicine Chp.: Ann Marie T. Sullivan, M.D. Room 410, Level 4, Marriott Participants: Neal L. Cohen, M.D., Martin H. Maurer, M.D., Juan E. Mezzich, M.D., Amy S. Hoffman, M.D., Richard A. 7 Charles E. Schwartz, M.D., on Working with HTV-Positive Young, M.D. Patients and Their Physicians Room 413, Level 4, Marriott

ISSUE WORKSHOP 18 9:00 a.m.-10:30 a.m. Grand Ballroom Salon K, Level 5, Marriott 8 Brian A. Fallen, M.D., on Recognizing and Treating Neuropsychiatric Lyme Disease BREAKING THE CYCLE OF MATERNAL Room 501, Level 5, Marriott ADDICTION: AN INTEGRATED TREATMENT PROGRAM MAKING A DIFFERENCE LECTURES 4-5 Chp.: Cynthia C. Crone, A.P.N. Participants: Linda L.M. Worley, M.D., Leanne Whiteside- LECTURE 4 Mansell, Ed.D., Veronica L. Williams, M.D. 11:00 a.m.-12:30 p.m. Rooms 108 A/B, Street Level, Convention Center

10:30 a.m. Session

ADVANCES IN RESEARCH Neuroscience in the New Millennium 10:30 a.m.-12:30 p.m. Rooms 201A-C, Level 200, Convention Center G*p.j Swart C Yudofsfcy, MJD. ,<3ChCIi|>,; Mark G. Barai&iD, UNDERSTANDING THE BRAIN AND BODY IN THE TREATMENT OF DEPRESSION AND Advances at a! levels of n«up>sns of Cblumbk University in New York City. Carol A. Tamminga, M.D., on Schizophrenia: What Can 110 served as Director of tne National Insti&tte of Functional Brain Imaging Tell? Neurological Disorders and Strofee within the National Herbert Y. Meltzer, M.D., on Advances in Institutes of Health from 1998 to 2QOt ThrougJiout Psychopharmacologic Treatment of Schizophrenia and his career, Dr. Fischbach has studied the formation and Related Psychosis maintenance of synapses. He pioneered the use of THIS SESSION WILL BE AUDIOTAPED. cultural neurons and muscle cells to characterize the biochemical, cellular, and electrophysiological mech- anisms underlying the neuromuscular junction. His iptrent researcJb focuses on trojjhic factors that 11:00 a.m. Sessions influence synaptic efficacy and nerve cell survival. A 1*4^ BreMdent of die Sodety i£ Neuroscience, Dr, DISCUSSION GROUPS 5-8 Fischbach is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, 11:00 a.m.-12:30 p.m. •4^^B,&utitute_ of Medicine, He reo?ive4 hte medical o^i^ ioitt Ctenell tfeivei^Me<£<^Scnooi. These sessions are limited to 25 participants on a first- Frontiers of Science Lecture Series : come, first-served basis. TlHS SfeSSIOTST WILL BE AUDIOTAPED.

20 MONDAY

LECTURES MEDIA SESSIONS 5-6 11:00 a»m»-l2^0 p,m. MEDIA SESSION 5 11;00 a.m.-2;00 p.m. Rooms 109 A/B, Street Level, Convention Goner Washington Rooms A-C, Third Floor, Loews Mary Jeanne Kreek,M.D. CULTURAL COLLISIONS Opioids and Single-Nucleodde Polymorphisms: Implications for Heroin and Cocaine Addictions Cnp.: Jacquelyn B. Chang, M.D. C2if»«: Richard K Rosentfeal, M£>. 5 Carved from the Heart: A Portrait of Grief, Healing, and C0*t2ip.s Joyce A, Tinsley, MJD. Community (30 minutes) Mary Jeanne Kreek, MJD«, examines the contributions of tne encbgenous opioid system to the "rewadKng* Distributor: New Day Films effects of drugs of abuse and to drug-induced changes 22-D Hollywood Avenue in the brain and discusses gene polymorphisms of the HoHoKus,NJ07423 endogenous opioid system that may play a role in adcfiction$. Dr. Kreek is Professor and Head of the Grieving father, Stan Marsden, loses his son to a cocaine Laboratory of the Biology of Addictive Disease at overdose. A Tsimshian wood carver, Marsden decides to create Rockefeller University and Senior Physician at a totem pole and invites the town of Craig, Alaska, to help. The Rockefeller tlnkersitf Hospital in New Yoik IB tjie project grows and brings people of diverse ages and back- 1960s, she was part of the Rockefeller Institute team grounds together. It acknowledges common problems of drug that conducted the initial studies on methadone in the abuse and violence and promotes healing within the community. management of heroin addiction. More recently her Carved from the Heart, acknowledges the intergenerational grief that research has focused on the molecular and neuro- grows out of rapid changes in lifestyles and interruptions to the biological basis of addictive diseases and on human passage of tradition and knowledge within Alaska Native and molecular genetics in the development of addictions. A American Indian communities. Fellow of toe American Cblege of Neuropsfcijo- pharmacology and tne New York Acatfcifty of Sciences, Discussant: Yadollah M. Jabbarpour, M.D. Dr* Kjpeek has received the R. BrinMey Sm^bers Distinguished Scientist Award from the American 6 Homeland Society on Addiction Medicine and the Nathan B. (57 minutes) EdkJjr Memorial Award for Lifetime ikcellenee in Drug Abuse Researcli from ttie Cofie|e on Problems of 0rug Distributor: University of California Extension Dependence. Br. Kreek received her medical degnee For V6 Center for Media and Independent Learning from Columbia University College of Physicians and &V7 2000 Center Street, 4th Floor Surgeons and her postgraduate training in internal Berkeley, CA 94704 medicine, gastroenterology, and neurc^ndocrinology at Cornell tJtoiversity-Hew York Hospital Medical Center, Set against the stunning backdrop of the Northern Plains, Frontiers of Science Lecture Series Hamdand is a rich and engaging documentary that weaves to- THIS SESSION WILL BE AUDIOTAPED, gether the stories of four Lakota Indian families on the Pine Ridge Indian Reservation in South Dakota. Shot over several years, the film provides an inspiring and intimate portrait of contemporary Native American life, as well as a unique and MASTER EDUCATOR CLINICAL compelling depiction of the strength and vitality of Native CONSULTATIONS 3-4 culture as it unfolds to the viewer over the course of the years. Ultimately, the film balances the many troubles that beset the 11:00 a.m.-12:30 p.m. reservation system with the resilience and fortitude of Lakota culture and spirituality. In doing so, it challenges viewers to These sessions are limited to 25 participants on a first- recognize and appreciate the power of family, the immense spirit come, first-served of the natural world, and the healing potential of humor and 3 Allan Tasman, M.D, on the Doctor-Patient Relationship in faith. Pharmacotherapy 7 Between Worlds Room 111 A, Street Level, Convention Center (57 minutes) 4 Salman Akhtar, M.D., on Psychotherapy with Immigrant Between Worlds explores over a period of six years the lives of Patients several Vietnamese Amerasians and their families who left Room 301, Level 3, Marriott Vietnam in 1992. Each of the families was sent to a refugee camp in the Philippines for six months of cultural orientation, THIS SESSION IS OPEN TO APA MEMBERS ONLY. before resettling in the U.S. The film details their experiences in BLUE REGISTRATION BADGE OR APA MEMBER- camp and follows their lives for five years as they struggle to SHIP CARD REQUIRED FOR learn English, find jobs, and pursue their education.

21 MONDAY

MEDIA SESSION 6 11:00 a.m.-12;30 p.m. 11:30 a.m. Congress Rooms A-C, Fourth Floor, Loews 3 Atypical Depression in Primary Anxiety Disorders Michael A. Van Ameringen, MD, Catherine L. Mancini, MD., IMAGES IN BLACK AND WHITE Jonathan Oakman, Ph.D., Mira Campbell, B A., Chris Watson

Chp.: Elyse D. Dubo, M.D. 12 noon 4 Risk Factors for PTSD in North Korean Defectors 8 M & M Smith: For Prosperity's Sake Wootaek Jeon, M.D., Sung-Kil Min, M.D. (57 minutes) THIS SESSION WILL BE AUDIOTAPED.

Distributor: New Day Films SCIENTIFIC AND CLINICAL REPORT SESSION 2 22-D Hollywood Avenue 11:00 a.m.-12:30 p.m. HoHoKus,NJ07423 Room 111 B, Street Level, Convention Center

M & M Smith: For Posterity's Sake eloquently explores the lives and EATING DISORDERS work of Morgan and Marvin Smith, twin brothers and prolific African-American artists. The Smiths moved from Kentucky to Chp.: Helen C. Kales, M.D. New York in 1933 to pursue careers unavailable to them in the Co-Chp.: Houshang G. Hamadani, MD. segregated South. In 1937, they opened a studio next to Harlem's Apollo Theatre and began 50 year-long careers as artists and still 11:00 a.m. and motion film photographers. The Smiths and their cameras 5 Perfectionism, Training, and Eating Behaviors in covered events in Harlem such as political rallies, street corner Runners orators, the training ground of Joe Louis, and the exciting Jason M. Andrus, M.D., Deborah Goebert, Ph.D., Alayne nightclub scene. They documented the celebrated and common Yates, M.D. citizens of their community and opened doors for models and actresses as they sought careers in the white dominated media. 11:30 a.m. The film features Marvin and Morgan Smith, performer Eartha 6 Self-Reported Hunger and Parasympathetic Tone Kitt, and photo historian Deborah Willis. Alayne Yates, M.D., George P. Danko, Ph.D, John H. Draeger, M.D.

MEDICAL UPDATE 1 12 noon 11:00 a.m.-12:30 p.m. 7 Topiramate Treatment of Bulimia Nervosa Room 103 A, Street Level, Convention Center Scott P. Hoopes, MD., Frederick W. Reimherr, M.D., Marc Kamin, M.D., Debra Karvois, MS., Norman E. MIGRAINE: DIAGNOSIS, TREATMENT, AND Rosenthal, M.D., Rezaul Karim, Ph.D. COMORBIDITY THIS SESSION WILL BE AUDIOTAPED.

Chp.: N. Kalaya Okereke, M.D. SCIENTIFIC AND CLINICAL REPORT SESSION 3 Presenter: Stephen C. Silberstein, M.D. 11:00 a.m.-12:30 p.m. THIS SESSION WILL BE AUDIOTAPED. Room 202 A, Level 200, Convention Center CONSULTATION-LIAISON PSYCHIATRY SCIENTIFIC AND CLINICAL REPORT SESSIONS 1-12 Chp.: Catherine A. Crone, MD. Co-Chp.: Mark S. Groves, M.D. SCIENTIFIC AND CLINICAL REPORT SESSION 1 11:00 a.m.-12:30 p.m. 11:00 a.m. 8 Mixed Anxiety Depressive Disorder in a Sample of Room 103 C, Street Level, Convention Center Primary Care Patients ANXIETY DISORDERS Risa B. Weisberg, Ph.D., Larry Culpepper, M.D., Martin B. Keller, M.D. Chp.: Michael J. Vergare, M.D. Co-Chp.: David H. Taylor, M.D. 11:30 a.m. 9 Psychopathological Aspects in 86 Chronic Fatigue 11:00 a.m. Syndrome Patients 2 Switching from Imipramine to Sertraline in Panic Massimo di Giannantonio, M.D., Anatolia Salone, M.D., Disorder with Agoraphobia Delia Racciatti, M.D., Daniela Mezzano, M.D., Eligio Matig R. Mavissakalian, M.D. Pizzigallo, M.D., Maria F. Ferro

22 MONDAY

12 noon SCIENTIFIC AND CLINICAL REPORT SESSION 6 10 Low Expression of Negative Affect and Denial Predict 11:00 a.m.-12:30 p.m. Breast Cancer Recurrence Room 204 A, Level 200, Convention Center Karen L. Weihs, M.D., Timothy Enright, Ph.D. THIS SESSION WILL BE AUDIOTAPED. PSYCHOPHARMACOLOGY OF MOOD DISORDERS

SCIENTIFIC AND CLINICAL REPORT SESSION 4 Chp.: Leslie H. Gise, M.D. 11:00 a.m.-12:30 p.m. Co-Chp.: Roger F. Haskett, M.D. Room 202 B, Level 200, Convention Center 11:00 a.m. ISSUES IN CROSS-CULTURAL PSYCHIATRY 17 Fluoxetine-Induced Weight Change in Depressive Subtypes Chp.: Giovanni Caracci, M.D. Christina M. Dording, M.D., Robert L. Gresham, B.A., Co-Chp.: Dinu P. Gangure, M.D. Heidi D. Montoya, B.A., John J. Worthington III, M.D., Jonathan E. Alpert, M.D., Andrew A. Nierenberg, M.D., 11:00 a.m. Maurizio Fava, M.D. 11 Is the Wechsler Intelligence Scale for Children, Third Edition (WISC-III UK) Applicable to Ghana? 11:30 a.m. Ama K. Edwin, M.B. 18 Adjunct Modafinil for Fatigue and Wakefulness in MDD 11:30 a.m. Karl Doghramji, M.D., Matthew A. Menza, MD., Murray H. 12 Dissociation, Childhood Trauma, and Ataque De Rosenthal, D.O., Ronald R. Fieve, M.D. Nervios Roberto Lewis-Fernandez, MD., Pedro J. Garrido, Ph.D., 12 noon Amaro Lakia, Ph.D., Maricarmen Bennasar, PsyD., 19 Short-Term Use of Estradiol as an Antidepressant Guoguang Ma, MS., Elsie Parrilla, L.C.S.W., Eva Strategy in Perimenopausal and Postmenopausal Petkova, Ph.D. Women Lee S. Cohen, M.D., Claudio N. Scares, M.D., Jennifer 12 noon Poitras, B.A., Jan L. Shifren, M.D., Allison B. Alexander, M.D. 13 Trauma, Creative Cognition, and Success Among Tribal THIS SESSION WILL BE AUDIOTAPED. South-African Students Albert Rothenberg, M.D. SCIENTIFIC AND CLINICAL REPORT SESSION 7 THIS SESSION WILL BE AUDIOTAPED. 11:00 a.m.-12:30 p.m. Room 204 B, Level 200, Convention Center SCIENTIFIC AND CLINICAL REPORT SESSION 5 11:00 a.m.-12:30 p.m. MANAGEMENT OF BIPOLAR DISORDER Room 203 A, Level 200, Convention Center Chp.: Ellen H. Sholevar, M.D. ISSUES IN MID LIFE AND BEYOND Co-Chp.: Martins A. Adoeye, MD.

Chp.: Lesley M. Blake, M.D. 11:00 a.m. Co-Chp.: Dylan P. Wint, M.D. 20 A Comparison of the Prevalence and Correlates of Anger Attacks in Bipolar Disorder 11:00 a.m. Roy H. Perlis, M.D., Jordan W. Smoller, M.D., Stephanie 14 Long-Term Effects of Depression on Symptoms and Racette, B A, Pamela A Roffi, B.S., Grace E. F. Rubenstein, B A, Function in Mid-Life Women Gary S. Sachs, M.D., Maurizio Fava, M.D. Joyce T. Bromberger, Ph.D., Charlotte Brown, Ph.D., Adriana Cordal, M.D., Howard M. Kravitz, D.O., Karen 11:30 a.m. Matthews, Ph.D. 21 Topiramate Treatment of Rapid-Cycling Mood Disorder Mohammad Z. Hussain, M.D., Zabaida A. Chaudhry, M.D., 11:30 a.m. Seema Hussain, M.D. 15 Socioeconomic Status and Depression Among Older Adults 12 noon John Cairaey, MA., Terrance J. Wade, Ph.D. 22 Cognitive and Psychosocial Deficits in Bipolar Disorder and Schizophrenia 12 noon Joseph Ventura, Ph.D., Lori L. Altshuler, M.D., Wilfred G. 16 Psychotherapy with the Elderly Van Gorp, Ph.D., David Theburge, Ph.D., Jim Mintz, Ph.D. Daniel A. Plotkin, M.D. THIS SESSION WILL BE AUDIOTAPED. THIS SESSION WILL BE AUDIOTAPED.

23 MONDAY

SCIENTIFIC AND CLINICAL REPORT SESSION 8 SCIENTIFIC AND CLINICAL REPORT SESSION 10 11:00 a.m.-12:30 p.m. 11:00 a.m.-12:30 p.m. Independence Ballroom I, Level 3, Marriott Rooms 407-409, Level 4, Marriott

SUICIDE TOPICS IN SCHIZOPHRENIA

Chp.: Maria A. Oquendo, M.D. Chp.: Lawrence A. Real, MD. Co-Chp.: Robert C. Marks, M.D. Co-Chp.: Brian Martis, MD.

11:00 a.m. 11:00 a.m. 23 Suicides in Youths Involved with Juvenile Justice and 29 The Relationship Between Negative and Positive Child Welfare Services Symptoms: A 15-Year Follow-Up Johanne Renaud, M.D., Francois Chagnon, Ph.D., Lambert Martin Harrow, Ph.D., Ellen S. Herbener, Ph.D., Thomas H. Farand, M.D. Jobe, M.D., Joseph F. Goldberg, MD., Eileen M Martin, PhD.

11:30 a.m. 11:30 a.m. 24 Predictors of Suicide Attempts in a Personality Disorder 30 Neurological Soft Signs and Psychopathology in Sample Schizophrenia Shirley Yen, PhD., M Trade Shea, PhD., Carlos M Grilo, PhD., Giuseppe Bersani, Simona Gherardelli, MD., Paolo Pancheri Charles A. Sanislow, Ph.D., Mary C. Zanarini, Ed.D., 12 noon Robert L. Stout, Ph.D., John G. Gunderson, MD. 31 Heterogeneity in Schizophrenia: Cognitive Deficits and Brain Abnormalities 12 noon Bruce E. Wexler, M.D., Patricia S. Goldman-Rakic, PhD., 25 Hostility and Impulsivity Among Suicidal Bipolar Robert K. Fulbright, M.D., John C. Gore, Ph.D., Bradley S. Patients Peterson, MD. Benjamin H. Michaelis, M.A., Glen P. Davis, B.A., Joseph F. THIS SESSION WILL BE AUDIOTAPED. Goldberg, MD. THIS SESSION WILL BE AUDIOTAPED. SCIENTIFIC AND CLINICAL REPORT SESSION 11 11:00 a.m.-12:30 p.m. SCIENTIFIC AND CLINICAL REPORT SESSION 9 Grand Ballroom Salon B, Level 5, Marriott 11:00 a.m.-12:30 p.m. Independence Ballrooms II/III, Level 3, Marriott OLANZAPINE: BIPOLAR DISORDERS AND AGITATION BPD Chp.: Philip G. Janicak, MD. Chp.: Vivian B. Pender, MD. Co-Chp.: Paul P. Yeung, MD. Co-Chp.: Jennifer K. Coffman, MD. 11:00 a.m. 11:00 a.m. 32 Effectiveness of Rapid Initial Dose Escalation of Oral 26 BPD, Medical Illness, Lifestyle Choices, and Health Olanzapine for Acute Agitation Care Utilization Robert W. Baker, MD., Bruce J. Kinon, MD., Hong Liu, PhD., Frances R. Frankenburg, M.D., Mary C. Zanarini, Ed.D., Angela Richey, B.S., Angela L. Hill, PharmD., Richard F. John Hennen, Ph.D., Kenneth R. Silk, MD. Bergstrom, Ph.D., Leslie M. Schuh, PhD.

11:30 a.m. 11:30 a.m. 27 Impulsivity, Gender, and 5HT in BPD 33 Olanzapine Combined with Lithium or Valproate for PaulH. Soloff, M.D., Thomas M. Kelly, PhD., Stephen J. Relapse Prevention of Bipolar Disorder: An 18-Month Strotmeyer, MPH., Kevin M Malone, MD., J. John Mann, MD. Study Mauricio F. Tohen, MD., K.N. Roy Chengappa, MD., Patricia 12 noon Suppes, MD., Robert W. Baker, MD., Richard C. Risser, MS.C, 28 Diagnostic Efficiency of BPD and Antisocial Personality Angela R. Evans, PhD., Joseph R. Calabrese, MD. Disorder (APD) Criteria in Monolingual Hispanic Men Daniel F. Becker, M.D., Carlos M. Grilo, PhD., Luis M. 12 noon Anez, Psy.D., Thomas H. McGlashan, MD. 34 Olanzapine Versus Divalproex Sodium for Mania: A 47- THIS SESSION WILL BE AUDIOTAPED. Week Study Robert W. Baker, M.D., Mauricio F. Tohen, M.D., Lori L. Altshuler, M.D., Carlos M. Zarate, Jr., M.D., Patricia Suppes, M.D., Terence A. Ketter, M.D., Richard C. Risser, M.S.C. THIS SESSION WILL BE AUDIOTAPED.

24 MONDAY

SCIENTIFIC AND CLINICAL REPORT SESSION 12 COMPONENT WORKSHOP 15 11:00 a.m.-12:30 p.m. 11:00 a.m.-12:30 p.m. Room 104 B, Street Level, Convention Center Grand Ballroom Salon C, Level 5, Marriott THE GOOD-ENOUGH MENTOR: PERSPECTIVES HEALTH SERVICES RESEARCH ON MENTORING IN PSYCHIATRIC TRAINING APA/GlaxoWellcome Fellows Chp.: Arthur L. Lazarus, M.D. Co-Chp.: Alisa B. Busch, M.D. Chp.: Paul E. Holtzheimer HI, M.D. Participants: Laurel L. Williams, D.O., Seema Malhotra, M.D., 11:00 a.m. Lyle B. Forehand, Jr., M.D., John B. Levine, M.D. 35 Consensus Development on Core Quality Measures for Mental Health Care COMPONENT WORKSHOP 16 11:00 a.m.-12:30 p.m. Richard C. Hermann, M.D., Scott E. Provost, M.S.W., Jeffrey Chan, B.S., Greta Lagodmos, B A., Michael Shwartz, Ph.D., Rooms 112 A/B, Street Level, Convention Center R Heather Palmer, M.D. TALKING ON YOUR FEET: SURVIVAL TIPS AND 11:40 a.m. TECHNIQUES FOR MEDIA INTERVIEWS 36 Improving the Competency of Clinicians Treating APA Joint Commission on Public Affairs People with Mental Illness Alexander S. Young, M.D., Sandra L. Forquer, Ph.D., Co-Chps.: Michael Blumenfield, M.D., Sandra C. Walker, M.D. Matthew J. Chinman, Ph.D., Melissa Rowe, Ph.D., Anita Participants: William E. Callahan, Jr., MD., James M Maier, MD., Miller, Ph.D., Edward Knight, Ph.D. John B. Blamphin THIS SESSION WILL BE AUDIOTAPED. COMPONENT WORKSHOP 17 11:00 a.m.-12:30 p.m. Room 203 B, Level 200, Convention Center WORKSHOPS PSYCHIATRY WITHOUT BORDERS: BREAKING COMPONENTS 12-18 THE BARRIERS APA Committee on International Medical Graduates COMPONENT WORKSHOP 12 11:00 a.m.-12:30 p.m. Rooms 102 A/B, Street Level, Convention Center Co-Chps.: Gopalakrishna K. Upadhya, M.D., Godehard Oepen, M.D. NAVIGATING GERIATRIC PSYCHIATRY RESEARCH: Participants: Bruce Singh, M.D., Deborah Spitz, M.D. ISSUES FOR THE BEGINNING RESEARCHER APA Committee on Ethnic Minority Elderly and APA Coundlon Aging COMPONENT WORKSHOP 18 11:00 a.m.-12;30 p.m. Rooms 401-403, Level 4, Marriott Chp.: Josepha A. Cheong, M.D. Participants: Arturo G. Quiason, MJD., Warachal E. Faison, MD., PSYCHIATRIC CASUALTIES IN THE MENTAL Michael J. Pratts, M.D., Jacobo E. Mintzer, M.D. HEALTH OF HISPANIC IMMIGRANTS APA Committee of Hispanic Psychiatrists COMPONENT WORKSHOP 13 11:00 a.m.-12:30 p.m. Room 103 B, Street Level, Convention Center Co-Chps.: Ana E. Campo, M.D., Eugenio M. Rothe, M.D. Participant: Rodrigo A. Munoz, M.D. EXPERTS OR PAWNS? PSYCHIATRIC CONSULTATION FOR GOVERNMENT AGENCIES APA Committee on Misuse and Abuse ofPsychiatry and Psychiatrists ISSUES 19-28

Chp.: Robert P. Cabaj, M.D. ISSUE WORKSHOP 19 11:00 a.m.-12;30 p.m. Participants: Jerry M Wiener, MD., Jose E. de La Gandara, MD., Abraham L. Halpern, M.D., Juan E. Mezzich, M.D. Rooms 302/303, Level 3, Marriott

COMPONENT WORKSHOP 14 11:00 a.m.-12:30 p.m. TREATING PSYCHOSIS ACROSS DIAGNOSIS Room 104 A, Street Level, Convention Center Chp.: Lewis A. Opler, M.D. Participants: Ian E. Alger, M.D., Clarice J. Kestenbaum, M.D., LEGAL AND PSYCHIATRIC CONTROVERSIES IN Eric R. Marcus, M.D. INTERFERON TREATMENT OF HEPATITIS-C APA New York County District Brandt's AIDS Committee Co-Chps.: Kristina L. Jones, M.D., Scott Bums, J.D. Participants: Silvia Hafliger, M.D., John AH, Grimaldi, Jr., MD.

25 MONDAY

ISSUE WORKSHOP 20 11:00 a.m.-12;30 p.m. ISSUE WORKSHOP 26 11:00 a.m.-12;30 p.m. Room 307, Level 3, Marriott Grand Ballroom Salon I, Level 5, Marriott

CHALLENGES OF THE CHIEF RESIDENT IN CONFIDENTIALITY ISSUES AND LEGAL PSYCHIATRY ESSENTIALS IN SEXUAL HARASSMENT CASES

Chp.: SadiqH. Al-Samarrai, M.D. Co-Chps.: Rita R. Newman, M.D., Annette J. Hollander, M.D. Participant: Thomas S. Newmark, M.D. Participants: Diane K. Shrier, MD., Margaret F. Jensvold, M.D., David W. Garland, Esq., Francine Weiss, Esq.

ISSUE WORKSHOP 21 11:00 a.m.-12;30 p.m. ISSUE WORKSHOP 27 11:00 a.m.-12;30 p.m. Rooms 309-310, Level 3, Marriott Grand Ballroom Salon J, Level 5, Marriott

NONSEXUAL BOUNDARY VIOLATIONS: SPECIAL PSEUDODEMENTIA IN THE 21ST CENTURY PROBLEMS IN SMALL COMMUNITIES Chp.: Maurice Preter, M.D. Chp.: Malkah T. Notman, M.D. Participants: Randolph B. Schiffer, MX)., Robin C. H2sabeck, PhD. Participants: Elissa P. Benedek, M.D., Linck M. Jorgenson, J.D., Carl P. Malmquist, M.D., Carol C. Nadelson, M.D. ISSUE WORKSHOP 28 11:00 a.m.-12;30 p.m. Grand Ballroom Salon K, Level 5, Marriott ISSUE WORKSHOP 22 11:00 a.m.-12;30 p.m. Liberty Ballroom C, Level 3, Marriott WHAT WORKS IN SUBSTANCE ABUSE TREATMENT? COGNITIVE THERAPY FOR PERSONALITY Substance A buse and Mental Health Services Administration DISORDERS Chp.: A. Thomas McLellan, Ph.D. Chp.: Judith S. Beck, Ph.D. Participants: D. Dwayne Simpson, Ph.D., Joseph C. J. Finney, M.D., Shelly F. Greenfield, M.D. ISSUE WORKSHOP 23 11:00 a.m.-12;30 p.m. Rooms 411/412, Level 4, Marriott 12 noon Sessions ASSESSING PSYCHOTHERAPY COMPETENCIES OF RESIDENTS FORUMS 1-4

Chp.: Joel Yager, M.D. FORUM 1 12 noon-l:30 p.m. Participants: David A. Goldberg, M.D., Lisa A. Mellman, M.D., Rooms 107 A/B, Street Level, Convention Center Jerald Kay, M.D., Jesse H. Wright, M.D. NEW YORK ACADEMIC CENTERS' RESPONSE TO ISSUE WORKSHOP 24 11:00 a.m.-12;30 p.m. THE WORLD TRADE CENTER ATTACK Rooms 414/415, Level 4, Marriott Chp.: Randall D. Marshall, M.D. PROFESSIONALISM IN THE TEACHER/LEARNER Participants: Rachel Yehuda, M.D., Marylene Goitre, Ph.D., RELATIONSHIP Spencer Eth, M.D., Harold S. Koplewicz, M.D. FORUM 2 12noon-l;30p.m. Chp.: Alison M. Heru, M.D. Participants: Marilyn Price, M.D., Patricia R. Recupero, M.D. Room 113 A, Street Level, Convention Center LEADERSHIP CHALLENGES IN MENTAL HEALTH ISSUE WORKSHOP 25 11:00 a.m.-12;30 p.m. AND SUBSTANCE ABUSE: A MEETING OF THE Grand Ballroom Salon D, Level 5, Marriott MINDS Substance A buse and Mental Health Services Administration PSYCHOTHERAPY TERMINATION: A CHALLENGE IN PSYCHIATRIC RESIDENCY TRAINING Chp.: Charles Curie

Chp.: Ami A. Matorin, M.D. FORUM 3 12 noon-l:30 p.m. Participants: Pedro Ruiz, M.D., Vinay Kapoor, M.D., David W. Room 113 C, Street Level, Convention Center Preven, M.D., Madhuri V. Ramble, M.D. EVIL

Chp.: Samuel C. Klagsbrun, M.D. Participants: Professor Robert Pollack, Carl Goldberg, Ph.D.

26 MONDAY

FORUM 4 12 noon-l:30 p.m. COURSE 52 1:00 p.m.-5:00 p.m. Liberty Ballroom A, Level 3, Marriott Concerto B, Third Floor, DoubleTree

MUSIC AND MOOD DISORDERS: TCHAIKOVSKY TREATING MEDICAL STUDENTS AND PHYSICIANS

Chp.: Richard Kogan, M.D. Co-Directors: Michael F. Myers, M.D., Leah J. Dickstein, M.D.

COURSE 53 1:00 p.m.-5:00 p.m. 12:30 p.m. Session Overture, Third Floor, DoubleTree COGNITIVE THERAPY: THE BASICS MEDIA SESSION 7 12:30 p.m.-2:00 p.m. Director: Dean Schuyler, M.D. Congress Rooms A-C, Fourth Floor, Loews COURSE 54 1:00 p.m.-5:00 p.m. WHEN NOT TO KEEP A SECRET Minuet, Fourth Floor, DoubleTree APA Alliance ENHANCING THE DOCTOR-PATIENT Chp.: Alicia A. Munoz, B.S.C. RELATIONSHIP

9 In the Mix Director: Geoffrey M. Margo, M.D. (30 minutes) Faculty: Katherine L. Margo, M.D., Laurel C. Milberg, Ph.D., C. Paul Scott, M.D. Distributor: Sue Castle Castle Entertainment COURSE 55 1:00 p.m.-5:00 p.m. 114 East 32nd Street, #903 New York, NY 10016 Rhapsody, Fourth Floor, DoubleTree

In the Mix is a weekly, half-hour PBS television series produced ENGAGING RESISTANT AND HOSTILE PATIENTS INTO PARTICIPATORY TREATMENT for, with, and by teens. From alcohol to activism, school violence to careers, fashion to finding money for college, music Director: David Mee-Lee, M.D. to relationships, the series tackles the topics teen care about in probing, thought-provoking investigative reports, and provides COURSE 56 1;0|I p.m.-5:00 p.m. information teens need to make positive life choices and to be Sonata 5, Fifth Floor, DoubleTree savvy consumers. In this segment, teens find a way to share their concerns about violence and mental illness affecting their BRIEF PSYCHODYNJIHIG'g^ptfjOVHERAPY: THE peers and community. CORE CONFLICTUAt R^I^tfONSHIP THEME METHOD Discussant: Alicia A. Munoz, B.S.C. Director: Howard E. Book, M.D. 1:00 p.m. Sessions NEW RESEARCH YOUNG INVESTIGATORS' ORAL/SLIDE SESSIONS 2-4 COURSES 51-56 Course descriptions are available in the 1:00 p.m.-2:30 p.m. CME Course Brochure included in your registration packet. Admission by ticket 2 SCHIZOPHRENIA only. Room 202 A, Level 200, Convention Center

COURSE 51 1:00 p.m.-5:00 p.m. 3 SUBSTANCE ABUSE AND MOOD DISORDERS Ormandy East, Street Level, DoubleTree Room 202 B, Level 200, Convention Center

OVERVIEW AND UPDATE OF SLEEP DISORDERS 4 ANXIETY DISORDERS AND ETHICS MEDICINE Room 203 A, Level 200, Convention Center

Director: Karl Doghramji, M.D. For further information on New Research Sessions, please refer Faculty: John W. Winkelman, M.D., Thomas D. Hurwitz, M.D. to the New Research Program and Abstracts Book included in your registration packet.

27 MONDAY

the aging brain. He has received the Leadership and 2:00 p.m. Sessions Excellence in Alzheimer's Disease Award from the National Institute on Aging and has been honored for ADVANCES IN PSYCHOPHARMACQLOGY his work by the Alzheimer's Association,, Dr. Mafeux 2:00 p.m.-5:30 p.m. received his medical degree from the University of Rooms 201A-C, Level 200, Convention Center Oklahoma and completed residencies in internal medicine at Boston City Hospital and in neurology at AN UPDATE ON THE ESSENTIALS OF CLINICAL Columbia Presbyterian Medical Center in New* York PSYCHOPHARMACOLOGY Frontiers ol Science Lecture Series OTIS SESSION WILL BE AUDI0TAPED. Chp.: Alan F. Schatzberg, M.D. Co-Chp.: Charles B. Nemeroff MEDIA SESSIONS 8-9 1 New Antidepressants in Development: Corticotrophin Releasing Hormone and Neurokinin Antagonists MEDIA SESSION 8 2:00 p.m.-5;00 p.m. Ranga K. Krishnan, M.D. Washington Rooms A-C, Third Floor, Loews

2 Nonbenzodiazepine Anxiolytics TRANSGENDER TRIALS Philip T. Ninan Chp.: Dan H. Karasic, M.D. 3 Atypical Antipsychotics Michael J. Owens, M.D. 10 Southern Comfort (90 minutes) 4 Anticonvulsants as Mood Stabilizers Susan L. McElroy, M.D. Distributor: Kate Davis 412 West End Avenue, #3E 5 Treatment of the Pregnant or Postpartum Woman New York, NY 10024 Zachary N. Stowe, M.D. Southern Comfort is the story of the last year of life for Robert Eades, a female-to-male transsexual in rural Georgia, and his LECTURES found family of transgendered people. Mr. Eades is a pipe- smoking, self-proclaimed hillbilly, comfortable in his country 2:00 p.m.-3:30 p.m. environment. But the intolerant world in which he lives is Rooms 109 A/B, Street Level, Convention Center evident in his difficulty obtaining medical care when he develops ovarian cancer. The film is able to demonstrate many truths Richard Mayeux,M.D. about the lives of transgendered people in general, and is named after a highlight for Eades and his friends, an annual convention Alzheimer's Disease: The Challenges of for transgendered people in Adanta. Big Risks and Small Gains Discussant: Dan H. Karasic, M.D. Chp.: Co-Chp.:Gregory H. Pelton, M.D. 11 Just Call Me Kade (26 minutes) 'In||k>itaat' 'ejues" to/tlte? ^j^f^^^i: ^^^j^^^'^^i^-- have come from genetic and epidemiologkal Distributor: Frameline Distribution investigations of patients and tne"" faizipbsv Richard 346 Ninth Street Mayeux, M.D., discusses the complex pathogenesis of San Francisco, CA 94103-3809 Alzheimer's disease and the various therapeutic targets that have been identified over the last decade. Dr, Kade Farlow Collins is a 16-year old female-to-male trans- Mayeux is the Gertrude H. Sergjevsty Professor of gendered person residing in Tucson, Arizona. Kade's parents Neuidbgf, Psydyatry» and Epidemiology at Columbia maintain a supportive and nurturing relationship to help their University College of Physicians and Surgeons in New teenage child face many challenges. As Kade's body began to York Qty. He is oirrendbf Director of the Gertrude H. transform during puberty, he became nearly suicidal. Realizing Sei^evsJgr Center for the epidemiological investigation that the issue was more complex than Kade being a tomboy or of neurological diseases and the Co-Director of the lesbian, the family searched for information. Through a local Taub Institute for Research on Alzheimer's Disease support group and the internet, Kade's mother found books and and the Aging Brain at Columbia University Health other resources pertaining to transgenderism. The family agreed Sciences Center. "Dt. Mayteox is the author of more to have their lives documented in order to bring awareness to than 250 publications dealing with various aspects of the subject. Alzheimer's disease and other degenerative diseases of

28 MONDAY

MEDIA SESSION 9 2:00 p.m.-5:00 p.m. C Clinical Utility and Cost-Benefit Profile of Diagnostic Congress Rooms A-C, Fourth Floor, Loews Testing in Delirium Christopher I. Kauffman, M.D. MOB MENTALITY: THE ANALYSIS OF TONY SOPRANO D The Use of Atypical Antipsychotics in the Treatment of Delirium Ohp.: Harvey R. Greenberg, M.D. Stephen J. Ferrando, M.D.

12 Sopranos E An Open Trial of Olanzapine in the Treatment of (90 minutes) Delirium William Breitbart, M.D. Distributor: Home Box Office THIS SESSION WILL BE AUDIOTAPED. Home Box Office Store www.store.hbo.com SYMPOSIUM 3 2:00 p.m.-5;00 p.m. Room 103 A, Street Level, Convention Center HBO series, The Sopranos is a complex drama built around a mobster, Tony Soprano, who struggles with two families; his PLAGUES, PRIONS, AND PARANOIA: THE wife and kids, and his gun-toting gang. The first season was NEUROPSYCHIATRY OF INFECTIOUS DISEASE built around what Tony learns when, whipsawed between those two worlds, he finds himself plunged into depression and seeks Chp.: Stanley N. Caroff, M.D. psychotherapy. With analysis built into the very spine of the Co-Chp.: E. Cabrina Campbell, M.D. show's elaborate episodic structure, creator/writer David Chase, produces an unpredictable series of parallel plots that twist from A Psychiatric and Cognitive Features of Lyme Disease tragedy, to farce, to social realism. Felice A. Tager, Ph.D., Brian A. Fallen, M.D.

B Regional Specificity and the Neuropathophysiology of PRESIDENTIAL SYMPOSIUM HIV-1 in Brain 2:00 p.m.-5:00 p.m. Karl Goodkin, M.D., Frances L. Wilkie, Ph.D., Diana Room 103 B, Street Level, Convention Center Lee, Psy.D., Robert Lecusay, Ten T. Baldewicz, Ph.D., Deshratn Asthana, Ph.D., Paul Shapshak, Ph.D. WHAT WILL THE 21ST CENTURY BRING TO THE TRAINING OF PSYCHIATRISTS? C The Neuropsychiatry of the Transmissible Spongiform Encephalopathies Chp.: Lisa A. Mellman, M.D. David N. Irani, M.D. Co-Chp.: Ronald O. Rieder, M.D. Presenters: Richard K. Harding, M.D., Carol A. Bernstein, M.D., D Psychiatric Manifestations of Acute Viral Encephalitis David Leach, M.D., Charles F. Reynolds III, M.D., Juan E. Stanley N. Caroff, M.D., Stephan C. Mann, M.D., Michael F. Mezzich, M.D. Gliatto, M.D., Kenneth A. Sullivan, Ph.D., E. Cabrina Campbell, M.D. Discussant: Sheldon I. Miller, M.D. THIS SESSION WILL BE AUDIOTAPED. E Neurosyphilis: A History and Clinical Review Michael F. Gliatto, M.D., Stanley N. Caroff, M.D.

SYMPOSIA 2-26 Discussant: Jan A. Fawcett, M.D. THIS SESSION WILL BE AUDIOTAPED. SYMPOSIUM 2 2:00 p.m.-5;00 p.m. Rooms 102 A/B, Street Level, Convention Center SYMPOSIUM 4 2:00 p.m.-5;00 p.m. Room 103 C, Street Level, Convention Center ADVANCES IN THE DIAGNOSIS AND TREATMENT OF DELIRIUM FEAR AND LOATHING IN THE MEDICATION CLINIC Chp.: John W. Barnhill, M.D. A PA Commission on Psychotherapy by Psychiatrists Co-Chp.: Khakasa H. Wapenyi, M.D. Chp.: Bernard D. Beitman, M.D. A The Experience of Delirium in Cancer Patients William Breitbart, M.D. A To Monitor or to Relate? Jerald Kay, M.D. B The Clinical Diagnosis of Delirium John W. Barnhill, M.D. (Continued an next page)

29 MONDAY

B Split-Treatment Angst D Primary Prevention of Eating Disorders: A Tale of Two Michelle B. Riba, M.D. Countries Katherine A. Halmi, M.D., Claire V. Wiseman, Ph.D., C The Divided Hour: Psychotherapy in the Medication Suzanne R. Sunday, Ph.D., Francesca Bortolotti, M.D. Check and Other Brief Sessions Jesse H. Wright, M.D. E E-Technologies and Eating Disorders: Problems and Prospects Discussant: Rachel Z. Ritvo, M.D. Joel Yager, M.D. THIS SESSION WILL BE AUDIOTAPED. THIS SESSION WILL BE AUDIOTAPED.

SYMPOSIUMS 2:00 p.m.-5:00 p.m. SYMPOSIUM 7 2:00 p.m.-5:00 p.m. Rooms 106 A/B, Street Level, Convention Center Room 111 B, Street Level, Convention Center

HEALTH INSURANCE PORTABILITY AND MANAGEMENT OF SCHIZOPHRENIA WITH ACCOUNTABILITY ACT: CLINICAL APPLICATIONS COMORBID DISORDERS AND IMPLICATIONS Chp.: Michael Y. Hwang, M.D. Chp.: Norman E. Alessi, M.D. Co-Chp.: Leslie L. Citrome, M.D.

A Basic Health Insurance Portability and Accountability A Management of Schizophrenia with Depression Act Overviews Samuel G. Siris, M.D. Norman E. Alessi, M.D. B Management of Schizophrenia with Comorbid Anxiety B Confidentiality and Security Concerns Under Health Disorders Insurance Portability and Accountability Act Michael Y. Hwang, M.D. Charles J. Rainey, M.D. C Clinical Management of Persistent Aggressive Behavior C Data Protection in Practice: The Impact of the Data in Schizophrenia Protection Act and Other Legislation in the United Leslie L. Citrome, M.D., Jan Volavka, M.D. Kingdom Brian Lunn, M.D. D Long-Term Outcome and Comorbid Conditions: Why THIS SESSION WILL BE AUDIOTAPED. Do We Know so Little? Nina R. Schooler, Ph.D. SYMPOSIUM 6 2:00 p.m.-5:00 p.m. Rooms 107 A/B, Street Level, Convention Center Discussants: Lewis A. Opler, M.D., Ming T. Tsuang, M.D. THIS SESSION WILL BE AUDIOTAPED. EATING DISORDERS 2002: BIOLOGICAL, CLINICAL, AND SOCIAL PERSPECTIVES SYMPOSIUM 8 2:00 p.m.-5:00 p.m. Rooms 112 A/B, Street Level, Convention Center Chp.: Joel Yager, M.D. Co-Chp.: David B. Herzog, M.D. DEPRESSIVE SPECTRUM DISORDER IN LATE LIFE: IMPLICATIONS FOR CLINICAL CARE A Trait-Related 5HT 1A Disturbances in Anorexia Nervosa: Relationship to Susceptibility Chp.: Helen Lavretsky, M.D. Walter H. Kaye, M.D., Guido Frank, M.D., Carolyn C. Meltzer, M.D., Julie Price, Ph.D. A Nonmajor Clinically Significant Depression: The Existing Evidence of a Continuum B Who's Dying from an Eating Disorder? Anand Kumar, M.D. David B. Herzog, M.D., Pamela K. Keel, Ph.D., David J. Dorer, Ph.D., Debra Franko, Ph.D., Kamryn T. Eddy, B.A., B Clinical Features of a Depressive Continuum Valerie E. Charat, B.A., Dana Charatan, B.A. George S. Alexopoulos, M.D.

C The Role of the Dentist in the Care of Eating-Disorder C Dysthymic Disorder in the Elderly Patients Davangere P. Devanand, M.D. James E. Mitchell, M.D., James Roerig, Pharm.D., Ross D. Crosby, Ph.D., Stephen A. Wonderlich, Ph.D., Melissa D Depression and Symptomatic Anxiety Burgard, B.S. Alastair J. Flint, M.B. THIS SESSION WILL BE AUDIOTAPED.

30 MONDAY

SYMPOSIUM 9 2:00 p.m.-5:00 p.m. SYMPOSIUM 11 2:00 p.m.-5;00 p.m. Room 113 A, Street Level, Convention Center Room 113 C, Street Level, Convention Center

INTERACTION OF STRESS AND PERSONALITY SOCIAL PSYCHIATRIC ASPECTS OF VIOLENCE A ssociatianfar Research in Personality Disorders AND TRAUMA American Association for Social Psychiatry Chp.: James H. Reich, M.D. Chp.: Pedro Ruiz, M.D. A Stress and Personality: Biological Implications Co-Chp.: Lawrence Hartmann, M.D. Kenneth R. Silk, M.D. A Trauma and Violence: A U.S. Perspective CarlC. Bell, M.D. B Clinical Characteristics of Stress-Induced Personality Disorders B Social Aspect of Trauma James H. Reich, M.D. S. Arshad Husain, M.D.

C Relationship Between Adjustment, Anxiety, and C Nostalgia as a Defense Against Fully Experiencing the Depressive Disorders Trauma of Immigration Peter Tyrer, M.D. Salman Akhtar, M.D.

D Job Stress Among Young Physicians: Working D Consequences of Psychosocial Interventions: The Conditions or Personality, A Prospective Study Potential to Harm and Help Per Vaglum, M.D., Reidar Tyssen, M.D., Nina Gronvold, M.D., Daniel L. Creson, M.D., Pedro Ruiz, M.D., Patricia Oivind Ekeberg, M.D. Blakeney, Ph.D.

E Schema-Focused Cognitive Therapy and Stress- E PTSD and Cultural Competency Exacerbated Personality Disorders Edward F. Foulks, M.D. David P. Bernstein, Ph.D. Discussants: Steven S. Sharfstein, M.D., R. Rao Gogineni, M.D. THIS SESSION WILL BE AUDIOTAPED. Discussant: Cesare Maffei, M.D. THIS SESSION WILL BE AUDIOTAPED. SYMPOSIUM 12 2:00 p.m.-5:00 p.m. Room 203 B, Level 200, Convention Center SYMPOSIUM 10 2:00 p.m.-5;00 p.m. Room 113 B, Street Level, Convention Center SADISTIC PERSONALITY DISORDER: ITS WIDE RANGE AND IMPORTANCE AS A DIAGNOSIS EVIDENCE-BASED PSYCHODYNAMIC THERAPY PART II: WHAT DO THE DATA SHOW? Chp.: Michael H. Stone, M.D. A merican A cademy of Psychoanalysis and American Psychoanalytic Association A Sadism and Forensic Psychiatry Michael M. Welner, M.D. Chp.: Sheila Hafter-Gray, M.D. Co-Chp.: Ann-Louise S. Silver, M.D. B Sadistic Personality Disorder: The Need to Reinstate in Future Editions of DSM A The Benefits of Individual Psychotherapy for Michael H. Stone, M.D. Schizophrenia Patients: A Meta-Analytic Review William H. Gottdiener, Ph.D., Nick Haslam C Sadistic Behaviors and Victim Response Ann Burgess, D.N. B Controlled Trials of Psychoanalytic Therapies for Young People D The Empirical Relationship Between Psychopathy and Sadism Peter Fonagy, Ph.D., Geoffrey Baruch, M.D., Anthony J.ReidMeloy,Ph.D. Bateman, M.D. THIS SESSION WILL BE AUDIOTAPED. C The Limited Effectiveness of Short-Term Therapy for SYMPOSIUM 13 2:00 p.m.-5;00 p.m. Anorexia Nervosa Rooms 302/303, Level 3, Marriott Authur L. Robin, Ph.D., Patricia Siegel, Ph.D. FROM RESEARCH TO PRACTICE: PRIMARY CARE D Randomized Clinical Trial of a Psychoanalytic RESEARCH IN SUBSTANCE ABUSE AND MENTAL Treatment of BPD HEALTH SERVICES FOR ELDERLY Anthony Bateman, M.D. Substance A buse and Mental Health Services Administration THIS SESSION WILL BE AUDIOTAPED. (Continued on next pa&) 31 MONDAY

Chp.: Sue E. Levkoff, Sc.D. SYMPOSIUM 15 2:00 p.m.-5;00 p.m. Co-Chp.: Maria D. Llorente, M.D. Independence Ballroom I, Level 3, Marriott

A Integration of Mental Health and Substance Abuse THE SOCIAL BRAIN AND PSYCHOTHERAPY Services in Primary Care for the Elderly World Psychiatric Association John S. Mclntyre, M.D. Chp.: Russell J. Gardner, Jr., M.D. B Consumers' and Researchers' Perspective on Improving Co-Chp.: John O. Beahrs, M.D. Elderly Asian-Americans' and Hispanic-Americans' Participation in Mental Health and Substance Abuse A Clinical Sociophysiology Research Russell J. Gardner, Jr., M.D. Hongtu Chen, Ph.D., Guiseppe Costantino, Ph.D., Sue E. B Sociodynamics in Psychotherapy Levkoff, Sc.D., Herman Sanchez, A.B. John O. Beahrs, M.D.

C Consumers and Researchers: New Partnership C The Social Brain as Site of Truth and Deception Challenges and Opportunities Godehard Oepen, M.D. Cynthia Zubritsky, Ph.D., Rosa Wims, Trudy Persky, M.S.W., William Faust, Paul Wohlford, Ph.D. D Biology of Family Psychotherapy Douglas A. Kramer, M.D. D Identification and Treatment of Alcohol Problems in Primary Care E A Skeptic's View of Bridging Efforts David W. Oslin, M.D., Frederic C. Blow, Ph.D. Alan A. Stone, M.D. THIS SESSION WILL BE AUDIOTAPED. E Health Policy Implications of (PRISMe) and the Promise of Research on Mental Health and Substance SYMPOSIUM 16 2:00 p.m.-5;00 p.m. Abuse Treatment of Older Persons in Primary Care Independence Ballrooms II/III, Level 3, Marriott Stephen]. Bartels, M.D., Betsy McDonel-Herr, Ph.D. SPECIAL TOPICS IN WOMEN'S MENTAL HEALTH Discussants: Michael English, Ph.D., Junius J. Gonzales, M.D. THIS SESSION WILL BE AUDIOTAPED. Chp.: Claudio N. Scares, M.D. Co-Chp.: Adele C. Viguera, M.D. SYMPOSIUM 14 2:00 p.m.-5:00 p.m. A Mood Disturbance and Pregnancy: Pros and Cons of Rooms 304-306, Level 3, Marriott Pharmacological Treatment Adele C. Viguera, M.D., Claudio N. Scares, M.D., Lee S. EXTINCTION VERSUS ADAPTATION: THE FUTURE Cohen, M.D. OF STATE HOSPITAL PSYCHIATRY A PA Caucus of State Hospital Psychiatrists and American A ssociation of B Psychiatric Characteristics of Binge Eating Disorder in Psychiatric Administrators Obese Women Jose C. Appolinario, M.D. Chp.: Yadollah M. Jabbarpour, M.D. Co-Chp.: Beatrice M. Kovasznay, M.D. C Gender and Addiction: What Is New? Monica L. Zilberman, Ph.D., Hermano Tavares, Ph.D., Nady A Building, Unbuilding, and Rebuilding America's State El-Guebaly,M.D. Hospitals Jeffrey L. Geller, M.D. D Impact of Estrogen and Other Sexual Hormones on Mood Disturbances B The Future of State Hospital Psychiatry Part II: Qaudio N. Soares, M.D., Jennifer Poitras, B.A., Jennifer Surviving Political Changes Prouty, R.N.C., Lee S. Cohen, MD. Thomas W. Hester, M.D. E Estrogens and Alzheimer's Disease in Elderly Women Monica Z. Scalco, M.D., Robert Van Reekum, M.D. C Recruitment and Retention THIS SESSION WILL BE AUDIOTAPED. Joel S. Feiner, M.D. SYMPOSIUM 17 2:00 p.m.-5:00 p.m. D Medical Leadership in State Hospital Systems Rooms 401-403, Level 4, Marriott Christopher G. Fichtner, M.D., Daniel J. Luchins, M.D., Thomas A. Simpatico, M.D., Louis J. Mini, M.D. PRACTICING PSYCHIATRY IN 2002 THIS SESSION WILL BE AUDIOTAPED. Chp.: Rodrigo A. Munoz, M.D. Co-Chp.: Harold I. Eist, M.D.

32 MONDAY

A The Minnesota Physician-Patient Alliance A Meeting the Needs of Students Exposed to Violence Lee H. Beecher, M.D. Through School-Based Programs Bradley D. Stein, M.D., Sheryl H. Kataoka, M.D., Lisa B Solo Practice Psychiatry in the Community Jaycox, Ph.D., Marleen Wong, M.S.W., Arlene Fink, Ph.D. Thomas W. Dodson, M.D. B Adolescent Alcohol and Drug Abuse: Challenges and C Brain and Mind in Clinical Practice Transitions Ronald D. Abramson, M.D. Sandra A. Brown, Ph.D. D Psychiatry in the 21st Century C Treatment Implications of Teen-Onset Mania Garry M. Vickar, M.D. Gabrielle Carlson, M.D. E Practicing Public Psychiatry in the 21st Century Roger Peele, M.D. D Diagnosis and Treatment of Dysthymia and Double Depression F General Hospital Psychiatry for the Future David L. Dunner, M.D. John C. Urbaitis, M.D. Discussant: Mark H. Rapaport, M.D. G Practicing Psychiatry Today with Enjoyment and THIS SESSION WILL BE AUDIOTAPED. Integrity Despite Managed Care Brian Crowley, M.D. SYMPOSIUM 20 2:00 p.m.-5:00 p.m. Rooms 414/415, Level 4, Marriott Discussants: Edward Gordon, M.D., Janis G. Chester, M.D. THIS SESSION WILL BE AUDIOTAPED. IS THERE A BIPOLAR SPECTRUM?

SYMPOSIUM 18 2;00 p.m.-5;00 p.m. Chp.: S. Nassir Ghaemi, M.D. Rooms 407-409, Level 4, Marriott Co-Chp.: Frederick K. Goodwin, M.D.

LOVE FROM PATHOLOGY TO NORMALITY A The Validity of the Bipolar Spectrum Hagop S. Akiskal, M.D. Chp.: Yves Thoret, M.D. Co-Chp.: John A. Talbott, M.D. B Predictors of Unipolar to Bipolar Conversion in A Change of Heart Between Attachment Network and Affective Disorders Romantic Love in Arranged Marriages Joseph F. Goldberg, M.D. Danielle Groleau, Ph.D. C The Bipolar Spectrum: The Clinician's View B Clinical Considerations About Pedophilia: Love, Sex, Jacob J. Katzow, M.D. and Transgressions Roland M. Coutanceau, M.D., Arnaud Martorell, M.D., Anne D Criticism of the Bipolar Spectrum as a Concept Andronikof, Ph.D. S. Nassir Ghaemi, M.D. THIS SESSION WILL BE AUDIOTAPED. C The Love Life of Melancholies Peter D. Kramer, M.D. SYMPOSIUM 21 2:00 p.m.-5;00 p.m. Grand Ballroom Salon A, Level 5, Marriott D Skin Deep: Trans sexuality, Gender Identity, and the Psychopathology of Love UPDATE ON TREATMENT OF STIMULANT ABUSE Nancy M. Blake, Ph.D.

E Love as a Mirror of Human Distress: A Transcultural Chp.: David A. Gorelick, M.D. Perspective Richard Rechtman, M.D., James K. Boehnlein, M.D. A Recovery-Oriented Psychosocial Treatments Douglas M. Ziedonis, M.D., Jonathan Krejci, Ph.D., Marc Discussant: Glen O. Gabbard, M.D. Steinberg, M.A., Jill Williams, M.D., Sylvia Atdjian, Jeffrey A. THIS SESSION WILL BE AUDIOTAPED. Berman, M.D.

SYMPOSIUM 19 2:00 p.m.-5;00 p.m. B Therapy and Placement Approaches for Cocaine-Abuse Rooms 411/412, Level 4, Marriott Treatment David R. Gastfriend, M.D., Estee Sharon, Psy.D., Sandrine ADOLESCENCE: THE TUMULTUOUS YEARS Pirard, M.D.

Chp.: MarkH. Rapaport, M.D. (Continual on next page)

33 MONDAY

C Pharmacological Treatment of Stimulant Abuse D Cutting-Edge Treatment of Gambling Addiction David A. Gorelick, M.D. Eric Hollander, M.D., Stefano Pallanti, M.D., Erica Sood, B A., Nicolo Baldini-Rossi, M.D., Sallie J. Hadley, M.D. D Psychiatric Comorbidity in Stimulant Abusers Richard N. Rosenthal, M.D. E Treatment of Comorbid Conditions Frances R. Levin, M.D. E Methamphetamine Abuse: 2002 Update Steven L. Batki, M.D. Discussant: Edward V. Nunes, M.D. THIS SESSION WILL BE AUDIOTAPED. THIS SESSION WILL BE AUDIOTAPED.

SYMPOSIUM 22 2;00 p.m.-5;00 p.m. SYMPOSIUM 24 2:00 p.m.-5;00 p.m. Grand Ballroom Salon B, Level 5, Marriott Grand Ballroom Salon D, Level 5, Marriott

NEW FRONTIERS IN THE PSYCHOTHERAPY RESEARCH: CHALLENGES FOR NEUROENDOCRINOLOGY OF AFFECTIVE THE 21ST CENTURY DISORDERS Chp.: John C. Perry, M.D. Chp.: Natalie L. Rasgon, M.D. Co-Chp.: Mark A. Frye, M.D. A Patient Response to the Brief Psychodynamic Investigation A Assessing Vulnerability to Depression: Role of HPA Jean-Nicolas Despland, M.D., Yves De Roten Axis Dysfunction D. Jeffrey Newport, M.D. B Matching Patients to Therapy: A Review of Empirical Studies of Psychotherapy B Gender Differences in Thyroid Indices in Depression PerA.Hoglend,M.D. Mark A. Frye, M.D., George Klee, M.D., Natasha S. Sane, M.D., Teresa Huggins, Ph.D., Lori L. Altshuler, M.D., C Moving Cognitive Therapy from the Research Clinic to Michael J. Gitlin, M.D., Robert M. Post, M.D. General Psychiatric Practice Robert J. DeRubeis, Ph.D. C Testosterone and Depression in Men: A Clinical Review Stuart N. Seidman, M.D., Steven P. Roose, M.D. D Are Recovery and Healthy Functioning Achievable Treatment Goals for Axis II Disorders? D Estrogen Use, Mood, and Cerebral Metabolism in John C. Perry, M.D. Menopausal Women Natalie L. Rasgon, M.D., Gary W. Small, M.D., Prahba E Long-Term Psychotherapy: Current Status and Future Siddarth, Karen Miller, Linda M. Ercoli, Susan Y. Directions Bookheimer, Micheal E. Phelps, M.D. Paul Crits-Christoph, Ph.D. THIS SESSION WILL BE AUDIOTAPED. Discussants: Stuart N. Seidman, M.D., D. Jeffrey Newport, MD. THIS SESSION WILL BE AUDIOTAPED. SYMPOSIUM 25 2:00 p.m.-5;00 p.m. Grand Ballroom Salon I, Level 5, Marriott SYMPOSIUM 23 2:00 p.m.-5;00 p.m. Grand Ballroom Salon C, Level 5, Marriott A RESEARCH AGENDA FOR DSM-V

ADDICTIONS: CUTTING EDGE TREATMENTS FOR Chp.: David J. Kupfer, M.D. GAMBLING AND SUBSTANCE ABUSE Co-Chp.: Darrel A. Regier, M.D.

Chp.: Herbert D. Kleber, M.D. A Nomenclature Recommendations Co-Chp.: David M. McDowell, M.D. Bruce J. Rounsaville, M.D., Renato D. Alarcon, M.D., Gavin Andrews, MD., James S. Jackson, Ph.D., Robert E. A Treatment of Cocaine Dependence Kendell, MD., Kenneth S. Kendler, M.D., Laurence J. Adam M. Bisaga, M.D. Kirmayer, M.D.

B Treatment of Heroin Dependence B Neuroscience Recommendations Herbert D. Kleber, M.D. Dennis S. Charney, M.D., David Barlow, Ph.D., Kelly N. Botteron, M.D., Jonathan D. Cohen, M.D., Raquel E. C Marijuana and Club Drugs: Cutting-Edge Gur, M.D., Keh-Ming Lin, M.D., Eric J. Nestler, M.D. Developments, New and Potential Treatments David M. McDowell, M.D.

34 MONDAY

C Developmental Recommendations Daniel Pine, M.D., Margarita Alegria, Ph.D., Edwin H. 6:00 p.m. Session Cook, Jr., MD., E. Jane Costello, Ph.D., Ronald E. Dahl, MD., Mina K. Dulcan, MD., Doreen S. Koretz, Ph.D. CONVOCATION OF FELLOWS

D Disability and Impairment Recommendations 6:00 p.m. Anthony F. Lehman, M.D., George S. Alexopoulos, M.D., Ballrooms A/B, Ballroom Level, Convention Center Howard H. Goldman, M.D., Dilip V. Jeste, M.D., Dan Offord, M.D., T. Bedirhan Ustun, M.D. All Fellows, members, and registered guests are invited. E Cross-Cultural Recommendations Renato D. Alarcon, M.D., Margarita Alegria, Ph.D., Carl C. Presiding: Richard K. Harding, M.D.. Presidex Bell, MX)., James S. Jackson, PhD., Laurence J. Kirmayer, MD., Ken-Ming Lin, M.D., T. Bedirhan Ustun, M.D. Grand Marshals: Richard G. Lonsdorf, MD., Helen S. Wagenham, MX). F Gaps in the Current System: Recommendations Michael B. First, MD., Carl G Bell, MD., John H. Krystal, MD., Marshals: Roger F. Haskeit, MD., Barbara A. David Reiss, M.D., M. Trade Shea, PhD., Thomas A. Schindler.MD, Widiger, PhD., Katherine L. Wisner, M.D. THIS SESSION WILL BE AUDIOTAPED. INTRODUCTION OF LIFE FELLOWS Paul S. Appelbaum, MD., Pttsiaex-Elect SYMPOSIUM 26 2:00 p.m.-5:00 p.m. Grand Ballroom Salon J, Level 5, Marriott INDUCTION OF FELLOWS Paul S. Appelbaum, M.D. ACADEMIC AND COMMUNITY MENTAL HEALTH: CAN THIS MARRIAGE BE SAVED? INTRODUCTION OF FIFTY-YEAR LIFE American Association of Community Psychiatrists FELLOWS, LIFE MEMBERS, AND INTERNATIONAL FELLOWS Chp.: Peter L. Forster, MD. Richard K. Harding, M.D. Co-Chp.: Stephen M. Goldfinger, MD. PRESENTATION OF SPECL^L A Public Academic Liaison: Can This Marriage Be Saved? PRESIDENTDVL COMMENDATIONS Anita Everett, MD. Richard K.Harding, M.D.

B How Do You Keep Them Down on the Farm? Training, PRESENTATION OF DISTINGUISHED Recruitment, and Retention SERVICE AWARDS Barbara M. Rohland, MD. Richard K. Harding, M.D.

C UC Davis and Sacramento County: A Shotgun Wedding INTRODUCTION OF THE MEMBERSHIP Turned Shared Vision for Public Mental Health COMMITTEE CHAIRPERSON AND AWARD Thomas J. Sullivan, M.S.W., Jonathan Nevfeld, Ph.D. BOARD CHAIRPERSONS THIS SESSION WILL BE AUDIOTAPED. Richard K. Harding, M.D.

PRESENTATION OF AWARDS 3:00 p.m. Session Richard K. Harding, M.D.

APA Award for Research in Psychiatry NEW RESEARCH YOUNG INVESTIGATORS' APA/Lilly Resident Research Awards POSTER SESSION 5 Francis J. BraceJand Award for Public Service 3:00 p.m.-5:00 p.m. Human Rights Award Exhibit Hall D, Street Level, Convention Center Blanche F. Itileson Award for Research in Child Psychiatry For further information on New Research Sessions, please refer Kempt Fund A^'ards for Research Development in to the New Research Program and Abstracts Book included in your Psycho biological Psychiatry registration packet. Agnes Purcell McGavin Awards

(Continued annextpag)

35 MONDAY

Robert T Morse Writers Awards William C Menninger Memorial Convocation Lecture, Isaac Ray Award Mr. McFarlane will address the effect of consumer Jack Wemberg Memorial Award for empowerment on psychiatric practice, as well as the Genuine Psychiatry impact of information available on the Internet, in broadcast, and in print advertising- He will delineate WILLIAM C. MENN1NGER MEMORIAL the new power of consumers in influencing directly CONVOCATION LECTURE FDA approval of new drugs, Congressional appropri- Rodger McPaH.uie ations for research at NTH (and NTMH), their influence with America's largest employers, and the handful of giant companies that compete to underwrite employee LECTURE 7 health. Mr. McFarlane will oudine how new legislation could benefit both mental health practitioners, as well 6:30 p.m.-7:30 p.m. as the consumer/patient. He will discuss the creation Ballrooms A/B, Ballroom Level of specific alliances between medical professional Convention Center associations and organized consumer advocacy in order to pursue mutual goals in the new century. WILLIAM C, MENMNGER THIS SESSION WILL BE AUDIOTAPED. MEMORIAL LECTURE AND APA'S PATIENT .ADVOCACY AWARD WINNER

Rodger McFarlane

Psychiatry and the Medical Consumer Movement

Rodger McFarlane is one of America's most respected medical consumer aciivisu. I le is author ot the bestseller, "The Co.Tiplete Bedside Companion: No- Nomense Advice on Curing for the Seriously 111" (Simon & Schuster], He ii a former director of clinical outcomes research lor the American Association of 1 lealth Plam, arid a torme: senior executive ai Empire Blue Cross Blue Shield, charged with consumer medic A)-decision support. In 19S2, Mr Md-oHane started America's tirsi AIDS hoOme on his personal answering service I le served as Executive Director ol the first and Lirges: AIDS service group, the Gay Men's Health Cans, Inc. lie is President-Emeritus of Bailey 1 louse, the nation's largest supportive homing program far terminally ill, dual ^d:agno sis patients. Me is a founder and lormer executive director ol Broadway Cares, and one ol the instigators ot the red ribbon AIDS awareness campaign on all the awards show telecasts I le has helped raise over S20C million for AIDS groups worldwide. During the 1980s, Mr. MJarlane was a senior cons\Jiant to the Commissions' ot Menta] Healih of WC, in charge of developing I [IV screening, referral, and treatment capabilities m every hospital and psythiatric facility in all five boroughs Mr. McFarlane is also a Tony-winning producer, an elite competitive athlete in several disciplines, and veteran o) seven over-ice treks to the North Pole (including three solo), I le represented the U.S. in the 1998 Fco-Challenge ("the world's toughest race"), and will aga;n represent the U.S. there this fall, lie is an honorably discharged and highly decorated former U.S. Navy "nuke," having run the nuclear engineering plant on the attack submarine thai set the siill-slanding under-:ce navigation record. In this year's

36 TUESDAY, MAY 21, 2002 155TH ANNUAL MEETING

A Avoiding Neuroendocrine Disruptions with Atypical 7:00 a.m. Sessions Antipsychotic Agents David C. Henderson, M.D. PART 2 OF INDUSTRY-SUPPORTED BREAKFAST SYMPOSIA 25-30 B Emerging Bioethical Issues in Antipsychotic Pharmacotherapy: Do Unto Others INDUSTRY-SUPPORTED BREAKFAST Henry A. Nasrallah, M.D. SYMPOSIUM 25, PART 2 7:00 a.m.-8:30 a.m. INDUSTRY-SUPPORTED BREAKFAST Millennium Hall, Second Floor, Loews SYMPOSIUM 28, PART 2 7:00 a.m.-8:30 a.m. CLINICAL CHALLENGES IN DEPRESSION Grand Ballroom Salons G/H, Level 5, Marriott Supported by GlaxoSmitbKline UNDERSTANDING SLEEP MEDICINE: WHAT THE Chp.: Prakash S. Masand, M.D. PSYCHIATRIST NEEDS TO KNOW Supported by Wyeth Pharmaceuticals A Can Long-Term Outcome Be Improved in Depression? The Role of Side Effects and Compliance Chp.: Milton K. Erman, M.D. Prakash S. Masand, M.D. A Morbidity of Insomnia B Helping Patients with Sexual Dysfunction During Thomas Roth, Ph.D. Antidepressant Treatment Lori Calabrese, M.D. B Mechanism of Action of Hypnotics Stephen Stahl, M.D. INDUSTRY-SUPPORTED BREAKFAST SYMPOSIUM 26, PART 2 INDUSTRY-SUPPORTED BREAKFAST 7:00 a.m.-8:30 a.m. SYMPOSIUM 29, PART 2 Regency Ballrooms A-C, Second Floor, Loews 7:00 a.m.-8:30 a.m. Wyndham Ballrooms A/B, First Floor, Wyndham NOVEL ANTIPSYCHOTIC DRUGS: ADVANCES IN THE TREATMENT OF PSYCHOTIC SPECTRUM ONE SIZE DOESN'T FIT ALL: DEPRESSION DISORDERS THERAPIES FOR THE 21ST CENTURY Supported by Bristol-Myers Squibb Company Supported by Eli U,lly and Company

Chp.: Robert E. Hales, M.D. Chp.: David L. Dunner, M.D. Co-Chp.: Stuart C. Yudofsky, M.D. A Lost in Depression: The Treatment-Resistant Patient A The Role of Antipsychotics in Acute Mania Holly A. Swartz, M.D. John M. Zajecka, M.D. B Depression and Substance Use B Clinical Challenges in Managing Psychosis in the Kathleen T. Brady, M.D. Elderly Dilip V. Jeste, M.D., Christian Dolder, Pharm.D., Hoang A. C Putting the Pieces Together: Treatments for the Present Nguyen, M.D., Laura B. Dunn, M.D., Jorge F. Porras, M.D., and Future Enid Rockwell, M.D. David L. Dunner, M.D.

INDUSTRY-SUPPORTED BREAKFAST INDUSTRY-SUPPORTED BREAKFAST SYMPOSIUM 27, PART 2 SYMPOSIUM 30, PART 2 7:00 a.m.-8:30 a.m. 7:00 a.m.-8:30 a.m. Grand Ballroom Salons E/F, Level 5, Marriott Wyndham Ballrooms C/D, First Floor, Wyndham

ANTIPSYCHOTIC PHARMACOTHERAPY AND THE BREAKING THE SILENCE OF CHILDREN'S HIPPOCRATIC OATH: ABOVE ALL DO NO HARM MENTAL ILLNESS: NATIONAL INITIATIVES, Supported by A.straZeneca Pharmaceuticals EARLY DETECTION, AND NEW PHARMACO- THERAPIES Chp.: Henry A. Nasrallah, M.D. Supported by Jans sen Pharmaceutica

(Continued on next page)

37 TUESDAY

Chp.: Robert L. Findling, M.D. COURSE 61 8:00 a.m.-12 noon Maestro, Fourth Floor, DoubleTree A Evolving Treatments for Psychiatric Disorders in Young Patients with Evidence from Bipolar and Other Conditions HOW TO USE YOUR PALM PERSONAL DIGITAL Janet Wozniak, M.D., Joseph Biederman, M.D., Jennifer ASSISTANT IN PSYCHIATRIC PRACTICE Richards, B.A.

B Antipsychotic Pharmacotherapy in Children and Director: John Luo, MJD. Adolescents: What Is the Evidence for Long-Term Faculty: CarlyleH. Chan, M.D., Charles J. Rainey, M.D., Safety? Richard A. Montgomery, M.D. Robert L. Findling, M.D. COURSE 62 8:00 a.m.-12 noon C A Parent's Perspective on Interventions for Children's Minuet, Fourth Floor, DoubleTree Mental Health Ellen Kingsley, M.A. HOW TO SET UP AND RUN A JUVENILE JUSTICE CLINIC

Director: Gabriel Kaplan, M.D. 8:00 a.m. Sessions Faculty: Honorable Lee Forrester, Michael Swerdlow, Ph.D., Denise M. Williams-Johnson, Ph.D., Dorothy Adam COURSES 57-64 Course descriptions are available in the CME COURSE 63 8:00 a.m.-12 noon Course Brochure included in your registration Rhapsody, Fourth Floor, DoubleTree packet. Admission by ticket only. DOING RESEARCH ON A SHOESTRING BUDGET

COURSE 57 8:00 a.m.-12 noon Director: Mantosh J. Dewan, M.D. Ormandy East, Street Level, DoubleTree Faculty: Michelle T. Pato, M.D., Edward K. Silberman, M.D.

DRUG TREATMENT OF SCHIZOPHRENIA COURSE 64 8:00 a.m.-12 noon Sonata 5, Fifth Floor, DoubleTree Director: Philip G. Janicak, M.D. Faculty: Stephen R. Marder, M.D., Rajiv Tandon, M.D., Rajiv P. PARTIAL HOSPITALIZATION FOR PATIENTS WITH Sharma, M.D. BPD

COURSE 58 8:00 a.m.-12 noon Director: Lawrence L. Kennedy, M.D. Ormandy West, Street Level, DoubleTree

THE DETECTION OF MALINGERED MENTAL ILLNESS 9:00 a.m. Sessions

Director: Phillip J. Resnick, M.D. CLINICAL CASE CONFERENCE 2 9:00 a.m.-10:30 a.m. COURSE 59 8:00 a.m.-12 noon Room 103 B, Street Level, Convention Center Aria A, Third Floor, DoubleTree DEPRESSION IN THE MEDICAL SETTING SEXUAL DISORDERS: DIAGNOSIS AND TREATMENT REVISITED: THE PROBLEM OF THE DEPRESSIVE SPECTRUM DISORDERS Director: Waguih W. Ishak, M.D. Faculty: Marina Bussel, M.D., Steve A. Eklund, M.D., Romana Moderator: Robert J. Boland, M.D. Markvitsa, M.D., Anatoly Postolov, M.D. Presenter: Colin J. Harrington, M.D.

COURSE 60 8:00 a.m.-12 noon THIS SESSION IS OPEN TO APA MEMBERS ONLY. Overture, Third Floor, DoubleTree BLUE REGISTRATION BADGE OR APA MEMBER- SHIP CARD REQUIRED FOR ADMITTANCE. ECT PRACTICE UPDATE

Director: Charles H. Kellner, M.D. Faculty: Richard L. Jaffe, M.D., W. Vaughn McCall, M.D., Richard D. Weiner, M.D.

38 TUESDAY

CONTINUOUS CLINICAL CASE CONFERENCE 1: COURSE 69 9:00 a.m.-4:00 p.m. PART 2 Sonata 4, Fifth Floor, DoubleTree 9:00 n.m.-l2 noon Rooms 106 A/B, Street Level, Convention Center TRANSPERSONAL PSYCHIATRY: CLINICAL APPLICATIONS LIVES AND TREATMENTS: TWO PATIENTS, TWO THERAPISTS Co-Directors: John F. Hiatt, M.D., William W. Foote, M.D.

Moderator: James W. Lomax II, M.D. Presenters: Glen O. Gabbard, M.D., Irma J. Bland, M.D. DEBATE 9:00 a.m.-10:30 a.m. THIS SESSION IS OPEN TO APA MEMBERS ONLY. Rooms 107 A/B, Street Level, Convention Center BLUE REGISTRATION BADGE OR APA MEMBER- SHIP CARD REQUIRED FOR ADMITTANCE. RESOLVED: POLITICAL CORRECTNESS HAS NO PLACE IN MEDICINE?

COURSES 65-69 Moderator: Patricia I. Ordorica, M.D. Course descriptions are available in the CMS Affirmative: Sally L. Satel, M.D. Course Brochure included in your registration Negative: Paul S. Appelbaum, M.D. packet. Admission by ticket only. THIS SESSION WILL BE AUDIOTAPED.

COURSE 65 9:00 a.m.-4;00 p.m. DISCUSSION GROUPS 9-13 Orchestra Room, Second Floor, DoubleTree 9:00 a.m.-10:30 a.m. DAVANLOO'S INTENSIVE SHORT-TERM DYNAMIC PSYCHOTHERAPY IN CLINICAL PRACTICE These sessions are limited to 25 participants on a first- come, first-served basis. Director: James Q. Schubmehl, M.D. Faculty: Alan R. Beeber, M.D., Tewfik Said, M.D. 9 Carol A. Bernstein, M.D., on Surviving Residency: Perspectives from the Training Office COURSE 66 9:00 a.m.-4:00 p.m. Room 308, Level 3, Marriott Concerto B, Third Floor, DoubleTree 10 Silvia Hafliger, M.D., on Living Organ Donation: INTRODUCTION TO COGNITIVE-BEHAVIORAL Psychiatric Aspects and Ethical Dilemmas for Donor and THERAPY Recipient Room 410, Level 4, Marriott Co-Directors: Robert M. Goisman, M.D., Philip G. Levendusky, Ph.D. 11 Paula T. Trzepacz, M.D., on Delirium: Phenomenology, Neuropathogenesis, and Treatment Interrelationships COURSE 67 9:00 a.m.-4:00 p.m. Room 413, Level 4, Marriott Symphony Ballroom, Third Floor, DoubleTree 12 Stuart C. Yudofsky, M.D., on Neuropsychiatry and the MED-PSYCH DRUG-DRUG INTERACTIONS: AN Future of Psychiatry (Meet the Authors) UPDATE Room 501, Level 5, Marriott Co-Directors: Scott C. Armstrong, M.D., Kelly L. Cozza, M.D. 13 Robert I. Simon, M.D. and Daniel W. Shuman, on Faculty: Jessica R. Oesterheld, M.D., David Benedek, M.D. Retrospective Assessment of Mental States in Litigation: Predicting the Past (Meet the Authors) COURSE 68 9:00 a.m.-4:00 p.m. Room 502, Level 5, Marriott Sonata 3, Fifth Floor, DoubleTree

BEING AN EFFECTIVE SCHOOL CONSULTANT

Director: Lois T. Flaherty, M.D. Faculty: Trina B. Allen, M.D., Richard L. Gross, M.D., Eugenio M. Rothe, M.D.

39 TUESDAY

LECTURES 8-10 difficult environments through the application of child development and mental health principles ;n schools. LECTURE 8 James P. Comer, M.D., founder of the School Development Program, which has been disseminated 9:00 a.m.-10:30 a.m. to more than 700 schools across the country, discusses Rooms 108 A/B, Street Level, Convention Center the program's approach for mobilizing school staff and parents to support students' learning and overall Mary Jane Massie, M.D. development. Dr. Comer is the Maunce Falk Professor of Child Psychiatry at Yale Child Study Center ind You Are Twenty-Four and You Have What? Associate Dean of Yale University School of Medicine in New Haven, Connecticut. Mis research interests in Chp.: Donna E, Stewart, M.D. schools as a preventive psychiatry focus, race relations, Co-Chp.: Diana Oupa, M.D. and child rearing are reflected in his books School Power, Beyond Black and White, and Raising Black Researchers have described the psychological concerns Children and in numerous other publications in of women with breast cancer, bin little attention has psychiatry and education. A Fellow of the American been given to young women with this disease and the Academy of Arts and Sciences, Dr. Comer has received special problems they face in education, work and APA's Special Presidential Commendation and the career, body image, relationships, sexuality, child- Presidential Citation of the American Educational bearing, and childrearing. Mary Jane Massie, M.D., Research Association. Dr. Comer graduated from discusses the risk factors for and treatment of breast Howard University School of Medicine in Washington, cancer in young women arid the issues thai arise in the D.C.. completed a master's degree in public health at psychiatric treatment of young women with this the University of Michigan, and received his training in disease. Dr. Massie is Director of ihe Barbara White psychiatry ai Yale University School of Medicine, Yile Fishman Center for Psychological Counseling at Child Study Center, and Hilkrest Children's Center in Memorial Sloan-Kettering Cancer Center in New York Washington, D.C, and Professor of Clinical Psychiatry at Weil! Medical THIS SESSION WILL BE AUDIOTAPED. College of Cornell University in New York. Her current research focuses on community outreach to improve LECTURE 10 - CANCELLED opportunities for breast cancer education and screening of minority women. A Fellow o( the APA, Dr. Massie has chaired the APA Committee on Consultation/ MASTER EDUCATOR CLINICAL Liaison Psychiatry and Primary Care Education and the CONSULTATIONS 5-6 Elections Committee. She is c-LirrentJy President-Elect ot the Academy of Psychosomatic Medicine. Dr. 9:00 a.m.-10:30 a.m. Massie received her medical degree from the State University of New York at Buffalo School of Medicine These sessions are limited to 25 participants on a first- and completed her residency in psychiatry at Monieflore come, first-served basis. Hospital/Albert Einstein College ot Medicine in the Bronx and a fellowship in psychiatric oncology at 5 Kenneth Z. Altshuler, M.D., on the Psychotherapies: Do Memorial Sloan-K altering Cancer Center. Similarities Outweigh Differences? Distinguished Psychiatrist Lecture Series Room 111 A, Street Level, Convention Center

LECTURE 9 6 Lisa A. Mellman, M.D., on Brief Dynamic Therapy: For the Patient or for Managed Care? 9:00 a.m.-10:30 a.m, Room 301, Level 3, Marriott Rooms 109 A/B, Street Level, Convention Center THESE SESSIONS ARE OPEN TO APA MEMBERS APA'S BENJAMIN RUSH AWARD LECTURE ONLY. BLUE REGISTRATION BADGE OR APA MEMBERSHIP CARD REQUIRED FOR James P. Comer, M.D. ADMITTANCE.

Problems Facing Inner-City School Educators and MEDIA SESSIONS 10-11 the Role of Psychiatry in Addressing Them MEDIA SESSION 10 9:00 a.m.-10:30 a.m. Chp.: Richard J, Thuirell, M.D. Washington Rooms A-C, Third Floor, Loews Co-Chp.: Jock C. Westman, M.D, PLANETARY PRESSURES Academic and personal development can be signifi- Chp.: Elyse D. Dubo, M.D. cantly improved for students trom marginal and

40 TUESDAY

13 Six Billion and Beyond RESEARCH ADVANCES IN MEDICINE (56 minutes) 9:00 a.m.-ll:00 a.m. Room 111 B, Street Level, Convention Center Distributor: University of California Extension LONG-TERM MECHANICAL CIRCULATORY For V13, Center for Media and Independent Learning SUPPORT V14 & V15 2000 Center Street, 4th Floor Berkeley, CA 94704 Chp.: Peter A. Shapiro, M.D. Co-Chp.: James L. Levenson, M.D. Half of the world's six billion people are under the age of 25. The decisions they make about how many children to have and Participant: Eric Rose, M.D. when to have them will be critical in shaping life on earth in the Frontiers of Science Lecture next 50 years. This thought-provoking documentary is perhaps THIS SESSION WILL BE AUDIOTAPED. the most comprehensive introduction available on video to the interconnected issues of population growth, economic develop- ment, equal rights and opportunities for women, and environ- REVIEW OF PSYCHIATRY: SECTION 1 mental protection around the world. 9:00 a.m.-12:30 p.m. Rooms 201 A-C, Level 200, Convention Center MEDIA SESSION 11 9:00 a.m.-10:30 a.m. EMERGENCY PSYCHIATRY Congress Rooms A-C, Fourth Floor, Loews Chp.: Michael H. Allen, M.D. UP CLOSE AND PERSONAL 1 The Structure and Function of Psychiatric Emergency Services Chp.: Ian E. Alger, M.D. Richard E. Breslow, M.D. 14 Slippery Blisses 2 Medical, Psychiatric, and Cognitive Assessment in (42 minutes) Psychiatric Emergencies Glenn W. Currier, M.D. Kissing is one of our most complex and delicate forms of 3 Assessment and Treatment of the Suicidal Patient communication. It brings our senses of touch, smell, and taste Peter L. Forster, M.D. together with a variety of powerful emotions and behavioral messages. Slippery Blisses interweaves the commentary of ordinary 4 Emergency Treatment of Agitation and Aggression people who recall their best and worst kisses with a quirky cast Jean-Pierre Lindenmayer, M.D. of behavioral experts who discuss the "science" of kissing and raise numerous discussion-inducing questions. The film depicts 5 Psychosocial Interventions in the Psychiatric a visit to Paris, the world's most romantic city, and along the way Emergency Service: A Skills Approach Ronald C. Rosenberg, M.D. explores the turbulent history of kissing in the movies, interiews a sex therapist, and features a socialite hairdresser who shows how cheek-kissing bonds high-society together. Slippery Blisses TELECOMMUNICATIONS SESSION 1 ultimately demonstrates that, as with all human behavior and 9:00 a.m.-12 noon communication, there is nothing simple about a simple kiss. Room 204 C, Level 200, Convention Center

15 Personal Space: Exploring Human Proxemics APPLICATIONS OF ADVANCED INFORMATION (28 minutes) TECHNOLOGIES Chp.: Norman E. Alessi, M.D. Space is a silent language, and we all speak it, whether con- sciously or not. Personal Space: Exploring Human Proxemics is a 9:15 a.m. fascinating and frequently runny video that portrays the effects 1 The Use of Digital Streaming Video for Distance of space on everyday human behavior in an engaging and dramatic Education in Telepsychiatry manner. Topics covered in the video include: 1) individual Gregory L. Barker reactions to invasions of personal space; 2) the powerful effect 10:00 a.m. of cultural differences and strong habitual patterns in how 2 DAVID: Depression Animation Video Image Database individuals use space; 3) family spatial arrangements; 4) how Earl C. Lawrence, MA., Mike Ward spatial factors affect our perceptions of relationships; and 5) hierarchical space in organizations. The video blends student 11:00 a.m. testimony and often amusing field experiments to illuminate the 3 Open Infrastructure for Outcomes: From Plug and Play use of space, territory, and touching in virtually every facet of life. Web Forms to Evidence-Guided Treatment AndrewP.Ho,M.D.

41 TUESDAY

WORKSHOPS ISSUE WORKSHOP 30 9:00 a.m.-10:30 a.m. Room 103 A, Street Level, Convention Center COMPONENTS 19-22 THE NEUROBIOLOGYOF LEARNING: COMPONENT WORKSHOP 19 9:00 a.m.-10:30 a.m. IMPLICATIONS FOR TEACHING Room 103 C, Street Level, Convention Center Chp.: Janet E. Osterman, M.D. HEALTH CARE LEGISLATION: THE ROLE FOR THE 21ST-CENTURY BLACK PSYCHIATRIST ISSUE WORKSHOP 31 9:00 a.m.-10:30 a.m. A PA Committee of Black Psychiatrists Room 104 A, Street Level, Convention Center

Co-Chps.: Michelle O. Clark, MD., Lishan Workeneh, M.D. EXPLORING THE MEDIA'S ROLE IN IMITATION Participants: Bethany J. Tucker, M.D., Honorable Louis Stokes VIOLENCE

COMPONENT WORKSHOP 20 9:00 a.m.-10:30 a.m. Chp.:PaulA.Kettl,M.D. Liberty Ballroom C, Level 3, Marriott Participant: Kathleen Jamison, Ph.D.

HOW TO LAUNCH A SUCCESSFUL PRIVATE ISSUE WORKSHOP 32 9:00 a.m.-10:30 a.m. PRACTICE: PART I Room 104 B, Street Level, Convention Center APA Committee of Early Career Psychiatrists WE CAN IMPROVE CARE FOR THOSE WITH Co-Chps.: William E. Callahan, Jr., MD., Keith W. Young, MD. MENTAL HEALTH AND SUBSTANCE ABUSE Participants: Jacqueline M. Melonas, J.D., Martin G. Tracy, J.D. DISORDERS

COMPONENT WORKSHOP 21 9:00 a.m.-10:30 a.m. Chp.: Katherine E. Watkins, M.D. Rooms 407-409, Level 4, Marriott Participants: John Sheehe, M.S.W., Dina Daleo, Ph.D.

MEDICAL STUDENT EDUCATION IN ADDICTION: ISSUE WORKSHOP 33 9:00 a.m.-10:30 a.m. COMPETENCIES AND RESOURCES Rooms 112 A/B, Street Level, Convention Center A PA Committee on Training and Education in Addiction Psychiatry and American Academy of Addiction Psychiatry COUPLES TREATMENT BY PARALLEL COORDINATED INDIVIDUAL PSYCHOTHERAPY Co-Chps.: Jonathan I. Ritvo, M.D., Richard S. Schottenfeld, MD. Participants: William M Greenberg, MD., Timothy W. Fong, MD., Chp.: Michael C. Hughes, M.D. Christopher J. Welsh, M.D., Marjorie E. Waldbaum, M.D. Participant: Eva C. Ritvo, M.D. COMPONENT WORKSHOP 22 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 34 9:00 a.m.-10:30 a.m. Rooms 411/412, Level 4, Marriott Room 113 A, Street Level, Convention Center DISCUSSION: SURGEON GENERAL'S REPORT ON AMERICAN INDIANS AND ALASKA NATIVES MOTION PICTURES: THE THERAPEUTIC A PA Committee of American Indian, Alaska Native, and Native MODALITY OF THE 21ST CENTURY Hawaiian Psychiatrists Chp.: M. Fuat Ulus, M.D. Co-Chps.: Frank W. Brown, MD., Yvonne L. De Cory- Participants: Conni Sharp, Ed.D., Eda Ulus, B.S. Woronoff, M.D. Participants: Mary H. Roessel, MD., Richard L. Livingston, M.D., ISSUE WORKSHOP 35 9:00 a.m.-10:30 a.m. R. Dale Walker, M.D. Room 113 B, Street Level, Convention Center

INNOVATIVE STRATEGIES IN THIRD-YEAR ISSUES 29-57 MEDICAL STUDENT PSYCHIATRIC EDUCATION

ISSUE WORKSHOP 29 9:00 a.m.-10:30 a.m. Chp.: Molly J. Hall, M.D. Rooms 102 A/B, Street Level, Convention Center Participants: Timothy J. Lacy, M.D., Brenda J. Roman, M.D., Donald A. West, M.D., Stephen B. Shanfield, M.D. WORKING WITH PARENTS DURING THEIR BABY'S FIRST YEAR OF LIFE

Chp.: James M. Murphy, M.D.

42 TUESDAY

ISSUE WORKSHOP 36 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 42 9:00 a.m.-10:30 a.m. Room 113 C, Street Level, Convention Center Room 204 B, Level 200, Convention Center

NATIONAL COMMISSION ON MARIJUANA AND TEN YEARS OF TEACHING ABOUT BOUNDARIES: DRUG ABUSE REPORT: 30 YEARS LATER WHAT HAVE WE LEARNED?

Chp.: J. Thomas Ungerleider, M.D. Chp.: Gregg E. Gorton, M.D. Participant: Michael R. Sonnenreich,J.D. Participants: Steven E. Samuel, Ph.D., Gail Zivin, Ph.D.

ISSUE WORKSHOP 37 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 43 9:00 a.m.-10:30 a.m. Room 202 A, Level 200, Convention Center Rooms 302/303, Level 3, Marriott

BRIDGING THE GAP: DEPRESSION, CHRONIC EVIDENCE-BASED TREATMENT FOR MARIJUANA MEDICAL DISEASE, CULTURE, AND ETHNICITY DEPENDENCE Substance Abuse and Mental Health Services Administration Chp.: Annelle B. Primm, M.D. Participants: William T. Regenold, M.D., Evelyn L. Lewis, M.D. Chp.: Karen Steinberg, Ph.D. Participants: Roger A. Roffinan, D.S.W., Ronald Kadden, Ph.D., ISSUE WORKSHOP 38 9:00 a.m.-10:30 a.m. Jerome H. Jaffe, M.D. Room 202 B, Level 200, Convention Center ISSUE WORKSHOP 44 9:00 a.m.-10:30 a.m. OLFACTORY DYSFUNCTION IN PSYCHIATRY AND Rooms 304-306, Level 3, Marriott NEUROLOGY ENHANCING AND FUNDING MENTAL HEALTH Co-Chps.: Teodor T. Postolache, M.D, Richard L. Doty, Ph.D. SERVICES: NEW FREEDOM INITIATIVE Participants: Paul J. Moberg, Ph.D., Marilyn Jones-Gotman, Ph.D. Substance Abuse and Mental Health Services Administration

ISSUE WORKSHOP 39 9:00 a.m.-10:30 a.m. Co-Chps.: Mary Jane England, M.D., Eileen Elias, M.Ed. Room 203 A, Level 200, Convention Center Participants: Shelley E. Bishop, Vincent J. Hughes, Eileen C. Wolkstein, Ph.D., Marilyn L. Eckley, M.P.A. NEUROBEHAVIORAL SEQUELAE OF TRAUMA TO THE FRONTAL LOBES ISSUE WORKSHOP 45 9:00 a.m.-10:30 a.m. Room 307, Level 3, Marriott Chp.: Marilyn F. Kraus, M.D. Participants: Harvey Levin, Ph.D., Thomas Gualtieri, M.D. BUPRENORPHINE: A NEW OFFICE-BASED TREATMENT FOR OPIOID DEPENDENCE ISSUE WORKSHOP 40 9:00 a.m.-10:30 a.m. Substance Abuse and Mental Health Services Administration Room 203 B, Level 200, Convention Center Co-Chps.: Herbert D. Kleber, M.D, H. Westley Clark, M.D. CULTURAL COMPETENCE IN PSYCHIATRIC RESIDENCY TRAINING PROGRAMS ISSUE WORKSHOP 46 9:00 a.m.-10:30 a.m. Substance Abuse and Mental Health Services Administration Independence Ballroom I, Level 3, Marriott

Chp.: Francis G. Lu, M.D. IMPROVING THE QUALITY OF SERVICE IN A Participants: Renato D. Alarcon, M.D., Pedro Ruiz, M.D., MEDICAID HMO James W. Thompson, M.D. Chp.: James M. Schuster, M.D. ISSUE WORKSHOP 41 9:00 a.m.-10:30 a.m. Participants: Deborah Wasilchak, Frank Ghinassi, Kelly Room 204 A, Level 200, Convention Center Kelleher, M.D.

A LEGAL PRIMER FOR PSYCHIATRISTS INVOLVED ISSUE WORKSHOP 47 9:00 a.m.-10:30 a.m. IN ISSUES OF SEXUAL ORIENTATION Independence Ballrooms II/III, Level 3, Marriott

Co-Chps.: John E. Fryer, M.D., Mark-Allen Taylor, J.D. IMPLEMENTATIONS OF DBT IN CORRECTIONAL Participants: Nancy J. Knauer, J.D., David L. Scasta, M.D. ENVIRONMENTS

Chp.: Robert L. Trestman, M.D. Participants: Daniel Bannish, Psy.D, M. Paul Chaplin, Ph.D.

43 TUESDAY

ISSUE WORKSHOP 48 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 55 9:00 a.m.-10:30 a.m. Rooms 401-403, Level 4, Marriott Grand Ballroom Salon J, Level 5, Marriott

HEPATITIS-C IN ADDICTION PSYCHIATRY ADDICTION TREATMENT 2002: NEW DIRECTIONS Chp.: Vasant P. Dhopesh, M.D. Participants: Kyong-Mi Chang, M.D., Robert M. Weinrieb, M.D. Chp.: Richard J. Frances, M.D. Participants: Sheila B. Blume, M.D., Sheldon I. Miller, M.D., ISSUE WORKSHOP 49 9:00 a.m.-10:30 a.m. Marc Galanter, M.D., Robert B. Millman, M.D., Lionel P. Rooms 414/415, Level 4, Marriott Solursh, M.D., Frances R. Levin, M.D.

GROUP PSYCHOTHERAPY FOR SUBSTANCE ISSUE WORKSHOP 56 9:00 a.m.-10:30 a.m. ABUSERS Grand Ballroom Salon K, Level 5, Marriott Co-Chps.: David W. Brook, M.D., Henry I. Spitz, M.D. TARASOFF REVISITED: CHANGING TRENDS IN ISSUE WORKSHOP 50 9:00 a.m.-10:30 a.m. DUTY TO WARN THIRD PARTIES Grand Ballroom Salon A, Level 5, Marriott Chp.: Chowallur D. Chacko, M.D. WORLD FEDERATION OF PSYCHIATRIC Participants: Robert L. Sadoff, M.D., Liz M. Chacko TRAINEES: SATISFACTION AND INTERNATIONAL EXCHANGE IN PSYCHIATRIC ISSUE WORKSHOP 57 9:00 a.m.-10:30 a.m. Co-Chps.: Victor J.A. Buwalda, M.D., Michelle B. Riba, M.D. Grand Ballroom Salon L, Level 5, Marriott

ISSUE WORKSHOP 51 9:00 a.m.-10:30 a.m. IMPLEMENTING AN EFFECTIVE TRUANCY- Grand Ballroom Salon B, Level 5, Marriott REDUCTION PROGRAM

SPIRITUAL DIMENSION AND RELIGIOUS ISSUES Chp.: Stephen M. Soltys, M.D. IN AN URBAN CMHC CLINICAL PRACTICE Participants: Mary Jo Davoren, M.Ed., David Mahrer, Ph.D., Haitian-American Psychiatric Association Kenneth M. Rogers, M.D. Chp.: Jean B. Tropnas, M.D. Participants: Ophie Franklin, Yvette Sealy, Ph.D., Meeta Gandhi, M.S.W., Donna M. Serrant, M.S.W. 11:00 a.m. Sessions ISSUE WORKSHOP 52 9:00 a.m.-10:30 a.m. Grand Ballroom Salon C, Level 5, Marriott DISCUSSION GROUPS 14-18 ETHICS OF PHARMACEUTICAL INVOLVEMENT IN 11:00 a.m.-12:30 p.m. PSYCHIATRIC EDUCATION These sessions are limited to 25 participants on a first- Chp.: Nalini V. Juthani, M.D. come, first-served basis. Participants: Jeffrey M. Levine, M.D., Uday K Mukherjee, M.D., Huma K. Khan, M.D., Mikhail Y. Ziskin, M.D. 14 Rachel Yehuda, Ph.D., on Treatment of Trauma Survivors: Theory Versus Practice (Meet the Authors) ISSUE WORKSHOP 53 9:00 a.m.-10:30 a.m. Room 308, Level 3, Marriott Grand Ballroom Salon D, Level 5, Marriott 15 Frances R. Levin, M.D., on Treating Substance Abusers THE PORTRAYAL OF PSYCHIATRY IN RECENT AMERICAN FILMS with Comorbid Psychiatric Disorders: Potential Pitfalls Room 410, Level 4, Marriott Chp.: Steven E. Pflanz, M.D. 16 Thomas N. Wise, M.D., on Depression in the Medically 111 ISSUE WORKSHOP 54 9:00 a.m.-10:30 a.m. Room 413, Level 4, Marriott Grand Ballroom Salon I, Level 5, Marriott 17 Elisabeth J.S. Kunkel, M.D., on Managing Depression and HIV, AIDS, HEPATITIS-C, MENTAL ILLNESS, AND Anxiety in Patients with Cancer and Other Medical Illnesses SUBSTANCE ABUSE: CONVERGING ILLNESS Room 501, Level 5, Marriott Substance Abuse and Mental Health Services Administration 18 Karen K. Milner, M.D., on Integrating Physical-Mental Chp.: Marshall Forstein, M.D. Health Care: The WCHO Experience Participants: Marvin S. Swartz, M.D., Lawrence Brown, M.D., Room 502, Level 5, Marriott Jennifer F. Havens, M.D.

44 TUESDAY

LECTURES 11-12 can occur during the time of life termed "dying." Although suffering is common among dying patients, LECTURE 11 the ability to make meaning, review one's life, complete relationships, express love, and explore spiritual realms 11:00 a.m.-12:3C p.m. all may continue to exist. Ira R. Byock, M.D., describes Rooms 108 A/B, Street Level, Convention Center a developmental conceptual framework for under- standing the nature of suffering and opportunity at the APA/NIMH VESTERMARK PSYCHIATRY end of life and discusses ways in which psychiatric EDUCATOR AWARD LECTURE specialists can alleviate suffering and preserve the oppor- tunity for people to grow, individually and together, Marc Galanter, M.D. through the very end of life. Dr. Byock is Director of Palliative Care Service in Missoula, Montana, and Healing Through Social and Spiritual Affiliation Research Professor in the Department of Philosophy at the University of Montana, where is he also a faculty Chp.: Richard Balon, M.D. member in the Practical Ethics Center, His numerous Co-Chp.: Patrick I. Ordorica, M.D. publications on end-of-life care include the book Dying Weil: The Prospect for Gwuth at the End a{ Life. He has Although largely overlooked by conventional bio- received the National Hospice Orgamzation's Person medical practice, social and spiritual affiliation can be of the Year award and the National Coalition of Cancer valuable in promoting recovery from psychiatric dis- Survivorship's Natalie Davis Spingarn Writers Award. orders, particularly substance abuse. Marc Galanter, MD., Dr. Byock graduated from the University of Colorado draws on research on addicted patients' experience in School of Medicine and completed his residency in Alcoholics Anonymous to illustrate the potent impact family practice at Valley Medical Center in I;resno, of a spiritual message imparted in a cohesive social California. group. He also discusses the model ot ideologically Frontiers of Science Lecture Series grounded affiliation as it relates to behavioral changes THIS SESSION WILL BE AUDIOTAPED. observed in cultic, terrorist, and mental health support groups. Dr. Galanier is Professor of Psychiatry and Director of the Division of Alcoholism and Drug MASTER EDUCATOR CLINICAL Abuse at New York University School of Medicine. A CONSULTATIONS 7-8 Fellow of the APA, Dr. Galanter is Past President of the American Academy of Addiction Psychiatry- and 11:00 a.m.-12:30 p.m. the American Society of Addiction Medicine and ihe Editor-in-Chief of SuhsMnce Abase. He received the These sessions are limited to 25 participants on a first- McGovern Award from the Association for Medical come, first-served basis. Education and Research in Substance Abuse, and his dinical program received the APA Gold Achievement 7 Jerald Kay, M.D., on Integrating Psychotherapy and Award for innovative care. His research is presented in Pharmacotherapy more than 250 publications, including two books, Cults: Room 111 A, Street Level, Convention Center faith, H&dtng, and Gxmcr: and Network Therapy for AltoM and Drug Abuse. Dr, Galanier received his 8 Lawrence Hartmann, M.D., on Child and Adolescent medical and psychiatric training at Albert Einstein Clinical Work: Integrating Bio-, Psycho-, and Social College of Medicine in the Bronx. Room 301, Level 3, Marriott THIS SESSION WILL BE AUDIOTAPED. THESE SESSIONS ARE OPEN TO APA MEMBERS LECTURE 12 ONLY. BLUE REGISTRATION BADGE OR APA MEMBERSHIP CARD REQUIRED FOR 11:00 a.m.-12:30 p.m. ADMITTANCE. Rooms 109 A/B, Street Level, Convention Center

Ira R- Byock, M.D, MEDIA SESSIONS 12-13

Dying Well: Beyond Symptoms and Suffering, MEDIA SESSION 12 11:00 a.m.-l:00 p.m. Human Development at the End-of-Life Washington Rooms A-C, Third Floor, Loews Chp.: Mary E. Foti, MD. Co-Chp.: Maunce D, Steinberg, M.D. AFTER APARTHEID

Narratives of people confronting life's end provide Chp.: J. Charles Ndlela, M.D. empiric evidence of the range ot human experience that (Continued next page) 45 TUESDAY

16 Long Night's Journey into Day that has proven deeply unreliable, with strangers who may or (94 minutes) may not offer comfort and protection. Take This Heart is the story of three boys who struggle to make sense of their harsh Distributor: California Newsreel fates, each in his own way. Their stories reveal the 149 9th Street, Suite 420 remarkable resiliency and the tough-minded will with which San Francisco, CA 94103 they go on with their lives, not utterly consoled, but not broken. The film explores the experiences of a few children in This film captures some of the pain with an outpouring of one foster home in Seattle, and in so doing gives voice to an emotions during the hearing before the Truth and Reconciliation invisible population of children otherwise consigned to silence Commission, which was a process chosen by South Africa to at the margins of society. facilitate healing from Apartheid trauma. Nobel Prize Laureate Archbishop Desmond Tutu states, "This is an impressive, heart- rending film and deserves wide circulation." The directors have MEDICAL UPDATE 2 attempted to explore the workings of the "restorative justice" in 11:00 a.m.-12:30 p.m. a dramatic presentation accompanied by rich, emotionally arousing Room 103 A, Street Level, Convention Center South African music. CARDIAC EFFECTS OF OPIOID ADDICTION Discussant: J. Charles Ndlela, M.D. PHARMACOTHERAPY Substance A buse and Mental Health Services Administration MEDIA SESSION 13 11:00 a.m.-12;30 p.m. Congress Rooms A-C, Fourth Floor, Loews Chp.: Richard S. Schottenfeld, M.D. Presenters: Elinore F. McCance-Katz, M.D., Robert VICTIMS AT AN EARLY AGE Maslansky, M.D. THIS SESSION WILL BE AUDIOTAPED. Chp.: Edward K. Rynearson, M.D.

17 Making Visible the Hidden: Serving Child Victims in RESEARCH CONSULTATION WITH the Healthcare Community (15 minutes) 11:00 a.m.-12:30 p.m.

Distributor: Deborah Spungen, M.S.S. This session is limited to 25 participants on a first-come, AVP first-served basis. 633 WestRittenhouse Street, #C-14 Philadelphia, PA 19144 1 Steven P. Roose, M.D., on Depressed Patients with Heart Disease and Late-Life Depression Healthcare providers are often the first to respond to child victims Anthony Room, Third Floor, Loews of violence, but their focus on treating the physical wounds sometimes causes them to overlook children's emotional and mental (the hidden) needs. Without timely and appropriate SCIENTIFIC AND CLINICAL REPORT intervention, the effects of trauma can last a lifetime. Making SESSIONS 13-24 Visible the Hidden: Serving Child Victims in the Healthcare Community highlights three programs in which professionals in medical SCIENTIFIC AND CLINICAL REPORT SESSION 13 settings are incorporating victim-oriented practices into the service 11:00 a.m.-12:30 p.m. they provide. The stories of child victims vividly illustrate the Room 103 C, Street Level, Convention Center importance of early intervention. GENDER ISSUES Discussant: Deborah Spungen, M.S.S. Chp.: Antonia L. Baum, M.D. 18 Take This Heart Co-Chp.: Melva I. Green, M.D. (58 minutes) 11:00 a.m. Distributor: University of California Extension 37 Meat Consumption and Risk of Depression: A Center for Media and Independent Learning Prospective, Population-Based Study 2000 Center Street, 4th Floor Antti Tanskanen, M.D., Heimo Viinamaki, M.D., Kaisa Berkeley, CA 94704 Haatainen, M.H.S.C., Kristiina Nyyssonen, Ph.D., Tiina H. For the nearly one million American children who are Rissanen, R.N., Sari Voutilainen, Ph.D., Jukka T. Salonen, M.D. compelled to live in foster care, daily life is a forbidding venture. Cast adrift at an early age, dispossessed of everyone they have known or loved, they are left to grow up in a world 46 TUESDAY

11:30 a.m. 11:30 a.m. 38 A Multinational Study of the Emergence of Gender 44 ADHD Treatment with a Once-Daily Formulation of Differences in Depression Methylphenidate Hydrochloride: A Two-Year Study Terrance J. Wade, Ph.D., John Cairney, MA., David J. Timothy E. Wilens, M.D., William E. Pelham, Jr., Ph.D., Pevalin, MA. Mark Stein, Ph.D., C. Keith Conners, Ph.D., Howard Abikoff, Ph.D. 12 noon 39 Efficacy and Safety of Sildenafil Citrate in Men with 12 noon Depression and Erectile Dysfunction: Six-Month, 45 Long-Term Safety and Efficacy of Adderall Extended Open-Label Treatment Release in Children with ADHD Stuart N. Seidman, M.D., Steven P. Roose, M.D., Vera J. Mark C. Chandler, M.D., Frank A. Lopez, M.D., Joseph Stecher, Ph.D., Matthew A. Menza, M.D., Raymond C. Biederman, M.D. Rosen, Ph.D. THIS SESSION WILL BE AUDIOTAPED. SCIENTIFIC AND CLINICAL REPORT SESSION 16 11:00 a.m.-12:30 p.m. SCIENTIFIC AND CLINICAL REPORT SESSION 14 Room 204 A, Level 200, Convention Center 11:00 a.m.-12:30 p.m. Room 113 B, Street Level, Convention Center CULTURAL ISSUES IN VIOLENCE

BIPOLAR TREATMENT ISSUES Chp.: Jose M. Canive, M.D. Co-Chp.: Martin A. Adeoye, MD. Chp.: David L. Dunner, M.D. Co-Chp.: N. Kalaya Okereke, MD. 11:00 a.m. 46 Partner Violence and Risk of Major Depression in 11:00 a.m. Chinese-American Women 40 End-Stage Chronic Renal Failure from Prolonged MadelynH. Hicks, M.D. Lithium Therapy Gregory Braden, M.D., David L. Honeyman, M.D., Anthony 11:30 a.m. Poindexter, M.D., Jane Garb, MS., Michael Germain, M.D., 47 Violence in Colombia: Mental Health Impact in Lewis M. Cohen, MD. Children Ruby C. Castilla-Puentes, M.D., Ivan S. Gomez, M.D., 11:30 a.m. Sandra-Rocio Castilla Puentes, M.D., Wilma-Ines Castilla 41 Topiramate in the Treatment of Refractory Bipolar Puentes, M.D., Miguel Habeych, M.D., Linda Depression McWilliams, M.P.H., Boris Birmaher, M.D. Mohammad Z. Hussain, M.D., Zabaida A. Chaudhry, M.D., Seema Hussain, M.D. 12 noon 48 Epidemiology, Trauma, and Transcultural Psychiatry 12 noon Joop De Jong, M.D., Ivan Kompore, Ph.D., Mark Van 42 Prescribing Practices in Bipolar Disorder Ommeren, Daya Somasundaram, M.D. Bonnie L. Szarek, R.N., John W. Goethe, M.D., Uzma S. THIS SESSION WILL BE AUDIOTAPED. Faheem, M.D. THIS SESSION WILL BE AUDIOTAPED. SCIENTIFIC AND CLINICAL REPORT SESSION 17 11:00 a.m.-12:30 p.m. SCIENTIFIC AND CLINICAL REPORT SESSION 15 Room 204 B, Level 200, Convention Center 11:00 a.m.-12:30 p.m. Room 113 C, Street Level, Convention Center BIPOLAR DISORDER

DRUG THERAPY OF ADHD Chp.: Paul J. Goodnick, M.D. Co-Chp.: Daniel Tsao, M.D. Chp.: Paul P. Yeung, M.D. Co-Chp.: Albert Y. Ma, M.D. 11:00 a.m. 49 Increased Rates of Antipsychotic-Induced EPS in Mood 11:00 a.m. Disorders: Myth or Reality? 43 Once-Daily Administration of Atomoxetine: A New Patrizia A. Cavazzoni, M.D., Paul H. Berg, M.S., Robert W. Treatment for ADHD Baker, MD., Angela R. Evans, Ph.D., Mauricio F. Tohen, MD. David Michelson, M.D.

(Continued next pagp)

47 TUESDAY

11:30 a.m. 11:30 a.m. 50 Cyclothymia in Atypical Depression: The Borderline- 56 Visually Enhanced Psychosexual Therapy Bipolar II Connection Frank G. Sommers, M.D. Giulio Perugi, M.D., Christina Toni, M.D., Chiara Travierso, M.D., Giuseppe Ruffolo, M.D., Hagop S. 12 noon Akiskal, M.D. 57 Dichotomous Thinking and Thought Suppression in Managing Anger 12 noon David M. Magder, M.D. 51 Substance Use and Perceived Symptom Improvement in THIS SESSION WILL BE AUDIOTAPED. Bipolar Disorder Roger D. Weiss, M.D., Monika Kolodziej, Ph.D., Margaret L. SCIENTIFIC AND CLINICAL REPORT SESSION 20 Griffin, Ph.D., Lisa M Najavits, Ph.D., Lara M Jacobson, BA., 11:00 a.m.-12:30 p.m. Shelly F. Greenfield, M.D. Grand Ballroom Salon B, Level 5, Marriott THIS SESSION WILL BE AUDIOTAPED. ETHICAL AND EXPLANATORY MODELS IN SCIENTIFIC AND CLINICAL REPORT SESSION 18 PSYCHIATRY 11:00 a.m.-12:30 p.m. Independence Ballrooms II/III, Level 3, Marriott Chp.: Alan M. Gruenberg, M.D. Co-Chp.: David M. McDowell, M.D. PREDICTORS OF OUTCOME 11:00 a.m. Chp.: Linmarie Sikich, M.D. 58 Principles of Clinical Explanation in 21st-century Co-Chp.: Michael A. Scharf, MD. Psychiatry David H. Brendel, M.D. 11:00 a.m. 52 Outcome of Early-Phase Psychosis Concurrent with 11:30 a.m. Substance Use 59 Experience of Research Participation by Patients with Carol LM. Caton, Ph.D., Deborah S. Hasin, Ph.D., Severe Mental Illness Michael B. First, M.D., Ellen M. Stevenson, M.D., Robert E. Russell S. Omens, Psy.D., Cherise Rosen, MA., Sheila Drake, M.D., Francine Cournos, M.D., Patrick Shrout, Ph.D. Donovan, PhD., Martin Harrow, PhD., Philip G. Janicak, MD.

11:30 a.m. 12 noon 53 Predictors of Syndromal and Functional Recovery in 60 Attitudes of Physicians Towards Gifts from the Patients with First-Episode Mania Pharmaceutical Industry: A Pilot Study Mauricio F. Tohen, M.D., John Hennen, PhD., Carlos M. Amarsingh M. Ghorpade, M.D., Saurabh Kaushik, M.D., Zarate, Jr., M.D., Stephan M. Strakowski, M.D., Ross J. Parinda Parikh, M.D., Vasundhara Kalasapudi, M.D., Baldessarini, M.D. Sheldon S. Berman, M.D. THIS SESSION WILL BE AUDIOTAPED. 12 noon 54 High Birth Weight as a Predictor of Schizophrenia: A SCIENTIFIC AND CLINICAL REPORT SESSION 21 31-Year Follow-Up 11:00 a.m.-12:30 p.m. Kristiina Moilanen, M.D., Jari Jokelainen, M.S.C., Anna-Liisa Grand Ballroom Salon C, Level 5, Marriott Hartikainen, Ph.D., Marjo-Riitta Jarvelin, Ph.D., Peter B. Jones, Ph.D., Matti K. Isohanni, M.D. RELIGION, SPIRITUALITY, AND PSYCHIATRY THIS SESSION WILL BE AUDIOTAPED. Chp.: David A. Casey, M.D. SCIENTIFIC AND CLINICAL REPORT SESSION 19 Co-Chp.: John P. Hendrick, M.D. 11:00 a.m.-12:30 p.m. Rooms 407-409, Level 4, Marriott 11:00 a.m. 61 Effects of Falun Gong Practice on Physical and Mental BEHAVIOR AND COGNITIVE THERAPY Health Jing-Duan Yang, M.D., Ashwin A. Patkar, M.D., Li-Shan Chp.: John C. Markowitz, M.D. Huang, Ph.D., Daniel A. Monti, M.D., Sue Jiang, MLS., Co-Chp.: Anton C. Trinidad, MD. CuirongRen,Ph.D.

11:00 a.m. 11:40 a.m. 55 Does Cognitive-Behavioral Group Treatment Improve 62 Moral Conflict as a Component of Anxiety and Worry Personality Measures in Panic Disorder Patients? Jerome L. Kroll, M.D., Kathleen S. Carey, MS., Paul Frederico Cavaglia, M.S.C., Cristina Pablo, M.D., Ana Matos- Erickson, M.D., Elizabeth Egan, PhD., Myles Johnson, PhD. Pires, M.S.C., Nuno Goncalves, M.D. THIS SESSION WILL BE AUDIOTAPED.

48 TUESDAY

SCIENTIFIC AND CLINICAL REPORT SESSION 22 Chp.: Steven A. Epstein, M.D. 11:00 a.m.-12:30 p.m. Co-Chp.: Henry W.J. Weisman, M.D. Grand Ballroom Salon J, Level 5, Marriott 11:00 a.m. USES OF MODAFINIL 69 The Burden of Hepatitis-C Among Mentally 111 Persons in Long-Term Care Chp.: Maria T. Caserta, M.D. Elsie J. Freeman, M.D., Kenneth S. Duckworth, M.D. Co-Chp.: Kevan R. Wylie, M.D. 11:30 a.m. 11:00 a.m. 70 Double Jeopardy: Mental Illness, Medical Conditions, 63 Effect of Modafinil on Mood and Quality of Life in and Early Death Patients with Narcolepsy Elsie J. Freeman, M.D., Kenneth S. Duckworth, M.D., Philip M. Becker, M.D.Jonathan Schwartz, M.D., Neil Robert Goldstein, Ph.D., MaryLou Sudders Feldman, M.D., Rod J. Hughes, Ph.D. 12 noon 11:30 a.m. 71 Prevalence and Symptom Patterns of Depression 64 Long-Term Safety and Efficacy of Modafinil for Among College Students Daytime Sleepiness Shamsah B. Sonawalla, M.D., Nicole B. Neault, B.A., Mary B. O'Malley, M.D. Christina M. Dording, M.D., Megan E. Hughes, B.A., Albert Yeung, M.D., Timothy J. Petersen, Ph.D., Maurizio Fava, M.D. 12 noon THIS SESSION WILL BE AUDIOTAPED. 65 Modafinil Enhances Motivation in the Absence of Overt Sleepiness Matthew S. Miller, Ph.D., Elaine Fiocchi, B.S., Dorothy G. WORKSHOPS Flood, Ph.D., Amy DiCamillo, M.S. THIS SESSION WILL BE AUDIOTAPED. COMPONENTS 23-31

SCIENTIFIC AND CLINICAL REPORT SESSION 23 COMPONENT WORKSHOP 23 11:00 a.m.-12:30 p.m. 11:00 a.m.-12:30 p.m. Rooms 102 A/B, Street Level, Convention Center Grand Ballroom Salon K, Level 5, Marriott MENTAL HEALTH CARE FOR ASIAN AMERICANS CROSS-CULTURAL PSYCHIATRY: ASIAN ISSUES AND PACIFIC ISLANDERS APA Committee of Asian-American Psychiatrists Chp.: Maria R. Yee, M.D. Co-Chp.: Victor Hong Co-Chps.: Nang Du, M.D., Surinder S. Nand, M.D. Participants: Francis G. Lu, M.D., Keh-Ming Lin, M.D., Kana 11:00 a.m. Enomoto, M.A. 66 Integrating Psychiatry and Primary Care Improves Treatment Acceptability Among Asian Americans COMPONENT WORKSHOP 24 11:00 a.m.-12:30 p.m. Albert Yeung, M.D., Grace E. F. Rubenstein, B.A., Henry Room 104 A, Street Level, Convention Center Chung, M.D., Pamela A. Roffi, B.S., Andrew A. Nierenberg, M.D., Maurizio Fava, M.D., David SURVIVOR MUR: WHO GETS VOTED IN? Mischoulon, M.D. APA Assembly Committee of Representatives of Minority/ Underrepresented Groups 11:30 a.m. 67 Anger Discomfort in Japanese, Chinese, and Caucasian Co-Chps.: Jeffrey Akaka, M.D., Ana E. Campo, M.D. Females Participants: Donna M. Norris, M.D., Rodrigo A. Munoz, M.D., Alayne Yates, M.D., Jeanne Edman, Ph.D., Mata Aruguette, Ph.D. Pedro Ruiz, M.D., Nada L. Stodand, M.D., R. Dale Walker, M.D. 12 noon COMPONENT WORKSHOP 25 11:00 a.m.-12:30 p.m. 68 Anatomy of Jeong Christopher K. Chung, M.D., Samson J. Cho, M.D. Room 104 B, Street Level, Convention Center THIS SESSION WILL BE AUDIOTAPED. AMBULATORY DETOXIFICATION FROM SCIENTIFIC AND CLINICAL REPORT SESSION 24 ALCOHOL: HOW TO DO IT WELL AND GET PAID 11:00 a.m.-12:30 p.m. TOO Grand Ballroom Salon L, Level 5, Marriott APA Committee on Treatment Services for Addicted Patients

EPIDEMIOLOGY Co-Chps.: George F. Kolodner, M.D., Samuel M. Silverman, M.D. Participants: Brealyn M. Sellers, M.D., Victor Sierra, M.D.

49 TUESDAY

COMPONENT WORKSHOP 26 11:00 a.m.-12;30 p.m. ISSUES 58-68 Rooms 112 A/B, Street Level, Convention Center ISSUE WORKSHOP 58 11:00 a.m.-12;30 p.m. THE TERRORIST CRISIS OF 2001: USE AND IMPACT Room 202 B, Level 200, Convention Center OF ELECTRONIC COMMUNICATION APA Committee an Information Technology, APA New York County PSYCHODYNAMICS IN TREATMENT-REFRACTORY District Branch, and the Psychiatric Society for Informatics DEPRESSION

Co-Chps.: Ronnie S. Stangler, M.D., Julie K. Schulman, M.D. Co-Chps.: Eric M. Plakun, MX)., Edward R. Shapiro, M.D. Participant: David L. Mintz, MX). COMPONENT WORKSHOP 27 11:00 a.m.-12:30 p.m. Room 202 A, Level 200, Convention Center ISSUE WORKSHOP 59 11:00 a.m.-12;30 p.m. Room 203 A, Level 200, Convention Center KIDS, SCHOOLS, AND PARENTS: FROM THE 20TH CENTURY INTO THE 21ST CENTURY THE ART OF THE UNCONSCIOUS: SHAKESPEARE, APA CammOee an History and Library POETRY, FILM, AND PSYCHIATRY

Chp.: Richard J. Thurrell, M.D. Co-Chps.: Steven E. Pflanz, M.D., Charles R. Joy, M.D. Participants: David F. Musto, M.D., James P. Comer, M.D., Elissa P. Benedek, M.D., Jack C. Westman, M.D. ISSUE WORKSHOP 60 11:00 a.m.-12:30 p.m. Room 203 B, Level 200, Convention Center COMPONENT WORKSHOP 28 11:00 a.m.-12:30 p.m. Rooms 302/303, Level 3, Marriott USE OF RESTRAINTS IN PSYCHIATRIC PRACTICE: PROS, CONS, AND ALTERNATIVES THE MENTAL HEALTH CARVEOUT: STRATEGIES TO ERASE THE STIGMA Chp.: Ann Marie T. Sullivan, M.D. APA Work Group on Carueouts Participants: William Fisher, M.D., Charles T. Barren, M.D., Janet Bezmen, R.N., John O'Brien, M.D., Yuange Hu, M.D. Co-Chps.: Lawrence B. Lurie, MX)., Jonathan E. Gudeman, MX). Participants: Janis G. Chester, MX)., Norman A. Clemens, M.D., ISSUE WORKSHOP 61 11:00 a.m.-12;30 p.m. Jerome H. Rogoff, M.D., Kenneth R. Silk, M.D. Rooms 309-310, Level 3, Marriott

COMPONENT WORKSHOP 29 11:00 a.m.-12:30 p.m. METHAMPHETAMINE TREATMENT: WHAT Room 307, Level 3, Marriott PSYCHIATRISTS NEED TO KNOW Substance A buse and Mental Health Services Administration MISSION IMPOSSIBLE II: WHEN THE DISORDERED CHILD BECOMES AN ADULT Chp.: Richard A. Rawson, M.D. APA Committee on Childrenwith MentalorDevelopmental Disorders Participants: William F. Haning III, M.D., Walter Ling, M.D.

Chp.: Roxanne C. Dryden-Edwards, M.D. ISSUE WORKSHOP 62 11:00 a.m.-12;30 p.m. Participants: Paula J. Lockhart, MX)., Donald J. Mordecai, MX)., Liberty Ballroom B, Level 3, Marriott Lisa J. Nelson, M.D., Lee M. Price, L.S.W. FROM PSYCHOANALYTIC PSYCHOTHERAPIST TO COMPONENT WORKSHOP 30 11:00 a.m.-12:30 p.m. PSYCHOANALYTIC ORGANIZATIONAL CORPORATE Liberty Ballroom A, Level 3, Marriott CONSULTANT: AN INTRODUCTORY WORKSHOP CLINICIAN SAFETY APA Task Fc^ on Psychiatric Aspects of Violence Chp.: Howard E. Book, M.D. Participant: Jeffrey P. Kahn, MX). Chp.: Arthur Z. Berg, M.D. Participants: Carl C. Bell, M.D., Bradley R. Johnson, M.D. ISSUE WORKSHOP 63 11:00 a.m.-12;30 p.m. Independence Ballroom I, Level 3, Marriott COMPONENT WORKSHOP 31 11:00 a.m.-12:30 p.m. Liberty Ballroom C, Level 3, Marriott ROLE OF AMYTAL IN CONVERSION DISORDER HOW TO LAUNCH A SUCCESSFUL PRIVATE PRACTICE: PART II Chp.: Sadiq H. Al-Samarrai, M.D. APA Committee of Early Career Psychiatrists Participant: Thomas S. Newmark, M.D.

Co-Chps.: William E. CaUahan, Jr., MX)., Keith W. Young, MX). Participants: Tracy K Gordy, MX)., Chester W. Schmidt, Jr., M.D. 50 TUESDAY

ISSUE WORKSHOP 64 11:00 a.m.-12;30 p.m. 12 noon Sessions Rooms 401-403, Level 4, Marriott

MINORITY PSYCHIATRISTS WHO HAVE SUFFERED FORUMS 5-8 MENTAL ILLNESS: OVERCOMING STIGMA National Alliance for the Mentally III FORUMS 12 noon-l;30 p.m. Co-Chps.: Michael F. Myers, M.D., Leah J. Dickstein, M.D. Room 103 B, Street Level, Convention Center Participants: Michelle O. Gark, MD., Raymond M. Reyes, M.D., Suzanne E. Vogel-Scibilia, M.D. HOMOSEXUALITY AND RELIGION: HEALING THE WOUND ISSUE WORKSHOP 65 11:00 a.m.-12;30 p.m. A ssociation of Gay and Lesbian Psychiatrists andAPA Committee on Rooms 411/412, Level 4, Marriott Gay, Lesbian, and Bisexual Issues Chp.: Daniel W. Hicks, M.D. THE CHALLENGE OF PARENTAL MENTAL Participants: David L. Scasta, M.D., Stuart M. Sotsky, M.D., ILLNESS Thomas P. Welch, M.D. Substance A buse and Mental Health Services Administration FORUM 6 12 noon-l:30 p.m. Chp.: Judith Katz-Leavy, M.Ed. Participants: Beth Hinden, Ph.D., Lucinda Mallen, William R. Rooms 107 A/B, Street Level, Convention Center Beardslee, M.D., Joanne Nicholson, Ph.D. THE DEATH PENALTY AND THE ROAD TO EXECUTION: PSYCHOLOGICAL ISSUES FOR ISSUE WORKSHOP 66 11:00 a.m.-12;30 p.m. CORRECTIONAL OFFICERS; APPROPRIATE AND Rooms 414/415, Level 4, Marriott INAPPROPRIATE ROLES FOR PSYCHIATRISTS AFTERMATH OF PROFESSIONAL BOUNDARIES Chp.: Robert Michels, M.D. VIOLATIONS: TREATMENT OF VICTIMS Co-Chp.: Philip G. Zimbardo, Ph.D. Participants: Michael J. Osofsky, Howard J. Osofsky, M.D., Chp.: Gail E. Robinson, M.D. Warden B. Cain Participants: P. Susan Penfold, M.D., Werner Tschan, M.D., GaryR. Schoener, Psy.D. FORUM 7 - CANCELLED FORUMS 12 noon-l;30 p.m. ISSUE WORKSHOP 67 11:00 a.m.-12;30 p.m. Room 113 A, Street Level, Convention Center Grand Ballroom Salon D, Level 5, Marriott THE CHALLENGES OF IDENTIFYING AND A RECIPE FOR ACADEMIC/PERSONAL SUCCESS: INTERVIEWING POTENTIAL SUBSTANCE SOME KEY INGREDIENTS ABUSERS A ssociationfor A cad&nic Psychiatry Substance A buse and Mental Health Services Administration

Chp.: Linda L.M. Worley, M.D. Chp.: Joseph H. Autry III, M.D. Participants: Josepha A. Cheong, MD., Robert J. Boland, M.D., Co-Chp.: H. Westley Clark, M.D. Donald M. Hilty, M.D., Michelle B. Riba, M.D.

ISSUE WORKSHOP 68 11:00 a.m.-12;30 p.m. NEW RESEARCH POSTER SESSION 6 Grand Ballroom Salon I, Level 5, Marriott 12 noon-2:00 p.m. Exhibit Hall D, Street Level, Convention Center THE BODY IN 21ST-CENTURY PSYCHIATRY: DIAGNOSTIC DIMENSIONS AND THERAPEUTIC BRAIN IMAGING; GENETICS; RESEARCH ISSUES; CHALLENGES COMBINED PHARMACOTHERAPY AND PSYCHOTHERAPY; BEHAVIOR AND COGNITIVE Co-Chps.: Elena B. Bezzubova, M.D., Barton J. Blinder, M.D. THERAPIES; NEUROPSYCHIATRY; BIOLOGICAL, Participants: Jon E. Grant, M.D., Donca Vianu, M.D. CONSULTATION-LIAISON, AND GERIATRIC PSYCHIATRY; OCD; AND COGNITIVE, SOMATOFORM, AND ANXIETY DISORDERS

For further information on New Research Sessions, please refer to the New Research Program and Abstracts Book included in your registration packet.

51 TUESDAY

1:00 p.m. Sessions COURSE 76 1:00 p.m.-5:00 p.m. Minuet, Fourth Floor, DoubleTree

COURSES 70-78 MULTICULTURAL APPROACH TO THE Course descriptions ate available in the CME TREATMENT OF WOMEN Course Brochure included in your registration packet. Admission by ticket only. Director: Susan R. Downs, M.D. Faculty: Ellen Haller, M.D., Sylvia W. Olarte, M.D., Gloria Pitts, D.O., Alice C. Tso, M.D. COURSE 70 1:00 p.m.-5:00 p.m. Ormandy East, Street Level, DoubleTree COURSE 77 1:00 p.m.-5:00 p.m. Rhapsody, Fourth Floor, DoubleTree VAGAL NERVE STIMULATION ARTS AND HUMANITIES FOR SELF-RENEWAL Co-Directors: Ziad H. Nahas, M.D., Mustafa M. Husain, M.D. Faculty: Linda L. Carpenter, M.D., Robert H. Rowland, M.D., Director: Paul R. Miller, M.D. Mitchel A. Kling, M.D. Faculty: Margaret Nazarey, M.S.N.

COURSE 71 1:00 p.m.-5:00 p.m. COURSE 78 1:00 p.m.-5:00 p.m. Ormandy West, Street Level, DoubleTree Sonata 5, Fifth Floor, DoubleTree

I FOUND IT AT THE MOVIES: USING FILM CLIPS SEXUAL HARASSMENT: PSYCHOLOGICAL AND TO UNDERSTAND AND TEACH PSYCHIATRY LEGAL ASPECTS

Director: Frederick W. Engstrom, M.D. Director: Gail E. Robinson, M.D. Faculty: Renee L. Binder, M.D., Sharyn A. Lenhart, M.D., COURSE 72 1:00 p.m.-5:00 p.m. Michael F. Myers, M.D. Aria A, Third Floor, DoubleTree

THE ADVANCED PRACTICE OF PSYCHOTHERAPY MEDIA SESSIONS 14-15

Director: T. Byram Karasu, M.D. MEDIA SESSION 14 1:00 p.m.-2:00 p.m. Washington Rooms A-C, Third Floor, Loews COURSE 73 1:00 p.m.-5:00 p.m. Concerto A, Third Floor, DoubleTree WE ARE WHAT WE EAT

ACHIEVING EFFECTIVE DUAL DIAGNOSIS Chp.: Sandra C. Walker, M.D. TREATMENT 19 A World of Food: Tastes and Taboos in Different Director: John W. Tsuang, M.D. Cultures Faculty: Andrew P. Ho, M.D., Thomas Newton, M.D. (34 minutes)

COURSE 74 1:00 p.m.-5:00 p.m. Distributor: University of California Extension Overture, Third Floor, DoubleTree Center for Media and Independent Learning INTEGRATED MODEL FOR TREATMENT OF CO- 2000 Center Street, 4th Floor OCCURRING PSYCHIATRIC AND SUBSTANCE Berkeley, CA 94704 DISORDERS From vegans to cannibals, human beings consume an infinite Director: Kenneth Minkoff, M.D. variety of foods. They also form fiercely emotional views about people who follow food practices unlike their own. Many COURSE 75 1:00 p.m.-5:00 p.m. Americans, for example, are horrified by the consumption of Maestro, Fourth Floor, DoubleTree dog meat in certain Asian countries. But staples of the American diet may be equally horrifying to others. A. World of Food is the COMPUTERS IN PSYCHIATRY: A PRIMER perfect antidote to ethnocentrism, the all too common assump- tion that one's own culture is superior to others. This video will Director: Robert S. Kennedy, M.A. teach the critical lesson that all cultures consume foods that Faculty: Carlyle H. Chan, M.D., John Luo, M.D. people in other cultures see as highly debatable, inherently disgusting, or simply too bizarre to eat at all. It will help develop an enhanced understanding of food practices in other cultures 52 TUESDAY and a deeper awareness of the need for cross-cultural under- Psychiatry, of which he is the founding Director. Dr. standing in an increasingly interconnected world. Alexopoulos has conducted studies on clinical, neuropsychological, electroph\'$iological, neurochemical, MEDIA SESSION 15 1:00 p.m.-2;00 p.m. imaging, and treatment as peas of geriatric mood Congress Rooms A-C, Fourth Floor, Loews disorders. His research has focused on course and long-term outcomes is means of addressing the hetero- ATTACK ON AMERICA: LOOKING BACK, LOOKING geneity of geriatric mood disorders. Dr Alexopoulos INWARD AND VIRTUAL REALITY ENHANCED has received the Senior Investigator's Award from the EXPOSURE THERAPY FOR PTSD AFTER American Association of Geriatric Psychiatry, He is SEPTEMBER 11 the Editor for North Amenca of the Iniemanand loiffnal of Genafnc Prxktaoy, He received his medical degree Co-Chps.: Richard E. D'Alli, M.D., Ian E. Alger, M.D., from the National University of Athens {Greece') and Edward K. Rynearson, M.D., JoAnn Difede, Ph.D. completed his residency in psychiatry at New Jersey Medical School, New Jersey College of Medicine and 20 World Trade Center and Pentagon Disasters Demistry. (30 minutes) Distinguished Psychiatrist Lecture Series THIS SESSION WILL BE AUDIOTAPED. Distributor: Richard E. D'Alli, M.D. Department of Psychiatry LECTURE 14 Johns Hopkins Medical Institute 600 N. Wolfe Street, CMSC 387 2:00 p.m.-3:JC p.m. LECTURE 14 Baltimore, MD 21287 Rooms 1M A/B, Street Level, Convention Center

From the first horrifying images of lower Manhattan and the APA'S ALEXANDRA SYMONDS Pentagon on September 11,2001, through the war that followed, AWARD LECTURE the media refocused America, if not much of the world, on a common enemy. How did the media's choice of imagery affect CarotC. Nadelson, M.D. the meaning of the course of events since that dark day? Dr. Difede will give a presentation, which will enable the audience to Women's Leadership in Medicine and Psychiatry view the "virtual world" of the World Trade Center attack. Chp.: Donna H. Stewart, M.D. Co-Chp.: Cheryl F. McGinnry, M.D.

2;00 p.m. Sessions Throughout history women have he IT. tart-takers and healers and, more rarely, leaders ana policy mixers in LECTURES 13-14 health and mental health, i'jio! C NideUon, M.D., reviews the history of women's health care roles and LECTURE 13 proposes strategies to advance women's leadership in contemporary medicine and psychiatry. Dr. Naddson 2:00 p.m.-3:30 p.m. is Clinical Professor oi Psychiatry at Harvard Medical Rooms 108 A/B, Street Level, Convention Center School. She was tne iirst woman to sen's a\ APA President, in 1984-1986. A former President and Chief George S. Alexopoulos, M.D. Executive Officer of the American IVchiairu: Press, Inc., she has served on the t,cii:onil Boards oi many What Can Late Life Teach Us About Depression? journals, including ffosjntui .«*/ Cawrscon P^maa*,, Journal ty Mania' and /vmitfi1 '/'JCTJSPV. and founia! of Chp.: Gary J. Kennedy, M.D. PwxoxTtiatK Oktemcs xxt &jKooiag>. She is the author Co-Chp,: Josepha A. Cheong, M.D. of more than 200 papers ana book chapters and is the co-editor of 20 books. Dr. Nactelscm has received the Late-life depression occurs in the context of ill health Elizabeth Blaekuvll Award from the American Medical and disability. George S. Alexopoulos, M.D., discusses Women's Association, the Distinguished Service Award recent research on the pathophysiology of late-life from the American College of Psychiatrists, and the depression and its potential impact on the developmem Seymour Yesiermark Award trom APA. She graduated of pharmacological and nonpharmacological interven- from the Cmversiiy oi Rochester Medical School, was a tions. Dr. Alexopoulos is Professor of Psychiatry at resident in ps>pchiatiy .it Massachuseui Menial Health WetU Medical College of Cornell University and Center and Be(h Israel Hospital in Eos-.on. and Professor at the Graduate School ot Medical Sciences received her psychoanalytic training at the Boston at Cornell University. He U Director of ihe NIMH- Ps)'choanal)tic Institute. funded Clinical Research Center for Geriatric Mood THIS SESSION WILL BE. AUDIOTAPED. Disorders at [he Cornell Institute of Geriatric

53 TUESDAY

MEDIA SESSIONS 16-17 ancestors owned one of Carmelita's as a slave. As a result, the pair decide to travel to South Carolina to unravel their linked MEDIA SESSION 16 2;00 p.m.-5;00 p.m. heritage. This video shows their journey through pain, Washington Rooms A-C, Third Floor, Loews resentment, embarrassment, and ultimately acceptance, as each woman, in her own way, comes to terms with their shared WOMANHOOD... SISTERHOOD history.

Chp.: Robert L. Sadoff, M.D. MEDIA SESSION 17 2:00 p.m.-5:00 p.m. Congress Rooms A-C, Fourth Floor, Loews 21 Standing on My Sisters' Shoulders (60 minutes) PSYCHIATRY GOES TO THE MOVIES

Distributor: Laura J.Lipson Chp.: Ronald L. Kamm, M.D. ABC 802 Sierra Drive 24 Remember the Titans Beverly Hills, CA 90210 (114 minutes)

Standingon My Sister's Shoulders is a documentary that dramatically Distributor: Buena Vista Home Entertainment portrays the involvement of both black and white women Department CS working together during the Civil Rights period. Their efforts Burbank,CA 91521 helped to change the rules of race relations in the South forever. Issues relating to voter registration; desegregation of schools; Next to a family, a team is one of the most influential groups to and individual, family, and community involvement will be which an individual ever belongs. R&nemher the Titans tells the experienced through the words and feelings of women who were true story of the 1971 integration of a previously all-white there and who participated in the historical events. The film is Alexandria, Virginia, high school and its football team. Not only certain to touch the lives of those who view it. are black students bussed to the school over the objection of the white community, but also a black coach, played by Denzel Discussants: Robert L. Sadoff, M.D., Joan Sadoff, M.S.W. Washington, is brought in to replace a beloved, white coach. Washington's character, Herman Boone, is faced with the 22 Women of the Wall daunting task of creating a cohesive, winning team when half his (31 minutes) squad is racially at war with the other. The coach's strengths are his unwavering commitment to win, his caring relationship with Distributor: New Day Films players of both races, and the evolving willingness of his white 22-D Hollywood Avenue counterpart, Bill Yoast, to take a subordinate role for the sake of HoHoKus,NJ07423 the team. This is a class study of how to form a cohesive group to all those trying to bridge the racial divide that still exists. In 1989, a group of Jewish women marched toward the Western Wall in Jerusalem carrying a Torah scroll, determined to pray Discussants: Ian R. Tofler, M.D., Herman Boone, Coach Bill openly as women without male leadership or approval. Violently Yoast, Terry "Rev." Harris (the Titans Quarterback) attacked by right-wing opposition, the Women of the Wall filed a petition with the Supreme Court asserting their right to pray openly. This documentary is an insightful exploration of the REVIEW OF PSYCHIATRY: SECTION 2 women's struggle for free spiritual expression in a climate of 2:00 p.m.-5:30 p.m. increasing governmental control over religious practice. Rooms 201 A-C, Level 200, Convention Center

23 Loyalties THE MANY FACES OF DEPRESSION IN (58 minutes) CHILDHOOD AND ADOLESCENCE

Distributor: Filmakers Library Co-Chps.: David Shaffer, M.D., Bruce D. Waslick, M.D. Attn: Linda Gottesman 124 East 40th Street 6 Depression in Children and Adolescents: An Overview New York, NY 10016 Bruce D. Waslick, M.D., Rachel Kandel, Aprhodite Kakouros

Loyalties is the poignant story of two women who discover they 7 Psychotherapy for Depression and Suicidal Behavior in share two halves of a common past in the painful lineage of Children and Adolescents slave and slave holder. Carmelita Robertson, a black graduate Laura Mufson, Ph.D., DrewM. Velting, Ph.D. student who worked at a museum of national history and her co- worker, Dr. Ruth Holmes Whitehead, a white ethnologist, met 8 Pharmacological Treatment of Children and for a professional lunch. They soon discover that they have a Adolescents with MDD strange common thread. Almost certainly, one of Ruth's Boris Birmaher, M.D., David A. Brent, M.D.

54 TUESDAY

9 Bipolar Disorder in Youth: A Critical Review D Familial and Biological Characteristics of Psychotic Gabrielle Carlson, M.D. PTSD Fredric J. Sautter, Ph.D., Janet J. Johnson, M.D., Arth 10 Child and Adolescent Suicide and Suicidal Behavior Issette, Ph.D., Justin Wiley, Ph.D., John Comwell, Ph.D., David Shaffer, M.D., Ted Greenberg, M.P.H. Madeline Uddo, Ph.D., Gina Mire, Ph.D. THIS SESSION WILL BE AUDIOTAPED.

SYMPOSIA 27-56 SYMPOSIUM 29 2:00 p.m.-5;00 p.m. Room 103 B, Street Level, Convention Center SYMPOSIUM 27 2;00 p.m.-5;00 p.m. Rooms 102 A/B, Street Level, Convention Center NEW DEVELOPMENT IN MEDICATIONS FOR THE TREATMENT OF SUBSTANCE ABUSE NEW TREATMENT TARGET IN SCHIZOPHRENIA: American Academy of Addiction Psychiatry UPDATE ON SOCIAL ANXIETY Chp.: Marc Galanter, M.D. Chp.: Stefano Pallanti, M.D. Co-Chp.: Robert G. Stern, M.D. A Overview of Medications Development for Alcohol and Drug Dependence A Shyness, Sociability, and Social Dysfunction in Henry R. Kranzler, M.D. Schizophrenia Joel Goldberg, Ph.D., La Schmidt, M.D, M.K. Jetha B Buprenorphine for Opioid Dependence Eric C. Strain, M.D. B Comparison and Assessment Procedures of Primary Versus Comorbid Social Anxiety C Stimulant Treatment of Cocaine Dependence Stefano Pallanti, M.D., Leonardo Quercioli, M.D., Adolfo Frances R. Levin, M.D. Pazzagli, Ph.D. D Ondansetron Is Effective in Treating Biological C Determining and Treating Social Anxiety in Psychosis Alcoholism David Castle, M.D. Bankole A. Johnson, M.D., Nassima Ait-Daoud, M.D.

D The Relationship of Social Anxiety to Level of Function E Anticonvulsants in Substance-Use Disorders Over Time in Patients with Schizophrenia Kathleen T. Brady, M.D., Hugh Myrick, M.D., Robert J. Robert G. Stem, MD., Denise Frank, B A, Suhaila Farook, MD., Malcolm, Jr., M.D. Michelle Beyer, B.A. THIS SESSION WILL BE AUDIOTAPED. Discussants: Richard N. Rosenthal, MD., Jonathan I. Ritvo, MD. THIS SESSION WILL BE AUDIOTAPED. SYMPOSIUM 28 2:00 p.m.-5;00 p.m. Room 103 A, Street Level, Convention Center SYMPOSIUM 30 2:00 p.m.-5;00 p.m. Room 103 C, Street Level, Convention Center PSYCHOTIC SYMPTOMS IN CHRONIC PTSD: PREVALENCE, COMORBIDITY, AND TREATMENT HYPERAROUSAL AND BPD: NEW STUDIES ON ORIGINS, IMAGING, TAXONOMY, AND Chp.: Daniella David, M.D. TREATMENT

A Psychotic Features, Illness Severity, and Atypical Chp.: Thomas H. McGlashan, M.D. Antipsychotics in PTSD Mark B. Hamner, M.D., Christopher B. Frueh, Ph.D., A Construct Validity of BPD Helen G. Ulmer, M.S.W., George W. Arana, M.D. Carlos M. Grilo, Ph.D., Charles A. Sanislow, Ph.D., Thomas H. McGlashan, M.D. B Adjunctive Risperidone Treatment in Combat Veterans with Chronic PTSD B Borderline Symptoms in Maltreated Children Daniella David, M.D., Ludrnila Defaria, M.D., Olga M. Joan Kaufman, Ph.D., Deborah S. Lipschitz, M.D., Seth R. Lapeyra, M.D., Thomas A. Mellman, M.D. Axelrod, Ph.D., Steven M. Southwick, M.D.

C Racial Differences in Psychotic Symptoms Among C Exploring the Phenomenological Interface of BPD and Combat Veterans with PTSD PTSD Christopher B. Frueh, Ph.D., Mark B. Hamner, M.D., Seth R. Axelrod, PhD., Carlos M. Grilo, Ph.D., Charles A. Jason B. Belant, Ph.D., George W. Arana, M.D., Sanislow, Ph.D., Deborah S. Lipschitz, M.D., Thomas H. Samuel M. Turner, Ph.D., Terence M. Keane, Ph.D. McGlashan, M.D., Steven M. Southwick, M.D. (Continued'next page) 55 TUESDAY

D Neural Substrates of Affective Dysregulation in BPD B BPD and MDD: Their Co-Occurrence and Implications Nelson H. Donegan, Ph.D., Charles A. Sanislow, Ph.D., for Treatment Robert K. Fulbright, M.D., John C. Gore, Ph.D., Pawel John G. Gunderson, M.D. Skudlarski, Ph.D., Thomas H. McGlashan, M.D., Bruce E. Wexler,M.D. C Principles of Psychotherapy for BPD Glen O. Gabbard, M.D. E Repetitive Transcranial Magnetic Stimulation for BPD Adrian Preda, M.D., Ralph E. Hoffman, M.D., Thomas H. D A Comparison of Cognitive-Behavioral and McGlashan, M.D. Psychodynamic Therapy for BPD John F. Clarkin, Ph.D., Ken Levy, Ph.D. F The BPD Status Change Scale: An Interview to Assess Change and Functioning E Do Patients with BPD Receive Appropriate Medications Charles A. Sanislow, Ph.D., Carlos M. Grilo, Ph.D., John M. Oldham, M.D., Andrew E. Skodol II, M.D., Thomas H. McGlashan, M.D. Donna S. Bender, Ph.D., Ingrid R. Dyck, M.PH. THIS SESSION WILL BE AUDIOTAPED. Discussant: Mary C. Zanarini, Ed.D. SYMPOSIUM 31 2:00 p.m.-5;00 p.m. THIS SESSION WILL BE AUDIOTAPED. Rooms 106 A/B, Street Level, Convention Center SYMPOSIUM 33 2:00 p.m.-5;00 p.m. FALSE MEMORY SYNDROME: RECOVERY AND Room 111 B, Street Level, Convention Center FAMILY RECONCILIATION DARWINIAN EVOLUTION: AFFECTIVE Chp.: Paul R. McHugh, M.D. TEMPERAMENT AND CLINICAL Co-Chp.: Harold I. Lief, M.D. CONSIDERATIONS

A The False Memory Foundation and Its Survey of Family Chp.: Daniel R. Wilson, M.D. Reconciliations Co-Chp.: Hagop S. Akiskal, M.D. Pamela Freyd A Affective Temperaments: Evolutionary Significance B Recovered Memory Accusers of Incest: Interactions Hagop S. Akiskal, M.D. with Their Families Harold I. Lief, M.D., Janet M. Fetkewicz, B.A. B Evolutionary Epidemiology and the Neuropsychiatry of Manic Depression C Memory and Hypnosis: Facts and Fictions Daniel R. Wilson, M.D. Herbert Spiegel, M.D. C Affective Disorders as Communicational State: Brain D Recovered Memory in the Courts Research Implications Alan A. Stone, M.D. Russell J. Gardner, Jr., M.D.

E The Recovered Memory Craze Onset and Offset from D Evolutionary Trait Variation: Implications for Clinical 1990-1998 Care and Research Paul R. McHugh, M.D. Michael McGuire, M.D. THIS SESSION WILL BE AUDIOTAPED. Discussant: Russell J. Gardner, Jr., M.D. SYMPOSIUM 32 2:00 p.m.-5;00 p.m. THIS SESSION WILL BE AUDIOTAPED. Rooms 107 A/B, Street Level, Convention Center SYMPOSIUM 34 2:00 p.m.-5:00 p.m. COURSE AND TREATMENT OF BPD Rooms 112 A/B, Street Level, Convention Center

Chp.: John M. Oldham, M.D. SUCCESSFUL CLINICAL APPLICATIONS OF Co-Chp.: Andrew E. Skodol II, M.D. TELEPSYCHIATRY

A Course of Diagnoses and Impairment in Patients with Chp.: Steven E. Hyler, M.D. BPD Andrew E. Skodol II, M.D., Thomas H. McGlashan, M.D., A The Invisible Interface of Telepsychiatry: Is It Really? M. Trade Shea, Ph.D., John G. Gunderson, M.D., Leslie C. Norman E. Alessi, M.D. Morey, Ph.D., Robert L. Stout, Ph.D., IngridR. Dyck,M.PH. B Sustaining an Extensive Prison Telepsychiatry Network William M. Tucker, M.D., Gerald Segal, M.S., Steven E. Hyler, M.D. 56 TUESDAY

C Telepsychiatry: A Canadian Perspective on Program C The Enemy's Daughter: Psychological Effects of Design and Implementation Stalinism on Female Children of Political Prisoners Hany Karlinsky, M.D., James Coyle, MA, Julian Somers, PhD., Jana H. Svehlova, Ph.D. Elliot M. Goldner, M.D., Susan Quinn, RJST. D Telling Histories: Survivors' Testimonies of Political D Success of Telepsychiatry with Geriatric Patients Violence Beverly N. Jones, M.D. Stevan M. Weine, M.D. THIS SESSION WILL BE AUDIOTAPED. E Countering Sequelae of Culturecide in Kosovo SYMPOSIUM 35 2;00 p.m.-5;00 p.m. James L. Griffith, M.D., Ferid Agani, M.D., Stevan M. Room 113 A, Street Level, Convention Center Weine, M.D., Afrim Blita, M.D., John S. Rolland, M.D., Shqipe Ukshini, Ph.D., Melita Kallaba, M.D. DEPRESSION AND THE TRANSITION TO PERIMENOPAUSE: THE HARVARD STUDY OF F Recovery from the Cambodian Holocaust: The Role of MOODS AND CYCLES Political, Religious, and Medical Leaders David S. Liebling, M.D. Chp.: Lee S. Cohen, M.D. Co-Chp.: Bernard L. Harlow, Ph.D. Discussant: David A. Rothstein, M.D. THIS SESSION WILL BE AUDIOTAPED. A The Methods and Characteristics of Women Participants in the Harvard Study of Moods and Cycles SYMPOSIUM 37 2:00 p.m.-5;00 p.m. Bernard L. Harlow, Ph.D., Lee S. Cohen, M.D., Michael W. Room 113 C, Street Level, Convention Center Otto, Ph.D., D. Speigelman, Daniel W. Cramer, M.D. UNDERSTANDING PSYCHOLOGICAL TRAUMA: B The Impact of a Mood Disorder on Reproductive MULTIDISCIPLINARY PERSPECTIVE Function During the Menopausal Transition Lee S. Cohen, M.D., Michael W. Otto, Ph.D., Claudio N. Chp.: Randall D. Marshall, M.D. Scares, M.D., Bernard L. Harlow, Ph.D. A The Cognitive-Affective Science of Trauma and C Depression and Its Influence on Menopausal Development Transitions: Clinical and Public Health Implications Dan J. Stein, M.D. Claudio N. Scares, M.D., Lee S. Cohen, M.D., Michael W. Otto, Ph.D., Bernard L. Harlow, Ph.D. B Variable for Aging Demand Rearing in Primates: Relevance to Trauma D Psychosocial Predictors of Depression in the Harvard Jeremy D. Coplan, M.D., Eric L. Smith, Ph.D., Bruce A. Study of Moods and Cycles Scharf, Shirn Baptiste, Altamash L Qureshi, M.D., Jack M. Michael W. Otto, Ph.D., Lee S. Cohen, M.D., Bernard L. Gorman, M.D., Leonard A. Rosenblum, Ph.D. Harlow, Ph.D. C Ethnocultural Factors in PTSD Discussant: Stephen M. Stahl, MD. Roberto Lewis-Fernandez, M.D., J. Blake Turner, Ph.D., THIS SESSION WILL BE AUDIOTAPED. Randall D. Marshall, M.D., Bruce Dohrenwend, Ph.D.

SYMPOSIUM 36 2:00 p.m.-5;00 p.m. D Contemporary Psychodynamic Perspective on Trauma Room 113 B, Street Level, Convention Center AriehY. Shalev,M.D.

THE PSYCHOLOGICAL WOUNDS OF NATIONAL E Integrating Therapeutic Models for Psychological TRAUMA: CAUSES, CONSEQUENCES, AND Trauma TREATMENTS Randall D. Marshall, M.D.

Chp.: Jerrold M. Post, M.D. Discussant: Charles R. Marmar, M.D. THIS SESSION WILL BE AUDIOTAPED. A Hate-Mongering Leaders and Vulnerable Followers: The Psychopolitics of Hatred Jerrold M. Post, M.D.

B Processing Collective Trauma: The Israeli Society and the Mental Health Community Arie Nadler, Ph.D.

57 TUESDAY

SYMPOSIUM 38 2;00 p.m.-5;00 p.m. SYMPOSIUM 40 2:00 p.m.-5;00 p.m. Room 202 A, Level 200, Convention Center Room 203 A, Level 200, Convention Center

BEYOND THE SURGEON GENERAL'S REPORT: THE THERAPEUTIC MISCONCEPTION IN PSYCHIATRY FOR A DIVERSE POPULATION RESEARCH: BARRIER OR NECESSITY? Substance Abuse and Mental Health Services Administration Chp.: Philip J. Candilis, M.D. Chp.: William B. Lawson, M.D. A An Empirical Study of Therapeutic Misconception A Policy Implications of the Surgeon General's Report for Charles Lidz, Ph.D., Paul S. Appelbaum, M.D., Thomas a Diverse Population Grisso, M.D. Kana Enomoto, MA. B Decisional Capacity and Therapeutic Misconception in B Mental Health: Culture, Race, and Ethnicity Alzheimer's Disease Jeanne Miranda, Ph.D. Scott Y. Kim, M.D.

C Interface Between Biology, Pharmacology, and Culture C Historical Perspectives on the Therapeutic William B. Lawson, M.D. Misconception Gary S. Belkin, M.D. D Alcohol and Drug Use in College Samples: Racial Differences D Therapeutic Misconception and Therapeutic Intent: Deborah Deas, M.D. Where Do the Problems Lie? Donna T. Chen, M.D. E Influence of Culture on Child Development and Early THIS SESSION WILL BE AUDIOTAPED. Psychopathology in the 21st Century Harry H. Wright, M.D. SYMPOSIUM 41 2:00 p.m.-5;00 p.m. THIS SESSION WILL BE AUDIOTAPED. Room 203 B, Level 200, Convention Center

SYMPOSIUM 39 2:00 p.m.-5:00 p.m. COMBINED TREATMENT: DYNAMIC Room 202 B, Level 200, Convention Center PSYCHOTHERAPY AND MEDICATION A merican College of Psychoanalysts andAPA Illinois Psychiatric Society DEFINING EVIL: CLINICAL AND FORENSIC IMPLICATIONS Chp.: Jerome A. Winer, M.D.

Chp.: Michael M. Welner, M.D. A Dilemmas for Psychiatrists Doing Split Psychotherapy and Pharmacotherapy A Dilemmas in Defining Depravity at the Criminal Law Malkah T. Notman, M.D. and Psychiatry Interface Michael M. Welner, M.D. B The Ethics of the Pharmaceutical Dynamic Complex Brenda C. Solomon, M.D. B Sadistic Mothers and Fathers: Parents at the Edge of Evil C The Teaching and Learning of Conjoint Psychotherapy Michael H. Stone, M.D. and Pharmacotherapy Sidney H. Weissman, M.D. C Theology Challenges to Defining Depravity: Can Accountability Meet Therapy and Redemption? D When the Well-Meaning Psychiatrist Becomes the Lawrence Gesy, M.D. Patient's Negative Other Jerome A. Winer, M.D. D Depravity at the Workplace: Clinical and Forensic THIS SESSION WILL BE AUDIOTAPED. Implications Joseph P. Merlino, M.D. SYMPOSIUM 42 2:00 p.m.-5;00 p.m. Room 204 A, Level 200, Convention Center E The Depravity Scale: Validating a Psychiatric and Forensic Measure of Evil Actions AMERICA ATTACKED: THE AMERICAN Michael M. Welner, M.D. PSYCHIATRIC ASSOCIATION AND ITS MEMBERS THIS SESSION WILL BE AUDIOTAPED. RESPOND APA Committee on Psychiatric Dimensions of Disasters

Chp.: Ann E. Norwood, M.D. Co-Chp.: Michael Blumenfield, M.D. 58 TUESDAY

A The American Psychiatric Association Leadership Chp.: John A. Talbott, M.D. Responds to the Terrorism: Lessons Learned Co-Chp.: Herve Bokobza, M.D. Richard K. Harding, M.D. A Principles of Evidence-Based Practice: U.S. Style B The Saint Vincent's Psychiatric Response to the Robert A. Rosenheck, M.D. September llth Terrorist Attack Spencer Eth, M.D. B Effective Implementation of Guidelines: An Example of Suicide Prevention in France C New York City Responds to the Attack on the World Jacques Glikman, M.D., Boland Bouet, M.D., Catherine Trade Center Mayault, M.D., Jean-Louis Terra, M.D. Neal L. Cohen, M.D. C Assertive Community Treatment as Evidence-Based D Psychiatry at Ground Zero Practice Vivian B. Fender, M.D. Robert E. Drake, M.D., Kim T. Mueser, Ph.D., Gary R. Bond, Ph.D. E Psychiatric Intervention at the Pentagon Following the September llth Terrorist Attack D The French Sectorization System: What Evidence? Stephen J. Cozza, M.D. Francois C. Petitjean, M.D., Valerie Siari, M.D., Jean-Claude THIS SESSION WILL BE AUDIOTAPED. Demant, M.D., Denis Leguay, M.D.

SYMPOSIUM 43 2;00 p.m.-5;00 p.m. E The Efficacy-Effectiveness Gap Limits Confidence in Room 204 B, Level 200, Convention Center Evidence-Based Practices Lisa B. Dixon, M.D. WHAT'S NEW IN EATING DISORDERS: A CLINICAL RESEARCH TREATMENT UPDATE F Evidence-Based Medicine in the Treatment of Patients with Schizophrenia: A Critical Point of View Chp.: Evelyn Attia, M.D. J.M.Vanelle,J.C.Loirat

A Treatment of Bulimia in a Primary Care Setting Discussant: Alexandra MacLean, M.D. B. Timothy Walsh, M.D., Christopher Fairburn, M.D., Diane Mickley, M.D., Robyn Sysko, B A. SYMPOSIUM 45 2:00 p.m.-5:00 p.m. Rooms 304-306, Level 3, Marriott B Optimizing Treatment for Binge-Eating Disorders Michael J. Devlin, M.D., Juli A. Goldfein, Ph.D., Pamela S. COLLABORATIVE PRACTICE IN PSYCHIATRY: Raizman, Ph.D., B. Timothy Walsh, M.D. DATA AND PRINCIPLES FOR PRACTICE

C Partial Hospitalization for Anorexia Nervosa: Who Chp.: Mark S. Bauer, M.D. Gains, How and at What Cost? Co-Chp.: Gregory E. Simon, M.D. Angela S. Guarda, M.D., Leslie J. Heinberg, Ph.D. A Collaborative Practice for Bipolar Disorder: A Multisite D Family-Based Treatment for Adolescents with Anorexia Controlled Trial Nervosa Mark S. Bauer, M.D. Katherine L. Loeb, Ph.D., Dene M. Reeman, M.D., B. Timothy Walsh, M.D.James D. Lock, M.D. B Using Collaborative Care Models to Improve the Treatment of Schizophrenia E Bulimia Nervosa in Adolescents: Do Adult Treatments Alexander S. Young, M.D., Donna L. Bean, M.B.A., Translate to Teens? Stephen R. Marder, M.D. Lisa A. Kotler, M.D., Michael J. Devlin, M.D., B. Timothy Walsh, M.D. C Collaborative Management of Depression Gregory E. Simon, M.D. Discussant: G. Terrence Wilson, Ph.D. THIS SESSION WILL BE AUDIOTAPED. D Improving Depression Care for Older Adults Jurgen Unutzer, M.D. SYMPOSIUM 44 2:00 p.m.-5;00 p.m. Rooms 302/303, Level 3, Marriott E Collaborative Management of Chronic Lower Back Pain Benjamin H. K. Balderson, Ph.D. EVIDENCE-BASED PSYCHIATRY: PRINCIPLES, EXAMPLES, AND CRITIQUES IN THE U.S. AND Discussants: Lydia J. Lewis, B.A., Michael E. Thase, M.D. FRANCE THIS SESSION WILL BE AUDIOTAPED. French Federation of Psychiatry 59 TUESDAY

SYMPOSIUM 46 2;00 p.m.-5;00 p.m. SYMPOSIUM 48 2:00 p.m.-5;00 p.m. Liberty Ballroom C, Level 3, Marriott Independence Ballrooms II/III, Level 3, Marriott

HOW TO LAUNCH A SUCCESSFUL PRIVATE DEPRESSION CARE IN MEDICAL SETTINGS: PRACTICE: PART III APPROACHES FOR THE FUTURE APA Committee of Earfy Career Psychiatrists Chp.: Steven A. Cole, M.D. Chp.: William E. Callahan, Jr., M.D. Co-Chp.: Keith W. Young, M.D. A Interrelationships of Mental Health and Primary Care Harold A. Pincus, M.D., Constance M. Pechura, Ph.D., A Personal Factors Leading to a Successful Private Lynn I. Elinson, Ph.D., Amy R. Pettit, B.A. Practice Ann S. Maloney, M.D. B Improving Outcomes of Depression with Stepped-Care Principles B Office Location and Design for Efficiency and Success Wayne J. Katon, M.D., Michael Von Korff, Sc.D. Barry W.Wall,M.D. C Depression Breakthrough Series: Quality Improvement C Streamlining Overhead and Managing Your Business in in Primary Care Dissemination Project Private Practice David J. Katzelnick, M.D. Keith W. Young, M.D. D The MacArthur Initiative on Depression in Primary D Marketing Your Unique Private Practice Care William E. Callahan, Jr., M.D. Thomas E. Oxman, M.D., Allen Dietrich, M.D., Kurt Kroenke, M.D., James E. Barrett, M.D., Paul Nutting, M.D., Discussants: Ann S. Maloney, M.D., Barry W. Wall, M.D. John Williams, M.D., Kathryn M. Rost, Ph.D. THIS SESSION WILL BE AUDIOTAPED. E Depression in Patients with Congestive Heart Failure SYMPOSIUM 47 2:00 p.m.-5;00 p.m. Steven A. Cole, M.D., Nancy Farber, R.N., Joseph S. Independence Ballroom I, Level 3, Marriott Weiner, M.D., Michelle Sulfaro, R.N., Alan Silver, M.D., David J. Katzelnick, M.D. MAJOR DEPRESSION: CURRENT GUIDELINES, THIS SESSION WILL BE AUDIOTAPED. PRACTICES, AND EFFECTIVENESS RESEARCH SYMPOSIUM 49 2:00 p.m.-5:00 p.m. Chp.: Darrel A. Regier, M.D. Rooms 401-403, Level 4, Marriott Co-Chp.: John S. Mclntyre, M.D. GLOBAL PSYCHIATRY AND PATIENTS' RIGHTS: A Evidence-Based Treatment Guidelines for MDD INFORMED CONSENT Alan J. Gelenberg, M.D. Chp.: Rodrigo A. Munoz, M.D. B Sequenced Treatment Alternatives to Relieve Co-Chp.: Harold I. Eist, M.D. Depression (STAR*D) A.JohnRush,M.D. A Overview of Informed Consent: A Public Perspective Debra Lappin, J.D. C Results from the Texas Medication Algorithm Project MDD Treatment Module B Constrained Consent: The Law and Research in Special Madhukar H. Trivedi, M.D. Populations Rosemary Quigley, J.D. D The Treatment of MDD in Routine Practice Joyce C. West, Ph.D., Farifteh F. Duffy, Ph.D., Steve Marcus, C National and International Application of Standard William E. Narrow, M.D., Victoria E. Cosgrove, B A, Darrel A. Federal Regulations for Conduct of Research Regier, M.D. Harold I. Eist, M.D., Norman Sartorius, M.D.

Discussant: Martin B. Keller, M.D. D World Psychiatric Association Committee to Review the THIS SESSION WILL BE AUDIOTAPED. Abuse of Psychiatry Marianne C. Kastrup, M.D.

E Cultural Factors and Informed Consent Norman Sartorius, M.D.

Discussant: Paul S. Appelbaum, M.D. 60 TUESDAY

SYMPOSIUM 50 2;00 p.m.-5;00 p.m. B Implications of Comorbid Social Phobia for Major Rooms 407-409, Level 4, Marriott Depressive Subtypes and Course Jonathan E. Alpert, M.D., Megan E. Hughes, B.A., Joel A. THE PSYCHIATRIC TREATMENT OF HIV DISEASE Pava, Ph.D., Nicole B. Neault, B.A, Timothy J. Petersen, Ph.D., IN THE THIRD DECADE OF AIDS Andrew A. Nierenberg, M.D., Maurizio Fava, M.D. APA Commission an AIDS Chp.: Marshall Forstein, M.D. C Interpersonal Sensitivity in SAD Gerlinde C. Harb, M.S., Richard G. Heimberg, Ph.D., Vko A HIV Treatment Update Agosti, M.S.W., Franklin R. Schneier, M.D., Michael R. Marshall Forstein, M.D. Liebowitz, M.D.

B CNS Manifestations D Social Phobia and Comorbidity with Depression: A Karl Goodkin, M.D. Dichotic Listening Study C Mood and Anxiety Disorders Gerard E. Bruder, Ph.D., Franklin R. Schneier, M.D., Stephen J. Ferrando, M.D. Jonathan W. Stewart, M.D., Patrick J. McGrath, M.D., Paul Leite, MA., Frederick M. Quitkin, M.D. D The Multiply Diagnosed HIV Patient and Drug-Drug Interactions E Citalopram Treatment of Comorbid Social Anxiety Francine Cournos, M.D. Disorder and Major Depression THIS SESSION WILL BE AUDIOTAPED. Franklin R. Schneier, M.D., Michael R. Liebowitz, M.D., Raphael Campeas, M.D., Carlos Bianco, M.D., Roberto SYMPOSIUM 51 2:00 p.m.-5:00 p.m. Lewis-Fernandez, M.D., Randall D. Marshall, M.D., J. Arturo Rooms 411/412, Level 4, Marriott Sanchez-Lacay, M.D. AMERICAN PSYCHIATRIC ASSOCIATION'S RESPONSES TO THE SURGEON GENERAL'S Discussant: R. Bruce Lydiard, M.D. REPORTS ON MENTAL HEALTH THIS SESSION WILL BE AUDIOTAPED.

Chp.: Altha J. Stewart, M.D. SYMPOSIUM 53 2:00 p.m.-5;00 p.m. Grand Ballroom Salon A, Level 5, Marriott A Mental Health: A Report of the Surgeon General Zebulon C. Taintor, M.D. ADAPTATIONS TO SEVERE STRESS: NORMAL RESPONSES AND THERAPEUTIC STRATEGIES B Suicide: An American Psychiatric Association Plan of Action Chp.: Lenore C. Terr, M.D. Selby C. Jacobs, M.D. A Preschool Witnesses of Domestic Violence: Pathways to C Child and Adolescent Disorders: Treatment and Recovery Prevention Alicia F. Lieberman, Ph.D., Patricia Van Horn, Ph.D., G. Pirooz Sholevar, M.D. Chandra Ghosh-Ippen, Ph.D.

D Youth Violence: A Report of the Surgeon General B The Effect of Trauma on the Grieving Process in CarlC. Bell, M.D. Children When One Parent Kills the Other Guinevere Tufnell, MH.G, Dora Black, Tony Kaplan, M.R.C., E Mental Health: Cultural Issues Jean Harris-Hendriks Altha J. Stewart, M.D. THIS SESSION WILL BE AUDIOTAPED. C Gender Similarities and Differences in the Stress Reaction of Kurdish and Swedish Boys and Girls SYMPOSIUM 52 2:00 p.m.-5;00 p.m. Viveka Sundelin-Wahlsten, Ph.D., Abdulbaghi Ahmad, M.D. Rooms 414/415, Level 4, Marriott D Coping with the Diagnosis and Progression of Cancer SOCIAL ANXIETY DISORDER AND COMORBID David Spiegel, MX)., Lisa Butler, Ph.D., Cheryl Koopman, Ph.D., MAJOR DEPRESSION Matthew Cordova, Ph.D.

Chp.: Franklin R. Schneier, M.D. E Natural Healing Processes in the Essays of 111 Columbine Students at 2-3 Weeks A Perspectives on Social Phobia and Depressive Lenore C. Terr, M.D., Daniel Bloch, Ph.D. Comorbidity Murray B. Stein, M.D. Discussant: Robert Michels, M.D. THIS SESSION WILL BE AUDIOTAPED.

61 TUESDAY

SYMPOSIUM 54 2;00 p.m.-5;00 p.m. D Bipolar Depression: Mood Stabilizers Alone, or Grand Ballroom Salon B, Level 5, Marriott Antidepressant Augmentation? S. Nassir Ghaemi, M.D. FAMILY TREATMENT OUTCOMES OF ADOLESCENTS WITH SUBSTANCE USE E Augmenting Treatment of Bipolar Disorder with DISORDERS: CULTURAL ISSUES Psychotherapy David J. Miklowitz, Ph.D. Chp.: Jose M. Canive, M.D. THIS SESSION WILL BE AUDIOTAPED. Co-Chp.: Joan D. Koss-Chioino, Ph.D. SYMPOSIUM 56 2:00 p.m.-5;00 p.m. A Engagement and Retention in Family Therapy for Grand Ballroom Salon D, Level 5, Marriott Mexican-American Adolescents Luis Vargas, Ph.D., Joan D. Koss-Chioino, Ph.D., Jose M. PAIN IN THE ADDICTED PATIENT: BASIC Canive, M.D. SCIENCE, THE LAW, AND TREATMENT Substance A buse and Mental Health Services Administration B Outcomes of Treating Southwestern Latino Youth: Salient Questions Chp.: Howard A. Heit, M.D. Joan D. Koss-Chioino, Ph.D., Luis Vargas, Ph.D., Jose M. Canive, M.D. A Neurobiology of Pain David Borsook, M.D. C Involving Parents and Adolescents in Adolescent Drug- Abuse Treatment B Addiction Mechanisms: Receptors, Neurotransmitters, Michael S. Robbins, Ph.D., James F. Alexander, Ph.D., and Pathways Charles W. Turner, Ph.D. Eliot L. Gardner, PhD.

D Clinical Trial Outcomes for Treatment of Adolescent C Relieving Pain While Preventing Diversion Alcohol and Drug Abuse David E. Joranson, M.S.W. Holly B. Waldron, Ph.D., Charles W. Turner, PhD., Janet Brody, Ph.D., Thomas R. Peterson, M.S., Sheryl Kern- D Addiction, Physical Dependence, and Tolerance with Jones, Ph.D. Opioid Pain Management Howard A. Heit, M.D. E Trauma Exposure and Consequences: The Case of Latino Adolescents E Approach to the Pain Patient with the Disease of Jose M. Canive, M.D., Joan D. Koss-Chioino, Ph.D., Luis Addiction Vargas, Ph.D. Seddon R. Savage, M.D. THIS SESSION WILL BE AUDIOTAPED. Discussant: Pedro Ruiz, M.D.

SYMPOSIUM 55 2:00 p.m.-5;00 p.m. TELECOMMUNICATIONS SESSION 2 Grand Ballroom Salon C, Level 5, Marriott 2:00 p.m.-5:00 p.m. Room 204 C, Level 200, Convention Center COMBINATION THERAPY FOR BIPOLAR DISORDER: RATIONALES AND CONTROVERSIES EVIDENCE-BASED MEDICINE AND TELEPSYCHIATRY Chp.: Joseph F. Goldberg, M.D. Chp.: Gregory E. Gray, M.D. A The Rationale for Combining Medications in the Management of Bipolar Disorder 2:15 p.m. Frederick K. Goodwin, M.D. 1 Introduction to Evidence-Based Mental Health Gregory E. Gray, M.D. B Complex Combination Therapy in Refractory Bipolar Illness 3:30 p.m. Robert M. Post, M.D. 2 Individual and Group Psychotherapy Via Telepsychiatry Brian J. Grady, M.D. C The Use of Atypical Antipsychotics Plus Standard Mood Stabilizers in Bipolar Disorder Joseph F. Goldberg, M.D.

62 TUESDAY

B Childhood Trauma and the Neurobiology of Mood 3:00 p.m. Session Disorders Charles B. Nemeroff, M.D. NEW RESEARCH POSTER SESSION 7 3:00 p.m.-5:00 p.m. C Advances in Functional Brain Imaging in Depression Exhibit Hall D, Street Level, Convention Center and Anxiety Clinton D. Kilts, M.D. MOOD DISORDERS; SEXUAL AND GENDER DISORDERS; WOMEN'S HEALTH; PMDD; GENDER D Neurobiology, Sleep, and Mood Disorders: A New Look ISSUES; AND PSYCHOIMMUNOLOGY David J. Kupfer, M.D.

For further information on New Research Sessions, please refer E Stress, Neurogenesis, and the Adult Brain to the New Research Program and Abstracts Book included in your Elizabeth Gould, Ph.D. registration packet. Discussant: Michael J. Owens, Ph.D.

INDUSTRY-SUPPORTED SYMPOSIUM 33 7;00 p.m. Sessions 7:00 p.m.-10:00 p.m. Regency Ballrooms A-C, Second Floor, Loews INDUSTRY-SUPPORTED SYMPOSIA 31-37 MANAGING AGGRESSION ACROSS THE LIFE SPAN: INDUSTRY-SUPPORTED SYMPOSIUM 31 FROM THE PEDIATRIC TO THE GERIATRIC 7:00 p.m.-10:00 p.m. PATIENT Ballrooms A/B, Ballroom Level, Convention Center Supported byjanssen Pharmaceutica

BIPOLAR DEPRESSION AND RAPID CYCLING: Chp.: Douglas H. Hughes, M.D. CURRENT MANAGEMENT STRATEGIES Supported by GlaxoSmithKline A Managing the Aggressive Patient Douglas H. Hughes, M.D. Chp.: Joseph R. Calabrese, M.D. B Evidence-Based Approach to Pharmacotherapy of the A The Underestimated Need and Treatment Challenges Aggressive Child of Bipolar Depression Jorge L. Armenteros, M.D. MarkA.Frye,M.D. C Aggression and Psychiatric Disorders: Confronting the War Within B Stabilizing Mood in Bipolar Disorder from Below Robert R. Conley, M.D. Baseline Over Long Periods Joseph F. Goldberg, M.D. D Strategies and Interventions for Late-Life Aggression Soo Borson, M.D. C Rapid Cycling: Clinical Presentation and Treatment Approaches E Long-Term Adverse Effects of Antipsychotic Therapy Robert M. Post, M.D. Prakash S. Masand, M.D.

D Managing Common Benign and Uncommon Serious INDUSTRY-SUPPORTED SYMPOSIUM 34 Adverse Effects 7:00 p.m.-10:00 p.m. Terence A. Ketter, M.D. Grand Ballroom Salons E/F, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 32 TREATING FEAR: PERSPECTIVES ON THE 7:00 p.m.-10:00 p.m. BIOLOGY AND THERAPY OF ANXIETY DISORDERS Millennium Hall, Second Floor, Loews Supported by Sohxcy Pharmaceuticals, Inc.

THE NEW NEUROBIOLOGY OF MOOD AND Chp.: Jack M. Gorman, M.D. ANXIETY DISORDERS Supported by GlaxoSmithKline A Neurobiology of Fear and Social Anxiety Justine M. Kent, M.D. Chp.: Charles B. Nemeroff, M.D. B Developmental Antecedents of Anxiety Disorders A Clinical Relevance of Norepinephrine in Mood Daniel Pine, M.D. Disorders Kerry J. Ressler, M.D. (Continued next pa^)

63 TUESDAY

C New Developments in Pharmacotherapy of Anxiety D The Spectrum of Norepinephrine-Responsive Disorders Disorders James J. Hudziak, M.D. Jonathan R.T. Davidson, M.D. E Combining Serotonin and Norepinephrine Mechanisms D Accelerating Response and Treating Comorbidity in in Depression Anxiety J.Craig Nelson, M.D. Eric Hollander, M.D., Sallie J. Hadley, M.D., Stefano Pallanti, M.D., Sherie L. Novotny, M.D., Erica Sood, BA., INDUSTRY-SUPPORTED SYMPOSIUM 37 Nicolo Baldini-Rossi, M.D., Jennifer Friedberg, B.S. 7:00 p.m.-10:00 p.m. Wyndham Ballrooms C/D, First Floor, Wyndham E Minimizing Side Effects and Enhancing Compliance of Antianxiety Treatments BEHAVIORAL DISTURBANCES IN DEMENTIA: Francisco A. Moreno, M.D. DIAGNOSTIC AND TREATMENT GUIDELINES Supported by Nauxrtis Pharmaceuticals Corporation INDUSTRY-SUPPORTED SYMPOSIUM 35 7:00 p.m.-10:00 p.m. Chp.: Steven G. Potkin, M.D. Grand Ballroom Salons G/H, Level 5, Marriott Co-Chp.: Mustafa M. Husain, M.D.

RAISING EXPECTATIONS IN SCHIZOPHRENIA: A The Pathophysiology of Abnormal Behavior and Mood ENHANCING LONG-TERM OUTCOMES in Dementia Supported by Pfizer Inc. Mustafa M. Husain, M.D.

Chp.: Daniel E. Casey, M.D. B Impact of Cholinesterase Inhibitors on Sleep Co-Chp.: NinaR. Schooler, Ph.D. Disturbance in Alzheimer's Disease P. Murali Doraiswamy, M.D. A Acute Psychotic Agitation: Challenges and Treatment Alan J. Mendelowitz, M.D. C Dementia with Lewy Bodies: The Frontiers of Effective Treatment and Diagnosis B Long-Term Treatment Goals Martin K. Farlow, M.D. NinaR. Schooler, Ph.D. D Treating Behavioral Disturbances Observed in C Adverse Effects Profile of New Antipsychotic Agents Alzheimer's Disease: Pharmacological and Daniel E. Casey, M.D. Nonpharmacologic Interventions Steven G. Potkin, M.D. D Mechanisms of Medication-Associated Glucose Metabolism Impairment David C. Henderson, M.D.

E Schizophrenia and the Risk of Cardiovascular Disease Charles H. Hennekens, M.D.

INDUSTRY-SUPPORTED SYMPOSIUM 36 7:00 p.m.-10:00 p.m. Wyndham Ballrooms A/B, First Floor, Wyndham

CLINICAL DIFFERENCES IN SEROTONIN AND NOREPINEPHRINE ANTIDEPRESSANT EFFECTS Supported by Eli Lilfy and Company

Chp.: J. Craig Nelson, M.D.

A Serotonin and Norepinephrine Mechanisms of Action Gerard Sanacora, M.D.

B Clinical Outcome of Serotonin and Norepinephrine Agents in Depression Pedro L. Delgado, M.D.

C The Spectrum of Serotonin-Responsive Disorders JohnH. Greist,M.D.

64 WEDNESDAY, MAY 22, 2002

155TH ANNUAL MEETING

A Pharmacological Properties of Antipsychotics: Teasing 7:00 a.m. Sessions Out Potential Mechanisms of Action Michael J. Owens, Ph.D. PART 1 OF INDUSTRY-SUPPORTED BREAKFAST SYMPOSIA 38-42 B Restoring the Balance in Manic or Depressive Bipolar Patients Through Thoughtful Pharmacotherapy INDUSTRY-SUPPORTED BREAKFAST S. Nassir Ghaemi, M.D. SYMPOSIUM 38, PART 1 7:00 a.m.-8:30 a.m. C Augmentation Strategies to Expand Ballrooms A/B, Ballroom Level, Convention Center Pharmacotherapeutic Potential in Treatment-Refractory Major Depression CHRONIC EPISODIC DISORDERS: COMORBIDITY Richard C. Shelton, M.D. AND COMPREHENSIVE INTEGRATED TREATMENT Supported by GlaxoSmithKline INDUSTRY-SUPPORTED BREAKFAST SYMPOSIUM 41, PART 1 Chp.: Julia K. Warnock, M.D. 7:00 a.m.-8:30 a.m. Grand Ballroom Salons E/F, Level 5, Marriott A Unraveling the Complexity: Comorbidity, Mechanistic Link, and Pharmacologic Response THE PATHOPHYSIOLOGY AND TREATMENT OF Anita H. Clayton, M.D. IMPULSIVITY AND AGGRESSION IN PSYCHIATRIC DISORDERS B New Development in Obesity Supported by Abbott Laboratories Donna H. Ryan, M.D. Chp.: Alan C. Swann, M.D. C Comorbid Physical Symptoms Associated with Female- Specific Mood Disorders A Mechanisms of Impulsivity Julia K. Warnock, M.D. Alan C. Swann, M.D.

INDUSTRY-SUPPORTED BREAKFAST B Mood Stablilizers as Adjunctive Treatment in SYMPOSIUM 39, PART 1 Schizophrenia 7:00 a.m.-8:30 a.m. Daniel E. Casey, M.D. Millennium Hall, Second Floor, Loews C Aggression, Violence, and Psychopathology: A AGE, GENDER, AND DIAGNOSIS: INFLUENCES ON Developmental Approach DRUG RESPONSE Hans Steiner, M.D. Supported by Pfizer Inc. INDUSTRY-SUPPORTED BREAKFAST Chp.: Alexander H. Glassman, M.D. SYMPOSIUM 42, PART 1 7:00 a.m.-8:30 a.m. A Can Treating Depression Alter Cardiovascular Disease? Grand Ballroom Salons G/H, Level 5, Marriott Alexander H. Glassman, M.D. NEW PERSPECTIVES ON SCHIZOPHRENIA B Comobidity and Its Implications on Treatment: Change SPECTRUM DISORDERS AND THEIR TREATMENT Over the Life Span Supported by Janssen Pharmaceutica Tana A. Grady-Weliky, M.D. Chp.: Larry J. Siever, M.D. INDUSTRY-SUPPORTED BREAKFAST Co-Chp.: Barbara Cornblatt, Ph.D. SYMPOSIUM 40, PART 1 7:00 a.m.-8:30 a.m. A Validating Schizotaxia Criteria for Future Prevention of Regency Ballrooms A-C, Second Floor, Loews Schizophrenia Ming T. Tsuang, M.D. THERAPEUTIC CHALLENGES, NOVEL APPROACHES: ANTIPSYCHOTICS IN THE MANAGEMENT OF MOOD B The Schizophrenia Prodrome: Early Treatment AND ANXIETY DISORDERS Findings Supported by Eli Lilly and Company Barbara Cornblatt, M.D., Todd Lencz, Ph.D., Michael Obuchowski, Christopher Smith, M.S., Manoj R. Shah, M.D. Chp.: Richard C. Shelton, M.D. 65 WEDNESDAY

8:00 a.m. Sessions 9:00 a.m. Sessions

COURSES 79-84 CLINICAL CASE CONFERENCE 3 Course descriptions are available in the CME 9:00 a.m.-10:30 a.m. Course Brochure included in your registration Room 103 B, Street Level, Convention Center packet. Admission by ticket only. MOTIVATIONAL ENHANCEMENT THERAPY FOR THE MEDICALLY ILL, SUBSTANCE ABUSE COURSE 79 8:00 a.m.-12 noon PATIENT WITH DEPRESSION Ormandy East, Street Level, DoubleTree Moderator: Robert M. Weinrieb, M.D. COGNITIVE THERAPY FOR SEVERE MENTAL Presenter: Deborah H.A. Van Dorn, Ph.D. DISORDERS THIS SESSION IS OPEN TO APA MEMBERS ONLY. Director: Jesse H. Wright, M.D. BLUE REGISTRATION BADGE OR APA Faculty: Monica A. Basco, Ph.D., Michael E. Thase, M.D. MEMBERSHIP CARD REQUIRED FOR ADMITTANCE. COURSE 80 8:00 a.m.-12 noon Aria A, Third Floor, DoubleTree CONTINUOUS CLINICAL CASE INSANITY DEFENSE EVALUATIONS CONFERENCE 2: PART 1 9:00 a.m.-12 noon Director: Phillip J. Resnick, M.D. Rooms 106 A/B, Street Level, Convention Center

COURSE 81 8:00 a.m.-12 noon MANAGING NEGATIVE OUTCOMES IN GENERAL Maestro, Fourth Floor, DoubleTree PSYCHIATRY

INTERPERSONAL PSYCHOTHERAPY Moderator: Richard G. Hersh, M.D. Presenter: Mary S. Sciutto, M.D. Director: John C. Markowitz, M.D. THIS SESSION IS OPEN TO APA MEMBERS ONLY. COURSE 82 8:00 a.m.-12 noon BLUE REGISTRATION BADGE OR APA Rhapsody, Fourth Floor, DoubleTree MEMBERSHIP CARD REQUIRED FOR ADMITTANCE. EVIDENCE-BASED MEDICINE: AN INTRODUCTION FOR PSYCHIATRISTS COURSES 85-90 Director: Gregory E. Gray, M.D. Course descriptions are available in the CME Faculty: Gabrielle F. Beaubrun, M.D., Letitia A. Pinson, M.D. Course Brochure included in your registration packet. Admission by ticket only. COURSE 83 8:00 a.m.-12 noon Sonata 5, Fifth Floor, DoubleTree COURSE 85 9:00 a.m.-4:00 p.m. PERSONALITY DISORDERS: COMBINED INTERPERSONAL AND PHARMACOTHERAPY Orchestra Room, Second Floor, DoubleTree

Director: Roy O. Resnikoff, M.D. PSYCHOTHERAPY OF BORDERLINE PERSONALITY COURSE 84 8:00 a.m.-5:00 p.m. Ormandy West, Street Level, DoubleTree Co-Directors: Otto F. Kemberg, M.D., Frank E. Yeomans, M.D. Faculty: John F. Clarkin, Ph.D., Eve Caligor, M.D. OFFICE-BASED TREATMENT OF OPIATE DEPENDENT PATIENTS COURSE 86 9:00 a.m.-4:00 p.m. American Academy of Addiction Psychiatry, APA Council on Addiction Concerto A, Third Floor, DoubleTree Psychiatry, and Substance Abuse and Mental Health Services Administration HOW TO PRACTICE EVIDENCE-BASED PSYCHIATRY Co-Directors: Eric C. Strain, M.D., Thomas R. Kosten, M.D. Faculty: H. Westley Clark, M.D., David Fiellin, M.D., Director: David R.S. Haslam, M.D. Herbert D. Kleber, M.D., Laura F. McNicholas, M.D. Faculty: John Geddes, M.R.C., Elliot M. Goldner, M.D., David M. Gardner, Pharm.D. 66 WEDNESDAY

COURSE 87 9:00 a.tn.-4:00 p.m. LECTURES 15-18 Concetto B, Third Floor, DoubleTree LECTURE 15 CARING FOR REFUGEES AND SURVIVORS OF TORTURE 9:00 a.m.-10:30 a.m. Rooms 108 A/B, Street Level, Convention Center Director: Linda Prwowarczyk, M.D. Faculty: Michael A. Grodin, M.D., Ricardo Restrepo, M.D., Phihp G. Zimbardo, Ph.D. Terence M. Keane, Ph.D. Evil in the World and Terror in Our Nation: Transferring Vulnerabilities into Resilience COURSE 88 9:00 a.m.-4:00 p.m. Symphony Ballroom, Third Floor, DoubleTree Chp.: Huw.iid 1 '.W-kv. M D. Co-Chp,: r-tith Vivt'k, ''! D A PRACTICAL APPROACH TO HERBS AND NUTRIENTS IN PSYCHIATRY On SdMi'ilil'i:! 1 I. I lii: '.veil L'n iu!in.iiod turnm?! jnii_ks on lhc \Vurid T'-tdi.- ('.i'lircr .md 'he I'ttiUgOU pl'-in^cd Co-Directors: Richard P. Brown, M.D., Patricia L. Gerbarg, M.D. list I iHi-jJ M.ites into anef .mil tcrsfir .\iyu_-ru:.ins liv.ind it .ilino-i m^jiKi'iY.i':'!!.- rhir .111 org.iiuzcd group COURSE 89 9:00 a.m.-4:00 p.m. \vuuld i't willing ~ii liill rhoii-.i!id = o! miioeerir indi- Minuet, Fourth Floor, DoubleTree viduals .Hid int-thodi^.illv pi.m rhi'ir n\vn ;iLn:id-_-> l)y pilortni; hiiaiktii pUno K> jtsTfULimn ijh:hp t: THE ASSESSMENT AND TREATMENT OF CHILD /.mn.b.L[xto, ijh 15 , t,-\,iiTii]]t!> how >ilu.ttii.>ii.tl fi>ri;c» MOLESTERS Cf>n[nbiitc lo t:\~\\ (>fh.iviorr ;iti(.t ho\\' propuy:uitlj L> Director: John M. Bradford, M.B. utjL/tJ lo --h.ipc ihc i.H-lit-r^ o: .1 iZLiltiirc hit *lsi> Faculty: Gene G. Abel, M.D., Graham G. Glancey, M.B., Jiiifii-isci mtn:.i] :ic-.]l;:i proic^jioiial-' <.nflinl>utii.)ii? ro J. Paul Fedoroff, M.D. iiK:rt.isi[\i; tlii- rc.'>iiicn(.L- *>: cill^i.-i[i Ijiied \\ith ,tn inidTI.1111 U'rrun^' 'lirt'.U Di ZLmt'.ird'.j. [rU1 LL;r.renl 1 COURSE 90 9:00 a.m.-4:00 p.m. PrtsiJi-sil 11! 'iit .\nitni.in i'>'i'-':iu;L>V .[- Sr.mii.iriJ L niVL-r-itri,- mid Ditcitot 1.11" rtu- ^t.iiit'oril Lniv-/isii\ MH.-I*! PsyLhiulogi S 1 THE BIOPSYCHOSOCIAL FORMULATION: AN Cir.idiLitt Rcs'-Mrd'. I Mining I'mar-im HL :s di: .tLiilior APPROACH TO ORAL BOARD PRESENTATIONS ul jutjrt' thai'. 2n'- prijtL-ssion.i] ,irnck'> jnd buok kluptL-rs .ind si:vtr.il tx'oks, mill.!ding lhc ifitroauirtor. r r : Co-Directors: Robert M. Rohrbaugh, M.D., William H. n-i tholii(>\ *.'Xt - '~f. J'tiMi'i -'•''•' /j'*' Jiid rhc ir^d; bonks Campbell, M.D. i'-H':'ii :iiui 'i'•:' .'". h:v duiin^insr.fd t tic lung j.i Belitsky, M.D. S[:iiil'ii:d .mJ iron: othvr :n-titutifi!is jnd hi-, .ilso ri'i ti\'i:i.i j'.k'.ii'd- tor hi> resiMs^h in MJL:,*| ps'.vhrilfj^v jnd Iv.piums Ik1 :-'jLL':vcd hi? dtn:;or:tl iiegrct trom DISCUSSION GROUPS 19-22 l'.i!t l.':iivtr>ir1,'. THIS SESSION WILL BE AL'DIOTAPED. 9:00 a.m.-10:30 a.m. LECTURE 16 These sessions are limited to 25 participants on a first- come, first-served basis. 9:00 a.m.-10:30 a.m. Rooms 109 A/B, Street Level, Convention Center 19 Alan F. Schatzberg, M.D., on Essentials of Clinical Psychopharmacology (Meet the Authors) APA'S OSKAR PFISTER AWARD LECTT'RE Room 308, Level 3, Marriott TBA

20 Jesse S. Rosenthal, M.D., on Psychopharmacologic The NcJrly Forgoiten Fjctar in Psvchiatrv: \\liat a Treatment of Comorbid Attention Disorders in Adults Difference J Decade Makes Room 410, Level 4, Marriott Chp.: ^rvins: S Vi K--IKT, M l"J 21 Peter A. Shapiro, M.D., on Psychiatric Aspects of Co-Chp.: Ki-VfiL-id <:[.i:k -. .\i,i, Ph O Cardiovascular Disease Room 413, Level 4, Marriott >pinll..il JniJ :i.'lijjHiU; t.iLtot^ th.d iiujhf cidii'r ht-ip ;>.iin-ill« iit'pi' nr ,iiiJ in p,j,iik'iu-' ciititLcr* have hi=fc>r 22 Norman A. Clemens, M.D., on the APA Business Initiative u..il:( tJt.Lvv:! >.".!:it jlti-nliuis in p-'iliuln. Dunir; and the Future of Psychiatric Practice Room 502, Level 5, Marriott ((Continued on next page)

67 WEDNESDAY

[hi- pasi decade, however, a qu.el bin constructive and Samuel G. Hibbs A^-ard. Dr, Terr graduated from tramtorrruuon lus increased ilir recognition and the University of Michigan Medical School in Ann clinical understanding ol ipmtiul and religious issues in Arbor and completed a residency in psychiatry at the patients' lives David B l^rson, M.D., highlights the University of Michigan Neuropsychiairic Institute and a thanges in psychiatric research, education, and care that fellowship in child psychiatry at the University of have characterized this triniiormation. Dr lanon is Michigan Children's Psychiatric Hospital. [he President ot the International Center tor the THIS SESSION WILL BE AUDIOTAPED. Integration of Health and Spirituality in Rockville, Maryland, lie .ilso serves as Adjunct Professor at LECTURE IS Duke LJnivenny Medical tenter in Durham, North Carolina, Northwestern University Medical School in 9:00 a.m.-10:3Q a.m. Chii^kgo, .nid ihe Unilurmed Services University of the Lecture Hall 114, Street Level, Convention Center I !ealih Sciences in Bc"hesd.i, Maryland. Formerly a Senior Researcher ;n :he Of I ice of the Director at the APA'S PATIENT ADVOCACY National Institutes ot I leal;h. Or. Larson is the author AWARD LECTURE oi more ;hjri 2^0 scientific papers and book chapters examining the impact ot ;-pimualjry on a variety ot David Satcher, M.D. physic-a! and mental health outcome*. A Fellow of the APA, he received his medical degree from Temple Mental Health: A Perspective from the Surgeon University Medical School in Philadelphia, completed General Who Listens hii residency in psvch.atry and a gmair.c fellowship at Duke University- Medical Center, and received his Chp.: CarlC. Bell, M.D. master's degree in public health it ihe University' of Co-Chp.: Neal L, Cohen, M.D. North Carolina in ('Jupd 1 lill. THIS SESSION WILL BE ALJDIOTAPED. David Satcher, M.D., was the 16th Surgeon General of the United States, serving a four-year term that ended in LEC'mRE 17 February 2002. Currently a Fellow at ihe Henry J, Kaiser Family Foundation, Dr. Satcher will assume the post of 9:30 a.m.-1C:3C a.m. Director of the National Center for Primary Core ai Room 113 B, Street l.evel, Convention Center Morehouse School of Medicine in Atlanta in the fall of 2002. Dr. Satcher was Director of the Centers for APA'S MARMOR AWARD LECTURE Disease Control and Prevention and Administrator of the Agency for Toxic Substances and Disease RegUtry LenoreC. Terr, M.D. from 1993 to 1998 and President of Meharry Medical College in Nashville from 1982 to 1993. A former Terror, Horror, and fright: Past and Current Robert Wood Johnson Clinical Scholar, Dr. S.ucher has Perspectives received numerous honors, including top awards from the American Medical Association, the American College Chp.: John K Greck-n, M.D. of Physicians, the American Academy of Family Co-Chp.: Mama K. Cioin. M.D. Physicians, and Ebony magazine. He is a Fellow of the American Academy of Family Physicians, the Amencan 'lo understand ihe piychokigicaj challenges to our College of Preventive Medicine, and the Amencan nation Irom war u-.iged by terrorists, ps\-chiatrists may College of Pnvsiaans, Dr. Satcher received his rnedcal need to become increasingly knowledgeable about the and doctorate degrees from Case Western Reserve effects o) inumj-relaied conditions. Ignore Terr, M.D., University in Cleveland and received residency and discusses :he pin-chologica. eliects ot traumatizing evenu fellowship training at Strong Memorial 1 iospiul in and the possibilities for healing, drawing on her re- Rochester, New York, the University of Rochester, search on children's reactions 10 the 1976 ChowchilU, UCLA, and Ring-Drew Medical Center in I,os Angeles. ColiiorrLa, school bus kidnapping, :he 1986 Challenges THIS SESSION WILL BE AUDIOTAPED. space shuttle disasver. the 1999 Columbine I ligh School shootings, and the terrorist attacks of September 11, MASTER EDUCATOR CLINICAL 2001. Dr, Terr is Clinical Professor of Psychiatry ai the CONSULTATIONS 9-11 University of California, San l-'rancisco, and Attending 9:00 a.m.-10:30 a.m. Physician at the I>anglc\- Poiter Neuropsychiainc InsUtulc, and is in the private practice ot adult and These sessions are limited to 25 participants on a first- child psychiatry. Her books inJudr Too ScrW la Cry: come, first-served basis. Psychic Jraiara tri 0mihe»d ojid Bfyrrti I oie arid Work: It'frl Adults AVw/ K> PLty. A Fellow of the APA and the 9 Carol C. Nadelson, M.D., on Changing and Evoking Roles Amenc-in Academy of Chiid and Atiolescent Psychia- for the Clinicians tr,-, she ha> received APA'i Blanche F. Inleson Award Room 111 A, Street Level, Convention Center 68 WEDNESDAY

10 Barbara A. Schindler, M.D., on the Addicted Woman: REVIEW OF PSYCHIATRY: SECTION 3 Diagnostic and Treatment Challenges 9:00 a.m.-12:30 p.m. Room 301, Level 3, Marriott Rooms 201 A-C, Level 200, Convention Center 11 Eric R. Marcus, M.D., on Adults with Learning Disabilities and Mood Disorders PSYCHIATRY IN MEDICINE Room 501, Level 5, Marriott Chp.: Nada L. Stotland, M.D. THESE SESSIONS ARE OPEN TO APA MEMBERS ONLY. BLUE REGISTRATION BADGE OR APA 11 Psychiatric Disorders and the Menstrual Cycle MEMBERSHIP CARD REQUIRED FOR Laura J. Miller, M.D. ADMITTANCE. 12 Psychiatric Factors in Solid Organ Transplantation MEDIA SESSIONS 18-19 Catherine A. Crone, M.D. MEDIA SESSION 18 9:00 a.m.-10:30 a.m. 13 Gastroenterology Washington Rooms A-C, Third Floor, Loews Thomas N. Wise, M.D.

SOUL OF A SISTER 14 Mind and Heart: The Interplay Between Psychiatric and Cardiac Illness Chp.: Lesly T. Mega, M.D. Theodore A. Stern, M.D. 25 Leona's Sister Gerri (57 minutes) WORKSHOPS Distributor: New Day Films 22-D Hollywood Avenue COMPONENTS 32-41 HoHoKus,NJ07423 Leona's Sister Gerri is the story of Gerri Santoro, the real COMPONENT WORKSHOP 32 9:00 a.m.-10:30 a.m. person in the police photograph of an anonymous woman Room 104 A, Street Level, Convention Center collapsed on a motel room floor, dead from an illegal abortion. Reprinted thousands of times in newspapers, magazines, and COMPETENCE REQUIREMENTS IN RESIDENT books, this image has become a symbol for reproductive EDUCATION: PROGRESS AND PROBLEMS freedom. Addressing issues of reproductive rights and APA Task Farce on Competency and Graduate Education domestic violence, this video is the dramatic and engrossing story of a woman's life and society's response to her death. Chp.: Sherwyn M. Woods, M.D. MEDIA SESSION 19 9:00 a.m.-10:30 a.m. Participants: Lisa A. Mellman, M.D., Eugene V. Beresin, M.D., Congress Rooms A-C, Fourth Floor, Loews Stephen C. Scheiber, M.D., Francis G. Lu, M.D. DENYING THE DEMON COMPONENT WORKSHOP 33 9:00 a.m.-10:30 a.m. Room 104 B, Street Level, Convention Center Chp.: Richard E. D'Alli, M.D. QUALITY INDICATORS FOR CHILDREN AND 26 Blink (57 minutes) ADOLESCENTS: WHO CARES? APA Council mQt^itylmpnjuement Distributor: University of Calif. Extension Center for Media and Independent Learning Chp.: James C. Maclntyre II, M.D. 2000 Center Street, 4th Floor Participants: John M. Oldham, MX)., Rhonda Joyce R. Beale, M.D., Berkeley, CA 94704 Richard C. Hermann, M.D.

This powerful and thought-provoking documentary examines COMPONENT WORKSHOP 34 9:00 a.m.-10:30 a.m. the dramatic story of one-time white supremacist leader Gregory Withrow, and in so doing, explores the underlying Room 111 B, Street Level, Convention Center strains of violence and domination in American life and culture. Withrow's flight from the militant white Aryan PRACTICING REWARDING PSYCHIATRY IN JAILS resistance captured the attention of the national media when AND PRISONS: A PRACTICUM Withrow was found beaten and his hands nailed to a board. APA Council on Psychiatric Services Now, more than a decade later, Withrow is married to a Mexican-American woman and lives a low-key, semi-isolated rural existence. Blink explores the complex middle ground Chp.: Henry C. Weinstein, M.D. where Withrow still battles his demons and questions the Participants: Kathryn A. Bums, M.D., Kenneth G. Gilbert, M.D., possibility of fundamental personal change. Cassandra F. Newkirk, M.D., Annette L. Hanson, M.D., John S. Zil, M.D.

69 WEDNESDAY

COMPONENT WORKSHOP 35 9:00 a.m.-10:30 a.m. COMPONENT WORKSHOP 41 9:00 a.m.-10:30 a.m. Rooms 112 A/B, Street Level, Convention Center Grand Ballroom Salon J, Level 5, Marriott

WHOSE CHILDREN? PSYCHIATRY IN THE THE RULES OF THE CLUB: CAREER CULTURAL MOSAIC OF AMERICA'S SCHOOLS ADVANCEMENT FOR WOMEN APA Committee on Psychiatry and Mental Health in the Schools APA Comrnitieeon Women

Chp.: Mary E. Schwab-Stone, M.D. Co-Chps.: Donna E. Stewart, M.D., Ami A. Matorin, M.D. Participants: Trina B. Allen, MX)., Eugenic M. Rothe, M.D., Participants: Deborah Spitz, M.D., Leslie H. Gise, MX). Hong Shen, M.D., Nichole D. Grier, M.D.

COMPONENT WORKSHOP 36 9:00 a.m.-10:30 a.m. ISSUES 69-88 Room 202 A, Level 200, Convention Center ISSUE WORKSHOP 69 9:00 a.m.-10:30 a.m. IT'S NOT GAY ENOUGH: INTERPRETING ANTIGAY Rooms 102 A/B, Street Level, Convention Center BIAS IN THE 21ST CENTURY APA Commiaee on Gay, Lesbian, and Bisexual Issues TREATING GAY AND LESBIAN YOUTH AT RISK

Chp.: Jack Drescher, M.D. Co-Chps.: William Resnick, M.D., Steven Sokoll, M.D. Participants: Kenneth B. Ashley, M.D., Daniel W. Hicks, M.D., Howard C. Rubin, M.D., Julie K. Schulman, M.D., Susan A. ISSUE WORKSHOP 70 9:00 a.m.-10:30 a.m. Turner, M.D., Serena Yuan Volpp, M.D. Room 103 A, Street Level, Convention Center

COMPONENT WORKSHOP 37 9:00 a.m.-10:30 a.m. GRIEVOUS BODILY HARM AND CLUB DRUGS: Rooms 304-306, Level 3, Marriott TREATMENT AND OTHER CONSIDERATIONS

DYNAMIC DUEL: DILEMMAS OF SPLIT Chp.: Jeffrey N. Wilkins, M.D. TREATMENT APA Consortiumon Treatment Issues Participants: Waguih W. Ishak, M.D., Romana Markvitsa, MX)., Katherine Mellott, M.D., Lewis Nelson, MX). Co-Chps.: Sally L. Godard, M.D., Richard J. Kessler, D.O. ISSUE WORKSHOP 71 9:00 a.m.-10:30 a.m. COMPONENT WORKSHOP 38 9:00 a.m.-10:30 a.m. Room 103 C, Street Level, Convention Center Room 307, Level 3, Mamott RECENT STUDIES ON PARITY AND EMPLOYER- TALKING WITH THE TERMINALLY ILL ABOUT SPONSORED INSURANCE DEATH AND DYING Substance A buse and Mental Health Services Administration APA Committee on End-of-Life Issues Chp.: Darrel A. Regier, M.D. Co-Chps.: Maurice D. Steinberg, MXX, Edwin H. Cassem, MX). Participants: Ira R. Byock, M.D., Samuel C. Klagsbrun, MX). Participants: Jeffrey Buck, Ph.D., Mady Chalk, Ph.D. COMPONENT WORKSHOP 39 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 72 9:00 a.m.-10:30 a.m. Rooms 309-310, Level 3, Marriott Room 113 A, Street Level, Convention Center

PSYCHOLOGIST PRESCRIPTION PRIVILEGES: IS IT PSYCHOPHARMACOGENETICS AND ETHNICITY: COMING? SHOULD IT? CURRENT PERSPECTIVES A PA Commission on Publk Policy, Litigation, and Advocacy Co-Chps.: Pedro Ruiz, M.D., Keh-Ming Lin, M.D. Co-Chps.: Amin N. Azzam, Raymond J. Kotwicki, MX). Participants: William B. Lawson, M.D., EdmondH.T. Pi, M.D., Participant: Frederick Y. Huang, M.D. Ricardo P. Mendoza, M.D., Tarek A. Okasha, M.D.

COMPONENT WORKSHOP 40 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 73 9:00 a.m.-10:30 a.m. Liberty Ballroom A, Level 3, Marriott Room 202 B, Level 200, Convention Center

COMBINED RESIDENCY TRAINING: YOU WANT PRACTICAL PHARMACOTHERAPY OF MOOD TO DO WHAT? DISORDERS APA Committee on Consultation-Liaison Psychiatry and Primary Care Education Co-Chps.: Gary E. Miller, M.D., Richard L. Noel, M.D.

Co-Chps.: Shannon T. Suo-Chan, M.D., Susan L. Padrino, MX). Participants: Quinton E. Moss, Jodi E. Star, Dylan P. Wint, MX).

70 WEDNESDAY

ISSUE WORKSHOP 74 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 80 9:00 a.m.-10:30 a.m. Room 203 A, Level 200, Convention Center Room 406, Level 4, Marriott

MINDFULNESS AND AWARENESS PRACTICE IN TEACHING BEHAVIORAL SCIENCES TO FAMILY THE MEDICINE BUDDHA TRADITION OF TIBET DOCTORS

Chp.: James T. Sacamano, M.D. Chp.: Jonathan S. Davine, M.D.

ISSUE WORKSHOP 75 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 81 9:00 a.m.-10:30 a.m. Room 203 B, Level 200, Convention Center Rooms 407-409, Level 4, Marriott

DRUG THERAPY FOR FUNCTIONAL SOMATIC MUSIC AS MIRROR: REFLECTIONS OF THE SYNDROMES PSYCHE IN WORKS BY THE GREAT COMPOSERS

Chp.: Peter Manu, M.D. Chp.: Chelsea L. Chesen, M.D. Participant: Eli S. Chesen, M.D. ISSUE WORKSHOP 76 9:00 a.m.-10:30 a.m. Room 204 A, Level 200, Convention Center ISSUE WORKSHOP 82 9:00 a.m.-10:30 a.m. Rooms 411/412, Level 4, Marriott IN SEARCH OF THE EMPATHIC HEALER ASSISTING PHYSICIANS AND OTHER Chp.: Michael J. Bennett, M.D. PROFESSIONALS WHO VIOLATE BOUNDARIES

ISSUE WORKSHOP 77 9:00 a.m.-10:30 a.m. Chp.: Werner Tschan, M.D. Room 204 B, Level 200, Convention Center Participants: Michael F. Myers, M.D., Carolyn Quadrio, M.D., Gary R. Schoener, Psy.D. DISABILITY MYTHS: UNDERSTANDING THE SOCIAL SECURITY ADMINISTRATION DISABILITY ISSUE WORKSHOP 83 9:00 a.m.-10:30 a.m. PROGRAM Rooms 414/415, Level 4, Marriott

Chp.: Bernard J. Arseneau, D.O. WOMEN AND SMOKING Participants: Cathy Lively, Ph.D., Henry G. Conroe, M.D. Co-Chps.: Sarah M. Whitman, MD., David Rubenstein, Psy.D. ISSUE WORKSHOP 78 9:00 a.m.-10:30 a.m. Liberty Ballroom B, Level 3, Marriott ISSUE WORKSHOP 84 9:00 a.m.-10:30 a.m. Grand Ballroom Salon A, Level 5, Marriott NEW DIRECTIONS IN MENTAL HEALTH RESPONSE TO DISASTERS AND LARGE-SCALE CLOZAPINE USE IN HIV CRISES Substance Abuse and Mental Health Services Administration Chp.: Richard H. McCarthy, M.D. Participant: Mara J. Fiorentino, M.D. Chp.: Mary E. Nelson, M.S.W. ISSUE WORKSHOP 85 9:00 a.m.-10:30 a.m. Participants: Matthew J. Friedman, M.D., Sharon E. Carpinello, Ph.D., Farris Tuma, Sc.D., Chip J. Felton, M.S.W., Grand Ballroom Salon B, Level 5, Marriott Elissa P. Benedek, M.D. INTERGENERATIONAL ASPECT OF TRAUMA AND TRAUMA-RELATED BEHAVIORAL PATTERNS ISSUE WORKSHOP 79 9:00 a.m.-10:30 a.m. Independence Ballrooms II/III, Level 3, Marriott Chp.: Andrei Novae, M.D. Participants: Rita R. Newman, M.D., Rachel Yehuda, Ph.D. CHILDHOOD TRAUMA INTERVENTION AND AFTERMATH: ACCESS TO QUALITY CARE ISSUE WORKSHOP 86 9:00 a.m.-10:30 a.m. Substance A buse and Mental Health Services Administration Grand Ballroom Salon C, Level 5, Marriott

Chp.: Malcolm A. Gordon, Ph.D. DO RESTRICTED FORMULARIES SERVE AS Participants: Judith A. Cohen, MD., Mary Beth Williams, Ph.D., BARRIERS TO CARE? Chris M. Kirchner, M.S.W. Co-Chps.: Mitchel J. Stein, M.D., Joseph R. Mawhinney, M.D. Participants: Stephen M. Goldfinger, M.D., Kenneth S. Duckworth, M.D., Peter L. Forster, M.D.

71 WEDNESDAY

ISSUE WORKSHOP 87 9:00 a.m.-10:30 a.m. completed residencies in psychiatry at Massachusetts Grand Ballroom Salon D, Level 5, Marriott Mental Health Center and Massachusetts General Hospital, where he also completed a dm.cal .ind re- ADVOCACY 101: INFLUENCING MENTAL HEALTH search fellowship in psychutry. POLICY Distinguished Psychiatrist Lecture Series THIS SESSION WILL BE AUDIOTAPFD. Chp.: Jay B. Cutler, J.D. Participants: Heather Whyte, Helen M. Foster, M.D., John E. LECTURE 20 Kraus, Jr., M.D., Jason Pray ll^Ca.m.-12:30p.m. ISSUE WORKSHOP 88 9:00 a.m.-10:30 a.m. Rooms 109 A/B, Street Level, Convention Center Grand Ballroom Salon I, Level 5, Marriott APA'S KUN-PO SOO AWARD LECTURE CAREER DEVELOPMENT AND RISK MANAGEMENT Kch-MingLin,M.D.

Chp.: Bany W. Wall, M.D. Journey to the West: Reflections on Culture and Participants: Martin G. Tracy, J.D., Jacqueline M. Melonas, J.D., Psychiatry Entering the New Century Joseph M. Schwartz, M.D. Chp.:NangDu,M.D. Co-Chp.: John Luo, M.D.

11:00 a.m. Sessions Rooted in Western traditions, psychia'.ry has trans- cended sociocultural divides to find its niche nearly LECTURES 19-21 everywhere in the world. At the same time, cross- cultural experiences have challenged the universality LECTURE 19 of prevailing psychiatric concepts and practices. Keh- Ming Lin, M.D., examines the influence ot culture on 11:00 a.m.-12:3C p.m. vulnerability and resilience to psychiatric illness and Rooms 108 A/B, Street Level. Convention Center response to interventions and discusses the importance of integrating cultural and biomedic-al perspectives in Edwin H. Cassem, M.D. psychiatric assessment and care. Dr. Lin is Prolessor of Psychiatry at the University of California, Los Can the Third Millennium Psychiatrist Help Angeles, and Director of the National Institute of Persons at the End-of-Life? Menial Health/I larbor-L'Q A Research Center on :he Psychobiology of F.ihnicity. The founder of two Chp.: Jonathan F. Borus, M.D. menial health centers serving Asian Americans in Co-Chp.: Theodore A. Stern, M.D. California, he has made major contributions in cross- ethnic psycho pharmacology one psychiatric nosology, Dau from the Netherlands suggest that terminally ill epidemiology, medical anthropology, and refugee mental patients who request euthanasia frequently do so for health. Dr. Lin is a Fellow of the APA, the Amencan reasons involving psychiatric, psycho social, cultural, Association tor Social Psychiatry, and the Pacific Run existential and spiritual factors, Edwin H. Cassem, M.D., College of Psychiatrists and currently serves on APA's discusses ihe effects of lermiiul illness on patients' Council on Research. A member of [he Editorial sense of dignity and meaning and describes ways Board of American Psychiair.c Press, Inc., he U the psychiatrists can help terminally ill persons ind their author of more than 150 articles and book chapters and famJy members to find nrw goals, enhance self-respect, the author, editor, or translator o; eight books. Dr. Lin ind improve quality of life in the dying person's received his medical training at National Taiwan remaining lime. An ordained pnest in the Jesun Order, University and postgraduate training at the University Dr. Cassem is Professor of Psychiatry at Harvard of Washington in Seattle. Medical School and a psychiatric at Massachusetts. THIS SESSION WILL BE AUDIOTAPED. Genera] Hospital in Boston. He is a member of the Editorial Board ot several journals, including Joumaj of LECTURE 2\ Genome Prxhtatry mid :Vewraicgy, Psydx&xnatxs, and Hzruad Reuew of Psym&try. Dr. Cassem is a Fellow of ll:COa.m.-12:30p.m. APA, the Amencan College of Physicians, and the Lecture Hall 114, Street Level, Convention Center Academy of Psyc ho somatic Medicine. He formerly was President of the American Psycho somatic Society ElioJ. Frattaroli, M.D. ind the Academy of Psychosomatic Medicine. A graduate of Harvird Medical School, Dr. Cassem 72 WEDNESDAY

Healing the Soul in the Age of the Brain: Chp.: Steven Sokoll, M.D. Reflections on the Meaning of Psychiatry After September 11 27 "In the Life" Television News Magazine (57 minutes) Chp.: David M. McDowell, M.D. Co-Chp.: Patricia I. Ordorica, M.D. Distributor: David P. Martin In the Life Media, Inc. The root meaning of the word "psychiatry" is "healing 30 West 26th Street, 7th Floor the soul," but psychiatry has increasingly become New York, NY 10010 focused on the physical and the external (brain and behavior) and given less attention to the emotional and In the Life is a national television series in a newsmagazine the spiritual, EJio J. Frattaroli, M.D., discusses the format that reports on gay and lesbian issues and culture. disparity between biological and psychocherapeutic Episode 701, "Back to School," addresses multiple issues approaches in psychiatry in terms of a larger cultural relevant to the education and mental health of gay and lesbian conflict between opposing philosophies of life and the youth and to the families of gay and lesbian youth. The first nature of illness and health. Dr. Frartaroli is a psychi- segment focuses on adolescent suicide, followed by segments atrist and psychoanalyst tn private practice in Bala on the process involved in establishing a Gay Student's Rights G-mnyd, Pennsylvania. I le is also Assistant Clinical Bill and gay-straight alliances. Final segments report on Professor of Psychiatry at the University of Pennsylvania, model gay and lesbian support centers. a member of the faculty of the Psychoanalytic Center ot Philadelphia, and Associate Director of the center's Discussant: Steven Sokoll, M.D. Psychodvnarruc Psychotherapy Training Program. Dr. Frattaroli studied Shakespeare at Harvard University MEDIA SESSION 21 11:00 a.m.-2;00 p.m. and trained uitri Bruno Beuelheim at the University of Congress Rooms A-C, Fourth Floor, Loews Chicago before turning to medicine. He has written and lectured on Shakespeare as well as on psychiatry TEMPERING TROUBLED MINDS and psychoanalysis. Dr. Frattaroli received his medical degree at the University of Chicago, completed hus Chp.: Bill Lichtenstein residency in psychiatry' at the Institute of Pennsylvania Hospital, and received his psychoanalytic training at the 28 West 47th Street Institute of the Philadelphia Association for (108 minutes) Psychoanalysis, THIS SESSION WILL BE AUDIOTAPED. Distributor: Bill Lichtenstein Lichtenstein Creative Media 25 West 36th Street MASTER EDUCATOR CLINICAL New York, NY 10018 CONSULTATION West 47th Street offers an unprecedented window in the lives 11:00 a.m.-12:30 p.m. of people who are often feared, ignored, and seldom under- stood. This warm and intimate film follows five people with This session is limited to 25 participants on a first-come, mental illness, off the streets and out of homeless shelters, in first-served and out of the hospital, and at home and at work, over a three year period. The film presents a story about people who approach 12 Michelle T. Pato, M.D., on Obsessive Compulsive and tremendous obstacles with humor, optimism, and grace. Related Disorders Room 111 A, Street Level, Convention Center Discussants: Bill Lichtenstein, June Peoples, Michael M. Faenza, M.S.S.W., Wayne S. Fenton, M.D., John A. Talbott, MD. THIS SESSION IS OPEN TO APA MEMBERS ONLY. BLUE REGISTRATION BADGE OR APA MEMBERSHIP CARD REQUIRED FOR MEDICAL UPDATE 3 ADMITTANCE. 11:00 a.m.-12:30 p.m. Room 103 A, Street Level, Convention Center

MEDIA SESSIONS 20-21 STRATEGIC UPDATE OF ALZHEIMER'S DISEASE: LINKING DISEASE WITH THERAPEUTICS MEDIA SESSION 20 11:00 ajn.-12:30 p.m. Washington Rooms A-C, Third Floor, Loews Chp.: Marion Z. Goldstein, M.D. Presenter: Carol Lippa, M.D. GROWING UP GAY THIS SESSION WILL BE AUDIOTAPED.

73 WEDNESDAY

RESEARCH CONSULTATION WITH 11:30 a.m. 76 Psychiatric Diagnosis for Children Under Age Five 11:00 a.m.-12:30 p.m. Referred to a Public Mental Health System Harry H. Wright, M.D., Michael L. Cuccaro, Ph.D., This session is limited to 25 participants on a first-come, Rosetta H. Penny, M.S.W., Tami V. Leonhardt, Ph.D., first-served basis. Kristin M. Wieduwilt, Ruth K. Abramson, Ph.D.

2 Raquel E. Gur, M.D., on Brain Behavior Studies in 12 noon Schizophrenia 77 Modafinil in Children with ADHD: A Double-Blind, Anthony Room, Third Floor, Loews Placebo-Controlled Study Thomas A. Rugino, M.D., Teresa C. Samsock, MS., Laura Adkins, Ph.D. SCIENTIFIC AND CLINICAL REPORT THIS SESSION WILL BE AUDIOTAPED. SESSIONS 25-33 SCIENTIFIC AND CLINICAL REPORT SESSION 27 11:00 a.m.-12:30 p.m. SCIENTIFIC AND CLINICAL REPORT SESSION 25 Room 113 C, Street Level, Convention Center 11:00 a.m.-12:30 p.m. Room 111 B, Street Level, Convention Center PSYCHOTHERAPIES

TREATMENT OF PERSONALITY DISORDERS Chp.:JeraldKay,M.D. Co-Chp.: Frederick E. Miller, MD. Chp.: Andrew J. Kolodny, M.D. Co-Chp.: David A. Rothstein, M.D. 11:00 a.m. 78 Music Therapy and Medication Compliance in 11:00 a.m. Psychotic Patients 72 Risperidone Treatment of Schizotypal Personality Ruby C. Castilla-Puentes, M.D., Nora Danies, M.D., Janeth Disorder Valero, MS.C, Janeth Vargas, RN., Orlando Gongora, MS.G, Harold W. Koenigsberg, M.D., Marianne Goodman, M.D., Carmenleonor Pava, M.S.C., James Perel, Ph.D. Antonia S. New, M.D., Vivian Mitropoulou, MA., Robert L. Trestman, MD., Jeremy Silverman, PhD., Larry J. Siever, MD. 11:30 a.m. 79 Controlled Study of NAMI Family-to-Family Education 11:30 a.m. Program 73 A Preliminary Trial of Omega-3 Fatty Acids in Women lisa B. Dixon, MD., Joyce Burland, Ph.D., Alicia Lucksted, PhD., with BPD Bette Stewart, B.S., Leticia T. Postrado, Ph.D., Colleen Mary C. Zanarini, Ed.D., Frances R. Frankenburg, M.D., McGuire, M.A., Marcia Hoffman, MA. Anna Vujanovic, A.B., Elizabeth A. Parachini, B.A. 12 noon 12 noon 80 An Additional Guideline for Choosing Appropriate 74 Is Chemical Imbalance a Useful Concept in Treating Supportive Psychotherapy Techniques Personality Disorders? Frederick S. Mendelsohn, M.D. Kenneth R. Silk, M.D., Joann Heap, M.S.W. THIS SESSION WILL BE AUDIOTAPED. THIS SESSION WILL BE AUDIOTAPED. SCIENTIFIC AND CLINICAL REPORT SESSION 28 SCIENTIFIC AND CLINICAL REPORT SESSION 26 11:00 a.m.-12:30 p.m. 11:00 a.m.-12:30 p.m. Room 202 A, Level 200, Convention Center Room 113 B, Street Level, Convention Center ADDICTION PSYCHIATRY ISSUES IN CHILD PSYCHIATRY Chp.: David W. Brook, M.D. Chp.: Tanya R. Anderson, M.D. Co-Chp.: Meera Vaswani, Ph.D. Co-Chp.: Duru Sakhrani M.D. 11:00 a.m. 11:00 a.m. 81 Ecstasy: Complications and Neurotoxicity 75 ADHD Comorbidity: Age and Gender Differences Tina M. Vreys, M.D. Atilla Turgay, MD., Levent Tonga, MD., Rubaba Ansari, MA, Hashem Khosroshahi, M.D., David Ng, M.D.

74 WEDNESDAY

11:30 a.m. 12 noon 82 Predicting Treatment Outcome of Cocaine-Dependent 89 Divorce and Marital Instability in Different Subtypes of Patients Major Affective Disorders Ashwin A. Patkar, M.D., Raman N. Gopalakrishnan, M.D., Zoltan Rihmer, M.D., Erika Szadoczky, M.D., Sandor Rozsa, Charles C. Thornton, Ph.D., Stephen P. Weinstein, Ph.D., Kitty Kiss, Janos Furedi, M.D. Edward Gottheil, M.D., Wade H. Berrettini, M.D., THIS SESSION WILL BE AUDIOTAPED. Kevin P. Hill, B.A. SCIENTIFIC AND CLINICAL REPORT SESSION 31 12 noon 11:00 a.m.-12:30 p.m. 83 5HT Uptake, Impulsivity, Aggression, and Craving Room 204 A, Level 200, Convention Center Among Cocaine Abusers Ashwin A. Patkar, M.D., Raman N. Gopalakrishnan, M.D., ISSUES IN MEDICATION MANAGEMENT Edward Gottheil, M.D., Wade H. Berrettini, M.D., Sean Parnell, Kevin P. Hill, B A., Stephen P. Weinstein, Ph.D. Chp.: Lon R. Hays, M.D. THIS SESSION WILL BE AUDIOTAPED. Co-Chp.: Elisabeth J.S. Kunkel,M.D.

SCIENTIFIC AND CLINICAL REPORT SESSION 29 11:00 a.m. 11:00 a.m.-12:30 p.m. 90 Compliance and Treatment Discontinuation in Panic- Room 202 B, Level 200, Convention Center Disorder Patients Giulio Perugi, MX)., Christina Toni, M.D., Franco Frare, M.D., ISSUES IN PSYCHIATRIC TREATMENT Carlo Torti, M.D.

Chp.: Dinu P. Gangure, M.D. 11:30 a.m. Co-Chp.: Daniel P. Chapman, Ph.D. 91 Meta-Analysis of Antidepressant Levels in Lactating Mothers' Breastmilk and Nursing Infants 11:00 a.m. Alicia M. Weissman, M.D., Arthur J. Hartz, Ph.D., Suzanne 84 Civil Commitment in Turkey: Reflections on a Bill Bentler, M.S., Micca Donohue, Vicki L. Ellingrodringold, Ph.D., Drafted by Psychiatrists Katherine L. Wisner, M.D. Rasim Arikan, M.D., Paul S. Appelbaum, M.D., Mustafa Sercan, M.D., Solmaz Turkcan, M.D., Nevzat Satmis, M.D., 12 noon Aslihan Polat, M.D. 92 Clinical Problems in the Treatment of Adults with ComorbidADD 11:30 a.m. Marc D. Schwartz, M.D. 85 Malpractice Liability in Shared Treatment THIS SESSION WILL BE AUDIOTAPED. Eugene L. Lowenkopf, M.D., Abe M. Rychik, J.D. SCIENTIFIC AND CLINICAL REPORT SESSION 32 12 noon 11:00 a.m.-12:30 p.m. 86 Assertive Community Treatment Team Patient Room 204 B, Level 200, Convention Center Employment Outcomes Jessica Hebrank, B.A., Carolyn M. Young, M.D., Catherine MANAGING SIDE EFFECTS AND DEFICITS Laughlan, Richard Leong, C.S.W., Brian F. Meade, Sandy Pastor, M.S., Ranganathan Ram, M.D. Chp.: Robert W. Baker, M.D. THIS SESSION WILL BE AUDIOTAPED. Co-Chp.: Khakasa H. Wapenyi, M.D.

SCIENTIFIC AND CLINICAL REPORT SESSION 30 11:00 a.m. 11:00 a.m.-12:30 p.m. 93 Branched-Chain Amino Acid Treatment of Tardive Room 203 A, Level 200, Convention Center Dyskinesia SOCIAL AND COMMUNITY PSYCHIATRY Mary Ann Richardson, Ph.D., Margaret L. Bevans, R.N., Helen M. Chao, Ph.D., Laura L. Read, Ph.D., Leslie L. Chp.: Susan Stabinsky, M.D. Citrome, M.D., James D. Clelland Co-Chp.: Nelda F. Scott, M.D. 11:30 a.m. 11:00 a.m. 94 Nonadrenergic Noncholinergic Sildenafil Treatment of 87 Defining Disability Down SRI- Associated Sexual Dysfunction Howard W. Telson, M.D. H. George Nurnberg, M.D., Paula L. Hensley, M.D., Alan J. 11:30 a.m. Gelenberg, M.D., Maurizio Fava, M.D., John Lauriello, M.D., 88 Marital Disruption and Mental Health: A Nine Wave Susan Paine, M.D. Panel Study Terrance J. Wade, Ph.D., David J. Pevalin, MA. (Continued next page)

75 WEDNESDAY

12 noon COMPONENT WORKSHOP 44 11:00 a.m.-12:30 p.m. 95 Rivastigmine Tartrate in Neurocognitive Deficits in Room 104 B, Street Level, Convention Center Schizophrenia Patients Treated with Clozapine Mohammad Z. Hussain, M.D., Zabaida A. Chaudhry, M.D., CRITICAL ISSUES FOR TREATING DOMESTIC Seema Hussain, M.D. VIOLENCE SURVIVORS AND THEIR CHILDREN APA Committeeon Family Violence and Sexual Abuse SCIENTIFIC AND CLINICAL REPORT SESSION 33 11:00 a.m.-12:30 p.m. Co-Chps.: Carole L. Warshaw, M.D., Graeme Hanson, M.D. Liberty Ballroom A, Level 3, Marriott Participants: Susan M. Ditter, MD., Sandra L. Bloom, MD.

MANAGEMENT OF DEPRESSION COMPONENT WORKSHOP 45 11:00 a.m.-12;30 p.m. Rooms 112 A/B, Street Level, Convention Center Chp.: Megan T. Marumoto, M.D. Co-Chp.: Abel A. Gonzalez, MD. PSYCHIATRY'S RESPONSE TO THE DATA: SPIRITUALITY AS A RELEVANT CLINICAL FACTOR 11:00 a.m. APA Committee en Religion, Spirituality, and Psychiatry 96 Psychosocial Functioning as a Predictor of Response to Nortriptyline in Treatment-Resistant Depression Chp.: Irving S. Wiesner, M.D. Timothy J. Petersen, Ph.D., Heidi D. Montoya, B.A., Participants: Harold G. Koenig, M.D., Francis G. Lu, M.D., Robert L. Gresham, BA, George Papakostas, MD., Andrew A S. Atezaz Saeed, M.D. Nierenberg, M.D., Jonathan E. Alpert, M.D., Maurizio Fava, M.D. COMPONENT WORKSHOP 46 11:00 a.m.-12:30 p.m. Room 203 B, Level 200, Convention Center 11:30 a.m. 97 Efficacy of Citalopram as an Augmenting Strategy for LESBIAN, GAY, BISEXUAL, AND TRANSGENDERED Menopausal Women with Estrogen-Resistant RESIDENTS: CHALLENGES IN TRAINING Depression APA Northern California Psychiatric Society's Committee on Lesbian, Gaudio N. Scares, M.D., Jennifer Poitras, B A., Jan L. Gay, Bisexual, and Transgender Issues Shifren, MD., Allison B. Alexander, MD., Lee S. Cohen, MD. Chp.: Dan H. Karasic, M.D. 12 noon Participants: Ellen Haller, M.D., Rodney J. Erwin, M.D., 98 Polypharmacy with Antidepressants Kristin P. Riley-Lazo John W. Goethe, M.D., Bonnie L. Szarek, R.N. THIS SESSION WILL BE AUDIOTAPED. COMPONENT WORKSHOP 47 11:00 a.m.-12:30 p.m. Liberty Ballroom B, Level 3, Marriott

WORKSHOPS NEW TRENDS AND CHALLENGES IN RESIDENCY EDUCATION COMPONENTS 42-49 APA Committeeon Graduate Education

COMPONENT WORKSHOP 42 11:00 a.m.-12:30 p.m. Co-Chps.: Joyce A Tinsley, MD., Paul E. Holtzheimer ffl, MD. Rooms 102 A/B, Street Level, Convention Center Participants: Leighton Y. Huey,M.D., Laura B. Dunn, MD.

EDUCATING THE COURTS: RECENT APA AMICUS COMPONENT WORKSHOP 48 11:00 a.m.-12:30 p.m. CURIAE BRIEFS Grand Ballroom Salon D, Level 5, Marriott APA Commission on Judicial Action HIPAA PRIVACY RULE: WHAT EVERY Chp.: Renee L. Binder, M.D. PSYCHIATRIST NEEDS TO KNOW Participants: Howard V. Zonana, MD., Richard G. Taranto, JX). APA Council on Psychiatry and Law and APA Committeeon Confidentiality COMPONENT WORKSHOP 43 11:00 a.m.-12:30 p.m. Room 104 A, Street Level, Convention Center Chp.: Jeffrey L. Metzner, M.D. Participants: Margo P. Goldman, MD., William M Reinhart, MD. MEDICARE UPDATE 2002 APA Medicare Advisory Committee

Chp.: Edward Gordon, M.D. Participants: Irvin L. Muszynski, JX)., Ellen Jaffe, Seth P. Stein, JX)., Gerald Rogan, M.D., Lloyd I. Sederer, M.D.

76 WEDNESDAY

COMPONENT WORKSHOP 49 11:00 a.m.-12:30 p.m. ISSUE WORKSHOP 94 11;00 a.m.-12;30 p.m. Grand Ballroom Salon K, Level 5, Marriott Grand Ballroom Salon I, Level 5, Marriott

MEETING THE MENTAL HEALTH NEEDS OF ELECTRONIC MEDICAL RECORDS ENHANCE MINORITIES IN THE 21ST CENTURY QUALITY AND PRODUCTIVITY: THE TIME HAS A PA /Center for Mental Health Services Minority Fellows and COME APA/AstraTjeneca Minority Fellows Chp.: Daniel A. Deutschman, M.D. Chp.: Michael J. Pratts, M.D. Participant: Joshua E. Freedman, M.D. Participants: Alvaro Camacho, M.D., Cherry Chevy, M.D., Denise De Guzman, M.D., Nancy Sheng-Shih Wu, M.D., ISSUE WORKSHOP 95 11:00 a.m.-12;30 p.m. Bethany J. Tucker, M.D. Grand Ballroom Salon J, Level 5, Marriott

DILEMMAS OF MELANCHOLIA: LET PHILOSOPHY ISSUES 89-95 HELP A ssociationfor the Advancement of Philosophy and Psychiatry ISSUE WORKSHOP 89 11;00 a.m.-12;30 p.m. Liberty Ballroom C, Level 3, Marriott Chp.: Michael F. Myers, M.D. Participants: Jennifer Radden, Ph.D., Deborah Spitz, M.D., ASSESSING EDUCATIONAL EXPERIENCES IN Leah J. Dickstein, M.D., Zachary Myers PSYCHIATRY Chp.: Joel Yager, M.D. 12 noon Sessions Participants: Paula L. Hensley, M.D., Deepa N. Nadiga, Michael A. HoUifield, M.D. FORUMS 9-11 ISSUE WORKSHOP 90 11:00 a.m.-12;30 p.m. Independence Ballrooms II/III, Level 3, Marriott FORUM 9 12 noon-l;30 p.m. Room 103 B, Street Level, Convention Center THE PSYCHIATRIC FITNESS-FOR-DUTY EXAM KILLING IN THE NAME OF GOD: OSAMA BIN Chp.: Robert C. Larsen, M.D. LADEN AND RADICAL ISLAM

ISSUE WORKSHOP 91 11:00 a.m.-12:30 p.m. Chp.: Jerrold M. Post, M.D. Rooms 401-403, Level 4, Marriott Participants: Ambassador Nathaniel Howell, Ph.D., Jessica Stern, Ph.D., Vamik D. Volkan, M.D. YOUTH VIOLENCE: A REPORT OF THE SURGEON GENERAL FORUM 10 12 noon-l;30 p.m. Substance A buse and Mental Health Services Administration Room 103 C, Street Level, Convention Center

Co-Chps.: Marilyn B. Benoit, M.D., Norma Hatot ABPN UPDATE: REQUIREMENTS FOR ABPN Participants: Delbert Elliott, Ph.D., Carl C. Bell, M.D. EXAMINATION

ISSUE WORKSHOP 92 11:00 a.m.-12;30 p.m. Chp.: Stephen C. Scheiber, M.D. Grand Ballroom Salon B, Level 5, Marriott Participants: Glenn C. Davis, M.D., Michael H. Ebert, M.D., Larry R. Faulkner, M.D., Burton V. Reifler, MD., Pedro Ruiz, M.D., SELF-MUTILATION IN PRISON James R Scully, Jr., MD., Elizabeth B. Weller, MD., Daniel K. Winstead,M,D. Co-Chps.: Lee H. Rome, M.D., James E. Dillon, M.D. FORUM 11 12 noon-l:30 p.m. ISSUE WORKSHOP 93 11:00 a.m.-12:30 p.m. Room 113 A, Street Level, Convention Center Grand Ballroom Salon C, Level 5, Marriott LATIN AMERICA PSYCHIATRIC ILLNESS AND THE WORKPLACE Chp.: Rodrigo A. Munoz, M.D. Chp.: Steven E. Pflanz, M.D. Participants: Harold I. Eist, M.D., Gerardo Heinze, M.D., Juan E. Mezzich, M.D., Miguel R. Jorge, M.D., Gonzalo F. Viale, M.D., Rodrigo J. Munoz T, M.D.

77 WEDNESDAY

NEW RESEARCH POSTER SESSION 8 and film from Yuen's archives which he named The Frog in 12 noon-2:00 p.m. the Well after a Chinese fable. The relationship of personal Exhibit Hall D, Street Level, Convention Center development and creativity; the immigrant experience in America; the boundary between productivity and obsessional SCHIZOPHRENIA; CHILD AND ADOLESCENT dysfunction are issues raised by this video. PSYCHIATRY; TREATMENT TECHNIQUES AND OUTCOME STUDIES; SOCIAL AND COMMUNITY Discussant: David C. Martinez, M.F.A. PSYCHIATRY; CROSS-CULTURAL AND MINORITY ISSUES; HEALTH SERVICES RESEARCH; AND PSYCHIATRIC REHABILITATION 1:00 p.m. Sessions For further information on New Research Sessions, please refer to the New Research Program and Abstracts Book included in your registration packet. COURSES 91-96 Course descriptions are available in the CME Course Brochure included in your registration 12:30 p.m. Session packet. Admission by ticket only.

MEDIA SESSION 22 12:30 p.m.-2:00 p.m. COURSE 91 1:00 p.m.-5:00 p.m. Washington Rooms A-C, Third Floor, Loews Ormandy East, Street Level, DoubleTree

ACROSS THE GENERATIONS SLEEP MEDICINE UPDATE: ADVANCED TOPICS

Chp.: David C. Martinez, M.F.A. Director: Thomas D. Hurwitz, M.D. Faculty: Max Hirshkowitz, Ph.D., Lois Krahn, M.D. 29 Bubbeh Lee and Me (35 minutes) COURSE 92 1:00 p.m.-5:00 p.m. Aria A, Third Floor, DoubleTree Distributor: New Day Films 22-D Hollywood Avenue COGNITIVE THERAPY FOR SCHIZOPHRENIA Ho Ho Kus, NJ 07423 Co-Directors: Jesse H. Wright, M.D., Aaron T. Beck, M.D. What can a grandchild discover through a grandparent? When Faculty: Jan L. Scott, M.D. the filmmaker of Bubbeh Lee and Me arrives in Florida to visit COURSE 93 1:00 p.m.-5;00 p.m. his feisty, 87-year old Jewish grandmother and speaks with Overture, Third Floor, DoubleTree her heart-to-heart about love, death, and sexuality, their two worlds collide and the strength of their bond emerges. A ADVANCED ASSESSMENT AND TREATMENT OF spirited reflection on aging, identity, diversity, and acceptance, ADD this classic film examines the legacies passed through families and generations, and shows that the journey of self-discovery Director: Thomas E. Brown, Ph.D. can begin at any age. Faculty: Jefferson B. Prince, M.D. COURSE 94 1:00 p.m.-5:00 p.m. 30 The Frog in the Well: The Life and Work of Hoh-Kun Maestro, Fourth Floor, DoubleTree Yuen (28 minutes) CPT CODING AND DOCUMENTATION 2002 Distributor: The Freedom Archives Director: Chester W. Schmidt, Jr., M.D. 522 Valencia San Francisco, CA 94110 COURSE 95 1:00 p.m.-5:00 p.m. Rhapsody, Fourth Floor, DoubleTree This video chronicles the life and work of Hoh-Kun Yeun, physicist, father, ice skater, and radical documentarian. Yeun, IMPROVING MEDIA COVERAGE OF SUICIDE: THE ROLE OF THE PSYCHIATRIST a Chinese-American immigrant, recorded decades of social American Foundation for Suicide Prevention movements in and around Berkeley and the Bay Area begin- ning in 1963 with the Free Speech movement, including the Co-Directors: Herbert Hendin, M.D., Kathleen Jamison, Ph.D. Black Panther movement, the Women's Movement, the anti- Faculty: John T. Maltsberger, M.D., Madelyn Gould, Ph.D., Vietnam War Movement, and the Anti-Apartheid struggles of Patrick Jamieson the 80's. His work, inspired by a radical view of science and history, is described using photos, tape recordings, newsprint, 78 WEDNESDAY

COURSE 96 1:00 p.m.-5:00 p.m. LECTURE 23 Sonata 5, Fifth Floor, DoubleTree 2:00 p.m.-3:30p,m. TREATMENT OF CREATIVE PATIENTS Rooms 109 A/B, Street Level, Convention Center

Director: Albert Rothenberg, M.D. Elizabeth B.Weller,M.D.

Mania in Youth: A Transition from Ignorance to 2:00 p.m. Sessions Enlightenment to Confusion Chp.: Jerry M. Wiener, MX). LECTURES 22-23 Co-Chp.: Sandra Y. Lotan, M.D.

LECTURE 22 Bipolar disorder has not been well studied in children and adolescents. Historically it was assumed that 2:00 p.m.-3:30 p.m. children and adolescents had immature ego Rooms 108 A/B, Street Level, Convention Center development and thus could not surfer from mood disorders. Elizabeth B. Weller, M.D., reviews the Benedetto Saraceno, M.D. development of support for the diagnosis of bipolar disorder in children and adolescents and discusses Global Implications on the World Health advances in diagnostic tools and progress in genetic Organization's World Health Report 2001 on studies that promise to clarify the nature of this Mental Health disorder in this age group. Dr. Weller is Professor of Psychiatry and Pediatrics and Vice Chair of the Chp.: Darrel A. Regier, M.D, Department of Psychiatry at the University of Co-Chp.: Regirta C. Casper, M.D. Pennsylvania School of Medicine in Philadelphia. A Fellow of APA and the American Academy of Child The World Health Organization World Health Report and Adolescent Psychiatry, she has received several for 2001, vVfoitW Health: A«? Understanding New Hope^ clinical research awards from die American Academy analyzes the costs of mental disorders in human, social, of Clinical Psychiatry. She is the author of numerous and economic terms and describes core actions needed professional articles and book chapters on the to improve mental health in a manner compatible with diagnosis and treatment of mood disorders in children the realities of development In individual countries. and adolescents. Dr. Weller received her medical Benedetto Saraceno, M.D.. Director of the WHO degree from the American University of Beirut in Department of Mental Health and Substance Lebanon and completed residencies in general and Dependence in Geneva, highlights ihe key findings ind child and adolescent psychiatry at Washington recommendations discussed in the report. Dr. University School of Medicine in St. Louis and Saraceno previously served as Head of the Laboratory University of Kansas Medical Center in Kansas Ciry. of Epidemiology and Social Psychiatry and Director of Distinguished Psychiatrist Lecture Series the WHO Collaborating Center for Research in Mental Health at Mario Negri Institute in Milan and as advisor to the Pan American Health Organization, where he MEDIA SESSIONS 23-24 assisted policy makers in mental health services reform in several South and Central American countries. He MEDIA SESSION 23 2:00 p.m.-5;00 p.m. was President of the World Association for Washington Rooms A-C, Third Floor, Loews Psychosocia] Rehabilitation and a Founding Member and Vice-President of the Societa Italians di PSYCHIATRY GOES TO THE MOVIES Epidemiologia Psichiatrica. The author of more than 100 scientific articles and the co-author or editor of Chp.: Max Fink, M.D. several books, Dr. Saraceno received his medical degree from the University of Milan, his postdoctoral degree 31 A Beautiful Mind in psychiatry from the University of Parma, and his (122 minutes) training in public health and epidemiology" at Mario Negn Insutute, Distributor: Facets Multimedia International Psychiatrist Lecture Series 1517 West Fullerton THIS SESSION WILL BE AUDIOTAPED. Chicago, IL 60614

A Beautiful Mind is the true story of John Forbes Nash, Jr., a man whose formulas established the mathematical principles (Continued next page)

79 WEDNESDAY of the "Game Theory" of economics. The theory eventually 17 Psychiatric Evaluation of Gay or Lesbian Identified won Mr. Nash the Nobel Prize. By the age of 30, John Nash, Persons for Legal Processing Jr., was diagnosed with paranoid schizophrenia. He had a Richard G. Dudley, Jr., M.D. varied sexual life, which included an arrest for indecent exposure in a men's restroom, and fathering a child out of 18 History and Update on Sexual Conversion (Reparative) wedlock. The film focuses on his relationship with his wife Therapies and the path his life took from success to mental illness to Jack Drescher, M.D. recovery. 19 The Intersection of Transgender Mental Health with MEDIA SESSION 24 2;00 p.m.-5;00 p.m. Homosexuality and Race Congress Rooms A-C, Fourth Floor, Loews Donald E. Tarver II, M.D.

PSYCHIATRY GOES TO THE MOVIES SYMPOSIA 57-75 Chp.: Alan A. Stone, M.D. SYMPOSIUM 57 2:00 p.m.-5;00 p.m. 32 King of Masks: Gender and Tradition in China Room 103 A, Street Level, Convention Center (101 minutes) SPORTS THROUGH THE LIFE CYCLE Distributor: Sameul Goldwyn Studio International Society for Sport Psychiatry 1133 Broadway New York, NY 10010 Chp.: Ronald L. Kamm, M.D.

The King of Masks is the story of a proud artist in a Sichuan A The Pros and Cons of Coaching One's Own Child Province. The province has been shaken by war and ravaged Ronald L. Kamm, M.D. by floods. Starving parents are selling their sons and will give their daughters to anyone who promises the child a home. The B The Mid-Career Athlete: Coping with Psychiatric Illness artist, called The King of Masks, takes advantage of the Antonia L. Baum, M.D. opportunity to buy a child. He does not want the daughters who are thrust at him by their mothers, but he wants a son. He C When the Cheering Stops: Career Termination Issues in is just about to give up when a child's voice cries out "Yeh Athletes Yeh," (grandfather in Chinese). The King of Masks turns back Joshua W. Calhoun, M.D. to behold who he thought was the son he always wanted, but is really a girl, and agrees upon a price. The film shows how this Discussants: Marvis Frazier, Wendy Wilson, Gary Cobb indignant little girl conquers that age-old tradition to the THIS SESSION WILL BE AUDIOTAPED. benefit of everyone. SYMPOSIUM 58 2:00 p.m.-5;00 p.m. Discussants: Alan A. Stone, M.D., Francis G. Lu, M.D., Rooms 106 A/B, Street Level, Convention Center NadaL. Stodand, M.D. COMMUNITY CARE IN GERIATRIC PSYCHIATRY IN THE 21ST CENTURY REVIEW OF PSYCHIATRY: SECTION 4 2:00 p.m.-5:30 p.m. Chp.:PaulA.Kettl,M.D. Rooms 201 A-C, Level 200, Convention Center A Mental Health Disorders Among Rural Elders MENTAL HEALTH ISSUES IN THE LESBIAN/GAY/ Kathleen M. Fisher, Ph.D. BISEXUAL/TRANSGENDER COMMUNITY B Primary Care Management of Late-Life Depression Co-Chps.: Billy E. Jones, M.D., Marjorie Hill, Ph.D. IraR. Katz,M.D.

15 Gay, Lesbian, Bisexual, and Transgender Youth C Managing the Behavioral Complications of Dementia Jeffrey S. Akman, M.D., Garry Fisher, M.D. Robert P. Roca, M.D.

16 Taboo Topics in Psychiatry: Aging and Sexual D Caring for Elder Depression in the 21st Century Orientation PaulA.Kettl,M.D. Douglas C. Kimmel, Ph.D. E Depression in Patients with Recent-Onset-Bilateral- Age-Related Macular Degeneration Barry W. Rovner, M.D., Robin Casten, Ph.D. THIS SESSION WILL BE AUDIOTAPED. 80 WEDNESDAY

SYMPOSIUM 59 2;00 p.m.-5;00 p.m. Chp.: Andrew E. Skodol II, M.D. Room 111 B, Street Level, Convention Center Co-Chp.: Mary C. Zanarini, EdD.

BRAIN STIMULATION IN NEUROPSYCHIATRIC A Six-Year Symptomatic and Functional Course of BPD ILLNESS Mary C. Zanarini, Ed.D., Frances R. Frankenburg, M.D., John Hennen, Ph.D., Kenneth R. Silk, M.D. Chp.: Mark S. George, M.D. Co-Chp.: Michael R. Trimble, M.D. B Two-Year Diagnostic Stability of Four DSM-IV Personality Disorders: Schizotypal Personality Disorder, A Brain Stimulation from Above and Below: Theoretical BPD, Avoidant Personality Disorder, and OCD Issues Thomas H. McGlashan, M.D., John G. Gunderson, M.D., Mark S. George, M.D., Ziad H. Nahas, M.D., Andrew F. Andrew E. Skodol II, M.D., M. Trade Shea, Ph.D., Robert L. Kozel, M.D., Xingpao Li, M.D., Jeong-Ho Chae, MD. Stout, Ph.D., Charles A. Sanislow,PhD., Carlos M. Grilo, Ph.D.

B Seizures, ECT, and Transcranial Magnetic Stimulation: C Using Factor Analysis to Test Dimensional Stability of Therapeutic Options and New Directions Personality Disorder Constructs Harold A. Sackeim, Ph.D., Sarah H. Lisanby, MD. Charles A. Sanislow, Ph.D., Carlos M. Grilo, Ph.D., Leslie C. Morey, PhD., M Trade Shea, PhD., Andrew E. Skodol E, MD., C Brain Stimulation, Mood, and Epilepsy Robert L. Stout, Ph.D., Thomas H. McGlashan, MD. Michael R. Trimble, M.D. D Course of Functional Impairment in Personality D Vagus Nerve Stimulation in Affective Disorders: New Disorders Over Two Years Findings Andrew E. Skodol II, M.D., John G. Gunderson, M.D., Lauren B. Marangell, M.D. Thomas H. McGlashan, M.D., Leslie C. Morey, PhD., THIS SESSION WILL BE AUDIOTAPED. M. Trade Shea, Ph.D., Robert L. Stout, PhD., Donna S. Bender, PhD. SYMPOSIUM 60 2:00 p.m.-5;00 p.m. Rooms 112 A/B, Street Level, Convention Center E Personality Disorders and Axis I Disorders: Longitudinal Associations of Course LIFE-THREATENING HYPERTHERMIC M. Trade Shea, Ph.D., Robert L. Stout, Ph.D., Thomas H. SYNDROMES IN PSYCHIATRY McGlashan, MD., John G. Gunderson, M.D., Andrew E. Skodol II, M.D., Shirley Yen, PhD., Leslie C. Morey, PhD. Chp.: Stanley N. Caroff, M.D. Co-Chp.: Stephan C. Mann, M.D. Discussant: Paul S. Links, MD. THIS SESSION WILL BE AUDIOTAPED. A 5HT Syndrome Paul E. Keck, Jr., M.D., Lesley M Arnold, M.D. SYMPOSIUM 62 2:00 p.m.-5;00 p.m. Room 113 C, Street Level, Convention Center B Stimulant-Induced Hypothermia UnaD.McCann,M.D. CIRCUITRY OF FAILED COGNITIVE STRATEGIES IN ADDICTION C NMS: Still a Syndrome After All These Years? Ronald J. Gurrera, M.D. Chp.: Edythe London, PhD. Co-Chp.: Igor I. Galynker, MD. D The Malignant Catatonia Syndrome Stephan C. Mann, M.D., Stanley N. Caroff, M.D., E. Cabrina A Brain Metabolism During Early Abstinence from Campbell, M.D., Henry R. Bleier, M.D., Robert A. Methamphetamine Abuse Greenstein, M.D. Edythe London, PhD., Yun Dong, M.D., Sara Simon, Ph.D., Steven Berman, M.P.H., Ann Shirm, PhD., Mark E Heatstroke, Heatwaves, and Psychiatric Illness Mandelkern, Ph.D., John A. Matochik, PhD. Nigel M. Bark, M.D. B Impaired Decision Making and Impulse Control Discussant: Alan J. Gelenberg, M.D. Associated with Drug Misuse and Personality Disorders Robert D. Rogers, MD. THIS SESSION WILL BE AUDIOTAPED. C Nicotine and Cerebral Blood Flow During a Working SYMPOSIUM 61 2:00 p.m.-5;00 p.m. Memory Task Room 113 B, Street Level, Convention Center Monique Ernst, M.D., John A. Matochik, Ph.D., Stephen J. Heishman, PhD., John D. Van Horn, Ph.D., Jack E. COURSE OF PSYCHOPATHOLOGY AND Henningfield, Ph.D. FUNCTIONING IN PERSONALITY DISORDERS (Continued next page) 81 WEDNESDAY

D Differences in Cerebral Glucose Metabolism in Patients Chp.: Leah J. Dickstein, MD. On and Off Opiate Replacement Therapy Co-Chp.: Marion Z. Goldstein, MD. Igor I. Galynker, MD., John A. Matochik, Ph.D., Carlo Gbnteregg, MD., Akne S. Kimes, PhD., Monique Ernst, MX)., A Retrospective Career and Family Transitions for a Richard N. Rosenthal, MD., Edythe London, Ph.D., Carrie Clearer Vision into the 21st Century Weaver, MA, Enid C Gertmenian-King, B A, Varughese Marion Z. Goldstein, MD. Kurian, MP.H,, Donald C Des Jarlais, Ph.D., Christian R. Miner, Ph.D B Looking Back to Move Forward: The African-American Experience E Prefrontal Lobe Functioning in Cocaine Users Altha J. Stewart, MD. Karen I. Bolla, MD., Monique Ernst, MD., Maria Mouratidis, MA, John A Matochik, PhD., Dana Eldreth, B A, Kent Kiehl, Varughese Kurian, MP.H. C Women and National Leadership Roles: Getting There, THIS SESSION WILL BE AUDIOTAPED. Functioning Effectively Carol C Nadelson, MD. SYMPOSIUM 63 2:00 p,m.-5:00 p.m. Room 202 A, Level 2007 Convention Center D Academic Leadership Opportunities, Gender, Assumptions, and Outcomes PERSONALITY AND PERSONALITY DISORDERS IN Leah J. Dickstein, MD. THE COMMUNITY E The Hand That Rocks the Cradle Rocks the Boat The Chp.: Gerald Nestadt, MD. Empowerment of Women Ann R. Turkel, MD. A Prevalence and Correlates of Personality Disorders in a Community Sample Discussants: Nancy G Andreasen, MD., Marian I. Butterfield, MD. JackF. Samuels, PhD., William W. Eaton, PhD., Oscar J. THIS SESSION WILL BE AUDIOTAPED. Bienvenu III, MD., Clayton Brown, PhD., Paul T. Costa, Jr., PhD., Gerald Nestadt, MD. SYMPOSIUM 65 2:00 p.m.-5:00 p.m. Room 203 A, LeveI200, Convention Center B The Five Factor Model of Personality and Personality Disorders in a Community Study TAKING CONTROL OF THE FUTURE: ACADEMIC Paul T. Costa, Jr., PhD., Jeffrey H. Herbst, PhD., JackF. PSYCHIATRY AND 21ST-CENTURY PRACTICE Samuels, PhD., Gerald Nestadt, M.D., Oscar T. Bienvenu III, M.D., Irving M Reti, MD., William W. Eaton, PhD. Chp.: Lee McCabe, PhD. C Dimensions of DSM-IV Personality Disorders and Their Relationship to the NEO-PI-R A Psychiatry of the 21st Century: The Role of Academic Gerald Nestadt, MD., Fang-Chi Hsu, PhD., JackF. Health Systems Samuels, PhD., Oscar J. Bienvenu III, MD., Paul T. Leighton Y. Huey, MD. Costa, Jr., PhD., Irving M Reti, MD., William W. Eaton, PhD. B Shaping the Future Through Education D Comorbidity of Anxiety and Depressive Disorders and Michael A Hoge, PhD. Normal Personality Traits Oscar J. Bienvenu III, MD., Jack F. Samuels, PhD., Kung-Ye C Successful Models of Depression Disease Management Liang, PhD., Paul T. Costa, Jr., PhD., William W. Eaton, PhD., David J. Katzelnick, MD. Gerald Nestadt, MD. D The Use of Performance Indicators in Quality E The Role of Parenting in the Development of Improvement and Financial Reimbursement Personality Allen S. Daniels, EdD. Irving M Reti, MD., William W. Eaton, PhD., Jack F. Samuels, PhD., Gerald Nestadt, MD., Paul T. Costa, Jr., PhD., Oscar J. Bienvenu III, MD. E Academic Psychiatry Managing Managed Care Joseph M Schwartz, MD., Peter J. Pagan, PhD., Chester W. Discussant: Thomas A Widiger, PhD. Schmidt, Jr., MD. THIS SESSION WILL BE AUDIOTAPED. Discussant: Steven S. Sharfstein, MD. SYMPOSIUM 64 2:00 p.m.-5:00 p.m. THIS SESSION WILL BE AUDIOTAPED. Room 202 B, Level 200, Convention Center

LESSONS LEARNED: LOOKING BACK TO MOVE FORWARD A ssociation of Women Psychiatrists

82 WEDNESDAY

SYMPOSIUM 66 2:00 p.m.-5;00 p.m. A Trends and Patterns in Club-Drug Use Room 203 B, Level 200, Convention Center Jane C. Maxwell, Ph.D.

RECENT PERSPECTIVES ON BEHAVIORAL B Neurotoxic Effects of 4- ADDICTIONS Methylenedioxymethamphetamine (Ecstasy) George A. Ricaurte, M.D. Chp.: David A. Gorelick, M.D. Co-Chp.: Michel Lejoyeux, M.D. C Club Drugs: Emergency Management Issues Brett A. Roth, M.D. A Application of Dependence Criteria to Uncontrolled Behaviors D A Review of Psychiatric Symptoms and Treatment for Jean Ades, M.D. Club-Drug Use Karen A. Miotto, M.D. B Pathological Gambling: Relationship to Substance Abuse E Club Drugs: Current and Potential Treatments David A. Gorelick, M.D. David M. McDoweU, M.D. THIS SESSION WILL BE AUDIOTAPED. C Neurobiology of Pathological Gambling Marc N. Potenza, M.D. SYMPOSIUM 69 2:00 p.m.-5;00 p.m. Rooms 401-403, Level 4, Marriott D Compulsive Buying: Clinical Aspects and Comorbidity Michel Lejoyeux, M.D. NALTREXONE TREATMENT OF ALCOHOLISM: A DECADE OF CLINICAL PROGRESS E Are Deviant Sexual Behaviors a Form of Addiction? Florence Thibaut, M.D. Chp.: Joseph R. Volpicelli, M.D. THIS SESSION WILL BE AUDIOTAPED. Co-Chp.: Charles P. O'Brien, MD.

SYMPOSIUM 67 2:00 p.m.-5;00 p.m. A Efficacy of Naltrexone in the Treatment of Alcoholism Room 204 A, Level 200, Convention Center Charles P. O'Brien, M.D., Helen Pettinati, Ph.D., David W. Oslin, M.D. DIAGNOSIS AND TREATMENT OF ADHD IN YOUNG CHILDREN B Optimizing Naltrexone Treatment of Alcohol Dependence Chp.: Christopher J. Kratochvil, M.D. Joseph R. Volpicelli, M.D., Ronald R. Ulm, Ph.D.

A A Population Perspective on Psychopharmacologic C Naltrexone: Alcoholism in Patients with Comorbid Treatment of ADHD in Youths: Review and Update Mental Illness Stephanie S. O'Malley, Ph.D., Rajita Sinha, Ph.D., Ismene L. Julio M. Zito, Ph.D. Petrakis, M.D., John H. Krystal, M.D., Bruce Rousaville, M.D. B Diagnostic Challenges in Preschool Children Helen L. Egger, M.D. D International Studies with Naltrexone Philip Morris, Ph.D. C Development and Initiation of the Preschool ADHD Treatment Study (PATS) Discussant: Raye Z. Litten, Ph.D. Laurence L. Greenhill, M.D. THIS SESSION WILL BE AUDIOTAPED. SYMPOSIUM 70 2:00 p.m.-5;00 p.m. D Pharmacotherapies in Young Children with ADHD Grand Ballroom Salon B, Level 5, Marriott Christopher J. Kratochvil, M.D. THIS SESSION WILL BE AUDIOTAPED. STATE-OF-THE-ART ADOLESCENT SUBSTANCE ABUSE PREVENTION AND TREATMENT SYMPOSIUM 68 2:00 p.m.-5;00 p.m. Substance A buse and Mental Health Services Administration Room 204 B, Level 200, Convention Center Chp.: Deborah R. Simkin, M.D. Co-Chp.: Michael L. Dennis, Ph.D. CLUB DRUGS: TRENDS, TOXICITIES, AND TREATMENTS A Effective Prevention: Center for Substance Abuse Substance A buse and Mental Health Services Administration Prevention's National Study of High-Risk Youth Programs Chp.: David M. McDowell, M.D. J. Fred Springer, Ph.D., Soledad Sambrano, Ph.D. Co-Chp.: Jane C. Maxwell, Ph.D. (Continued next page)

83 WEDNESDAY

B Psychiatric Comorbidity and Pharmacology Among SYMPOSIUM 73 2:00 p.m.-5:00 p.m. Adolescents Presenting to Treatment Grand Ballroom Salon I, Level 5, Marriott Deborah R. Simkin, M.D. C Main Findings of the Cannabis Youth Treatment CLINICAL AND TREATMENT CHALLENGES WITH Randomized Experiment HISPANIC PATIENTS Michael L. Dennis, Ph.D. Inter-American Council of Psychiatric Organizations

D Outcomes from the Adolescent Treatment Model Chp.: Roberto E. Chaskel, M.D. Programs Co-Chp.: Ruben J. Hernandez-Serrano, M.D. Marc Fishman, M.D. THIS SESSION WILL BE AUDIOTAPED. A The Hispanic Patient and the DSM-IV SYMPOSIUM 71 2:00 p.m.-5;00 p.m. Carlos Berganza, M.D., Miguel R. Jorge, M.D. Grand Ballroom Salon C, Level 5, Marriott B Perception of Illness in the Hispanic Patient TREATMENT OF VIOLENCE AND CONDUCT Carlos Leon-Andrade, M.D., Nestor F. Marchant, M.D. DISORDERS IN CHILDREN AND ADOLESCENTS C Personality and Hispanic Patients Chp.: R. Rao Gogineni, M.D. Andres Heerlein, M.D., Roberto E. Chaskel, M.D.

A Functional Family Therapy in the Treatment of Youth D Psychotherapeutic Intervention with the Hispanic with Conduct Disorder Ellen H. Sholevar, M.D. Patient Amelia Mvsacchio, M.D., Rodolfo D. Fahrer, M.D. B Community-Based Treatment of Conduct Disorder G. Pirooz Snolevar, M.D. E Psychopharmacological Issues with Hispanic Patients Antonio Pacheco, M.D., Ruben J. Hernandez-Serrano, M.D. C Medication Usage in Conduct Disorders Jacquelyn M. Zavodnick, M.D. Discussant: Renato D. Alarcon, M.D. THIS SESSION WILL BE AUDIOTAPED. Discussant: David A. Baron, D.O. THIS SESSION WILL BE AUDIOTAPED. SYMPOSIUM 74 2:00 p.m.-5;00 p.m. SYMPOSIUM 72 2;00 p.m.-5;00 p.m. Grand Ballroom Salon J, Level 5, Marriott Grand Ballroom Salon D, Level 5, Marriott PATIENTS WITH CHRONIC PAIN: AFFECTIVE INSTABILITY IN BPD MULTIDISCIPLINARY TREATMENT APPROACHES

Chp.: Harold W. Koenigsberg, M.D. Chp.: Allen Lebovits, Ph.D. A Affective Instability and Borderline Symptoms and Co-Chp.: Matthew B. Smith, M.D. Defenses Harold W. Koenigsberg, M.D., Philip D. Harvey, Ph.D., A Pain and Psychiatry: A General Overview Marianne Goodman, M.D., Antonia S. New, M.D., Vivian Matthew B. Smith, M.D. Mitropoulou, MA., Larry J. Siever, M.D. B An Integrative Model of the Psychobiology of Pain B The Relationship Between Childhood Trauma and Jeffrey D. Rome, M.D. Affective Instability in BPD Marianne Goodman, M.D., Harold W. Koenigsberg, M.D., Antonia S. New, M.D., Vivian Mitropoulou, MA, Tenko C The Use of Analgesics in Chronic Pain Raykov, Ph.D., Larry J. Siever, M.D. Michel Dubois, M.D.

C Treating the Affective Instability Domain in BPD D Chronic Pain: Nonanalgesic and Adjuvant Eric Hollander, M.D., Daphne Simeon, M.D., Andrea Pharmacological Options Allen, Ph.D., Jennifer Greenberg, B A. Michael R.Clark,M.D.

D Early Maltreatment and the Neurobiology of Affective E Cognitive-Behavioral Approaches to Chronic Pain Instability Martin H. Teicher, M.D., Susan Andersen, Ph.D., Ann M. Allen Lebovits, Ph.D. Polcari, RN., Carl M. Anderson, Ph.D., Caryl P. Navalta, Ph.D. Discussant: Paul Gusmorino, M.D. Discussant: Larry J. Siever, M.D. THIS SESSION WILL BE AUDIOTAPED. THIS SESSION WILL BE AUDIOTAPED.

84 WEDNESDAY

SYMPOSIUM 75 2:00 p.m.-5;00 p.m. A The Diagnosis and Treatment of Alzheimer's Disease: Grand Ballroom Salon K, Level 5, Marriott An Overview Barry D. Liebowitz, Ph.D. PHYSICIAN DISABILITY: TREATMENT, INDEPENDENT EVALUATION, INSURANCE, AND B Current Treatments for Alzheimer's Disease: CONFLICTS Cholinesterase Inhibitors Rachelle S. Doody, M.D. Chp.: Michael H. Gendel, M.D. Co-Clip.: Richard F. Limoges, M.D. C The Neuroanatomy of Alzheimer's Disease GaryL.Wenk,Ph.D. A Area of Conflict Between Disabled Physician Patients and Disability Insurers D Beyond Acetylcholine: The Search for Better Treatment Richard F. Limoges, M.D. Options (Part 1) Jacobo E. Mintzer, M.D. B Disability Insurance: Technical and Legal Aspects Mark F. Seltzer, Esq. E Beyond Acetylcholine: The Search for Better Treatment Options (Part 2) C Treating the Disabled Physician Mary Sano, Ph.D. Michael F. Myers, M.D. INDUSTRY-SUPPORTED SYMPOSIUM 44 D Performing an Independent Psychiatric Disability 7:00 p.m.-10:00 p.m. Evaluation as a Physician Millennium Hall, Second Floor, Loews Michael H. Gendel, M.D. SLEEP DISORDERS AND PSYCHIATRIC ILLNESSES: Discussant: Linda Logsdon, MD. SCIENTIFIC FOUNDATIONS THIS SESSION WILL BE AUDIOTAPED Supported by Sepracor, Inc

Chp.: Ruth M. Benca, M.D.

3:00 p.m. Session A Epidemiology and Economic Burden of Insomnia James K. Walsh, Ph.D. NEW RESEARCH POSTER SESSION 9 3:00 p.m.-5:00 p.m. B Sleep and Psychiatric Illnesses Exhibit Hall D, Street Level, Convention Center Thomas Roth, Ph.D. PSYCHOPHARMACOLOGY; ADDICTION PSYCHIATRY; ALCOHOL AND DRUG RELATED C Current and Next Generation Therapeutic Approaches DISORDERS; EATING, PERSONALITY, AND to Sleep DISSOCIATIVE DISORDERS; STRESS, VIOLENCE, Ruth M. Benca, M.D. TRAUMA, AND VICTIMIZATION; SUICIDE; AND DIAGNOSTIC ISSUES INDUSTRY-SUPPORTED SYMPOSIUM 45 7:00 p.m.-10:00 p.m. For further information on New Research Sessions, please refer Regency Ballrooms A-C, Second Floor, Loews to the New Research Program and Abstracts Book included in your registration packet. THE BURDEN OF SCHIZOPHRENIA: WHY PATIENTS DON'T GET BETTER Supported by A straTjeneca Pharmaceuticals 7:00 p.m. Sessions Chp.: Rajiv Tandon, M.D.

INDUSTRY-SUPPORTED SYMPOSIA 43-49 A Defining Nonresponse in Schizophrenia: Why Patients Don't Do Well INDUSTRY-SUPPORTED SYMPOSIUM 43 Rajiv Tandon, M.D. 7:00 p.m.-10:00 p.m. Ballrooms A/B, Ballroom Level, Convention Center B When Psychosis Doesn't Improve Alan J. Mendelowitz, M.D. NONCHOLINERGIC TREATMENTS FOR ALZHEIMER'S DISEASE: PRESENT KNOWLEDGE, C Negative and Cognitive Function FUTURE HOPE Michael D. Jibson, M.D. Supported by Forest Laboratories, Inc. (Continued next page) Chp.: Jacobo E. Mintzer, M.D. 85 WEDNESDAY

D Comorbidities in Schizophrenia: Depression and D Functional and Structural Neuroimaging in ADHD Substance Abuse George Bush, M.D. Peter F. Buckley, M.D. E Pharmacotherapy of Adults with ADHD E Why Patients Stop Their Antipsychotics and What to Do Thomas J. Spencer, M.D. About It Peter J. Weiden, M.D. INDUSTRY-SUPPORTED SYMPOSIUM 48 7:00 p.m.-10:00 p.m. INDUSTRY-SUPPORTED SYMPOSIUM 46 Wyndham Ballrooms A/B, First Floor, Wyndham 7:00 p.m.-10:00 p.m. ADVANCES IN THE UNDERSTANDING AND Grand Ballroom Salons E/F, Level 5, Marriott TREATMENT OF BINGE-EATING DISORDER Supported by Ortho-McNeil Pharmaceutical IDENTIFICATION AND MANAGEMENT OF DAYTIME FATIGUE AND SLEEPINESS IN Chp.: James I. Hudson, M.D. PSYCHIATRY Supported by Gephalan Inc. A Binge-Eating Disorder: Diagnosis and Behavior B. Timothy Walsh, M.D. Chp.: John W. Winkelman, M.D. B Epidemiology and Risk Factors William P. Carter, M.D. A Sleepiness and Fatigue: Neurobehavioral and Physiological Features C Treatment with Antidepressants David F. Dinges, Ph.D. James I. Hudson, M.D.

B Primary Sleep Disorders Associated with Excessive D Treatment with Appetite Suppressants and Daytime Sleepiness Antiepileptics Susan L. McElroy, M.D. MaryB.O'Malley,M.D. E Psychological Treatment C Fatigue and Excessive Daytime Sleepiness in DeniseE.Wilfley,Ph.D. Psychiatric Disorders Karl Doghramji, M.D. INDUSTRY-SUPPORTED SYMPOSIUM 49 7:00 p.m.-10:00 p.m. D Clinical Manifestations of Fatigue in Chronic Fatigue Wyndham Ballrooms C/D, First Floor, Wyndham Syndrome EXPLORATIONS IN DEMENTIA: NEW AND Anthony L. Komaroff, M.D. CURRENT PERSPECTIVES Supported by Eisai Inc., Pfczer Inc. E Novel Molecular Targets in Deficit Syndromes Daniel R. Weinberger, M.D. Chp.: Gary W. Small, M.D. Co-Chp.: Donna Masterman, M.D. INDUSTRY-SUPPORTED SYMPOSIUM 47 7:00 p.m.-10:00 p.m. A Early Detection and Genetic Risk Assessment in Grand Ballroom Salons G/H, Level 5, Marriott Alzheimer's Disease Gary W. Small, M.D. ADULT ADHD: FROM RESEARCH TO CLINICAL B Differential Diagnosis of Dementia Syndromes: A PRACTICE Psychiatric Perspective Supported by Shire US, Inc. J.Michael Ryan, M.D.

Chp.: Joseph Biederman, M.D. C Contemporary Issues in Mild Cognitive Impairment: Co-Chp.: Thomas J. Spencer, M.D. Fact or Fiction? Bradley F.Boeve,M.D. A Overview and Patterns of Comorbidity in Adults with D Charting the Course in Cerebrovascular Dementia ADHD Gustavo C. Roman, M.D. Joseph Biederman, M.D. E Alzheimer's Disease Therapy in the 21st Century: B The Neuropsychology of Adult ADHD Examining the Evidence LanyJ. Seidman, Ph.D., Joseph Biederman, M.D., E. Valera, Ph.D., Pierre N. Tariot, M.D. Allysa Doyle, Ph.D., Michael Monoteaux, B A., Stephen V. Faraone, Ph.D. F Managing Behavioral Disturbances in Dementia: Practical Approaches to Treatment C A Genetic Perspective of the Validity of Adult ADHD Stephen V. Faraone, Ph.D. Donna Masterman, M.D.

86 THURSDAY, MAY 23, 2002

155TH ANNUAL MEETING

INDUSTRY-SUPPORTED BREAKFAST 7:00 a.m. Sessions SYMPOSIUM 41, PART 2 7:00 a.m.-8:30 a.m. PART 2 OF INDUSTRY-SUPPORTED Grand Ballroom Salons E/F, Level 5, Marriott BREAKFAST SYMPOSIA 38-42 THE PATHOPHYSIOLOGY AND TREATMENT OF INDUSTRY-SUPPORTED BREAKFAST IMPULSIVITY AND AGGRESSION IN PSYCHIATRIC SYMPOSIUM 38, PART 2 DISORDERS 7:00 a.m.-8:30 a.m. Supported by Abbott Laboratories Ballrooms A/B, Ballroom Level, Convention Center Chp.: Alan C. Swann, M.D. CHRONIC EPISODIC DISORDERS: COMORBIDITY A Violence, Substance Use Disorders, and PTSD AND COMPREHENSIVE INTEGRATED TREATMENT Kathleen T. Brady, M.D. Supported by GlaxoSmithKline B The Impulsive-Aggression Symptom Domain in Chp.: Julia K. Warnock, M.D. Personality Disorders Eric Hollander, M.D. A The Relationship Between Psychiatric Illness and Irritable Bowel Syndrome INDUSTRY-SUPPORTED BREAKFAST R. Bruce Lydiard, M.D. SYMPOSIUM 42, PART 2 7:00 a.m.-8:30 a.m. B Management of Pain Syndromes: Fibromyalgia, Grand Ballroom Salons G/H, Level 5, Marriott Migraines, and Chronic Pain Diane S. Thompson, M.D. NEW PERSPECTIVES ON SCHIZOPHRENIA SPECTRUM DISORDERS AND THEIR TREATMENT Supported by Janssen Pharmaceutica INDUSTRY-SUPPORTED BREAKFAST SYMPOSIUM 39, PART 2 Chp.: Larry J. Siever, M.D. 7:00 a.m.-8:30 a.m. Co-Chp.: Barbara Cornblatt, Ph.D. Millennium Hall, Second Floor, Loews A Neurobiology and Pharmacologic Treatment of AGE, GENDER, AND DIAGNOSIS: INFLUENCES ON Schizotypal Personality: Implications for Pharmacology DRUG RESPONSE Larry J. Siever, M.D., Harold W. Koenigsber, M.D., Vivian Supported by Pfizer Inc. Mitropoulou, M.A., Marianne Goodman, M.D., Monte S. Buchsbaum, M.D. Chp.: Alexander H. Glassman, M.D. B Cognitive Enhancers in the Schizophrenia Spectrum A Epidemiology, Course, and Drug Response: How Are Marianne Goodman, M.D., Vivian Mitropoulou, M.A., Mood and Anxiety Disorders Different in Children? Harold W. Koenigsber, M.D., Antonia S. New, M.D., Liza John S. March, M.D. Maldari, M.A., Larry J. Siever, M.D.

B Treatment of Mood Disorders in Women C The Promise of Atypical Antipsychotics for Borderline Disorders Kimberly A. Yonkers, M.D. S. Charles Schulz, M.D., Kelly L. Camlin, M.S.W., SaUy A. Berry, M.D., Yanjee Adit, M.D., Lee Friedman, Ph.D. INDUSTRY-SUPPORTED BREAKFAST SYMPOSIUM 40, PART 2 7:00 a.m.-8:30 a.m. Regency Ballrooms A-C, Second Floor, Loews 8:00 a.m. Sessions

THERAPEUTIC CHALLENGES, NOVEL APPROACHES: ANTIPSYCHOTICS IN THE MANAGEMENT OF COURSES 97-99 MOOD AND ANXIETY DISORDERS Course descriptions are available in the CME Supported by Eli Lilly and Company Course Brochure included in your registration packet. Admission by ticket only. Chp.: Richard C. Shelton, M.D.

A Prognosis and Pharmacological Management of Men and Women with PTSD COURSE 97 8:00 a.m.-12 noon Frederick Petty, M.D. Ormandy East, Street Level, DoubleTree

B Interplay Between Disease and Treatment Regimen: ETHICAL DECISION-MAKING IN CLINICAL Special Safety Considerations PRACTICE Olga Brawman-Mintzer, M.D. Director: Stephen A. Green, M.D. Faculty: Sydney Bloch, M.D. 87 THURSDAY

COURSE 98 8:00 a.m.-12 noon COURSE 102 9:00 a.m.-4:00 p.m. Aria A, Third Floor, DoubleTree Sonata 5, Fifth Floor, DoubleTree

THE MISSING PIECE OF THE PUZZLE: TIC THE CONCEPTUAL BASIS OF PSYCHIATRY DISORDERS IN ADULTS WITH OCD OR ADD Co-Directors: S. Nassir Ghaemi, M.D., David H. Brendel, M.D. Director: Maria A. Pugliese, M.D. Faculty: J. Paul Hieble, Ph.D., Michael N. Rubenstein, M.D., LECTURE 24 Orrin Palmer, M.D., Sue Levi-Pearl, Mary Lou Reaver, R.N. 9:00 a.m,-10:30 a.m. COURSE 99 8:00 a.m.-12 noon Rooms 109 A/B, Street Level, Convention Center Concerto A, Third Floor, DoubleTree APA'S ADMINISTRATIVE PSYCHIATRY AWARD LECTURE ASSESSING THE RISK FOR VIOLENCE Steven S. Sharfstein, M,D, Director: Bradley R. Johnson, M.D. Does the Psychiatric Hospital Have a Future? Faculty: Judith Becker, Ph.D. Chp.: William H. Reid, M.D. Co-dtp.: S. Atezaz Saeed, MX),

9:00 a.m. Sessions Ten years ago, in response to managed care's challenge to psyd&atrichospital treatment and lengths of .stay/ CONTINUOUS CLINICAL CASE CONFERENCE 2: Sheppard and Enoch Pratt Hospital, a not-for-profit, PART 2 freestanding psychiatric hospital in Baltimore, began 9:00 a.m.-12 noon reorganization to become a continuum of care, the Sheppard Pratt Health System. Steven S. SharfsteJn, Rooms 106 A/B, Street Level, Convention Center M.D., President and Chief Executive Officer, describes MANAGING NEGATIVE OUTCOMES IN GENERAL the hospital's reinvention, considers the forms that PSYCHIATRY psychiatric hospitals are likely to take in the future, and discusses his personal experiences as a psychiatrist/ Moderator: Richard G. Hersh, M.D. administrator facing intensive change, Dr. Sharfstein is Presenter: Mary S. Sciutto, M.D. also Clinical Professor and Vice Chairman of the Department of Psychiatry at the University of Maryland. THIS SESSION IS OPEN TO APA MEMBERS ONLY. A Fellow of the APA, Dr. Sharfstein formerly served as BLUE REGISTRATION BADGE OR APA APA Secretory and Chairperson of the Ethics Appeals MEMBERSHIP CARD REQUIRED FOR Board. He currently is Vice Chairpersori of the APA Joint Commission on Government Relations and the Committee on Reimbursement for Psychiatric Care. He is ihe author of 150 professional articles and book COURSES 100-102 chapters and the author or editor of ten books. Dr, Course descriptions are available in the CME Sharfstein graduated from Albert Einstein College of Course Brochure included in your registration Medicine in Mew York, completed his residency in packet. Admission by ticket only. psychiatry at the Massachusetts Mental Health Center in Boston, and holds a master's degree in pubic administration from the John F. Kennedy School of COURSE 100 9:00 a.m.-4:00 p.m. Government at Harvard University. Maestro, Fourth Floor, DoubleTree THIS SESSION WILL BE AUBIOTAPEB.

Director: John R. Evaldson, M.D. Faculty: Mark Erickson, M.D., Annette J. Hollander, M.D., WORKSHOPS David Mullen, M.D., Daniel R. Wilson, M.D. COMPONENTS 50-55

COURSE 101 9:00 a.m.-4:00 p.m. COMPONENT WORKSHOP 50 9:00 a.m.-10:30 a.m. Sonata 3, Fifth Floor, DoubleTree Room 104 A, Street Level, Convention Center PTSD: AN HISPANIC UPDATE OF A UNIVERSAL CAREER CHOICES IN PSYCHIATRY PROBLEM (IN SPANISH) APA Assembly Committee of Area Member-in-Training Representatives

Director: Luis F. Ramirez, M.D. Co-Chps.: Shauna P. Reinblatt, M.D., Pamela J. Petersen-Crair, M.D. Faculty: Jose M. Canive, M.D., Dora Cardona, M.D., Roxana Participants: Blaine S. Greenwald, M.D., Keith W. Young, M.D., Galeno, M.D., Daniel Toledo, M.D., Renato D. Alarcon, M.D. Scott Masters, M.D. THURSDAY

COMPONENT WORKSHOP 51 9:00 a.m.-10:30 a.m. ISSUES 96-112 Room 104 B, Street Level, Convention Center ISSUE WORKSHOP 96 9:00 a.m.-10:30 a.m. CODING AND DOCUMENTATION UPDATE Rooms 102 A/B, Street Level, Convention Center APA Committee on RBR VS, Codes, and Reimbursements STIGMA STAYED: THE COST OF PREJUDICE IN Co-Chps.: Chester W. Schmidt, Jr., M.D., Tracy R. Gordy, MD. HIGH PLACES Participants: Ronald A. Shellow, M.D., Gerald Rogan, M.D., Joseph M. Schwartz, M.D., Edward Gordon, M.D. Chp.: Karl S. Burgoyne, M.D. Participants: Milton H. Miller, M.D., Marvin Southard, D.S.W., COMPONENT WORKSHOP 52 9:00 a.m.-10:30 a.m. James Allen, M.B.A. Rooms 107 A/B, Street Level, Convention Center ISSUE WORKSHOP 97 9:00 a.m.-10:30 a.m. PSYCHOLOGICAL ISSUES OF PEOPLE LIVING Room 103 A, Street Level, Convention Center LONGER WITH HIV APA Commission on AIDS THE OTHER SIDE OF THE MOUNTAIN: FROM RESIDENCY TO REALITY Chp.: Warren M. Liang, M.D. Participants: Karl Goodkin, M.D., Ellen M. Tedaldi, M.D., Chp.: Stephen M. Goldfinger, M.D. Robert S. Stasko, M.D. Participants: Deborah J. Hales, M.D., Mary Kay Smith, M.D., Ronald C. Albucher, M.D. COMPONENT WORKSHOP 53 9:00 a.m.-10:30 a.m. Room 111 B, Street Level, Convention Center ISSUE WORKSHOP 98 9:00 a.m.-10:30 a.m. Room 103 C, Street Level, Convention Center INFORMATION TECHNOLOGY: CORE COMPETENCIES FOR PS YCHIATRISTS TOWARDS GLOBAL DECRIMINALIZATION OF APA Committee on Information Technology DRUG ADDICTION

Chp.: Ronnie S. Stangler, M.D. Co-Chps.: Rodrigo A. Munoz, M.D., Guido Belsasso, MD. Participants: Thomas A.M. Kramer, M.D., Zebulon C. Participants: Gretchen Bergman, Pedro Ruiz, M.D., Jorge A. Taintor, M.D., David F. McMahon, MD. Zapatel, M.D., Harold I. Eist, M.D., Maria C. Bayon, M.D.

COMPONENT WORKSHOP 54 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 99 9:00 a.m.-10:30 a.m. Washington C, Third Floor, Loews Rooms 112 A/B, Street Level, Convention Center

SURGEON GENERAL'S REPORT ON CULTURE, POEMS ON PSYCHIATRY RACE, AND ETHNICITY: CLINICAL IMPLICATIONS APA Council on National Affairs Chp.: Charles R. Joy, M.D.

Co-Chps.: Sylvia W. Olarte, M.D., Theresa M. Miskimen, MD. ISSUE WORKSHOP 100 9:00 a.m.-10:30 a.m. Participants: Robert P. Cabaj, M.D., Nang Du, M.D., R. Dale Room 113 A, Street Level, Convention Center Walker, M.D. HOW TO GIVE A MORE EFFECTIVE LECTURE: COMPONENT WORKSHOP 55 9:00 a.m.-10:30 a.m. PUNCH, PASSION, AND POLISH Rooms 401-403, Level 4, Marriott Chp.: Phillip J. Resnick, M.D. BAD BOYS, BAD GIRLS: THE DEMONIZATION OF ADOLESCENCE ISSUE WORKSHOP 101 9:00 a.m.-10:30 a.m. APA Committee on Juvenile Justice Issues Room 113 B, Street Level, Convention Center

Chp.: Louis J. Kraus, M.D. TEACHING PRIMARY CARE RESIDENTS ABOUT Participants: Michael G. Kalogerakis, MD., Daphne DEPRESSION AND SUICIDE: CAN TECHNOLOGY Dorce, M.D., Lois T. Flaherty, M.D., William Arroyo, M.D. ALTER OUTCOMES?

Chp.: Donna M. Sudak, M.D. Participant: Rory P. Houghtalen, M.D.

89 THURSDAY

ISSUE WORKSHOP 102 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 108 9:00 a.m.-10:30 a.m. Room 113 C, Street Level, Convention Center Room 204 B, Level 200, Convention Center

RELIGIOUS AND SPIRITUAL ASSESSMENT IN MEDICATION USE FOR CHILDREN IN SYSTEMS OF CLINICAL PRACTICE CARE Substance Abuse and Mental Health Services Administration Chp.: Francis G. Lu, M.D. Participant* Christina M. Puchalski, MD. Co-Chps.: Rolando Santiago, Ph.D., David Fassler, MD. Participants: Wayne Holden, Ph.D., Andres J. Pumariega, M.D., ISSUE WORKSHOP 103 9:00 a.m.-10:30 a.m. Peter S. Jensen, M.D., Gayle Porter, Psy.D. Room 201 A, Level 200, Convention Center ISSUE WORKSHOP 109 9:00 a.m.-10:30 a.m. LITHIUM REVISITED: INTEGRATING RECENT Room 204 C, Level 200, Convention Center FINDINGS INTO CLINICAL PRACTICE WORKING THROUGH IN PSYCHOTHERAPY Co-Chps.: Robert T. Dunn, MD., Eric G. Smith, MD. Participants: Frederick K. Goodwin, MD., Michael]. Gitlin, MD. Chp.: Steven H. Lipsius, M.D.

ISSUE WORKSHOP 104 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 110 9:00 a.m.-10:30 a.m. Room 201 B, Level 200, Convention Center Washington A, Third Floor, Loews

THE DISRUPTIVE PHYSICIANS AND HOSPITAL ALPHA-DOWN EEC BIOFEEDBACK: A NOVEL CULTURE TREATMENT FOR ANXIETY

Co-Chps.: Glenn N. Siegel, M.D., Mary Pittman, M.S. Chp.: Thomas M. Brod, MD. Participants: William M.W. Scott, M.D., Meredith L. Sagan, MX). ISSUE WORKSHOP 105 9:00 a.m.-10:30 a.m. Room 201 C, Level 200, Convention Center ISSUE WORKSHOP 111 9:00 a.m.-10:30 a.m. Washington B, Third Floor, Loews EVIDENCE-BASED TABLES OF SIDE EFFECTS OF PSYCHOTROPIC MEDICATIONS: USEFUL? JOINING FORCES: WORKING WITH LAW ENFORCEMENT TO SERVE THE MENTALLY ILL Co-Chps.: David N. Osser, M.D., Andrew A. Sassani, MD. Participants: Alfredo Martija, MD., Alexandrina Darabus, MD., Chp.: Debra A. Finals, M.D. Michael J. Kittay, MD. Participants: Heidi S. Vermette, M.D., Richard M. Stanley, Kamlyn R. Haynes, M.D. ISSUE WORKSHOP 106 9:00 a.m.-10:30 a.m. ISSUE WORKSHOP 112 9:00 a.m.-10:30 a.m. Room 203 B, Level 200, Convention Center Congress Rooms A-C, Fourth Floor, Loews

USING YOUR PSYCHIATRIC SKILLS TO BUILD A ERIK ERIKSON EPIGENESIS AS DEPICTED IN PRODUCTIVE TEAM AT WORK ANDREW LLOYD WEBBER'S MUSICALS

Chp.: Saul M. Levin, M.D. Co-Chps.: Hani Raoul Khouzam, MD., Robert W. Herhoker, MD. Participant: Judy L. Stange, Ph.D. ISSUE WORKSHOP 107 9:00 a.m.-10:30 a.m. 11:00 a.m. Sessions Room 204 A, Level 200, Convention Center

THE FRONTIER OF PUBLIC HEALTH MEDICAL UPDATE 4 PSYCHIATRY: PREVENTING SUICIDE 11:00 a.m.-12:30 p.m. Substance A buse and Mental Health Services Administration Room 103 A, Street Level, Convention Center

Chp.: Eric D. Caine, M.D. COMPREHENSIVE HIV CARE: TREATMENT AND Participants: David A. Litts, O.D., Madelyn Gould, Ph.D., SERVICE UPDATE Yeates Conwell, M.D. Chp.: Velda Y. Rexach, M.D. Presenter: Maria J. Gold, M.D. THIS SESSION WILL BE AUDIOTAPED.

90 THURSDAY

RESEARCH CONSULTATION WITH 12 noon 104 Parental Separation at Birth and Criminality in 11:00 a.m.-12:30 p.m. Adulthood Pirjo H. Maki, M.D., Helina Hakko, Ph.D., Matti This session is limited to 25 participants on a first-come, Joukamaa, Ph.D., Matti K. Isohanni, M.D., Juha M. first-served basis. Veijola, M.D. THIS SESSION WILL BE AUDIOTAPED. 3 Elizabeth B. Weller, M.D., on Bipolar Disorders in Children and Adolescents SCIENTIFIC AND CLINICAL REPORT SESSION 36 Adams Room, Third Floor, Loews 11:00 a.m.-12:30 p.m. Room 113 B, Street Level, Convention Center

SCIENTIFIC AND CLINICAL REPORT USES OF ANTIPSYCHOTICS SESSIONS 34-42 Chp.: Harvey Stabinsky, M.D. SCIENTIFIC AND CLINICAL REPORT SESSION 34 Co-Chp.: Paul E. Holtzheimer III, M.D. 11:00 a.m.-12:30 p.m. Room 103 B, Street Level, Convention Center 11:00 a.m. 105 Polypharmacy in Patients with Schizophrenia FORENSIC PSYCHIATRY Robert E. McCue, M.D., Rubina Waheed, M.D., Leonel Urcuyo, M.D. Chp.: Rahn K. Bailey, M.D. 11:45 a.m. Co-Chp.: Thomas G. Cobb, M.D. 106 The Use of Atypical Antipsychotics in Adults with Developmental Disability 11:00 a.m. Karen J. Shedlack, M.D., Christine Magee, MS., Robert 99 Medications, Strange Intoxications, and Violent Crime Sisson, Ph.D. Michael M. Welner, M.D. THIS SESSION WILL BE AUDIOTAPED.

11:30 a.m. SCIENTIFIC AND CLINICAL REPORT SESSION 37 100 Treating Mentally 111 Offenders in a Residential 11:00 a.m.-12:30 p.m. Treatment Unit Room 113 C, Street Level, Convention Center Cristinel M. Coconcea , M.D., Nicoleta Coconcea, M.D. MOOD DISORDERS IN CHILDREN 12 noon 101 Presidential Assassination Syndrome Revisited: New Understanding Chp.: Jodi E. Star David A. Rothstein, M.D. Co-Chp.: Daniel A. Nelson, M.D. THIS SESSION WILL BE AUDIOTAPED. 11:00 a.m. SCIENTIFIC AND CLINICAL REPORT SESSION 35 107 Anxiety Disorders in Children and Adolescents with 11:00 a.m.-12:30 p.m. Bipolar Disorder Room 103 C, Street Level, Convention Center Giulio Perugi, MD., Gabriele Masi, MD., Christina Toni, MD., Maria Mucci, M.D., Stefania Millepiedi, M.D., Hagop S. Akiskal, M.D. ISSUES IN TRAUMA AND VIOLENCE 11:30 a.m. Chp.: Sandra L. Bloom, M.D. 108 Comorbidity in Child and Adolescent Major Co-Chp.: Richard P. Kluft, M.D. Depression Atilla Turgay, M.D., David Ng, M.D., Lillian Mok, M.D., 11:00 a.m. Joanna Blanchard, M.A. 102 Predicting Chronicity in Vietnam Veterans with PTSD: New Findings from the National Vietnam Veterans 12 noon Readjustment Study 109 Evaluation and Intervention of Prodromal Symptoms Randall D. Marshall, M.D., J. Blake Turner, Ph.D., Roberto of Bipolar I Disorder Lewis-Fernandez, M.D., Karestan Koenan, Ph.D., Yuval Mohammad Z. Hussain, M.D., Zabaida A. Chaudhry, MD., Yuria, M.D., Bruce Dohrenwend, Ph.D. Seema Hussain, M.D. THIS SESSION WILL BE AUDIOTAPED. 11:30 a.m. 103 Community and Inpatient Violence in Major Psychiatric Disorders Menahem I. Krakowski, M.D.

91 THURSDAY

SCIENTIFIC AND CLINICAL REPORT SESSION 38 SCIENTIFIC AND CLINICAL REPORT SESSION 40 11:00 a.m.-12:30 p.m. 11:00 a.m.-12:30 p.m. Room 204 A, Level 200, Convention Center Room 204 C, Level 200, Convention Center

ISSUES IN DEPRESSION MANAGED CARE AND HEALTH CARE FINDINGS

Chp.: Teodor T. Postolache, M.D. Chp.: David A. Casey, M.D. Co-Chp.: Mercedes M. Rodriguez, M.D. Co-Chp.: Daniel P. Chapman, MD.

11:00 a.m. 11:00 a.m. 110 Dysthymic Disorder: Integrating Research Findings 116 Alzheimer's Disease Increases Costs of Comorbidities into Clinical Treatment in Medicare-Managed Care David J. Hellerstein, M.D. Howard Fillit, M.D., Jerrold W. Hill, Ph.D., Robert Futterman, Ph.D., John R. Lloyd, B.S., Vera Mastey, MS. 11:30 a.m. 111 Effect of Adjunct Modafinil on Energy and 11:30 a.m. Concentration in Depressed Patients 117 Donepezil Is Associated with Lower Health Care Costs Matthew A. Menza, M.D., Karl Doghramji, M.D., in Medicare-Managed Care xRonaldR. Fieve, M.D., Murray H. Rosenthal, D.O. Jerrold W. Hill, Ph.D., Howard Fillit, M.D., Robert Futterman, Ph.D., Vera Mastey, MS. 12 noon 112 Parental Separation at Birth and Depression in 12 noon Adulthood 118 Managed Care and Malpractice Liability: Update 2002 Julia M. Veijola, M.D., Pirjo H. Maki, M.D., Matti Eugene L. Lowenkopf, M.D., Abe M. Rychik, J.D. Joukamaa, Ph.D., Helina Hakko, Ph.D., Matti K. Isohanni, M.D. SCIENTIFIC AND CLINICAL REPORT SESSION 41 THIS SESSION WILL BE AUDIOTAPED. 11:00 a.m.-12:30 p.m. Congress Rooms A-C, Fourth Floor, Loews SCIENTIFIC AND CLINICAL REPORT SESSION 39 11:00 a.m.-12:30 p.m. TREATMENT TECHNIQUES Room 204 B, Level 200, Convention Center Chp.: Gary S. Sachs, M.D. CLINICAL APPROACHES IN SCHIZOPHRENIA Co-Chp.: David M. McDowell, M.D.

Chp.: Abel A. Gonzalez, M.D. 11:00 a.m. Co-Chp.: Donald M. Hilty, M.D. 119 Matching Treatment to Type of Poor-Prognostic, Substance-Dependent Patients 11:00 a.m. Edward Gottheil, M.D., Charles C. Thornton, Ph.D., 113 Low-Frequency Transcranial Magnetic Stimulation Stephen P. Weinstein, Ph.D. Curtails Medication-Resistant Auditory Hallucinations 11:30 a.m. Ralph E. Hoffman, M.D., Keith A. Hawkins, Psy.D., 120 Tiagabine, a Selective GABA Reuptake Inhibitor for Fadddie H. Rachid, M.D., Ralitza Gueorguieva, Ph.D., the Treatment of Anxiety Kathleen M. Carroll, Ph.D., Nashaat N. Boutros, M.D., Daniel L. Crane, M.D. JohnH.Krystal,M.D. 12 noon 11:30 a.m. 121 Adjunctive Use of Tiagabine with Antidepressants in 114 Sibutramine Treatment of Obesity in Schizophrenia PTSD LjiljanaRadulovic, M.D., Peter J. Weiden, M.D., David B. Michael E. Lara, M.D. Allison, Ph.D., Catherine Camille, MA. THIS SESSION WILL BE AUDIOTAPED.

12 noon SCIENTIFIC AND CLINICAL REPORT SESSION 42 115 The Stabilization Phase of Schizophrenia: A Review of 11:00 a.m.-12:30 p.m. the Literature Rooms 401-403, Level 4, Marriott Peter J. Weiden, M.D, Judy Greene, B A., Nina R. Schooler, Ph.D. TRENDS IN SUICIDE RATES THIS SESSION WILL BE AUDIOTAPED. Chp.: David I. Greenspan, M.D. Co-Chp.: Hagit Bat-Avi, M.D. (Continued on next pag°)

92 THURSDAY

11:00 a.m. ISSUE WORKSHOP 115 11:00 a.m.-12;30 p.m. 122 Female Suicides in Texas Cities: 1994-1998 Room 201 C, Level 200, Convention Center Veena R. Doddakashi, M.D., Richard Wilcox, Ph.D., Lawrence A. Hauser, M.D. OUTPATIENT COMMITMENT: KENDRA'S LAW AND THE NEW YORK CITY EXPERIENCE 11:30 a.m. 123 Trends in Suicide Rates in New York City: Co-Chps.: David A. Trachtenberg, MD., Michael S. Lesser, MD. Implications for a Prevention Initiative Participants: Scott D. Rogge, M.D., Daniel Garza, M.D., Neal L. Cohen, M.D., Susan Wilt, Ph.D. Robert H. Berger, MD.

12 noon ISSUE WORKSHOP 116 11:00 a.m.-12;30 p.m. 124 Changing Suicide Rates in Europe: Possible Causes Room 202 B, Level 200, Convention Center Zoltan Rihmer, M.D., Annamaria Rihmer THIS SESSION WILL BE AUDIOTAPED. CREATING EFFECTIVE ALLIANCES WITH PHARMACEUTICAL INDUSTRY PHYSICIANS

WORKSHOPS Chp.: Arthur L. Lazarus, M.D. Participants: Paul E. Keck, Jr., M.D., David L. Garver, M.D., COMPONENTS 56-57 Rajiv Tandon, M.D.

COMPONENT WORKSHOP 56 11:00 a.m.-12:30 p.m. ISSUE WORKSHOP 117 11:00 a.m.-12;30 p.m. Room 104 A, Street Level, Convention Center Room 203 A, Level 200, Convention Center

GUIDELINES FOR THE TREATMENT OF SUICIDAL SUBSTANCE ABUSE PREVENTION AND BEHAVIORS TREATMENT: A PSYCHIATRIC PERSPECTIVE APA Steering Committee on Practice Guidelines Substance A buse and Mental Health Services Administration Chp.: Sheila Harmison, D.S.W. Chp.: John S. Mclntyre, M.D. Participants: Ruth Sanchez-Way, Ph.D., H. Westley Clark, MD. Participants: Douglas G. Jacobs, M.D., Yeates Conwell, MD. ISSUE WORKSHOP 118 11:00 a.m.-12;30 p.m. COMPONENT WORKSHOP 57 11:00 a.m.-12:30 p.m. Room 203 B, Level 200, Convention Center Room 104 B, Street Level, Convention Center HOW TO DEVELOP A LECTURE ASIAN AMERICANS IN INTERMARRIAGES: PSYCHOSOCIAL ADJUSTMENT AND IDENTITY Co-Chps.: Marianne T. Guschwan, M.D., Susan Tapert, Ph.D. APA Caucus of Asian-American Psychiatrists Participants: Christopher J. Welsh, MD., Donna L. Londino, MD.

Chp.: Jagannathan Srinivasaraghavan, MD. ISSUE WORKSHOP 119 11:00 a.m.-12;30 p.m. Participants: PrakashN. Desai,MD., Kathleen M. Kim, M.D., Washington A, Third Floor, Loews Francis G. Lu, M.D., Cynthia M. Nguyen, MD. A CLINICIAN'S GUIDE TO SUBSTANCE ABUSE TREATMENT FOR GAY, LESBIAN, BISEXUAL, AND ISSUES 113-119 TRANSGENDER PERSONS Substance A buse and Mental Health Semces Administration ISSUE WORKSHOP 113 11:00 a.m.-12:30 p.m. Chp.: Saul M. Levin, MD. Rooms 112 A/B, Street Level, Convention Center Participants: Frank Y. Wong, PhD., Michele J. Eliason, PhD. BRIDGES FOR HEALING: INTEGRATING FAMILY THERAPY AND PSYCHOPHARMACOLOGY 12 noon Sessions Chp.: Roy O. Resnikoff, M.D. FORUMS 12-13 ISSUE WORKSHOP 114 11:00 a.m.-12:30 p.m. Room 201 B, Level 200, Convention Center FORUM 12 12 noon-l:30 p.m. Rooms 102 A/B, Street Level, Convention Center VIDEO CASE STUDIES OF COUPLES IN TREATMENT PSYOP: PSYCHOLOGICAL OPERATIONS IN THE WAR AGAINST TERRORISM Chp.: Ian E. Alger, M.D. Chp.: Ronnie S. Stangler, MD.

93 THURSDAY

FORUM 13 12 noon-l;30 p.m. C Cultural Considerations for Treating HIV-Infected Rooms 107 A/B, Street Level, Convention Center Latino Patients Milton L. Wainberg, M.D. THE PHARMACEUTICAL INDUSTRY AND THE APA: CONTROVERSIES AND APPROACHES SYMPOSIUM 78 2:00 p.m.-5;00 p.m. APA Committee on Commercial Support Room 103 B, Street Level, Convention Center

Chp.: Stephen M. Goldfinger, M.D. BRAIN SUBSTRATES OF ADDICTION: Participants: Nyapati R. Rao, M J)., Troy L. Thompson n, M.D., NEUROIMAGING AS A TOOL OF CHOICE IN THE William B. Lawson, M.D., Anand Pandya, M.D., Philip R. 21ST CENTURY Muskin, M.D., Paula G. Panzer, M.D., David S. Wahl, M.D., Charles R. Goldman, M.D., James W. Thompson, M.D. Chp.: AnnaR. Childress, Ph.D. Co-Chp.: Charles P. O'Brien, M.D.

A Using PET to Image the Neuroanatomical and 2:00 p.m. Sessions Neurochemical Substrates of Cocaine Craving AnnaR. Childress, Ph.D., Paul Acton, Ph.D., KyleM. SYMPOSIA 76-93 Kampman, M.D., Teresa R. Franklin, Ph.D., Anna Fornash, Charles P. O'Brien, M.D. SYMPOSIUM 76 2;00 p.m.-5:00 p.m. Rooms 102 A/B, Street Level, Convention Center B Bold fMRI Versus Spin-Tagging in Cue-Induced Cocaine Craving (4T) CULTURALLY COMPETENT MENTAL HEALTH John M. Listerud, M.D., Jionjiong Wang, Ph.D., J. Detre, M.D., Jason Gray, B A, Charles P. O'Brien, MX)., AnnaR. Childress, Ph.D. CARE: IDENTIFYING AND REDUCING DISPARITIES C Functional MRI During Heroin Craving in Methadone- Maintained Subjects Chp.: Carl C.Bell,M.D. Daniel D. Langleben, M.D., Jionjiong Wang, Ph.D., Jason Co-Chp.: Renato D. Alarcon, M.D. Gray, B A, John M. Listerud, M.D., Charles P. O'Brien, M.D., AnnaR. Childress, Ph.D. A Bipolar Disorder in African Americans William B. Lawson, M.D. D fMRI of Cue-Induced Nicotine Craving Teresa R. Franklin, Ph.D., Jason Gray, B.A., Charles P. B Mental Health Care in Hispanic Populations: Clinical and O'Brien, M.D., Anna R. Childress, Ph.D. Therapeutic Issues Renato D. Alarcon, M.D. E Brain Substrates for Self-Control May Be Defective in Addiction C Cultural Competence Standards for Mental Health Services John R. Monterosso, Ph.D., Ronald Ehram, Ph.D., Kimberly Francis G. Lu, M.D. Napier, B A, Anna R Childress, PhD., Charles P. O'Brien, MD. THIS SESSION WILL BE AUDIOTAPED. D Race, Ethnicity, and Variations in Psychiatric Diagnosis and Treatment SYMPOSIUM 79 2:00 p.m.-5;00 p.m. Diane M. Herbeck, MA, Carl C. Bell, MD., Diana J. Fitek, B A, Room 103 C, Street Level, Convention Center Joyce C. West, Ph.D. OPTIMAL STRATEGIES FOR IDENTIFYING AND THIS SESSION WILL BE AUDIOTAPED. TREATING TRAUMATIZED CHILDREN

SYMPOSIUM 77 2:00 p.m.-5;00 p.m. Chp.: Judith A. Cohen, M.D. Room 103 A, Street Level, Convention Center A Screening for Traumatic Exposure and PTSD HIV TREATMENT DIMENSIONS AMONG DIVERSE Symptoms in Pediatric Settings ETHNIC AND CULTURAL POPULATIONS Anthony P. Mannarino, Ph.D., Judith A. Cohen, M.D., APA Commission on AIDS Daphne Ruben, L.C.S.W.

Chp.: Altha J. Stewart, M.D. B Cognitive-Behavioral Therapy for Traumatized Children and Their Parents A HlV-Positive Patient Panel Esther Deblinger, Ph.D. Altha J. Stewart, M.D. C Developmental Traumatology: Neurobiological Development in Childhood PTSD B Cultural Considerations for Treating HIV-Infected Michael D. DeBellis, M.D., Matcheri S. Keshavan, M.D., African-American Patients Sue R. Beers, Ph.D., Neal D. Ryan, M.D. Eric G. Bing, M.D. 94 THURSDAY

D Pharmacological Treatments for Traumatized Children D Multisystemic Treatment of Alcohol-Abusing Judith A. Cohen, M.D. Adolescents: Outcomes Scott W. Henggeler, Ph.D., Colleen A. Halliday- E Treating Child and Adolescent Victims of Crime: The Boykins, Ph.D., Philippe B. Cunningham, Ph.D., Jeff New California Guidelines Randall, Ph.D. Graeme Hanson, M.D. THIS SESSION WILL BE AUDIOTAPED. E Implementing Motivational Enhancement Therapy Allen Zweben, D.S.W. THIS SESSION WILL BE AUDIOTAPED. SYMPOSIUM 80 2:00 p.m.-5:00 p.m. Room 104 A, Street Level, Convention Center SYMPOSIUM 82 2:00 p.m.-5;00 p.m. Rooms 106 A/B, Street Level, Convention Center OPIATE-SUBSTITUTION TREATMENT: INTERNATIONAL TRENDS AND PERSPECTIVES THE SCHIZOPHRENIA PRODROME: UPDATE OF RESEARCH 2002 Chp.: Richard N. Rosenthal, M.D. Co-Chp.: Michael Krausz, Ph.D. Chp.: Scott W. Woods, M.D.

A Buprenorphine: Experiences with Office-Based A Intervention in the Schizophrenic Prodrome: Rationale, Substitution Treatment in Europe Studies, and Ethics Marc Auriacombe, M.D., Pascale Franques, M.D., Jean-Pierre Thomas H. McGlashan, M.D., Robert B. Zipursky, M.D., Daulouede, M.D., Jean L. Tignol, M.D. Diana O. Perkins, M.D., Jean M. Addington, Ph.D., Mauricio F. Tohen, M.D., Alan Ereier, M.D., Scott W. B Morphine Maintenance in the Treatment of Heroin Woods, M.D. Addiction B Diagnosis and Symptom Assessment in the Gabriele Fischer, M.D., Romana Ortner, M.D., Shiro Schizophrenia Prodrome Schindler, M.D., Harald Eder, M.D. Tandy J. Miller, Ph.D., Thomas H. McGlashan, M.D., Joanna L. Rosen, Ph.D., Jaak Rakfeldt, M.D., Shelly Nyman-Rose, C Is There a Gold Standard Medication in Opiate- M.S.W., Phillip Markovich, B.A., Scott W. Woods, M.D. Substitution Treatment? Robert G. Newman, M.D. C A Trial of Olanzapine Versus PBO in the Prodrome: Protocol and Baseline Sample D Heroin-Assisted Treatment Approaches in Europe Alan F. Breier, M.D., Robert B. Zipursky, M.D., Diana O. Wim Van Den Brink, M.D., Vincent Hendriks, Ph.D., Peter Perkins, M.D., Jean M. Addington, Ph.D., Mauricio F. Blaken, M.A., Jan Van Ree Tohen, M.D., Stacy R. David, Ph.D., Thomas H. McGlashan, M.D. E Outcome Criteria and Guidelines from an International D Neuropsychological Status of the First-Episode Point of View Prodrome Richard N. Rosenthal, M.D. Keith A. Hawkins, Psy.D., Diana O. Perkins, M.D., Jean M. Addington, Ph.D., Robert B. Zipursky, M.D., Kimberly B. Discussant: Thomas R. Kosten, M.D. Edwards, Ph.D., Stacy R. David, Ph.D., Thomas H. THIS SESSION WILL BE AUDIOTAPED. McGlashan, M.D. SYMPOSIUM 81 2:00 p.m.-5;00 p.m. E MRI and MRS Findings in Subjects with Prodromal Room 104 B, Street Level, Convention Center Symptoms Diana O. Perkins, M.D., Robert B. Zipursky, M.D., Guido ALCOHOL INTERVENTIONS ACROSS THE Geric, Ph.D., Cecil Charles, Ph.D., Hongbin Gu, Ph.D., SPECTRUM FOR COMMUNITY PRACTITIONERS Jeffrey A. Lieberman, M.D. Substance Abuse and Mental Health Services Administration F Olanzapine Versus Placebo for Prodromal Symptoms Chp.: Sheila B. Blume, M.D. Scott W. Woods, M.D., Robert B. Zipursky, M.D., Diana O. Perkins, M.D., Jean M. Addington, Ph.D., Tandy J. Miller, A Underage Drinking: Changing Community Norms Ph.D., Alan F. Breier, M.D., Thomas H. McGlashan, M.D. Robert Voas, Ph.D. THIS SESSION WILL BE AUDIOTAPED. B Identification of Fetal Alcohol Syndrome: SYMPOSIUM 83 2:00 p.m.-5:00 p.m. Differentiating Developmental Disorders from Fetal Rooms 107 A/B, Street Level, Convention Center Alcohol Syndrome Larry J. Burd, Ph.D., Jacob Kerbeshian, M.D. THE DUTY TO WARN AND PROTECT FOR THE 21ST-CENTURY PSYCHIATRIST C Implementing Naltrexone in Alcohol Treatment in Chp.: Alan R. Felthous, M.D. Community Settings Co-Chp.: Claudia A. Kachigian, M.D. Sherrie Gillette, MA. (Continued next page) 95 THURSDAY

A The Fin de Millenaire: Duty to Warn or Protect? C Prevention of Relapse Alan R. Felthous, M.D., Gaudia A. Kachigian, M.D. Steven D. HoUon, Ph.D., Richard C. Shelton, M.D., Richard Salomon, M.D., Margaret Lovett, M.Ed. B Judicial Responses to Tarasoff Statutes Claudia A. Kachigian, M.D., Alan R. Felthous, M.D. D Who Responds and Who Relapses Richard C. Shelton, M.D., Steven D. Hollon, Ph.D., Richard C Novel Approaches to Tarasoff Salomon, M.D., Margaret Lovett, M.Ed. Ralph Slovenko, L.L.B. THIS SESSION WILL BE AUDIOTAPED.

D Encroachments on Psychotherapist-Patient Privilege SYMPOSIUM 86 2:00 p.m.-5;00 p.m. Robert Weinstock, M.D. Room 113 A, Street Level, Convention Center REDUCING AGGRESSIVE BEHAVIOR: CHANGING E Risk Assessment in Tarasoff Situations THE TRAJECTORY FOR DRUG USE Randy Borum, Psy.D. Substance A buse and Mental Health Services Administration Discussant: Paul S. Appelbaum, M.D. Chp.: Ralph E. Tarter, Ph.D. THIS SESSION WILL BE AUDIOTAPED. Co-Chp.: Oscar G. Bukstein, MD. SYMPOSIUM 84 2;00 p.m.-5:00 p.m. A Intimate Partner Violence Among Whites, Blacks, and Room 111 B, Street Level, Convention Center Hispanics Raul Caetano, M.D., Craig Field, Ph.D., Scott Nelson, BA., CLINICAL CHALLENGES IN TREATING Susie Miller, Ph.D., John Schafer, Ph.D. SCHIZOPHRENIA B Modifying Aggressive Behavior via Strategic Peer Involvement Chp.: Prakash S. Masand, M.D. Gerald August, Ph.D., George M. Realmuto, M.D., Joel Hektner A From First Psychotic Episode to Long-Term Outcome in Schizophrenia C Cognitive-Behavioral Intervention for Aggressive John L. Waddington, D.Sc., Paul J. Scully, M.D., David J. Preadolescent Children (Ages 9-11) Meagher, MD., John F. Quinn, MX)., Patizia A Baldwin, MD., John E. Lochman, Ph.D., Karen C. Wells, Ph.D. Maria G. Morgan, M.D., Anthony Kinsella, M.S.C. D Diagnostic-Specific Treatments for Adolescents with B PET Imaging Studies of Atypical Antipsychotics: Substance-Use Disorders and Comorbidity Implications of Dosing and Mechanism of Action Oscar G. Bukstein, M.D. Shitij Kapur, M.D. E Family, Psychiatric, Drug Use, and Social Predictors of C Managing Violent Behavior in Patients with Violence Between Adolescence and Adulthood Schizophrenia: Emerging Standards of Care Ralph E. Tarter, Ph.D. Peter F. Buckley, M.D. THIS SESSION WILL BE AUDIOTAPED.

D Augmentation Strategies in Treatment-Refractory SYMPOSIUM 87 2:00 p.m.-5:00 p.m. Schizophrenia Room 113 B, Street Level, Convention Center Robert R. Conley, M.D., Deanna L. Kelly, Pharm.D. NEW DEVELOPMENTS IN INTERPERSONAL E Management of Long-Term Side Effects of Novel PSYCHOTHERAPY RESEARCH Antipsychotics Prakash S. Masand, M.D. THIS SESSION WILL BE AUDIOTAPED. Chp.: John C. Markowitz, M.D.

SYMPOSIUM 85 2:00 p.m.-5;00 p.m. A Maintenance Interpersonal Psychotherapy in Recurrent Rooms 112 A/B, Street Level, Convention Center Depression: Appropriate for Which Patients? Ellen Frank, Ph.D., David J. Kupfer, M.D., Holly A. COGNITIVE THERAPY VERSUS MEDICATIONS FOR Swartz, M.D., Kate Harkness, Ph.D., Patricia Houck SEVERE DEPRESSION B Treatment Strategies for Dysthmic Disorders Chp.: Jan A. Fawcett, M.D. John C. Markowitz, M.D., Kathryn L. Bleiberg, Ph.D., A Background and Design of a Placebo-Controlled James H. Kocsis, M.D. Comparison Robert J. DeRubeis, Ph.D., Jay D. Amsterdam, M.D., John P. C Interpersonal Psychotherapy Groups for Low-Income O'Reardon, M.D., Paula R. Young, Ph.D. Women with PTSD Janice L. Krupnick, Ph.D., Bonnie L. Green, Ph.D., Jeanne B Response to Acute Treatment Miranda, Ph.D. Jay D. Amsterdam, M.D., Robert J. DeRubeis, Ph.D., John P. O'Reardon, M.D., Paula R. Young, Ph.D. 96 THURSDAY

D Individual Interpersonal Psychotherapy for PTSD E Psychopharmacology of Traumatic Response in Adults Kathryn L. Bleiberg, Ph.D., John C. Markowitz, M.D. Richard Balon,M.D.

E Interpersonal Therapy Versus Supportive Therapy for Discussant: Elissa P. Benedek, M.D. Social Phobia THIS SESSION WILL BE AUDIOTAPED. Joshua D. Lipsitz, Ph.D. SYMPOSIUM 90 2:00 p.m.-5;00 p.m. Discussant: Myrna M. Weissman, Ph.D. Room 201 C, Level 200, Convention Center THIS SESSION WILL BE AUDIOTAPED. PSYCHIATRY AND THE PHARMACEUTICAL SYMPOSIUM 88 2;00 p.m.-5;00 p.m. INDUSTRY: WHERE IS THE BOUNDARY? Room 113 C, Street Level, Convention Center Chp.: Amy C. Brodkey, M.D.

TREATING MENTAL ILLNESS AND SUBSTANCE A Pharmaceutical Promotion: There Is no Free Lunch ABUSE IN THE CRIMINAL JUSTICE SYSTEM Amy C. Brodkey, M.D. Substance Abuse and Mental Health Services Administration B Academia, Medical Education, and the Pharmaceutical Chp.: Jeffrey L. Metzner, M.D. Industry Co-Chp.: Michael English, Ph.D. Frederick S. Sierles, M.D.

A Family Drug Courts: Early Evaluation Findings C The Pharmaceutical Industry and Public Psychiatry Nancy Young Robert M. Factor, M.D.

B Pelican Bay Super Max: Treatment in Correctional D Industry-Supported Medical Education: When Settings Educators Serve Two Masters Shama Chaiken, Ph.D. Diana M. Koziupa, M.D. THIS SESSION WILL BE AUDIOTAPED. C Jail Diversion: Mechanisms and Services Henry Steadman SYMPOSIUM 91 2:00 p.m.-5;00 p.m. Room 203 B, Level 200, Convention Center D Successful Community Reintegration of Offenders with THE EMPLOYMENT INTERVENTION Mental Illness DEMONSTRATION PROJECT: OUTCOME OF BEST FredC.Osher,M.D. PRACTICE THIS SESSION WILL BE AUDIOTAPED. Chp.: William R. McFarlane, M.D. SYMPOSIUM 89 2:00 p.m.-5;00 p.m. Room 201 B, Level 200, Convention Center A Best Practice in Employment Research: Views from the Employment Intervention Demonstration Program TRAUMATIC RESPONSE TO DISASTER: Coordinating Center NEUROBIOLOGY AND TREATMENT Judith A. Cook, Ph.D. Chp.: Carol S. North, M.D. B The Hartford Study of Supported Employment for Co-Chp.: Elissa P. Benedek, M.D. Severe Mental Illness: Employment and Nonvocational Outcomes A Neurobiological Mechanisms of PTSD Kim T. Mueser, Ph.D., Robin E. Clark, Ph.D., Michael Dennis S. Charney, M.D. Haines, M.A., Robert E. Drake, M.D., Gary R. Bond, Ph.D., Deborah R. Becker, M.Ed, Gregory McHugo, Ph.D., Susan M. B The Range of Human Response to Catastrophic Essock, Ph.D., Rosemarie Wolfe, MA, Anjana Sengupta, Ph.D. Trauma Carols. North, M.D. C Effects of Fact and an Employers Consortium on Employment in Severe Mental Illness William R. McFarlane, M.D., William Cook, Ph.D., Richard C Disaster Overview: Clinical Presentation National and Balser, Cindy Boyak, M.D., Renee Leavitt, O.T. International Perspectives David Benedek, M.D. D Improving Employment Outcomes for Persons with Severe Mental Illness D Psychopharmacotherapy of PTSD in Children and Anthony F. Lehman, M.D. Adolescents Elizabeth B. Weller, M.D., Arman K. Danielyan, M.D., E Effectiveness of Long-Term Employment Support for Ronald A. Weller,M.D. Individuals with Severe Mental Illness Laura E. Bianhertz, Ph.D. (Continued'next page)

97 THURSDAY

F Rural-Based Supported Employment Approaches: B Embracing the Real World: Virtually fMRI and Virtual Results from the South Carolina Site of the Employment Reality Intervention Demonstration Project Konstantine K. Zakzanis, Ph.D. NeilMeisler,M.S.W. C Virtual Reality Neuropsychological Assessment and G The Texas EARNS Supported Employment Rehabilitation: Present and Future Demonstration Project Albert A. Rizzo,Ph.D. Marcia Toprac, Ph.D., Sue K. Hoppe, Ph.D., Pamela Daggett, MA, Kate Wambach, Ph.D., Steven Onken, Ph.D., D Application of Advanced Information Technologies in Susan Burek, Shelley Blozis, Ph.D. the Creation of Virtual Humans Norman E. Alessi, M.D. Discussant: Crystal Byler, Ph.D. THIS SESSION WILL BE AUDIOTAPED. E Virtual Reality Therapy: A Cost-Benefit Analysis Mark D. Wiederhold, M.D. SYMPOSIUM 92 2:00 p.m.-5:00 p.m. THIS SESSION WILL BE AUDIOTAPED. Room 204 A, Level 200, Convention Center

TREATMENT OF ADHD: FROM CLINICAL TRIALS TO ROUTINE CLINICAL PRACTICE

Chp.: Benedetto Vitiello, M.D. Co-Chp.: Farifteh F. Duffy, Ph.D.

A The AACAP Stimulant Medication Practice Parameter for Treatment of ADHD Laurence L. Greenhill, M.D.

B Treatment of ADHD: From Multimodal Treatment ADHD Trials to Routine Psychiatric Practice Peter S. Jensen, M.D.

C Stimulant and Psychosocial Treatment of ADHD in Latino Children Glorisa Canino, Ph.D., Jose J. Bauermeister, Ph.D., Maritza Rubio-Stipec, Sc.D.

D The Role of Comorbidity in the Treatment of ADHD in Routine Psychiatric Practice Farifteh F. Duffy, Ph.D., William E. Narrow, M.D., Donald Rae, MA.

E Insurance Factors and ADHD Treatment in Psychiatric Practice William E. Narrow, M.D., Donald Rae, MA., Farifteh F. Duffy, PLD.

Discussant: Mark A. Riddle, M.D. THIS SESSION WILL BE AUDIOTAPED.

SYMPOSIUM 93 2:00 p.m.-5;00 p.m. Room 204 B, Level 200, Convention Center

VIRTUAL REALITY AND MENTAL HEALTH: STATE OF THE ART AND FUTURE DIRECTIONS

Chp.: Henry J. Moller, M.D. Co-Chp.: Albert A Rizzo, Ph.D.

A Virtual Environments: Using a Driving Simulator to Understand Consciousness Henry J. Moller, M.D.

98 2002 ANNUAL MEETING TOPIC AREAS FOR THE SCIENTIFIC PROGRAM

DISORDERS 30. Psychoanalysis 31. Research Issues 1. AIDS and HIV-Related Disorders 32. Social and Community Psychiatry 2. Alcohol and Drug-Related Disorders 33. Stress 3. Anxiety Disorders 34. Suicide 4. Attention Spectrum Disorders 35. Violence, Trauma, and Victimization 5. Cognitive Disorders (Delirium, Dementia, Amnestic, etc.) TREATMENTS 6. Eating Disorders 7. Mental Retardation (Child/Adolescent/Adult) 36. Behavior and Cognitive Therapies 8. Mood Disorders 37. Combined Pharmacotherapy and Psychotherapy 9. Personality Disorders 38. Couple and Family Therapies 10. Schizophrenia and Other Psychotic Disorders 39. Group Therapy 11. Sexual and Gender Identity Disorders 40. Individual Psychotherapies 12. Sleep Disorders 41. Psychopharmacology 13. Somatoform Disorders 42. Other Somatic Therapies 43. Treatment Techniques and Outcome Studies PRACTICE AREAS/SETTINGS OTHER ISSUES 14. Psychiatric Administration and Services: Public, Private, and University 44. Computers 15. Other 45. Creativity and the Arts 46. Electronic Medical Records SUBSPECIALTY AREAS OR SPECIAL 47. Gender Issues INTERESTS 48. Health Services Research 49. Historical Questions 16. Addiction Psychiatry 50. Information Technology 17. Biological Psychiatry and Neuroscience 51. Lesbian/Gay/Bisexual/Transgender Issues 18. Brain Imaging 52. Managed Care and Health Care Funding 19. Child and Adolescent Psychiatry and Disorders 53. Men's Health Issues 20. Consultation-Liaison and Emergency Psychiatry 54. Political Questions 21. Cross-Cultural and Minority Issues 55. Professional and Personal Issues 22. Diagnostic Issues 56. Religion, Spirituality, and Psychiatry 23. Epidemiology 57. Resident and Medical Student Concerns 24. Ethics and Human Rights 58. Presidential Theme: The 21st Century Psychiatrist 25. Forensic Psychiatry 59. Stigma/Advocacy 26. Geriatric Psychiatry 60. Telepsychiatry 27. Neuropsychiatry 61. Virtual Reality 28. Psychiatric Education 62. Women's Health Issues 29. Psychiatric Rehabilitation

GUIDE TO USING THE TOPIC INDEX

Use this index to find sessions of interest to you. There are five overall topics: Disorders, Practice Areas/Settings, Subspecialty Areas or Special Interests, Treatments, and Other Issues. Under each overall topic, you will find subtopics listed in alphabetical order with the formats (type of session) listed alphabetically underneath. Within each format you will find the title of the individual session listed by number. The listing will also show the page number the session appears on. You should refer to the page number in this Program Book to obtain further details about the session.

99 TOPIC INDEX

DISORDERS Page # DISCUSSION GROUP Page # 17 Managing Depression and Anxiety in Patients with Cancer and TOPIC 1: AIDS AND HIV-RELATED DISORDERS Other Medical Illnesses 44

DISCUSSION GROUP INDUSTRY-SUPPORTED SYMPOSIA 7 Working with HIV-Positive Patients and Their Physicians 20 2 Switching from Imipramine to Sertraline in Panic Disorder with Agoraphobia 22 MEDICAL UPDATE 3 Atypical Depression in Primary Anxiety Disorders 22 4 Comprehensive HIV Care: Treatment and Service Update 90 4 Risk Factors for PTSD in North Korean Defectors 22 8 Mixed Anxiety Depressive Disorder in a Sample of Primary Care Patients 22 SYMPOSIA 50 The Psychiatric Treatment of HIV Disease in the Third Decade of AIDS 61 MASTER EDUCATOR CLINICAL CONSULTATION 77 HIV Treatment Dimensions Among Diverse Ethnic and Cultural 12 Obsessive Compulsive and Related Disorders 73 Populations 94 SCIENTIFIC AND CLINICAL REPORTS WORKSHOP - COMPONENT 17 PTSD Versus Panic Disorder: Differences in HPA Axis/ 52 Psychological Issues of People Living Longer with HIV 89 Noradrenergic Functioning 23 18 Beyond One-Year Imipramine Maintenance in Panic Disorder WORKSHOP - ISSUE with Agoraphobia 23 54 HIV, AIDS, Hepatitis-C, Mental Illness, and Substance Abuse: 19 Social Phobia Treatment Survey 23 Converging Illness 44 25 Cigarette Smoking and Risk for Anxiety Disorders 23 121 Adjunctive Use ofTiagabine with Antidepressants in PTSD 92 TOPIC 2: ALCOHOL AND DRUG-RELATED DISORDERS SYMPOSIA 28 Psychotic Symptoms in Chronic PTSD: Prevalence, Comorbidity, COURSE and Treatment 55 74 Integrated Model for Treatment of Co-Occurring Psychiatric and 52 Social Anxiety Disorder and Comorbid Major Depression 61 Substance Disorders 52 TOPIC 4: ATTENTION SPECTRUM DISORDERS FORUM 2 Leadership Challenges in Mental Health and Substance Abuse: A COURSE Meeting of the Minds 26 93 Advanced Assessment and Treatment of ADD 78

SCIENTIFIC AND CLINICAL REPORT DISCUSSION GROUP 81 Ecstasy: Complications and Neurotoxicity 74 20 Psychopharmacologic Treatment of Comorbid Attention Disorders in Adults 67 SYMPOSIA 21 Update on Treatment of Stimulant Abuse 33 81 Alcohol Interventions Across the Spectrum for Community INDUSTRY-SUPPORTED SYMPOSIA Practitioners 95 5 New Approaches for Treating ADHD: The Whole-Life Perspective 3 47 Adult ADHD: From Research to Clinical Practice 86 WORKSHOP - COMPONENT 25 Ambulatory Detoxification from Alcohol: How to Do It Well and MASTER EDUCATOR CLINICAL CONSULTATION Get Paid Too 49 11 Adults with Learning Disabilities and Mood Disorders 69

WORKSHOPS - ISSUES TOPIC 5: COGNITIVE DISORDERS (DELIRIUM, 18 Breaking the Cycle of Maternal Addiction: An Integrated Treatment DEMENTIA, AMNESTIC, ETC.) Program Making a Difference 20 28 What Works in Substance Abuse Treatment? 26 36 National Commission on Marijuana and Drug Abuse Report: COURSE 30 Years Later 43 27 Alzheimer's Disease: Advanced Approaches to Treatment 7 43 Evidence-Based Treatment for Marijuana Dependence 43 49 Group Psychotherapy for Substance Abusers 44 DISCUSSION GROUP 61 Methamphetamine Treatment: What Psychiatrists Need to Know 50 11 Delirium: Phenomenology, Neuropathogenesis, and Treatment 70 Grievous Bodily Harm and Club Drugs: Treatment and Other Interrelationships 39 Considerations 70 98 Towards Global Decriminalization of Drug Addiction 89 117 Substance Abuse Prevention and Treatment: A Psychiatric INDUSTRY-SUPPORTED SYMPOSIA Perspective 93 1 Psychiatry Practice Paradigm: The Emerging Role of the Psychiatrist in Treating Alzheimer's Disease 2 TOPIC 3: ANXIETY DISORDERS 43 Noncholinergic Treatments for Alzheimer's Disease: Present Knowledge, Future Hope 85 COURSES 98 The Missing Piece of the Puzzle: TIC Disorders in Adults with MEDIA PROGRAM OCD or ADD 88 2 Memento 12 101 PTSD: An Hispanic Update of a Universal Problem (In Spanish) 88

100 TOPIC INDEX

TOPIC 6: EATING DISORDERS Page # Page# 25 Clinical Challenges in Depression, Part 1 13 COURSES 25 Clinical Challenges in Depression, Part 2 37 31 Bipolar Depression and Rapid Cycling: Current Management 10 Multimodal Treatment of Eating Disorders 2 Strategies 63 25 Therapeutic Interventions in Eating Disorders: Basic Principles 7 39 Age, Gender, and Diagnosis: Influences on Drug Response, Part 1 65 39 Age, Gender, and Diagnosis: Influences on Drug Response, Part 2 87 INDUSTRY-SUPPORTED SYMPOSIUM 40 Therapeutic Challenges, Novel Approaches: Antipsychotics in the 48 Advances in the Understanding and Treatment of Binge-Eating Management of Mood and Anxiety Disorders, Part 1 65 Disorder 86 40 Therapeutic Challenges, Novel Approaches: Antipsychotics in the Management of Mood and Anxiety Disorders, Part 2 87 SCIENTIFIC AND CLINICAL REPORTS 5 Perfectionism, Training, and Eating Behaviors in Runners 22 LECTURE 13 What Can Late Life Teach Us About Depression? 53 6 Self-Reported Hunger and Parasympathetic Tone 22 7 Topiramate Treatment of Bulimia Nervosa 22 RESEARCH CONSULTATION 114 Sibutramine Treatment of Obesity in Schizophrenia 92 1 Depressed Patients with Heart Disease and Late-Life Depression 46 SYMPOSIA REVIEW OF PSYCHIATRY: SECTION 1 6 Eating Disorders 2002: Biological, Clinical, and Social Perspectives 30 Treatment of Recurrent Depression: A Call to Arms 29 43 What's New in Eating Disorders: A Clinical Research Treatment Update 59 SCIENTIFIC AND CLINICAL REPORTS 17 Fluoxetine-Induced Weight Change in Depressive Subtypes 23 18 Adjunct Modafinil for Fatigue and Wakefulness in MDD 23 TOPIC 7: MENTAL RETARDATION 19 Short-Term Use of Estradiol as an Antidepressant Strategy in (CHILD/ADOLESCENT/ADULT) Perimenopausal and Postmenopausal Women 23 20 A Comparison of the Prevalence and Correlates of Anger Attacks in SCIENTIFIC AND CLINICAL REPORT Bipolar Disorder 23 106 The Use of Atypical Antipsychotics in Adults with Developmental 21 Topiramate Treatment of Rapid-Cycling Mood Disorder 23 Disability 91 22 Cognitive and Psychosocial Deficits in Bipolar Disorder and Schizophrenia 23 49 Increased Rates of Antipsychotic-Induced EPS in Mood Disorders: TOPIC 8: MOOD DISORDERS Myth or Reality? 47 50 Cyclothymia in Atypical Depression: The Borderline-Bipolar II ADVANCES IN PSYCHOPHARMACOLOGY Connection 48 Anticonvulsants as Mood Stabilizers 28 51 Substance Use and Perceived Symptom Improvement in Bipolar Disorder 48 96 Psychosocial Functioning as a Predictor of Response to Nortriptyline ADVANCES IN RESEARCH in Treatment-Resistant Depression 76 Depression and Coronary Heart Disease: Epidemiology, Treatment, 97 Efficacy of Citalopram as an Augmenting Strategy for Menopausal And Mechanisms 20 Women with Estrogen-Resistant Depression 76 Depression, Coronary Artery Disease, and Mortality 20 98 Polypharmacy with Antidepressants 76 109 Evaluation and Intervention of Prodromal Symptoms of Bipolar I CLINICAL CASE CONFERENCE Disorder 91 2 Depression in the Medical Setting Revisited: The Problem of the 110 Dysthymic Disorder: Integrating Research Findings into Clinical Depressive Spectrum Disorders 38 Treatment 92 111 Effect of Adjunct Modafinil on Energy and Concentration in Depressed Patients 92 COURSES 112 Parental Separation at Birth and Depression in Adulthood 92 12 Evidence-Based Management of SAD: Focus on Light Therapy 2 13 Neuroendocrinology in Mood Disorder: Dysregulation SYMPOSIA and Treatment 2 20 Is There a Bipolar Spectrum? 33 21 Anticonvulsants in Bipolar Disorder 5 22 New Frontiers in the Neuroendocrinology of Affective Disorders 34 38 Melatonin and Light Treatment of SAD, Sleep, and Other 35 Depression and the Transition to Perimenopause: The Harvard Body Clock Disorders 8 Study of Moods and Cycles 57 44 Using Humanities to Understand Mood Disorders 14 47 Major Depression: Current Guidelines, Practices, and Effectiveness 102 The Conceptual Basis of Psychiatry 88 Research 60 48 Depression Care in Medical Settings: Approaches for the Future 60 DISCUSSION GROUP 55 Combination Therapy for Bipolar Disorder: Rationales and 16 Depression in the Medically 111 44 Controversies 62 WORKSHOP - ISSUE INDUSTRY-SUPPORTED SYMPOSIA 37 Bridging the Gap: Depression, Chronic Medical Disease, Culture, 3 Bipolar Disorder: New Nationwide Data on Misdiagnosis and and Ethnicity 43 Community Costs 3 4 Improving Patient Outcomes Across the Spectrum of TOPIC 9: PERSONALITY DISORDERS Bipolar Disorder 3 9 Depressive Subtypes: The Multiple Faces of Depression 6 COURSES 10 Recovery from Depression: New Perspectives to Improve Outcomes 6 48 Disorders of the Self: Differential Diagnosis and Treatment 15 14 Customizing Care for Patients with Bipolar Disorder 8 64 Partial Hospitalization for Patients with BPD 38 15 The Aging Brain and Vulnerability to Depression 9 83 Personality Disorders: Combined Interpersonal and Pharmacotherapy 66 16 Long-Term Management of Mood Disorders 9 85 Psychotherapy of Borderline Personality 66 20 Atypical Depression: Overview and New Developments 11 21 New Developments in the Treatment of Bipolar Disorder 11 (Continued on next page) 101 TOPIC INDEX

LECTURE Page # MEDIA PROGRAM Page # 2 Personality Disorders: New Findings and Current Controversies 15 31 A Beautiful Mind 79

SCIENTIFIC AND CLINICAL REPORTS RESEARCH CONSULTATION 26 BPD, Medical Illness, Lifestyle Choices, and Health Care Utilization 24 2 Brain Behavior Studies in Schizophrenia 74 27 Impulsivity, Gender, and 5HT in BPD 24 28 Diagnostic Efficiency of BPD and Antisocial Personality Disorder SCIENTIFIC AND CLINICAL REPORTS (APD) Criteria in Monolingual Hispanic Men 24 29 The Relationship Between Negative and Positive Symptoms: A 72 Risperidone Treatment of Schizotypal Personality Disorder 74 15-YearFollow-Up 24 73 A Preliminary Trial of Omega-3 Fatty Acids in Women with BPD 74 30 Neurological Soft Signs and Psychopathology in Schizophrenia 24 74 Is Chemical Imbalance a Useful Concept in Treating Personality 31 Heterogeneity in Schizophrenia: Cognitive Deficits and Brain Disorders? 74 Abnormalities 24 52 Outcome of Early-Phase Psychosis Concurrent with Substance Use 48 SYMPOSIA 53 Predictors of Syndromal and Functional Recovery in Patients with 9 Interaction of Stress and Personality 31 First-Episode Mania 48 12 Sadistic Personality Disorder: Its Wide Range and Importance as a 54 High Birth Weight as a Predictor of Schizophrenia: A 31-Year Diagnosis 31 Follow-Up 48 30 Hyperarousal and BPD: New Studies on Origins, Imaging, Taxonomy, 113 Low-Frequency Transcranial Magnetic Stimulation Curtails and Treatment 55 Medication-Resistant Auditory Hallucinations 92 32 Course and Treatment of BPD 56 115 The Stabilization Phase of Schizophrenia: A Review of the Literature 92 61 Course of Psychopathology and Functioning in Personality Disorders 81 63 Personality and Personality Disorders in the Community 82 SYMPOSIA 72 Affective Instability in BPD 84 7 Management of Schizophrenia with Comorbid Disorders 30 82 The Schizophrenia Prodrome: Update of Research 2002 95 27 New Treatment Target in Schizophrenia: Update on Social Anxiety 55 84 Clinical Challenges in Treating Schizophrenia 96 WORKSHOPS - ISSUES 3 Cognitive-Behavioral Therapy Training for Residents: How to Teach, WORKSHOPS - ISSUES Measure, and Attain Resident Competency 18 13 Schizophrenia with Comorbid Conditions: Clinical and 7 Personality Disorders in the Mental Retardation and Development Research Issues 19 Disorders Population 19 84 Clozapine Use in HIV 71 22 Cognitive Therapy for Personality Disorders 26 101 Teaching Primary Care Residents About Depression and Suicide: Can TOPIC 11: SEXUAL AND GENDER IDENTITY Technology Alter Outcomes? 89 DISORDERS TOPIC 10: SCHIZOPHRENIA AND OTHER COURSES PSYCHOTIC DISORDERS 59 Sexual Disorders: Diagnosis and Treatment 38 89 The Assessment and Treatment of Child Molesters 67 ADVANCES IN RESEARCH Schizophrenia: What Can Functional Brain Imaging Tell? 20 MEDIA PROGRAM Advances in Psychopharmacologic Treatment of Schizophrenia and 11 Just Call Me Kade 28 Related Psychoses 20 SYMPOSIUM COURSE 18 Love from Pathology to Normality 33 19 Training in the Use of the Positive and Negative Syndrome Scale 5

INDUSTRY-SUPPORTED SYMPOSIA TOPIC 12: SLEEP DISORDERS 6 Antipsychotic Therapy and Cardiovascular Disease: The Unfolding Story 3 COURSES 12 Advances in the Treatment of Psychosis: Minimizing the Burden of 35 Irresistible Sleep: Narcolepsy Update 8 Disease 6 51 Overview and Update of Sleep Disorders Medicine 27 17 The Adherence Challenge: Chronic Issues and Emerging Solutions 91 Sleep Medicine Update: Advanced Topics 78 with Antipsychotic Therapy 9 18 Challenges and Opportunities in the Management of Psychotic INDUSTRY-SUPPORTED SYMPOSIA Disorders 9 28 Understanding Sleep Medicine: What the Psychiatrist Needs 26 Novel Antipsychotic Drugs: Advances in the Treatment of Psychotic to Know, Part 1 13 Spectrum Disorders, Part 1 13 28 Understanding Sleep Medicine: What the Psychiatrist Needs 26 Novel Antipsychotic Drugs: Advances in the Treatment of Psychotic to Know, Part 2 13 Spectrum Disorders, Part 2 13 44 Sleep Disorders and Psychiatric Illnesses: Scientific Foundations 85 33 Managing Aggression Across the Life Span: From the Pediatric to the 46 Identification and Management of Daytime Fatigue and Sleepiness Geriatric Patient 63 in Psychiatry 86 35 Raising Expectations in Schizophrenia: Enhancing Long-Term Outcomes 64 SCIENTIFIC AND CLINICAL REPORTS 42 New Perspectives on Schizophrenia Spectrum Disorders and Their 63 Effect of Modafinil on Mood and Quality of Life in Patients with Treatment, Part 1 65 Narcolepsy 49 42 New Perspectives on Schizophrenia Spectrum Disorders and Their 64 Long-Term Safety and Efficacy of Modafinil for Daytime Sleepiness 49 Treatment, Part 2 87

102 TOPIC INDEX

TOPIC 13: SOMATOFORM DISORDERS Page# DISCUSSION GROUP Page # 15 Treating Substance Abusers with Comorbid Psychiatric Disorders: COURSE Potential Pitfalls 44 15 The Evaluation and Management of Pain 2 FORUM SYMPOSIUM 8 The Challenges of Identifying and Interviewing Potential Substance 74 Patients with Chronic Pain: Multidisciplinary Treatment Approaches 84 Abusers 51

PRACTICE AREAS/SETTINGS LECTURE 5 Opioids and Single-Nucleotide Polymorphisms: Implications for TOPIC 14: PSYCHIATRIC ADMINISTRATION AND Heroin and Cocaine Addictions 21 SERVICES: PUBLIC, PRIVATE, AND UNIVERSITY MEDICAL UPDATE 2 Cardiac Effects of Opioid Addiction Pharmacotherapy 46 COURSES 6 Basic Concepts in Administrative Psychiatry: Theory, Human SCIENTIFIC AND CLINICAL REPORTS Resources, and Fiscal Management 1 82 Predicting Treatment Outcome of Cocaine-Dependent Patients 75 23 Basic Concepts in Administrative Psychiatry: Care Management, 83 5HT Uptake, Impulsivity, Aggression, and Craving Among Cocaine Law, and Ethics 6 Abusers 75 94 CPT Coding and Documentation 2002 78 SYMPOSIA DISCUSSION GROUP 23 Addictions: Cutting Edge Treatments for Gambling and Substance 18 Integrating Physical-Mental Health Care: The WCHO Experience 44 Abuse 34 56 Pain in the Addicted Patient: Basic Science, the Law, and Treatment 62 LECTURES 66 Recent Perspectives on Behavioral Addictions 83 14 Women's Leadership in Medicine and Psychiatry 53 68 Club Drugs: Trends, Tosicities, and Treatments 83 24 Does the Psychiatric Hospital Have a Future? 88 69 Naltrexone Treatment of Alcoholism: A Decade of Clinical Progress 83 80 Opiate-Substitution Treatment: International Trends and Perspectives 95 SYMPOSIA 14 Extinction Versus Adaptation: The Future of State Hospital WORKSHOPS - COMPONENTS Psychiatry 32 7 The Philadelphia Story: A VA University of Addiction Research 65 Taking Control of the Future: Academic Psychiatry and Collaboration 18 21st-century Practice 82 8 Substance Abuse in Special Populations 18 21 Medical Student Education in Addiction: Competencies and WORKSHOP - COMPONENT Resources 42 51 Coding and Documentation Update 89 WORKSHOPS - ISSUES WORKSHOP - ISSUE 45 Buprenorphine: A New Office-Based Treatment for Opioid 62 From Psychoanalytic Psychotherapist to Psychoanalytic Dependence 43 Organizational Corporate Consultant: An Introductory Workshop 50 48 Hepatitis-C in Addiction Psychiatry 44 55 Addiction Treatment 2002: New Directions 44 TOPIC 15 OTHER 83 Women and Smoking 71

CLINICAL CASE CONFERENCE TOPIC 17: BIOLOGICAL PSYCHIATRY 1 Contrasting Psychopathology in Adolescents and Adults 14 AND NEUROSCIENCE DEBATE COURSES Resolved: Political Correctness Has No Place in Medicine? 39 24 The Subjective Experience: Crucial Keys to Therapy and to the Human Mind 7 DISCUSSION GROUP 39 Introduction to Transcranial Magnetic Stimulation 14 13 Retrospective Assessment of Mental States in Litigation: Predicting the Past (Meet the Authors) 39 INDUSTRY-SUPPORTED SYMPOSIA FORUM 2 Molecules and Mood Disorders: Drug Discovery and the Treatment of Depression 2 10 ABPN Update: Requirements for ABPN Examination 77 32 The New Neurobiology of Mood and Anxiety Disorders 63 ROUND TABLE DISCUSSION Government Response to Terrorism 17 SYMPOSIA 33 Darwinian Evolution: Affective Temperament and Clinical Considerations 56 SUBSPECIALTY AREAS OR 59 Brain Stimulation in Neuropsychiatric Illness 81 SPECIAL INTERESTS WORKSHOP - ISSUE TOPIC 16: ADDICTION PSYCHIATRY 38 Olfactory Dysfunction in Psychiatry and Neurology 43

COURSES TOPIC 18: BRAIN IMAGING 34 Evidence-Guided Dual Diagnosis Treatment 8 73 Achieving Effective Dual Diagnosis Treatment 52 SYMPOSIUM 84 Office-Based Treatment of Opiate Dependent Patients 66 62 Circuitry of Failed Cognitive Strategies in Addiction 81

103 TOPIC INDEX

TOPIC 19: CHILD AND ADOLESCENT Page # WORKSHOPS - COMPONENTS Page # PSYCHIATRY AND DISORDERS 3 The American Psychiatric Association and Its Alliance Go to America's Schools 17 29 Mission Impossible II: When the Disordered Child Becomes COURSES an Adult 50 3 ADD in Children and Adolescents 1 68 Being an Effective School Consultant 39 WORKSHOP - ISSUE 57 Implementing an Effective Truancy-Reduction Program 44 INDUSTRY-SUPPORTED SYMPOSIA 7 Diagnosis and Treatment Issues in Child and Adolescent Bipolar TOPIC 20: CONSULTATION-LIAISON AND Disorders 5 EMERGENCY PSYCHIATRY 30 Breaking the Silence of Children's Mental Illness: National Initiatives, Early Detection, and New Pharmacotherapies, Part 1 14 30 Breaking the Silence of Children's Mental Illness: National Initiatives, COURSE Early Detection, and New Pharmacotherapies, Part 2 14 40 Psychiatric Consultations in Medical Settings: The Basics 14

LECTURE MEDICAL UPDATE 1 Migraine: Diagnosis, Treatment, and Comorbidity 22 23 Mania in Youth: A Transition from Ignorance to Enlightenment to Confusion 79 RESEARCH ADVANCES IN MEDICINE Long-Term Mechanical Circulatory Support 41 MASTER EDUCATOR CLINICAL CONSULTATIONS 1 Child Forensic Psychiatry Contemporary Issues 16 REVIEW OF PSYCHIATRY SECTIONS 2 the Aftermath of Childhood Parental Loss 16 1 Emergency Psychiatry 41 8 Child and Adolescent Clinical Work: Integrating Bio-, Psycho-, 3 Psychiatry in Medicine 69 and Social 45 SCIENTIFIC AND CLINICAL REPORTS MEDIA PROGRAMS 9 Psychopathological Aspects in 86 Chronic Fatigue Syndrome 9 In the Mix 27 Patients 22 17 Making Visible the Hidden: Serving Child Victims in the Healthcare 10 Low Expression of Negative Affect and Denial Predict Breast Community 46 Cancer Recurrence 23 18 Take This Heart 46 SYMPOSIUM RESEARCH CONSULTATION 2 Advances in the Diagnosis and Treatment of Delirium 29 3 Bipolar Disorders in Children and Adolescents 91 WORKSHOP - COMPONENT REVIEW OF PSYCHIATRY: SECTION 2 14 Legal and Psychiatric Controversies in Interferon Treatment of The Many Faces of Depression in Childhood and Adolescence 54 Hepatitis-C 25

SCIENTIFIC AND CLINICAL REPORTS WORKSHOP - ISSUE 38 A Multinational Study of the Emergence of Gender Differences in 17 How to Effectively Integrate Mental Health Services in General Depression 47 Care Systems 20 43 Once-Daily Administration of Atomoxetine: A New Treatment for ADHD 47 TOPIC 21: CROSS-CULTURAL AND MINORITY 44 ADHD Treatment with a Once-Daily Formulation of PSYCHIATRY Methylphenidate Hydrochloride: A Two-Year Study 47 45 Long-Term Safety and Efficacy of Adderall Extended Release in COURSES Children with ADHD 47 17 DSM-IV-TR Cultural Formulations: Diagnosis and Therapy 5 75 ADHD Comorbidity: Age and Gender Differences 74 76 Multicultural Approach to the Treatment of Women 52 77 Modafinil in Children with ADHD: A Double-Blind, Placebo- Controlled Study 74 DISCUSSION GROUP 107 Anxiety Disorders in Children and Adolescents with Bipolar 6 Psychiatry and Palliative Medicine 20 Disorder 91 108 Comorbidity in Child and Adolescent Major Depression 91 FORUM 11 Latin America 77 SYMPOSIA 19 Adolescence: The Tumultuous Years 33 LECTURES 54 Family Treatment Outcomes of Adolescents with Substance Use 9 Problems Facing Inner-City School Educators and the Role of Disorders: Cultural Issues 62 Psychiatry in Addressing Them 40 57 Sports Through the Life Cycle 80 20 Journey to the West: Reflections on Culture and Psychiatry Entering 67 Diagnosis and Treatment of ADHD in Young Children 83 the New Century 72 70 State-of-the-Art Adolescent Substance Abuse Prevention and Treatment 83 MEDIA PROGRAMS 71 Treatment of Violence and Conduct Disorders in Children and 5 Carved from the Heart: A Portrait of Grief, Healing, and Adolescents 84 Community 21 86 Reducing Aggressive Behavior: Changing the Trajectory for 6 Homeland 21 Drug Use 96 7 Between Worlds 21 92 Treatment of ADHD: From Clinical Trials to Routine 19 A World of Food: Tastes and Taboos in Different Cultures 52 Clinical Practice 98 21 Standing on My Sisters' Shoulders 54

104 TOPIC INDEX

SCIENTIFIC AND CLINICAL REPORTS Page # LECTURES Page # 11 Is the Wechsler Intelligence Scale for Children, Third Edition 12 Dying Well: Beyond Symptoms and Suffering, Human Development (WISC-III UK) Applicable to Ghana? 23 at the End-of-Life 45 12 Dissociation, Childhood Trauma, and Ataque De Nervios 23 19 Can the Third Millennium Psychiatrist Help Persons at the 13 Trauma, Creative Cognition, and Success Among Tribal South- End-of-Life? 72 African Students 23 66 Integrating Psychiatry and Primary Care Improves Treatment SCIENTIFIC AND CLINICAL REPORTS Acceptability Among Asian Americans 49 59 Experience of Research Participation by Patients with Severe Mental 67 Anger Discomfort in Japanese, Chinese, and Caucasian Females 49 Illness 48 68 Anatomy of Jeong 49 60 Attitudes of Physicians Towards Gifts from the Pharmaceutical 71 Prevalence and Symptom Patterns of Depression Among College Industry: A Pilot Study 48 Students 49 WORKSHOPS - COMPONENTS SYMPOSIA 2 Justice and Health Equity in Global Psychiatry 17 38 Beyond the Surgeon General's Report: Psychiatry for a Diverse 13 Experts or Pawns? Psychiatric Consultation for Government Population 58 Agencies 25 51 American Psychiatric Association's Responses to the Surgeon General's Reports on Mental Health 61 WORKSHOPS - ISSUES 73 Clinical and Treatment Challenges with Hispanic Patients 84 6 The Policing of Physician-Patient Boundaries: Some International 76 Culturally Competent Mental Health Care: Identifying and Reducing Perspectives 19 Disparities 94 21 Nonsexual Boundary Violations: Special Problems in Small Communities 26 WORKSHOPS - COMPONENTS 26 Confidentiality Issues and Legal Essentials in Sexual Harassment 4 When Your Physician Patient Is from an Ethnic Minority: A Cross- Cases 26 Cultural Approach to Treatment 17 17 Psychiatry Without Borders: Breaking the Barriers 25 TOPIC 25: FORENSIC PSYCHIATRY 18 Psychiatric Casualties in the Mental Health of Hispanic Immigrants 25 19 Health Care Legislation: The Role for the 21st-century Black Psychiatrist 42 COURSES 22 Discussion: Surgeon General's Report on American Indians and 18 The Psychiatrist as Expert Witness 5 Alaska Natives 42 30 Introduction to Correctional Psychiatry 7 23 Mental Health Care for Asian Americans and Pacific Islanders 49 58 The Detection of Malingered Mental Illness 38 35 Whose Children? Psychiatry in the Cultural Mosaic of America's 62 How to Set Up and Run a Juvenile Justice Clinic 38 80 Insanity Defense Evaluations 66 Schools 70 49 Meeting the Mental Health Needs of Minorities in the 21st Century 77 54 Surgeon General's Report on Culture, Race, and Ethnicity: Clinical SCIENTIFIC AND CLINICAL REPORTS Implications 89 84 Civil Commitment in Turkey: Reflections on a Bill Drafted by 57 Asian Americans in Intermarriages: Psychosocial Adjustment Psychiatrists 75 and Identity 93 85 Malpractice Liability in Shared Treatment 75 99 Medications, Strange Intoxications, and Violent Crime 91 100 Treating Mentally 111 Offenders in a Residential Treatment Unit 91 WORKSHOPS - ISSUES 101 Presidential Assassination Syndrome Revisited: New Understanding 91 9 Career Development for International Medical Graduates 19 15 Training a Culturally Competent Psychiatric Workforce 19 SYMPOSIA 72 Psychopharmacogenetics and Ethnicity: Current Perspectives 70 39 Defining Evil: Clinical and Forensic Implications 58 83 The Duty to Warn and Protect for the 21st-century Psychiatrist 95 TOPIC 22: DIAGNOSTIC ISSUES WORKSHOPS - COMPONENTS COURSE 34 Practicing Rewarding Psychiatry in Jails and Prisons: A Practicum 69 42 Educating the Courts: Recent APA Amicus Curiae Briefs 76 46 Advanced Interviewing Techniques 15 WORKSHOPS - ISSUES TOPIC 23: EPIDEMIOLOGY 56 Tarasoff Revisited: Changing Trends in Duty to Warn Third Parties 44 90 The Psychiatric Fitness-for-Duty Exam 77 SCIENTIFIC AND CLINICAL REPORTS 92 Self-Mutilation in Prison 77 69 The Burden of Hepatitis-C Among Mentally 111 Persons in Long-Term Care 49 TOPIC 26: GERIATRIC PSYCHIATRY 70 Double Jeopardy: Mental Illness, Medical Conditions, and Early Death 49 COURSE 22 Appreciating and Alleviating Spousal Caregiver Burden in Dementia 5 TOPIC 24: ETHICS AND HUMAN RIGHTS INDUSTRY-SUPPORTED SYMPOSIA 8 Late-Life Depression: Old Myths and New Data 5 COURSES 37 Behavioral Disturbances in Dementia: Diagnostic and Treatment 28 Medical Ethics 101 7 Guidelines 64 97 Ethical Decision-Making in Clinical Practice 87 49 Explorations in Dementia: New and Current Perspectives 86

DISCUSSION GROUP LECTURE 10 Living Organ Donation: Psychiatric Aspects and Ethical Dilemmas 6 Alzheimer's Disease: The Challenges of Big Risks and Small Gains 28 for Donor and Recipient 39 (Continued on next page) 105 TOPIC INDEX

MEDIA PROGRAM Page # WORKSHOPS - ISSUES Page # 29 Bubbeh Lee and Me 78 23 Assessing Psychotherapy Competencies of Residents 26 25 Psychotherapy Termination: A Challenge in Psychiatric Residency MEDICAL UPDATE Training 26 3 Strategic Update of Alzheimer's Disease: Linking Disease with 30 The Neurobiology of Learning: Implications for Teaching 42 Therapeutics 73 40 Cultural Competence in Psychiatric Residency Training Programs 43 42 Ten Years of Teaching About Boundaries: What Have We Learned? 43 80 Teaching Behavioral Sciences to Family Doctors 71 SCIENTIFIC AND CLINICAL REPORTS 100 How to Give a More Effective Lecture: Punch, Passion, and Polish 89 15 Socioeconomic Status and Depression Among Older Adults 23 118 How to Develop a Lecture 93 16 Psychotherapy with the Elderly 23 TOPIC 29: PSYCHIATRIC REHABILITATION SYMPOSIA 8 Depressive Spectrum Disorder in Late Life: Implications for Clinical Care 30 MEDIA PROGRAM 58 Community Care in Geriatric Psychiatry in the 21st Century 80 28 West 47th Street 73

WORKSHOPS - COMPONENTS SCIENTIFIC AND CLINICAL REPORT 86 Assertive Community Treatment Team Patient Employment 11 The Role of the Geriatric Psychiatrist in Palliative Care 18 Outcomes 75 12 Navigating Geriatric Psychiatry Research: Issues for the Beginning Researcher 25 SYMPOSIUM 75 Physician Disability: Treatment, Independent Evaluation, Insurance, WORKSHOP - ISSUE and Conflicts 85 2 Nursing Home Psychiatry: Problems and Solutions 18 TOPIC 30: PSYCHOANALYSIS TOPIC 27: NEUROPSYCHIATRY SYMPOSIA COURSES 1 Evidence-Based Psychodynamic Therapy Part I: Studying 5 ECT in Neurological Disorders 1 Clinical Work 17 20 The Evaluation and Identification of the Major Dementias 5 10 Evidence-Based Psychodynamic Therapy Part II: What Do the 47 Traumatic Brain Injury: Neuropsychiatric Assessment 15 Data Show? 31 49 Advances in Neuropsychiatry 15 TOPIC 31: RESEARCH ISSUES DISCUSSION GROUPS 8 Recognizing and Treating Neuropsychiatric Lyme Disease 20 COURSE 12 Neuropsychiatry and the Future of Psychiatry (Meet the Authors) 39 63 Doing Research on a Shoestring Budget 38

INDUSTRY-SUPPORTED SYMPOSIUM NEW RESEARCH SESSIONS 24 Molecules of the Mind: The Science of Schizophrenia 12 1 Young Investigators'Poster Session 17 2 Young Investigators' Oral/Slide Session 27 LECTURE 3 Young Investigators' Oral/Slide Session 27 4 Neuroscience in the New Millennium 20 4 Young Investigators' Oral/Slide Session 27 5 Poster Session 35 SYMPOSIUM 6 Poster Session 51 3 Plagues, Prions, and Paranoia: The Neuropsychiatry of Infectious 7 Poster Session 63 Disease 29 8 Poster Session 78 9 Poster Session 85 WORKSHOP - ISSUE 27 Pseudodementia in the 21st Century 26 SYMPOSIA 25 A Research Agenda for DSM-V 34 40 The Therapeutic Misconception in Research: Barrier or Necessity? 58 TOPIC 28: PSYCHIATRIC EDUCATION WORKSHOPS - ISSUES COURSES 39 Neurobehavioral Sequelae of Trauma to the Frontal Lobes 43 31 Integrative Psychotherapy Supervision: Basic Tools 7 116 Creating Effective Alliances with Pharmaceutical Industry Physicians 93 42 Teaching Psychiatry? Let Hollywood Help! 14 45 Pass the Boards! The Part II Oral Exam 15 54 Enhancing the Doctor-Patient Relationship 27 TOPIC 32: SOCIAL AND COMMUNITY PSYCHIATRY 71 I Found It at the Movies: Using Film Clips to Understand and Teach Psychiatry 52 COURSE 86 How to Practice Evidence-Based Psychiatry 66 37 Psychiatric Interventions in Disasters: Lessons from Experience 8 90 The Biopsychosocial Formulation: An Approach to Oral Board Presentations 67 LECTURE 3 Accessing Care: A Challenge to the Poor and Disadvantaged 16 WORKSHOPS - COMPONENTS 15 The Good-Enough Mentor: Perspectives on Mentoring in Psychiatric MEDIA PROGRAMS Training 25 13 Six Billion and Beyond 41 32 Competence Requirements in Resident Education: Progress and 14 Slippery Blisses 41 Problems 69 15 Personal Space: Exploring Human Proxemics 41 47 New Trends and Challenges in Residency Education 76 24 Remember the Titans 54

106 TOPIC INDEX

SCIENTIFIC AND CLINICAL REPORTS Page # DISCUSSION GROUP Page # 87 Defining Disability Down 75 14 Treatment of Trauma Survivors: Theory Versus Practice (Meet the 88 Marital Disruption and Mental Health: A Nine Wave Panel Study 75 Authors) 44 89 Divorce and Marital Instability in Different Subtypes of Major Affective Disorders 75 FORUMS 1 New York Academic Centers' Response to the World Trade Center SYMPOSIA Attack 26 26 Academic and Community Mental Health: Can This Marriage 3 Evil 26 Be Saved? 35 9 Killing in the Name of God: Osama bin Laden and Radical Islam 77 42 America Attacked: The American Psychiatric Association and Its 12 PSYOP: Psychological Operations in the War Against Terrorism 93 Members Respond 58 LECTURES WORKSHOPS - ISSUES 1 Rethinking Risk Assessment: The MacArthur Study of Mental 32 We Can Improve Care for Those with Mental Health and Substance Disorder and Violence 10 Abuse Disorders 42 17 Terror, Horror, and Fright: Past and Current Perspectives 68 65 The Challenge of Parental Mental Illness 51 21 Healing the Soul in the Age of the Brain: Reflections on the 77 Disability Myths: Understanding the Social Security Administration Meaning of Psychiatry After September 11 73 Disability Program 71 111 Joining Forces: Working with Law Enforcement to Serve the MEDIA PROGRAMS Mentally 111 90 1 Our Children 12 115 Outpatient Commitment: Kendra's Law and the New York City 20 World Trade Center and Pentagon Disasters 53 Experience 93 26 Blink 69

TOPIC 33: STRESS SCIENTIFIC AND CLINICAL REPORTS 46 Partner Violence and Risk of Major Depression in Chinese-American Women 47 MEDIA PROGRAM 47 Violence in Colombia: Mental Health Impact in Children 47 3 Time Frenzy 16 48 Epidemiology, Trauma, and Transcultural Psychiatry 47 102 Predicting Chronicity in Vietnam Veterans with PTSD: New Findings SYMPOSIUM from the National Vietnam Veterans Readjustment Study 91 53 Adaptations to Severe Stress: Normal Responses and Therapeutic 103 Community and Inpatient Violence in Major Psychiatric Disorders 91 Strategies 61 104 Parental Separation at Birth and Criminality in Adulthood 91

WORKSHOP - ISSUE SYMPOSIA 11 Social Psychiatric Aspects of Violence and Trauma 31 93 Psychiatric Illness and the Workplace 77 36 The Psychological Wounds of National Trauma: Causes, Consequences, and Treatments 57 TOPIC 34: SUICIDE 37 Understanding Psychological Trauma: Multidisciplinary Perspective 57 79 Optimal Strategies for Identifying and Treating Traumatized COURSE Children 94 95 Improving Media Coverage of Suicide: The Role of the Psychiatrist 78 89 Traumatic Response to Disaster: Neurobiology and Treatment 97 WORKSHOPS - COMPONENTS SCIENTIFIC AND CLINICAL REPORTS 30 Clinician Safety 50 23 Suicides in Youths Involved with Juvenile Justice and Child Welfare 44 Critical Issues for Treating Domestic Violence Survivors and Their Services 24 Children 76 24 Predictors of Suicide Attempts in a Personality Disorder Sample 24 55 Bad Boys, Bad Girls: The Demonization of Adolescence 89 25 Hostility and Impulsivity Among Suicidal Bipolar Patients 24 122 Female Suicides in Texas Cities: 1994-1998 93 WORKSHOPS - ISSUES 123 Trends in Suicide Rates in New York City: Implications for a 31 Exploring the Media's Role in Imitation Violence 42 Prevention Initiative 93 78 New Directions in Mental Health Response to Disasters and 124 Changing Suicide Rates in Europe: Possible Causes 93 Large-Scale Crises 71 79 Childhood Trauma Intervention and Aftermath: Access to WORKSHOP - COMPONENT Quality Care 71 56 Guidelines for the Treatment of Suicidal Behaviors 93 85 Intergenerational Aspect of Trauma and Trauma-Related Behavioral Patterns 71 WORKSHOPS - ISSUES 91 Youth Violence: A Report of the Surgeon General 77 8 The Impact on Clinicians of Suicide 19 107 The Frontier of Public Health Psychiatry: Preventing Suicide 90 TREATMENTS

TOPIC 35: VIOLENCE, TRAUMA, AND TOPIC 36: BEHAVIOR AND COGNITIVE VICTIMIZATION THERAPIES COURSES COURSES 53 Cognitive Therapy: The Basics 27 41 Risk Assessment for Violence 14 55 Engaging Resistant and Hostile Patients into Participatory Treatment 27 43 Families and Medical Illness: An Integrative Treatment Approach 14 66 Introduction to Cognitive-Behavioral Therapy 39 78 Sexual Harassment: Psychological and Legal Aspects 52 79 Cognitive Therapy for Severe Mental Disorders 66 87 Caring for Refugees and Survivors of Torture 67 92 Cognitive Therapy for Schizophrenia 78 99 Assessing the Risk for Violence 88 (Continued on next page) 107 TOPIC INDEX

SCIENTIFIC AND CLINICAL REPORTS Page # Page# 55 Does Cognitive-Behavioral Group Treatment Improve Personality 56 Brief Psychodynamic Psychotherapy: The Core Conflictual Measures in Panic Disorder Patients? 48 Relationship Theme Method 27 56 Visually Enhanced Psychosexual Therapy 48 65 Davanloo's Intensive Short-Term Dynamic Psychotherapy in Clinical 57 Dichotomous Thinking and Thought Suppression in Managing Practice 39 Anger 48 72 The Advanced Practice of Psychotherapy 52 81 Interpersonal Psychotherapy 66 WORKSHOP - ISSUE 47 Implementations of DBT in Correctional Environments 43 DISCUSSION GROUP 5 Psychodynamic Psychiatry in Clinical Practice: Third Edition (Meet the TOPIC 37: COMBINED PHARMACOTHERAPY Authors) 20 AND PSYCHOTHERAPY MASTER EDUCATOR CLINICAL CONSULTATIONS 4 Psychotherapy with Immigrant Patients 21 COURSES 5 The Psychotherapies: Do Similarities Outweigh Differences? 40 26 Money Matters: Using Theory in Clinical Practice 7 36 Integrating Pharmacotherapy and Psychotherapy 8 MEDIA PROGRAM 12 Sopranos 29 INDUSTRY-SUPPORTED SYMPOSIA 11 Treating Psychotic Illness Across the Life Span: Are Drugs Enough? 6 29 One Size Doesn't Fit All: Depression Therapies for the 21st SCIENTIFIC AND CLINICAL REPORTS 80 An Additional Guideline for Choosing Appropriate Supportive Century, Part 1 13 Psychotherapy Techniques 74 29 One Size Doesn't Fit All: Depression Therapies for the 21st 92 Clinical Problems in the Treatment of Adults with Comorbid ADD 75 Century, Part 2 37

MASTER EDUCATOR CLINICAL CONSULTATIONS SYMPOSIA 15 The Social Brain and Psychotherapy 32 3 The Doctor-Patient Relationship in Pharmacotherapy 21 41 Combined Treatment: Dynamic Psychotherapy and Medication 58 7 Integrating Psychotherapy and Pharmacotherapy 45 87 New Developments in Interpersonal Psychotherapy Research 96 SCIENTIFIC AND CLINICAL REPORT 78 Music Therapy and Medication Compliance in Psychotic Patients 74 WORKSHOPS - ISSUES 95 Dilemmas of Melancholia: Let Philosophy Help 77 109 Working Through in Psychotherapy 90 SYMPOSIA 4 Fear and Loathing in the Medication Clinic 29 45 Collaborative Practice in Psychiatry: Data and Principles for Practice 59 TOPIC 41: PSYCHOPHARMACOLOGY

WORKSHOPS - ISSUES ADVANCES IN RESEARCH 19 Treating Psychosis Across Diagnosis 25 An Update on the Essentials of Clinical Psychopharmacology 28 58 Psychodynamics in Treatment-Refractory Depression 50 Atypical Antipsychotics 28 113 Bridges for Healing: Integrating Family Therapy and Nonbenzodiazepine Anxiolytics 28 Psychopharmacology 93 COURSES TOPIC 38: COUPLE AND FAMILY THERAPIES 2 Antipsychotic-Induced Movement Disorders: Assessment and Treatment 1 9 Psychiatry Update for the International Spanish-Speaking Colleague SCIENTIFIC AND CLINICAL REPORT (In Spanish) 1 79 Controlled Study of NAMI Family-to-Family Education Program 74 57 Drug Treatment of Schizophrenia 38 67 Med-Psych Drug-Drug Interactions: An Update 39 WORKSHOPS - ISSUES 5 Children of Psychiatrists: 21st-century Insights 19 DISCUSSION GROUPS 29 Working with Parents During Their Baby's First Year of Life 42 3 Quickie Guide to the Cytochrome P450 System (Meet the Authors) 15 33 Couples Treatment by Parallel Coordinated Individual Psychotherapy 42 19 Essentials of Clinical Psychopharmacology (Meet the Authors) 67 114 Video Case Studies of Couples in Treatment 93 INDUSTRY-SUPPORTED SYMPOSIA TOPIC 39: GROUP THERAPY 23 Primary Mood Stabilizers as the Cornerstone of Treatment for Bipolar Disorder 11 DISCUSSION GROUP 27 Antipsychotic Pharmacotherapy and the Hippocratic Oath: Above 1 Save Time, Make Money, Have Fun! Outpatient Group Therapy All Do No Harm, Part 1 13 for the Seriously Mentally 111 15 27 Antipsychotic Pharmacotherapy and the Hippocratic Oath: Above All Do No Harm, Part 2 37 MEDIA PROGRAM 36 Clinical Differences in Serotonin and Norepinephrine Anti- 4 The Puppets of Di Con: New Psychodrama Approach 17 depressant Effects 64 41 The Pathophysiology and Treatment of Impulsivity and Aggression TOPIC 40: INDIVIDUAL PSYCHOTHERAPIES in Psychiatric Disorders, Part 1 65 41 The Pathophysiology and Treatment of Impulsivity and Aggression in Psychiatric Disorders, Part 2 87 COURSES 45 The Burden of Schizophrenia: Why Patients Don't Get Better 85 7 Interpersonal Psychotherapy 1 16 Dream Translation: One Empirically-Based Approach 2

108 TOPIC INDEX

SCIENTIFIC AND CLINICAL REPORTS Page # SCIENTIFIC AND CLINICAL REPORTS Page # 32 Effectiveness of Rapid Initial Dose Escalation of Oral Olanzapine 119 Matching Treatment to Type of Poor-Prognostic, Substance- for Acute Agitation 24 Dependent Patients 92 120 Tiagabine, a Selective GABA Reuptake Inhibitor for the Treatment 33 Olanzapine Combined with Lithium or Valproate for Relapse of Anxiety 92 Prevention of Bipolar Disorder: An 18-Month Study 24 34 Olanzapine Versus Divalproex Sodium for Mania: A 47-Week Study 24 SYMPOSIA 40 End-Stage Chronic Renal Failure from Prolonged Lithium Therapy 47 29 New Development in Medications for the Treatment of Substance 41 Topiramate in the Treatment of Refractory Bipolar Depression 47 Abuse 55 42 Prescribing Practices in Bipolar Disorder 47 85 Cognitive Therapy Versus Medications for Severe Depression 96 65 Modafinil Enhances Motivation in the Absence of Overt Sleepiness 49 88 Treating Mental Illness and Substance Abuse in the Criminal Justice 90 Compliance and Treatment Discontinuation in Panic-Disorder System 97 Patients 75 91 The Employment Intervention Demonstration Project: Outcome of 91 Meta-Analysis of Antidepressant Levels in Lactating Mothers' Best Practice 97 Breastmilk and Nursing Infants 75 93 Branched-Chain Amino Acid Treatment of Tardive Dyskinesia 75 94 Nonadrenergic Noncholinergic Sildenafil Treatment of SRI- WORKSHOPS - ISSUES 34 Motion Pictures: The Therapeutic Modality of the 21st Century 42 Associated Sexual Dysfunction 75 60 Use of Restraints in Psychiatric Practice: Pros, Cons, and Alternatives 50 95 Rivastigmine Tartrate in Neurocognitive Deficits in Schizophrenia 66 Aftermath of Professional Boundaries Violations: Treatment of Patients Treated with Clozapine 76 Victims 51 105 Polypharmacy in Patients with Schizophrenia 91

SYMPOSIUM OTHER ISSUES 60 Life-Threatening Hyperthermic Syndromes in Psychiatry 81 TOPIC 44: COMPUTERS WORKSHOPS - ISSUES 73 Practical Pharmacotherapy of Mood Disorders 70 COURSE 103 Lithium Revisited: Integrating Recent Findings into Clinical Practice 90 75 Computers in Psychiatry: A Primer 52 105 Evidence-Based Tables of Side Effects of Psychotropic Medications: Useful? 90 WORKSHOP - ISSUE 108 Medication Use for Children in Systems of Care 90 12 Use of the Personal Digital Assistant in Psychiatry 19

TOPIC 42: OTHER SOMATIC THERAPIES TOPIC 45: CREATIVITY AND THE ARTS

COURSES COURSES 60 ECT Practice Update 38 4 Writing About Clinical Experiences 1 70 Vagal Nerve Stimulation 52 96 Treatment of Creative Patients 79 88 A Practical Approach to Herbs and Nutrients in Psychiatry 67 FORUM WORKSHOPS - ISSUES 4 Music and Mood Disorders: Tchaikovsky 27 63 Role of Amytal in Conversion Disorder 50 75 Drug Therapy for Functional Somatic Syndromes 71 110 Alpha-Down EEC Biofeedback: A Novel Treatment for Anxiety 90 MEDIA PROGRAM 8 M & M Smith: For Prosperity's Sake 22 TOPIC 43: TREATMENT TECHNIQUES AND WORKSHOPS - ISSUES OUTCOME STUDIES 53 The Portrayal of Psychiatry in Recent American Films 44 59 The Art of the Unconscious: Shakespeare, Poetry, Film, and ADVANCES IN PSYCHOPHARMACOLOGY Psychiatry 50 New Antidepressants in Development: Corticotrophin Releasing 81 Music as Mirror: Reflections of the Psyche in Works by the Great Hormone and Neurokinin Antagonists 28 Composers 71 99 Poems on Psychiatry 89 CLINICAL CASE CONFERENCE 112 Erik Erikson Epigenesis as Depicted in Andrew Lloyd Webber's 3 Motivational Enhancement Therapy for the Medically 111, Substance Musicals 90 Abuse Patient with Depression 66 TOPIC 46: ELECTRONIC MEDICAL RECORDS CONTINUOUS CLINICAL CASE CONFERENCES 1 Lives and Treatments: Two Patients, Two Therapists: Part 1 15 COURSES 2 Lives and Treatments: Two Patients, Two Therapists: Part 2 39 1 Computer-Assisted Diagnostic Interview 1 1 Managing Negative Outcomes in General Psychiatry: Part 1 66 29 Build Your Own Relational Database Electronic Medical Record 7 2 Managing Negative Outcomes in General Psychiatry: Part 2 88 TELECOMMUNICATIONS PRESENTATION COURSE 3 Open Infrastructure for Outcomes: From Plug and Play Web Forms 32 Core Competencies in Workplace Psychiatry 7 to Evidence-Guided Treatment 41

DISCUSSION GROUPS WORKSHOP - ISSUE 2 What Makes People Change? 15 94 Electronic Medical Records Enhance Quality and Productivity: The 22 The APA Business Initiative and the Future of Psychiatric Practice 67 Time Has Come 77

109 TOPIC INDEX

TOPIC 47: GENDER ISSUES Page# REVIEW OF PSYCHIATRY: SECTION 4 Page # Mental Health Issues in the Lesbian/Gay/Bisexual/Transgender MEDIA PROGRAM Community 80 32 King of Masks: Gender and Tradition in China 80 WORKSHOPS - COMPONENTS SYMPOSIUM 9 Aging and Mourning in the Gay and Lesbian Community 18 44 Evidence-Based Psychiatry: Principles, Examples, and Critiques in the 36 It's Not Gay Enough: Interpreting Antigay Bias in the 21st Century 70 U.S. and France 59 46 Lesbian, Gay, Bisexual, and Transgendered Residents: Challenges in Training 76 WORKSHOP - COMPONENT 41 The Rules of the Club: Career Advancement for Women 70 WORKSHOPS - ISSUES 16 Transgender Care: New Perspectives 19 41 A Legal Primer for Psychiatrists Involved in Issues of Sexual TOPIC 48: HEALTH SERVICES RESEARCH Orientation 43 69 Treating Gay and Lesbian Youth at Risk 70 COURSE 119 A Clinician's Guide to Substance Abuse Treatment for Gay, 11 Outcomes: Use of Rating Scales 2 Lesbian, Bisexual, and Transgender Persons 93

DISCUSSION GROUP TOPIC 52: MANAGED CARE AND HEALTH 21 Psychiatric Aspects of Cardiovascular Disease 67 CARE FUNDING

SCIENTIFIC AND CLINICAL REPORTS MASTER EDUCATOR CLINICAL CONSULTATION 35 Consensus Development on Core Quality Measures for Mental 6 Brief Dynamic Therapy: For the Patient or for Managed Care? 40 Health Care 25 36 Improving the Competency of Clinicians Treating People with Mental Illness 25 SCIENTIFIC AND CLINICAL REPORTS 76 Psychiatric Diagnosis for Children Under Age Five Referred to a 116 Alzheimer's Disease Increases Costs of Comorbidities in Medicare- Public Mental Health System 74 Managed Care 92 117 Donepezil Is Associated with Lower Health Care Costs in Medicare- SYMPOSIA Managed Care 92 118 Managed Care and Malpractice Liability: Update 2002 92 13 From Research to Practice: Primary Care Research in Substance Abuse and Mental Health Services for Elderly (PRISMe) 32 49 Global Psychiatry and Patients' Rights: Informed Consent 60 WORKSHOPS - COMPONENTS 1 How to Convince Corporate CEOs that Mental Health Is a Good Investment 17 TOPIC 49: HISTORICAL QUESTIONS 28 The Mental Health Carveout: Strategies to Erase the Stigma 50 43 Medicare Update 2002 76 MEDIA PROGRAM 30 The Frog in the Well: The Life and Work of Hoh-Kun Yuen 78 WORKSHOPS - ISSUES 44 Enhancing and Funding Mental Health Services: New Freedom WORKSHOP - COMPONENT Initiative 43 27 Kids, Schools, and Parents: From the 20th Century into the 46 Improving the Quality of Service in a Medicaid HMO 43 21st Century 50 71 Recent Studies on Parity and Employer-Sponsored Insurance 70 86 Do Restricted Formularies Serve as Barriers to Care? 71 TOPIC 50: INFORMATION TECHNOLOGY TOPIC 53: MEN'S HEALTH ISSUES COURSES 61 How to Use Your Palm Personal Digital Assistant in Psychiatric SCIENTIFIC AND CLINICAL REPORTS Practice 38 37 Meat Consumption and Risk of Depression: A Prospective, 82 Evidence-Based Medicine: An Introduction for Psychiatrists 66 Population-Based Study 46 39 Efficacy and Safety of Sildenafil Citrate in Men with Depression and TELECOMMUNICATIONS PRESENTATIONS Erectile Dysfunction: Six-Month, Open-Label Treatment 47 1 The Use of Digital Streaming Video for Distance Education in Telepsychiatry 41 TOPIC 54: POLITICAL QUESTIONS 4 Introduction to Evidence-Based Mental Health 62 COURSE WORKSHOP - COMPONENT 8 Personality and Political Behavior 1 53 Information Technology: Core Competencies for Psychiatrists 89 FORUMS TOPIC 51: LESBIAN/GAY/BISEXUAL/ 6 The Death Penalty and the Road to Execution: Psychological Issues TRANSGENDER ISSUES for Correctional Officers; Appropriate and Inappropriate Roles for Psychiatrists 51 FORUM 13 The Pharmaceutical Industry and the APA: Controversies and 5 Homosexuality and Religion: Healing the Wound 51 Approaches 94

MEDIA PROGRAMS WORKSHOP - COMPONENT 10 Southern Comfort 28 39 Psychologist Prescription Privileges: Is It Coming? Should It? 70 27 "In the Life" Television News Magazine 73 110 TOPIC INDEX

TOPIC 55: PROFESSIONAL AND Page# RESIDENTS' SESSION Page # PERSONAL ISSUES Meet the Experts Sunny-Side Up 14

COURSES SYMPOSIUM 52 Treating Medical Students and Physicians 27 46 How to Launch a Successful Private Practice: Part III 60 77 Arts and Humanities for Self-Renewal 52 WORKSHOPS - COMPONENTS LECTURES 10 Psychiatry in the Neuroscience Curriculum: Promise and Peril 18 8 You Are Twenty-Four and You Have What? 40 20 How to Launch a Successful Private Practice: Part I 42 22 Global Implications on the World Health Organization's World 31 How to Launch a Successful Private Practice: Part II 50 Health Report 2001 on Mental Health 79 40 Combined Residency Training: You Want to Do What? 70 50 Career Choices in Psychiatry 88 SYMPOSIA 17 Practicing Psychiatry in 2002 32 WORKSHOPS - ISSUES 64 Lessons Learned: Looking Back to Move Forward 82 1 How to Get the Most Out of Supervision: What Residents Need to 90 Psychiatry and the Pharmaceutical Industry: Where Is the Boundary? 97 Know 18 4 Supervision 101: Sex, Lies, and Videotape? 18 WORKSHOPS - COMPONENTS 11 Access to Psychotherapy Training in Residency: A Current 6 Risk Management Issues in Psychiatric Practice 18 Perspective 19 24 Survivor MUR: Who Gets Voted In? 49 20 Challenges of the Chief Resident in Psychiatry 26 38 Talking with the Terminally 111 About Death and Dying 70 48 HIPAA Privacy Rule: What Every Psychiatrist Needs to Know 76 35 Innovative Strategies in Third-Year Medical Student Psychiatric Education 42 WORKSHOPS - ISSUES 50 World Federation of Psychiatric Trainees: Satisfaction and International Exchange in Psychiatric Education 44 24 Professionalism in the Teacher/Learner Relationship 26 89 Assessing Educational Experiences in Psychiatry 77 52 Ethics of Pharmaceutical Involvement in Psychiatric Education 44 64 Minority Psychiatrists Who Have Suffered Mental Illness: 97 The Other Side of the Mountain: From Residency to Reality 89 CK'ercoming Stigma 51 67 A Recipe for Academic/Personal Success: Some Key Ingredients 51 TOPIC 58: PRESIDENTIAL THEME: "THE 21ST 82 Assisting Physicians and Other Professionals Who Violate CENTURY PSYCHIATRIST" Boundaries 71 88 Career Development and Risk Management 72 104 The Disruptive Physicians and Hospital Culture 90 COURSE 106 Using Your Psychiatric Skills to Build a Productive Team at Work 90 100 Back to the Future: The Evolutionary Framework for Psychiatry 88

TOPIC 56: RELIGION, SPIRITUALITY, AND MASTER EDUCATOR CLINICAL CONSULTATION PSYCHIATRY 9 Changing and Evoking Roles for the Clinicians 68 COURSES PRESIDENTIAL SYMPOSIUM 50 Issues in Transpersonal Psychiatry 15 What Will the 21st Century Bring to the Training of Psychiatrists? 29 69 Transpersonal Psychiatry: Clinical Applications 39

LECTURES SCIENTIFIC AND CLINICAL REPORT 11 Healing Through Social and Spiritual Affiliation 45 58 Principles of Clinical Explanation in 21st-century Psychiatry 48 16 The Nearly Forgotten Factor in Psychiatry: What a Difference a Decade Makes 67 SYMPOSIA 5 Health Insurance Portability and Accountability Act: Clinical MEDIA PROGRAM Applications and Implications 30 16 Long Night's Journey into Day 46 24 Psychotherapy Research: Challenges for the 21st Century 34 78 Brain Substrates of Addiction: Neuroimaging as a Tool of Choice SCIENTIFIC AND CLINICAL REPORTS in the 21st Century 94 61 Effects of Falun Gong Practice on Physical and Mental Health 48 62 Moral Conflict as a Component of Anxiety and Worry 48 WORKSHOPS - COMPONENTS 5 The Psychiatrist and Migration in the 21st Century 18 26 The Terrorist Crisis of 2001: Use and Impact of Electronic WORKSHOP - COMPONENT Communication 50 45 Psychiatry's Response to the Data: Spirituality as a Relevant Clinical 33 Quality Indicators for Children and Adolescents: Who Cares? 69 Factor 76 WORKSHOPS - ISSUES WORKSHOPS - ISSUES 14 Psychotherapy Training for the 21st-century Psychiatrist 19 51 Spiritual Dimension and Religious Issues in an Urban CMHC 68 The Body in 21st-century Psychiatry: Diagnostic Dimensions and Clinical Practice 44 Therapeutic Challenges 51 74 Mindfulness and Awareness Practice in the Medicine Buddha 76 In Search of the Empathic Healer 71 Tradition of Tibet 71 102 Religious and Spiritual Assessment in Clinical Practice 90 TOPIC 59: STIGMA/ADVOCACY TOPIC 57: RESIDENT AND MEDICAL LECTURES STUDENT CONCERNS 7 Psychiatry and the Medical Consumer Movement 36 18 Mental Health: A Perspective from the Surgeon General Who Listens 68 DISCUSSION GROUP 9 Surviving Residency: Perspectives from the Training Office 39 (Continued on next page)

111 TOPIC INDEX

SYMPOSIUM Page # TOPIC 62: WOMEN'S HEALTH ISSUES Page# 31 False Memory Syndrome: Recovery and Family Reconciliation 56 ADVANCES IN RESEARCH WORKSHOP - COMPONENT Treatment of the Pregnant or Postpartum Woman 28 16 Talking on Your Feet: Survival Tips and Techniques for Media Interviews 25 COURSE 33 Psychiatric Disorders in Pregnancy and Postpartum 8 WORKSHOPS - ISSUES 87 Advocacy 101: Influencing Mental Health Policy 72 DISCUSSION GROUP 96 Stigma Stayed: The Cost of Prejudice in High Places 89 4 Postpartum Depression: Prevention and Intervention 15

TOPIC 60: TELEPSYCHIATRY INDUSTRY-SUPPORTED SYMPOSIA 22 Treatment of Mood and Anxiety Disorders in Women: What Is SYMPOSIUM Evidence and What Is Art? 11 38 Chronic Episodic Disorders: Comorbidity and Comprehensive 34 Successful Clinical Applications of Telepsychiatry 56 Integrated Treatment, Part 1 65 38 Chronic Episodic Disorders: Comorbidity and Comprehensive TELECOMMUNICATIONS PRESENTATION Integrated Treatment, Part 2 87 5 Individual and Group Psychotherapy Via Telepsychiatry 62 MASTER EDUCATOR CLINICAL CONSULTATION WORKSHOP - ISSUE 10 The Addicted Woman: Diagnostic and Treatment Challenges 69 10 Evaluation of Telepsychiatry Sen-ices in an Integrated Hospital System in the Veterans Administration and Department of Defense 19 MEDIA PROGRAMS 22 Women of the Wall 54 TOPIC 61: VIRTUAL REALITY 23 Loyalties 54 25 Leona's Sister Gerri 69 SYMPOSIUM 93 Virtual Reality and Mental Health: State of the Art and Future SCIENTIFIC AND CLINICAL REPORT Directions 98 14 Long-Term Effects of Depression on Symptoms and Function in Mid-Life Women 23 TELECOMMUNICATIONS PRESENTATION 2 DAVID: Depression Animation Video Image Database 41 SYMPOSIUM 16 Special Topics in Women's Mental Health 32

112 PARTICIPANT INDEX

APA 155TH ANNUAL MEETING

A Asthana, Deshratn 29 Bender, Donna S 56, 81 Atdjian, Sylvia 33 Benedek, David 39,97 Abel, Gene G 67 Attia, Evelyn 59 Benedek, Elissa P 16, 26, 50, 71, 97 Abikoff, Howard 47 August, Gerald 96 Benitez, Jaime M 18 Abramson, Ronald D 33 Aupperle, Peter M 7 Bennasar, Maricarmen 23 Abramson, Ruth K 74 Auriacombe, Marc 95 Bennett, Michael J 71 Acton, Paul 94 Autry III, Joseph H 51 Benoit, Marilyn B 77 Adam, Dorothy 38 Axelrod, Seth R 55 Bentler, Suzanne 75 Addington, Jean M 95 Ayonrinde, Deji 18 Beresin, Eugene V 69 Adeoye, Martins A 23, 47 Azzam, Amin N 70 Berg, Arthur Z 50 Ades,Jean 83 Berg, Paul H 47 Adit, Yanjee 87 B Berganza, Carlos 84 Adkins, Laura 74 Berger, Robert H 93 Adler, Lenard A 3 Bailey, Rahn K 91 Bergman, Gretchen 89 Agani, Ferid 57 Bakalar, Elizabeth 19 Bergstrom, Richard F 24 Agosti, Vito 61 Baker, Robert W 24, 47, 75 Berman, Jeffrey A 33 Agustines, Davin A 8 Balderson, Benjamin H. K 59 Berman, Sheldon S 48 Ahmad, Abdulbaghi 61 Baldessarini, RossJ 48 Berman, Steven 81 Aist, Reverend Clark S 67 Baldewicz, Ten T 29 Bernstein, Carol A 7, 14, 29, 39 Ait-Daoud, Nassima 55 Baldini-Rossi, Nicolo 34, 64 Bernstein, David P 31 Akaka, Jeffrey 49 Baldwin, Patizia A 96 Berrettini, Wade H 75 Akhtar, Salman 21, 31 Balon, Richard 45,97 Berry, Sally A 87 Akiskal, Hagop S 33, 48, 56, 91 Balser, Richard 97 Bersani, Giuseppe 24 Akman, Jeffrey S 80 Bannish, Daniel 43 Bevans, Margaret L 75 Al-Samarrai, Sadiq H 26, 50 Baptiste, Shim 57 Beyer, Michelle 55 Alarcon, Renato D 19, 34, 35, 43, 84, 88, 94 Barad, Mark G 8, 20 Bezmen, Janet 50 Albucher, Ronald C 89 Bark, Nigel M 81 Bezzubova, Elena B 51 Alegria, Margarita 35 Barker, Gregory L 41 Bianco, Carlos 61 Alessi, Norman E 30, 41, 56, 98 Barlow, David 34 Bianhertz, Laura E 97 Alexander, Allison B 23, 76 BarnhillJohnW 29 Biederman, Joseph 38, 47, 86 Alexander, James F 62 Baron, David A 84 Bienvenu III, Oscar J 82 Alexopoulos, George S 5, 30, 35, 53 Barr, Ellen F 5 Binder, Renee L 52, 76 Alger, Ian E 16, 25, 41, 53, 93 Barreira, Paul ] 6 Bing, Eric G 94 Allen, Albert J 3 Barrett, James E 60 Birmaher, Boris 47, 54 Allen, Andrea 84 Barren, Charles T 50 Bisaga, Adam M 34 Allen, James 89 Bartels, Stephen J 32 Bishop, Shelley E 43 Allen, Michael H 41 Barton, Gail M 19 Black, Dora 61 Allen, Trina B 39, 70 Baruch, Geoffrey 31 Blake, Lesley M 23 Allison, David B 92 Basco, Monica A 66 Blake, Nancy M 33 Alonso, Anne 6 Bat-Avi, Hagit 17,92 Blaken, Peter 95 Alpert, Jonathan E 23, 61, 76 Bateman, Anthony 31 Blakeney, Patricia 31 Altchuler, Steven 1 8 Batki, Steven L 34 Blamphin, John B 25 Altshuler, Kenneth Z 40 Battista, John R 15 Blanchard, Joanna 91 Bland, IrmaJ 15, 39 Altshuler, Lori L 23, 24, 34 Bauer, Mark S 59 Bleiberg, Kathryn L 96, 97 Amminger, Paul 9 Bauermeister,JoseJ 98 Bleier, Henry R 81 Amsterdam, Jay D 96 Baum, Antonia L 46, 80 Blinder, Barton J 8, 51 Andersen, Susan 84 Bayon, Maria C 89 Blita,Afrim 57 Anderson, Carl M 84 Beahrs.JohnO 32 Bloch, Daniel 61 Anderson, Tanya R 74 Beale, Rhonda Joyce R 69 Bloch, Sydney 87 Andreasen, Nancy C 82 Bean, Donna L 59 Bloom, Sandra L 76, 91 Andrews, Gavin 34 Beardslee, William R 51 Blow, Frederic C 32 Andronikof, Anne 33 Beaubrun, Gabrielle F 19, 66 Blozis, Shelley 98 Andrus, Jason M 22 Beck, Aaron T 78 Blume, Sheila B 44, 95 Anez, Luis M 24 Beck, Judith S 18, 26 Blumenfield, Michael 25,58 Ansari, Rubaba 74 Becker, Daniel F 24 Boehnlein, James K 33 Appelbaum, Paul S 10, 35, 39, 58, 60, 75, 96 Becker, Deborah R 97 Boeve, Bradley F 86 Appolinario, Jose C 32 Becker, Judith 88 Bokobza, Herve 59 Aquila, Ralph 6 Becker, Philip M 49 Boksay, IstvanJ.E 18 Arana, George W 55 Beeber, Alan R 39 Boland, Robert J 38, 51 Arikan, Rasim 75 Beecher,LeeH 33 Bolla, Karen 1 82 Arlinghaus, Kimberly A 5 Beers, Sue R 94 Bond, Gary R 59, 97 Armenteros, Jorge L 63 Beitman, Bernard D 8, 29 Book, Howard E 27, 50 Armstrong, Scott C 15, 39 Belant, Jason B 55 Bookheimer, Susan Y 34 Arnold, Lesley M 81 Belitsky, Richard 67 Boone, Herman 54 Arroyo, William 89 Belkin, GaryS 58 Borson, Soo 63 Arseneau, Bernard J 71 Bell, Carl C 17, 31, 35, 50, 61, 68, 77, 94 Borsook, David 62 Aruguette, Mata 49 Belsasso, Guido 89 Bortolotti, Francesca 30 Ashley, Kenneth B 70 Benca, Ruth M 85 Borum, Randy 96 113 PARTICIPANT INDEX

Borus, Jonathan F 72 Campeas, Raphael 61 Clayton, Anita H 65 Botteron, Kelly N 34 Campo, Ana E 25,49 Qelland, James D 75 Bouet, Boland 59 Candilis, Philip J 58 Clemens, Norman A 17, 50, 67 Boutros, Nashaat N 92 Canino, Glorisa 98 Qoitre, Marylene 26 Bowden, Charles L 8,11 Canive, Jose M 47, 62, 88 Cobb.Gary 80 Boyak, Cindy 97 Caracci, Giovanni 23 Cobb, Thomas G 91 Braden, Gregory 47 Cardona,Dora 88 Coconcea, Cristinel M 91 Bradford, John M 67 Carey, Kathleen S 48 Coconcea, Nicoleta 91 Brady, Kathleen T 37, 55, 87 Carlson, Gabrielle 33, 55 Coffey.C. Edward 1,15 Brainard, George 8 Carney, Robert 20 CoffmanJenniferK 24 Brawman-Mintzer, Olga 87 Caroff, Stanley N 29, 81 Cohen, Jonathan D 34 Breier.AlanF 95 Carpenter, Linda L 6,11, 52 Cohen, Judith A 71, 94, 95 Breitbart, William 20,29 Carpinello, Sharon E 17,71 Cohen, Let S 11,23,32,57,76 Brendel, David H 48,88 Carroll, Kathleen M 92 Cohen, Lewis M 47 Brent, David A 54 Carter, Diana 8 Cohen, NealL 20,59,68,93 Breslow, Richard E 41 Carter, William P 86 Cole, Steven A 60 Brod, Thomas M 90 Caserta, Maria T 49 Comer, James P 40, 50 Brodkey,AmyC 97 Casey, Daniel E 64, 65 Conley, Robert R. 63,96 Brody, Janet 62 Casey.DavidA 48, 92 Conners, C. Keith 47 Bromberger, Joyce T 23 Casper, Regina C 79 Connor, Kathryn M 8 Brook, David W 44,74 Cassem, Edwin H 70,72 Conroe, Henry G 71 Brown, Charlotte 23 Casten, Robin 80 Conteregg, Carlo 82 Brown, Clayton 82 Castilla-Puentes.RubyC 47, 74 Conus, Phillipe 9 Brown, Frank W. 42 Castilla Puentes, Sandra-Rocio 47 Conwell, Yeates 90,93 Brown, Lawrence 44 Castilla Puentes, Wilma-Ines 47 Cook, Judith A 97 Brown, Richard P 67 Castle, David 55 Cook, William 97 Brown, Sandra A 33 Caton, Carol LM 48 Cook, Jr., Edwin H 35 Brown, Thomas E 1,3,78 Cavaglia, Frederico 48 Coplan, Jeremy D 57 Bruder, Gerard E 61 Cavazzoni, Patrizia A 47 Cordal, Adriana 23 Buchsbaum, Monte S 87 Chacko, Chowallur D 44 Cordova, Matthew 61 Buck, Jeffrey 70 Chacko, LizM 44 Comblatt, Barbara 65, 87 Buckley, Peter F 86, 96 Chae, Jeong-Ho 81 Cornwell, John 55 Bukstein, Oscar G 96 Chagnon, Francois 24 Corral, Maria R. 8 Bunt, Gregory C 15 Chaiken, Shama 97 Cortese, Leonardo 1 Burd, Larry J 95 Chalk, Mady 70 Cosgrove, Victoria E 60 Burek, Susan 98 Chan,CarlyleH 38,52 Costa, Jr., Paul T 82 Burgard, Melissa 30 Chan, Jeffrey 25 Costantino, Guiseppe 32 Burgess, Ann 31 Chandler, Mark C 47 Costello, E.Jane 35 Burgoyne, Karl S 89 Chang, Jacquelyn B 21 Coumos, Francine 16, 48, 61 Burland, Joyce 74 Chang, Kiki D 5 Coutanceau, Roland M 33 Bums, Kathryn A 69 Chang, Kyong-Mi 44 Coyle, James 57 Cozza, Kelly L 15,39 Bums, Scott 25 Chang, Robert 8 Cozza, Stephen J 19, 59 Bursztajn, Harold J 12 Chao, Helen M 75 Cramer, Daniel W 57 Burt,Tal 5 Chapa, Diana 40 Crane, Daniel L 92 Burton, Anna M 17 Chaplin, M. Paul 43 Creson, Daniel L 31 Busch,AlisaB 25 Chapman, Daniel P 75, 92 Crits-Christoph, Paul 34 Busch,FredricN 17 Charat, Valerie E 30 Crone, Catherine A 22, 69 Bush, George 86 Charatan, Dana 30 Crone, Cynthia C 20 Bussel, Marina 38 Charles, Cecil 95 Crosby.Ross D 30 Buder, Lisa 61 Chamey, Dennis S 34, 97 Crossett, Judith H.W 18 Butterfield, Marian 1 82 Chaskel, Roberto E 84 Crowley, Brian 10,33 Buwalda, Victor JA 44 Chaudhry,ZabaidaA 23,47,76,91 Chen, Donna T 58 Cuccaro, Michael L 74 Byler, Crystal 98 Chen,Hongtu 32 Culpepper, Larry 22 Byock,IraK 45,70 Chengappa, K.N. Roy 24 Cunningham, Philippe B 95 Cheong, Josepha A 25, 51, 53 Curie, Charles 26 C Chesen, Chelsea L 18,71 Currier, Glenn W 41 Chesen, EliS 71 Cutler, Andrew J 6 Cabaj, Robert P 25, 89 Chester, Janis G 33, 50 Cutler, Jay B 72 Caetano.Raul 96 Chevy, Cherry 77 Cain, Warden B 51 Childress, AnnaR. 94 D Caine, EricD 90 Chiles, Catherine 67 Caimey, John 23, 47 Chinen, Allan B 15 Daggett, Pamela 98 Calabrese, Joseph R. 3, 5, 24, 63 Chinman, Matthew J 25 Dahl, Ronald E 35 Calabrese, Lori 37 Chiu, Charles 1 Daleo.Dina 42 Calhoun, Joshua W 80 Cho, Samson J 49 D'Alli, Richard E 53,69 Caligiuri, Michael 1 Chou, James C 15 Daniels, Allen S 82 Caligor, Eve 66 Chung, Christopher K 49 Danielyan, Arman K 97 CaUahan, Jr., William E 25, 42, 50, 60 Chung, Henry 49 Danies,Nora 74 Camacho, Alvaro 77 Chrome, Leslie L 30,75 Danko, George P 22 Camille, Catherine 92 Clark, HWestley 43,51,66,93 Darabus, Alexandrina 90 Camlin, Kelly L 87 dark, Michael R. 84 Daulouede, Jean-Pierre 95 Campbell, E. Cabrina 29, 81 Clark, Michelle 0 42,51 David, Daniella 55 Campbell, Mira 22 Clark, Robin E 97 David, Stacy R, 95 Campbell, William H 67 Clarkin, JohnF 56, 66 Davidson, Jonathan R.T 8, 64 114 PARTICIPANT INDEX

Davine, Jonathan S 71 Dunn, Robert T 90 Felton,ChipJ 17,71 Davis, Glen P 24 Dunner, David L 13, 33, 37,47 Fenton, Wayne S 73 Davis, Glenn C 77 Dvorak, Ramona 7 Ferguson, Yvonne B 7 Davis, Kenneth L 12 Dyck, IngridR 56 Ferrando, Stephen J 29, 61 Davoren, Mary Jo 44 Ferro, Maria F 22 Deas, Deborah 58 E Fetkewicz, Janet M 56 DeBellis, Michael D 94 Fichtner, Christopher G 1, 6,32 Deblinger, Esther 94 Eaton, William W 82 Field, Craig 96 De Coiy-Woronoff, Yvonne L 42 Ebert, Michael H 77 Fiellin, David 66 Defaria, Ludmila 55 Eckley, Marilyn L 43 Fieve, Ronald R 23,92 De Guzman, Denise 77 Eddy.KamrynT 30 Fillit, Howard 92 De Jong, Joop 19,47 Eder.Harald 95 Findling, Robert L 5,14,38 de La Gandara, Jose E 25 Edman, Jeanne 49 FinkjArlene 33 Delgado, Pedro L 64 Edwards, KimberlyB 95 Fink, Max 1,79 Demant, Jean-Claude 59 Edwin, AmaK 23 Finney, Joseph C. J 26 Dennis, Michael L 83, 84 Egan, Elizabeth 48 Fiocchi, Elaine 49 DeRoten,Yves 34 Egger, Helen L 83 Florentine, Mara J 71 DeRubeis, Robert J 34, 96 Ehram, Ronald 94 First, Michael B 14, 35, 48 Desai, PrakashN 93 Eist, Harold 1 32,60,77, 89 Fischbach, Gerald D 20 Des Jarlais, Donald C 82 Ekeberg, Oivind 31 Fischbein, Ellen R 18 Despland, Jean-Nicolas 34 Eklund, Steve A 38 Fischer, Gabriele 95 DetreJ 94 El-Guebaly,Nady 32 Fisher, Garry 80 Deutsch, Stephen 1 19 Eldreth,Dana 82 Fisher, Kathleen M 80 Deutschman, Daniel A 7,19,77 Elias, Eileen 43 Fisher, William 50 Devanand, Davangere P 30 Eliason, Michele J 93 Fishman, Marc 84 DeVane, C. Lindsay 2 Elinson, Lynn 1 60 Fitek, Diana J 94 Devarajan, S 13 Ellingrodringold, Vicki L 75 Flaherty, Lois T 39, 89 Devlin, Michael J 7,59 Elliott, Delbert 77 Fleming, Candace M 5 Dewan, Mantosh J 38 Elliott, Richard L 14 Flint, AlastairJ 30 Dhopesh, Vasant P 44 England, Mary Jane 17,43 Flood, Dorothy G 49 DiCamillo, Amy 49 English, Michael 32, 97 Fonagy, Peter 31 Dickstein, Leah J 19,27, 51, 77, 82 Engstrom, Frederick W 52 Fong, Timothy W 42 Di Cori, Ferruccio A 16 Enomoto, Kana 49, 58 Foote, William W 15,39 Dietrich, Allen 60 Enright, Timothy 23 Forehand, Jr., LyleB 25 DifedeJoAnn 53 Epstein, Steven A 49 Fornash, Anna 94 di Giannantonio, Massimo 22 Ercoli, Linda M 34 Forquer, Sandra L 25 Dillon, James E 7, 77 Ereier.Alan 95 Forrester, Honorable Lee 38 Dinges, David F 86 Erickson, Mark 88 Forstein, Marshall 44, 61 Dinwiddie, Stephen H 6 Erickson, Paul 48 Forster, Peter L 35,41,71 Ditter, Susan M 76 Erman, Milton K 13,37 Foster, Helen M 72 Dixon, Lisa B 59, 74 Ernst, Monique 81, 82 Foti,Mary E 45 Doddakashi,VeenaR 93 Erwin, Rodney J 76 Foulks, EdwardF 31 Dodson, Thomas W 33 Escobar, Javier 1 1 Frances, Richard J 44 Doghramji, Karl 13, 23, 27, 86, 92 Essock, Susan M 97 Frank, Denise 55 Frank, Ellen 3, 13, 96 Dohrenwend, Bruce 57, 91 Eth, Spencer 26, 59 Frank, Guido 30 Dolan-Sewell, Regina 17 EvaldsonJohnR. 88 Frankenburg, Frances R .. 24,74, 81 Dolder, Christian 37 Evans, Angela R 24,47 v Frankle, W. Gordon 8 Donegan, Nelson H 56 Everett, Anita 35 Dong,Yun 81 Franklin, Ophie 44 Donohue, Micca 75 Franklin, Teresa R 94 Donovan, Sheila 48 F Franko, Debra 30 Doody.RachelleS 85 Franques, Pascale 95 Doraiswamy, P. Murali 64 Faber, Raymond A 1, 5 Frare, Franco 75 Dorce, Daphne 89 Factor, Robert M 97 Frattaroli, Elio J 72 Dording, Christina M 23,49 Faenza, Michael M 73 Frazier, Jean A 6 Dorer, David J 30 Pagan, Peter J 82 Frazier, Marvis 80 Doty, Richard L 43 Faheem, Uzma S 47 Freedman, Joshua E 77 Downey, Jennifer 1 18 Fahrer, Rodolfo D 84 Freedman, Robert 12 Downs, Susan R 52 Fairbum, Christopher 59 Freeman, Elsie J 49 Doyle, Allysa 86 Faison, Warachal E 25 Freyd, Pamela 56 Draeger, John H 22 Fallen, Brian A 20,29 Friedberg, Jennifer 64 Drake, Robert E 48, 59, 97 Farand, Lambert 24 Friedman, Lee 87 Drescher, Jack 70, 80 Faraone, Stephen V 86 Friedman, Matthew J 17, 71 Dresner, Nehama 15 Farber, Nancy 60 Frueh, Christopher B 55 Dryden-Edwards, Roxanne C 50 Farlow, Martin K 64 Frye, Mark A 2,3,5,34, 63 Du,Nang 49, 72, 89 Farook, Suhaila 55 Fryer, John E 43 Dubin,HindaF 18 Fassler, David 90 Fulbright, Robert K 24,56 Dubo, Elyse D 22, 40 Faulkner, Larry R. 77 Furedi,Janos 75 Dubois, Michel 84 Faust, William 32 Futterman, Robert 92 Duckworth, Kenneth S 49, 71 Fava, Maurizio 6,13,23,49,61, 75, 76 Dudley, Jr., Richard G 80 FawcettJanA 29,96 G Duffy, Farifteh F 60, 98 Fedoroff, J.Paul 67 Dulcan,MinaK 35 Feiner, JoelS 32 Gabbard, Glen 0 15, 20, 33, 39, 56 Dunayevich, Eduardo 1 Feldman,Neil 49 Gal, Joseph 2 Dunn, Laura B 37, 76 Felthous, Alan R. 95, 96 Galanter, Marc 44, 45, 55 115 PARTICIPANT INDEX

Galeno, Roxana 88 Gorelick, David A 33,34, 83 Hansen, MarkR 8 Galynker, Igor 1 81, 82 Gorman, Jack M 3,57,63 Hanson, Annette L 69 Gandhi, Meeta 44 Gorton, Gregg E 43 Hanson, Graeme 76, 95 Gangure, Dinu P 23, 75 Gottdiener, William H. 31 Haponski, David 8 Cans, Jerome S 14 Gottheil, Edward 75, 92 Harb, Gerlinde C 61 Garb, Jane 47 Gould, Elizabeth 63 Harding, Richard K 7, 10, 14, 29,35, 59 Gardner, David M 66 Gould, Madelyn 78, 90 Harkness, Kate 96 Gardner, Eliot L 62 Grady, Brian J 19,62 Harlow, Bernard L 57 Gardner, Jr., Russell J 32,56 Grady-Weliky.TanaA 65 Harmison, Sheila 93 Garland, David W 26 Granacher, Robert P 15 Harrington, Colin J 38 Garrido, Pedro J 23 Grant, Jon E 51 Harris, Terry 54 Garver, David L 93 Gray, Gregory E 62, 66 Harris-Hendriks, Jean 61 Garza, Daniel 19, 93 Gray, Jason 94 Harrow, Martin 24,48 Gastfriend, David R. 33 Gray, Kevin F 5 Hartikainen, Anna-Liisa 48 Gaw, Albert C 7,19 Greden, John F 68 Hartmann, Lawrence 31, 45 Geddes.John 66 Green, Bonnie L 96 Hartz, Arthur J 75 Gelenberg, Alan J 60,75, 81 Green, Melva 1 46 Harvey, Philip D 84 GellerJeffreyL 32 Green, Stephen A 87 Hasin, Deborah S 48 Gendel, Michael H 85 Greenberg, Harvey R, 12,29 Haskett, Roger F 23,35 George, MarkS 9,15, 81 Greenberg, Jennifer 84 Haslam, David R.S 66 Gerbarg, Patricia L 67 Greenberg, Ted 55 Haslam,Nick 31 Geric, Guido 95 Greenberg, William M 42 Hatot,Norma 77 Germain, Michael 47 Greene, Judy 92 Hatti, Shivkumar 1 Gertmenian-King, EnidC 82 Greenfield, Shelly F 26,48 Hault, Connie 13 Gesy, Lawrence 58 Greenhill, Laurence L 83,98 Hauser, Lawrence A 93 Ghaemi, S. Nassir 33,62,65,88 Greenspan, David 1 92 Havens, Jennifer F 44 Gherardelli, Simona 24 Greenstein, Robert A 81 Hawkins, Keith A 92,95 Ghinassi, Frank 43 Greenwald, Blaine S 88 Haynes, KamlynR. 90 Ghorpade, Amarsingh M 48 Greiner, Carl B 18 Hays,LonR 75 Ghosh-Ippen, Chandra 61 Greist, JohnH 13,64 Heap.Joann 74 Giannini, Carol 8 Gresham, Robert L 23,76 Hebrank, Jessica 75 Gilbert, Kenneth G 69 Grier, Nichole D 70 Heck, Paul W 17 Gillette, Sherrie 95 Griffin, Margaret L 48 Heerlein, Andres 84 Gise, Leslie H 15,23,70 Griffith, James L 57 Heidel, Stephen H 7 Gitlin, Michael J 34,90 Grilo, Carlos M 24,55,56,81 Heimberg, Richard G 61 Glancey, Graham G 67 Grimaldi, Jr., John AJL 25 Heinberg, Leslie J 59 Classman, Alexander H 20,65,87 Grisso, Thomas 58 Heinze, Gerardo 77 Gliatto, Michael F 29 Grodin, Michael A 67 Heishman, Stephen J 81 Glikman, Jacques 59 Groleau, Danielle 33 Heit, Howard A 62 Godard, Sally L 70 Gronvold, Nina 31 Hektnerjoel 96 Goebert, Deborah 22 Gross, Richard L 39 Hellerstein, David J 92 Goethe, John W 47,76 Groves, Mark S 22 Henderson, David C 37, 64 Goff, Donald C 3 Gruenberg, Alan M 48 Hendin, Herbert 78 Gogineni, R. Rao 31, 84 Grunhaus, LeonJ 14 HendrickJohnP 48 Goin, MarciaK 68 Gu,Hongbin 95 Hendriks, Vincent 95 Goisman, Robert M 39 Gualtieri, Thomas 43 Henggeler, Scott W 95 Gold, Maria J 90 Guarda, Angela S 59 Hennekens, Charles H 64 Goldberg, Carl 26 Gudeman, Jonathan E 50 Hennen, John 24, 48, 81 Goldberg, David A 26 Gueorguieva, Ralitza 92 Henningfield, Jack E 81 Goldberg, Joel 55 Gunderson, John G 15,24, 56, 81 Hensley, Paula L 75,77 Goldberg, Joseph F 11,24,33,62,63 Gur, Raquel E 34,74 Herbeck, Diane M 94 GoldfeinJuliA 59 Gurrera, Ronald J 81 Herbener, Ellen S 24 Goldfinger, Stephen M 35, 71, 89, 94 Guschwan, Marianne T 93 Herbst, Jeffrey H 82 Goldman, Charles R. 94 Gusmorino, Paul 84 Herman, Sol 19 Goldman, Howard H 35 Guynn, Robert W 19 Hermann, Richard C 25, 69 Goldman, Margo P 76 Hernandez-Serrano, Ruben J 84 Goldman-Rakic, Patricia S 24 H Hersh, Richard G 66,88 Goldner, Elliot M 57, 66 Heru, Alison M 18,26 Goldstein, Marion Z 73, 82 Haatainen, Kaisa 46 Herzog, David B 30 Goldstein, Robert 49 Habeych, Miguel 47 Hester, Thomas W 32 Gomez, Ivan S 47 Hadley, Sallie J 34, 64 HiartJohnF 15,39 Goncalves, Nuno 48 Hafliger, Silvia 25,39 Hicks, Daniel W 51,70 Gongora, Orlando 74 Hafter-Gray, Sheila 17,31 Hicks, Madelyn H. 18,47 Gonzales, Junius J 32 Raines, Michael 97 Hieble, J. Paul 88 Gonzalez, Abel A 76, 92 Hakko,Helina 91,92 Hierholzer, Robert W 90 Goodkin, Karl 29,61, 89 Hales, Deborah J 89 HOI, Angela L 24 Goodman, Marianne 74, 84, 87 Hales, Robert E 13,28,37 Hill, Jerrold W 92 Goodnick, Paul J 47 Hall, Molly J 42 Hill, Kevin P 75 Goodwin, Frederick K 33,62,90 Haller, Ellen 52,76 Hill, Marjorie 80 Goodwin, GuyM 8,11 Halliday-Boykins, Colleen A 95 Hilsabeck, Robin C 26 Gopalakrishnan, Raman N 75 Halmi, Katherine A 7,30 Hilty, Donald M 51,92 Gordon, Edward 33,76, 89 Halpem, Abraham L 25 Hinden, Beth 51 Gordon, Malcolm A 71 Hamadani, Houshang G 22 Hirschfeld, Robert MA 3,11 Gordy, Tracy R. 50, 89 Hamner.MarkB 55 Hirshkowitz, Max 78 Gore, John C 24, 56 Haningffl, William F 50 Ho, Andrew P 8,41,52 116 PARTICIPANT INDEX

Hoffman, Amy S 20 Jetha,M.K 55 Kennedy, GaryJ 53 Hoffman, Marcia 74 Jiang, Sue 48 Kennedy, Lawrence L 38 Hoffman, Ralph E 56, 92 Jibson, Michael D 85 Kennedy, Robert S 52 Hoge, Michael A 82 Jimerson, David C 7 Kent, Justine M 63 Hoglend,PerA 34 Jobe, Thomas H. 24 Kerbeshian, Jacob 95 Holden, Wayne 90 Johnson, Bankole A 55 Kern-Jones, Sheryl 62 Holland, Jimmie C 17 Johnson, Bradley R. 50, 88 Kemberg, Otto F 66 Hollander, Annette J 26,88 Johnson, Janet J 55 Keshavan, Matcheri S 94 Hollander, Eric 34, 64, 84, 87 Johnson, Myles 48 Kessler, Richard J 70 Hollifield, Michael A 77 Jokelainen, Jari 48 Kessler, Ronald C 10 Hollon, Steven D 96 Jones, Beverly N. 57 Kestenbaum, Clarice J 25 Holtzheimer HI, Paul E 25, 76, 91 Jones, Billy E 80 Ketter, Terence A 5,24,63 Honeyman, David L 47 Jones, KristinaL 25 Kettl,Paul A 42, 80 Hong, Victor 49 Jones, Peter B 48 Khan,HumaK 44 Hoopes, Scott P 22 Jones-Gotman, Marilyn 43 Khan, Shahbaz A 18 Hoppe, Sue K 98 Joranson, David E 62 Khosroshahi, Hashem 74 Houck, Patricia 96 Jorge, Miguel R. 77, 84 Khouzam, Hani Raoul 90 Houghtalen,RoryP 89 Jorgenson, Linda M 19,26 Kiehl, Kent 82 Howe, Edmund G 7 Joukamaa, Matti 91,92 Kilts, Clinton D 63 Howell, Ambassador Nathaniel 77 Joy, Charles R. 50, 89 Kim, Kathleen M 93 Howland, Robert H 52 Juthani, Nalini V 44 Kim, Scott Y 58 Hsu, Fang-Chi 82 Kimes, Alane S 82 Kimmel, Douglas C 80 Hu,Rona 13 K King, Steven A 2 Hu,Yuange 50 Kingsley, Ellen 38 Huang, Frederick Y 70 Kachigian, Claudia A 95,96 Kinon, Bruce J 24 Huang, Li-Shan 48 Kadden, Ronald 43 Kinsella, Anthony 96 Hudson, James 1 86 Kahn, Jeffrey P 50 Kirchner, Chris M 71 Hudziak, James J 64 Kakouros, Aprhodite 54 Kalasapudi, Vasundhara 48 Kirmayer, Laurence J 34,35 Huey,LeightonY 76,82 Kales, Helen C 22 Kirwin, PaulD 67 Huggins, Teresa 34 Kalin,NedH. 11 Kiss, Kitty 75 Hughes, Douglas H 63 Kallaba,Melita 57 Kittay, Michael J 90 Hughes, Megan E 49,61 Kalogerakis, Michael G 89 Klagsbrun, Samuel C 26, 70 Hughes, Michael C 42 Kamble, Madhuri V 26 Kleber, Herbert D 34,43, 66 Hughes, Rod J 49 Karnin, Marc 22 Klee, George 34 Hughes, Vincent J 43 Karnm, Ronald L 54,80 Kleinman, Arthur M 17 Hurwitz, Thomas D 27,78 Kampman, KyleM 94 Kling,MitchelA 52 Husain, Mustafa M 52,64 Kandel, Rachel 54 Kluft, Richard P 91 Husain, S. Arshad 31 Kane, John M 9,13 Knauer, Nancy J 43 Hussain , Mohammad Z 23, 47, 76, 91 Kanefield, Marvin 10 Knight, Edward 25 Hussain, Seema 23, 47,76, 91 Kaplan, Ana 1 Kocsis, James H 96 Hwang, Michael Y 19,30 Kaplan, Gabriel 1, 38 Koenan, Karestan 91 Hyler, Steven E 12, 14, 56 Kaplan, Tony 61 Koenig, Harold G 76 Kapoor, Vinay 19,26 Koenigsberg, Harold W 74, 84, 87 I Kapur, Shitij 96 Kogan, Richard 27 Karasic, DanH. 19, 28, 76 Kolodner, George F 49 Iqbal, Naveed 19 Karasu, T. Byram 52 Kolodny, Andrew J 74 Irani, DavidN 29 Karim, Rezaul 22 Kolodziej, Monika 48 Ishak,WaguihW 38,70 Karlinsky, Harry 57 Komaroff, Anthony L 86 Isohanni, Matti K 48, 91, 92 Karp, Jordan F 18 Kompore, Ivan 47 Issette,Arth 55 Karvois, Debra 22 Koopman, Cheryl 61 Kastrup, Marianne C 60 Kopala, Ulli 13 Kataoka, SherylH 33 Koplewicz, Harold S 26 J Katon, Wayne J 60 Koretz, Doreen S 35 Katz, Bernard A 7 Jabbarpour.YadollahM 21,32 Kornstein, Susan G 6, 9 Katz,IraR. 80 Koss-Chioino, Joan D 62 Jackson, James S 34, 35 Katz-Leavy, Judith 51 Kosten, Thomas R. 66,95 Jackson, Richard S 7 Katzelnick, David J 60, 82 Kotler.LisaA 59 Jacobs, Douglas G 93 Katzow, Jacob J 33 Kotwicki, Raymond J 70 Jacobs, SelbyC 61 Kauffman, Christopher I ,,29 Koutsogiannis, John , ,,,,,,. 9 Jacobson, LaraM 48 Kaufman, Joan 55 Kovasznay, Beatrice M 32 Jaffe, Ellen 76 Kaushik, Saurabh 48 Kowatch, Robert A 5 Jaffe, Jerome H 43 Kay, Jerald 26,29,45,74 Kozel, Andrew F 81 Jaffe, Richard L 38 Kaye, Walter H 30 Koziupa, Diana M 97 Jamieson, Patrick 78 Keane, Terence M 55,67 Krahn, Lois 8,13,78 Jamison, Kathleen 42,78 Keck, Jr., Paul E 11, 81,93 Krakowski, Menahem I 91 Janicak, Philip G 24, 38, 48 Keel, Pamela K 30 Kramer, Douglas A 32 Jarboe, Kathleen 9 Keith, Samuel J 9 Kramer, Milton 2 Jarrett, Robin B 9 Kelleher, Kelly 43 Kramer, Peter D 33 Jarvelin, Marjo-Riitta 48 Keller, Martin B 11,22,60 Kramer, Thomas AM 89 Jaycox, Lisa 33 Kellner, Charles H 1,38 Kranzler, Henry R. 55 Jensen, Peter S 17, 90, 98 Kelly, DeannaL 96 Kratochvil, Christopher J 3, 83 Jensvold, Margaret F 26 Kelly, Thomas M 24 Kraus, Louis J 89 Jeon, Wootaek 22 Kendell, Robert E 34 Kraus, Marilyn F 43 Jeste, Dilip V 35, 37 Kendler, Kenneth S 34 Kraus, Jr., John E 72 117 PARTICIPANT INDEX

Krausz, Michael 95 Liebowitz, Michael R. 61 Mannarino, Anthony P 94 Kravitz, Howard M 23 Lief, Harold 1 56 Manu, Peter 71 Kreek, Maiy Jeanne 21 Lim, Russell F 5 Marangell, Lauren B 9,11, 81 Krejci, Jonathan 33 Limoges, Richard F 85 Marazziti, Donatella 7 Krishnan,RangaK 6,11,28 Lin, Keh-Ming 34,35,49,70,72 March, John S 87 Kroenke, Kurt 60 Lindenmayer, Jean-Pierre 41 Marchant, Nestor F 84 Kroll, Jerome L 48 Ling, Walter 50 Marcus, EricR. 25,69 Krupnick, Janice L 96 Links, Paul S 81 Marcus, Steve C 60 Krystal, JohnH 35, 83,92 Lippa, Carol 73 Marder, Stephen R 9, 38, 59 Kumar, Anand 5,30 Lipschitz, Deborah S 55 Margo, Geoffrey M 27 Kunkel, Elisabeth J.S 44,75 Lipsitz, Joshua D 97 Margo, Katherine L 27 Kupfer, David J 3,34,63,96 Lipsius, Steven H 90 Markovich, Phillip 95 Kurian, Varughese 82 Lisanby, Sarah H 14, 81 Markowitz, John C 6,48, 66, 96, 97 Listerud,JohnM 94 Marks, Robert C 24 L Iitten,RayeZ 83 Markvitsa, Romana 38,70 Litts,DavidA 90 Marmar, Charles R. 57 Lacy, Timothy J 42 Liu, Hong 24 Marshall, Randall D 17, 26, 57, 61, 91 Lagodmos, Greta 25 Lively, Cathy 71 Martija, Alfredo 90 Lakia, Amaro 23 Livingston, Richard L 42 Martin, Eileen M 24 Lam, Raymond W 2 Llorente, Maria D 32 Martinez, David C 78 Langleben, Daniel D 94 Lloyd, John R. 92 Martis, Brian 24 Lapeyra, OlgaM 55 Loboprabhu, Sheila M 5 Manorell, Arnaud 33 Lappin, Debra 60 Lochman, John E 96 Marumoto, Megan T 76 Lara, Michael E 92 Lock, James D 59 Masand, Prakash S 13,37,63,96 Larsen, Robert C 77 Lockhart, Paula J 50 Masi, Gabriele 91 Laub, Dori 12 Loeb, Katherine L 59 Maslansky, Robert 46 Laughlan, Catherine 75 Logsdon, Linda 85 Massie, Mary Jane 40 Lauriello, John 75 LoiratJ.C 59 Masterman, Donna 86 Lavretsky, Helen 30 Lomax II, James W 5,15,39 Masters, Scott 88 Lawrence, Earl C 41 Londino, Donna L 93 Masterson, Gayle 18 Lawson, William B 17,58,70,94 London, Edythe 81, 82 Masterson, James F 15 Lazarus, Arthur L 25,93 Lonsdorf, Richard G 35 Mastey, Vera 92 Leach, David 29 Lopez, Frank A 47 MatochikJohnA 81,82 Leavitt, Renee 97 Losonczy, Miklos F 19 Matorin,AnuA 19,26,70 Lebovits, Allen 84 Lotan, Sandra Y 79 Matos-Pires, Ana 48 Lecusay, Robert 29 Lovelace, Joe 9 Matthews, Karen 23 Lee, Diana 29 Lovett, Margaret 96 Maurer, Martin H 20 Leguay, Denis 59 Lowenkopf, Eugene L 75, 92 Mavissakalian, Matig R. 22 Lehman, Anthony F 35, 97 Lu, Francis G 5, 15, 43,49, 69, 76, 80, Mawhinney, Joseph R. 71 Lehmann, Laurent S 18 90, 93, 94 Maxwell, Jane C 83 Leibenluft, Ellen 3 Luchins, Daniel J 32 May, Catherine S 7 Leite,Paul 61 Lucksted, Alicia 74 Mayault, Catherine 59 Lejoyeux, Michel 83 Lunn, Brian 30 Mayeux, Richard 28 Lencz,Todd 65 Luo, John 19, 38, 52,72 McCabe, Lee 82 Lenhart, SharynA 52 Lurie, Lawrence B 50 McCall, W. Vaughn 38 Leon-Andrade, Carlos 84 Lydiard, R. Bruce 10, 61, 87 McCance-Katz, Elinore F 46 Leong, Richard 75 Lyketsos, Constanine G 7 McCann,UnaD 81 Leonhardt, Tami V 74 McCarthy, Richard H 71 Lesser, Michael S 93 M McCartney, Cheryl F 53 Levendusky, Philip G 39 McCommon, Jr., Benjamin H 18 Levenson, Alan 1 18 Ma, Albert Y 47 McCue, Robert E 91 Levenson, James L 41 Ma, Guoguang 23 McDonel-Herr, Betsy 32 Levi-Pearl, Sue 88 Maclntyre II, James C 69 McDougle, Christopher J 14 Levin, Frances R. 34,44, 55 MacLean, Alexandra 59 McDowell, David M 34,48,73, 83,92 Levin, Harvey 43 Maffei, Cesare 31 McElroy, Susan L 28,86 Levin, SaulM 90, 93 Magder, David M 48 McEvoy, Joseph P 9,10 Levine, Jeffrey M 44 Magee, Christine 91 McFarlane, Rodger 36 Levine,JohnB 25 Maguire, Gerald A 6 McFarlane, William R. 97 Levitt, Anthony J 2 Mahrer, David 44 McGlashan, Thomas H 24, 55,56, 81,95 Levkoff, Sue E 32 Maier, James M 25 McGorry, Patrick D 9 Levy, Ken 56 Maki, Pirjo H 91, 92 McGrath, Patrick J 61 Lewis, David A 12 Malcolm, Jr., Robert J 55 McGuire, Colleen 74 Lewis, Evelyn L 43 Maldari,Liza 87 McGuire, Michael 56 Lewis , Lydia J 59 Malhotra, Seema 25 McHugh, Paul R. 56 Lewis-Fernandez, Roberto 23, 57, 61, 91 Mallen, Lucinda 51 McHugo, Gregory 97 Lewy, Alfred J 8 Malmquist, Carl P 26 Mclntyre, John S 32,60,93 Li,Xingbao 81 Malone, Kevin M 24 McLellan, A. Thomas 18,26 Liang, Kung-Ye 82 Maloney, Ann S 60 McMahon, David F 89 Liang, Warren M 89 MaltsbergerJohnT 78 McNicholas, Laura F 18,66 lichtenstein, Bill 73 Malur.Chitra 1 McWilliams, Linda 47 Lidz, Charles 58 Mancini, Catherine L 22 Meade, Brian F 75 Lieberman, Alicia F 61 Mandelkern, Mark 81 Meagher, David J 96 Lieberman, Jeffrey A 9,10, 12,95 Manji, Husseini K 12 Mee-Lee, Denis 27 liebling, David S 57 Mann, J.John 24 Mega,LeslyT 69 Liebowitz, Barry D 85 Mann, Stephan C 29, 81 Meisler.Neil 98 118 PARTICIPANT INDEX

Mellman, Lisa A 26,29, 40, 69 Mucci, Maria 91 o Mellman, Thomas A 55 Mueser.KimT 59,97 Mellott, Katherine 70 Mufson, Laura 54 Oakman, Jonathan 22 Melonas, Jacqueline M 18, 42, 72 Mukherjee, Uday K 44 O'Brien, Charles P 18, 83, 94 Meloy, J.Reid 31 Mullen, David 88 O'Brien, John 50 Meltzer, Carolyn C 30 Munoz, Alicia A 17, 27 Obuchowski, Michael 65 Meltzer, Herbert Y 20 Munoz, Rodrigo A 25, 32, 49, 60, 77, 89 O'Dowd, Nancy 18 Mendelowitz, AlanJ 64, 85 Munoz T, Rodrigo J 77 Oepen, Godehard 16, 25,32 Mendelsohn, Frederick S 74 Murphy, Greer M 9 Oesterheld, Jessica R. 39 Mendoza, Ricardo P 70 Murphy, James M 42 Offord,Dan 35 Menza, Matthew A 23,47,92 Muskin, Philip R 10,20,94 Offsay, Julian 18 Merlino, Joseph P 58 Musselman, Dominique L 13 OHara.Ruth 9 Metzl, Jonathan M 16 Musto, David F 50 Okasha, Ahmed M.F 17 Metzner, Jeffrey L 76,97 Muszynski, Irvin L 76 Okasha,TarekA 70 Mezzano, Daniela 22 Mvsacchio, Amelia 84 Okereke, N. Kalaya 22,47 Mezzich, Juan E 20, 25, 29,77 Myers, Michael F 27,51,52,71,77,85 Olarte, Sylvia W 52, 89 Michaelis, Benjamin H 24 Myers, Zachary 19, 77 Oldham, JohnM 15,56, 69 Michels, Robert 51,61 Myrick,Hugh 55 OMaUey.MaryB 49, 86 Michelson, David 3, 47 OMalley, Stephanie S 83 Mickley, Diane 59 N Omens, Russell S 48 Mikalac, Cecilia M 7 Onken, Steven 98 Miklowitz, David J 62 Nadelson, Carol C 26, 53, 68, 82 Opler, Lewis A 5,19,25,30 Milberg, Laurel C 27 Nadiga, DeepaN 77 Oquendo, Maria A 24 Millepiedi, Stefania 91 Nadler.Arie 57 Ordorica, Patricia 1 39,45,73 Miller, Anita 25 Nahas,ZiadH 14,52,81 OUeardon, John P 96 Miller, Frederick E 74 Najavits, Lisa M 48 Ortner, Romana 95 Miller, Gary E 70 Nand, Surinder S 49 Osher, Fred C 97 Miller, Karen 34 Napier, Kimberly 94 Osinowo, Thomas 0 18 Miller, Laura J 69 Narrow, William E 60,98 Oslin, David W 32, 83 Miller, MatthewS 49 Nasrallah, Henry A 13,37 Osofsky, Howard J 51,67 Miller, Milton H 89 Navalta, Caryl P 84 Osof sky, Michael J 51 Miller, PaulR 1, 52 Nazarey, Margaret 52 Osser, David N 90 Miller, Sheldon 1 29, 44 Ndlela, J. Charles 5, 45, 46 Osterman, Janet E 19,42 Miller, Susie 96 Neal, Rebecca R 19 Otto, Michael W 11,57 Miller, Tandy J 95 Neault, Nicole B 49,61 Owens, Michael J 2, 28, 63, 65 Milliken, Heather 13 Nelson, Daniel A 91 Oxman, Thomas E 60 Millman, Robert B 44 Nelson, J. Craig 6, 64 Milner, Karen K 44 Nelson, Lewis 70 P Milrod, Barbara L 17 Nelson, Lisa J 50 Min, Sung-Kil 22 Nelson, Mary E 71 Pablo, Cristina 48 Miner, Christian R 82 Nelson, Scott 96 Pacheco, Antonio 84 Mini, Louis J 32 Nemeroff, Charles B 11,28,63 Padrino, Susan L 70 Minkoff, Kenneth 52 Nestadt, Gerald 82 Paine, Susan 75 Mintz, David L 50 Nestler,EricJ 34 Painter, Albert F 7 Mintz,Jim 23 Nevfeld, Jonathan 35 Pallanti, Stefano 34, 55, 64 MintzerJacoboE 7,25,85 New.AntoniaS 74,84,87 Palmer, Orrin 88 Miotto, Karen A 83 Newcomer, John W 3 Palmer, R. Heather 25 Miranda, Jeanne 58, 96 Newkirk, Cassandra F 69 Panahon, Norma C 19 Mire, Gina 55 Newman, RitaR 26,71 Pancheri, Paolo 24 Mirin, Steven M 7 Newman, Robert G 95 Pandya, Anand 94 Mirski, Dano F 1 Newmark, Thomas S 26, 50 Papakostas, George 76 Mischoulon, David 49 Newport, D.Jeffrey 2,34 Parachini, Elizabeth A 74 Miskimen, Theresa M 89 Newton, Thomas 52 Pardes, Herbert 20 Misri,Shaila 8 Ng, David 74, 91 Parikh, Parinda 48 Mitchell, James E 7,30 Nguyen, Cynthia M 93 Parnell.Sean 75 Mitropoulou, Vivian 74, 84, 87 Nguyen, Hoang A 37 Parrilla, Elsie 23 Moak, GaryS 2 Nicholson, Joanne 51 Passow, Emilie S 14 Moberg,PaulJ 43 Nierenberg, Andrew A 2, 6, 23, 49, 61, 76 Pastor, Sandy 75 Moffic, Steven 6 Ninan, Philip T 28 Patel, Vikram 17 Moilanen, Kristiina 48 Nir, Yehuda 12 Patkar.AshwinA 48,75 Mok, Lillian 91 Nocks, James J 19 Pato, Michelle T 38,73 Moller.HenryJ 98 Noel, Richard L 70 Pava, Carmenleonor 74 Monahan, John 10 Norko, Michael A 10 PavaJoelA 61 Monoteaux, Michael 86 Norris, Donna M 49 Pazzagli, Adolfo 55 Monterosso, John R 94 North, CarolS 8,97 Pechura, Constance M 60 Montgomery, Richard A 38 Northcott, Colleen J 18 Peele, Roger 33 Monti, Daniel A 48 Norwood, Ann E 58 Pelham, Jr., William E 47 Montoya, Heidi D 23,76 Notman,MalkahT 26,58 Pelton, GregoryH 28 Mordecai, Donald J 50 Novae, Andrei 71 Fender, Vivian B 24, 59 Penfold, P. Susan 51 Moreno, Francisco A 18, 64 Novotny, Sherie L 64 Morey, Leslie C 56, 81 Nunes, Edward V 34 Penny, Rosetta H 74 Peoples, June 73 Morgan, Maria G 96 Numberg, H. George 75 Perel, James 74 Morris, Philip 83 Nutting, Paul 60 Perkins, Diana 0 9, 13,95 Moss, Quinton E 70 Nyman-Rose, Shelly 95 Perlis,RoyH 23 Mouratidis, Maria 82 Nyyssonen, Kristiina 46 119 PARTICIPANT INDEX

PenyJohnC 34 Quinn,JohnF 96 Robinson, Gail E 19, 51, 52 Persky, Trudy 32 Quinn, Susan 57 Roca, Robert P 80 Perugi, Giulio 48, 75, 91 Quitkin, Frederick M 61 Rockwell, Enid 37 Pessar, Linda F 18 Qureshi, Altamash 1 57 Rodenhauser, Paul 7 Petersen, Timothy J 49,61,76 Rodriguez, Mercedes M 92 Petersen-Crair, Pamela J 88 R Roerig, James 30 Peterson, Bradley S 24 Roessel, MaryH 42 Peterson, Thomas R. 62 Racciatti, Delia 22 Roffi, Pamela A 23,49 Petit, Jorge R 1 Racette, Stephanie 23 Roffman, Roger A 43 Petitjean, Francois C 59 Rachid, Fadddie H 92 Rogan, Gerald 76, 89 Petkova, Eva 23 Racy, John C 18 Rogers, Kenneth M 44 Petrakis, Ismene L 83 Radden, Jennifer 77 Rogers, Robert D 81 Petrides, Georgios 1 Radulovic, Ljiljana 92 Rogge, Scott D 93 Pettinati, Helen 83 Rae, Donald 98 Rogoff, Jerome H 50 Pettit,AmyR 60 Rainey, Charles J 30,38 Rohland, Barbara M 35 Petty, Frederick 87 Raizrnan, Pamela S 59 Rohrbaugh, Robert M 67 Pevalin, David J 47, 75 Rakfeldtjaak 95 Rolland, John S 14,57 Pfefferbaum, Betty 8 Ram, Ranganathan 75 Roman, Brenda J 42 Pflanz, Steven E 7,44,50,77 Ramirez, Luis F 2,88 Roman, Gustavo C 86 Phelps, Micheal E 34 Ramirez, Paul M 5 Rome, Jeffrey D 84 Phillips, Lisa 9 Randall, Jeff 95 Rome, Lee H 7,77 Pi.EdmondH.T 70 Rao.NyapatiR. 19, 94 Roose, Steven P 5, 9,34,46,47 Finals, Debra A 90 Rapaport, MarkH 33 Rosario, Vernon A 19 Pincus, Harold A 60 Rasgon, Natalie L 2,34 Rose, Eric 41 Rosekind, MarkR. 13 Pine, Daniel 35,63 Rauch, Scott L 8 Rosen, Cherise 48 Pinson, Letitia A 66 Rawson, Richard A 50 Rosen, Joanna L 95 Pirard, Sandrine 33 Raykov, Tenko 84 Rosen, Raymond C. 47 Pittman,Mary 90 Read, Laura L 75 Rosenbaum, Jerrold F 2 Pitts, Gloria 52 Real, Lawrence A 24 Piwowarczyk, Linda 67 Rosenberg, Ronald C 41 Realmuto, George M 96 Rosenblum, Leonard A 57 Pizarro, Rodrigo A 1 Reaver, Mary Lou 88 Rosenheck, Robert A 59 Pizzigallo, Eligio 22 Rechtman, Richard 33 Rosenthal, Jesse S 67 Plakun, EricM 19,50 Recupero, Patricia R 26 Rosenthal, Murray R 23,92 Plapinger, Jane D 17 Reeman, DeneM 59 Rosenthal, Norman E 22 Plotkin, Daniel A 23 Regenold, William T 43 Rosenthal, Richard N 21, 34, 55, 82, 95 Poindexter, Anthony 47 Regier, Darrel A 34,60,70,79 Rost, KathrynM 60 Poitras, Jennifer 23,32,76 Reich, James H 31 Roston, Diane M 19 Polan, Jonathan 18 Reichman, William E 2,7 Roth, Brett A 83 Polat, Aslihan 75 Reid, William H 88 Roth, Thomas 37, 85 Polcari,AnnM 84 Reifler, Burton V 77 Rothbaum, Barbara 0 8, 11 Pollack, Mark H 10 Reimherr, Frederick W 22 Rothe, Eugenio M 25,39,70 Pollack, Professor Robert 26 Reinblatt, Shauna P 88 Rothenberg, Albert 23,79 Porras, Jorge F 37 Reinhart, William M 76 Rothman, Marc 1 18 Porter, Gayle 90 Reiss, David 35 Rothstein,DavidA 57, 74, 91 Post, JerroldM 1,57,77 Ren, Cuirong 48 Rounsaville, Bruce J 34 Post, Robert M 34, 62, 63 Renaud, Johanne 24 Rousaville, Bruce 83 Postolache,TeodorT 43,92 Resnick, Phillip J 5,14,38, 66,89 Rovner, Barry W 80 Postolov, Anatoly 38 Resnick, William 70 Rowe, Melissa 25 Postrado, Leticia T 74 Resnikoff, Roy 0 66, 93 Rozsa, Sandor 75 Potenza, Marc N 83 Ressler, Kerry J 63 Ruben, Daphne 94 Potkin, Steven G 64 Restrepo, Ricardo 67 Rubenstein, David 71 Pratts, Michael J 25,77 Red, Irving M 82 Rubenstein, Grace E. F 23, 49 Pray, Jason 72 Rexach,VeldaY 90 Rubenstein, Michael N 88 Preda, Adrian 56 Reyes, Raymond M 17,51 Rubin, Howard C 70 Preter, Maurice 12, 26 Reynolds HI, Charles F 5,9,29 Rubio-Stipec, Maritza 98 Preven, David W 26 Riba, Michelle B 19,30,44,51 RudisillJohnR. 7 Price, Julie 30 Ricaurte, George A 83 Ruffolo, Giuseppe 48 Price, Lee M 50 Richards, Jennifer 38 Rugino, Thomas A 74 Price, Marilyn ,26 Richardson, JarrettW 8 Ruiz, Pedro 7,16,26,31,43,49,62,70,77, 89 Primm, Annelle B 43 Richardson, Mary Ann 75 Rush, A. John 9, 60 Prince, Jefferson B 1, 78 Richey, Angela 24 Prouty, Jennifer 32 Ruskin, Paul E 19 Riddle, Mark A 98 Russakoff, L. Mark 1 Provost, Scott E 25 Rieder, Ronald 0 29 RyallJo-EllynM 7 Puchalski, Christina M 90 Rihmer, Annamaria 93 Ryan, Deirdre M 8 Pugliese.MariaA 88 Rihmer, Zoltan 75, 93 Ryan, Donna H 65 Pumariega, Andres J 90 Riley-Lazo, Kristin P 76 Ryan,J.Michael 2, 86 Punia, Surender P 18 Rissanen, Tiina H 46 Ryan,Neal D 13, 94 Pynoos, Robert S 17 Risser, Richard C 24 Rychik, AbeM 75, 92 Ritvo, Eva C 42 Rynearson, Edward K 19, 46, 53 Q Ritvo, Jonathan 1 42,55 Ritvo, Rachel Z 30 S Quadrio, Carolyn 19, 71 Rizzo, Albert A 98 Quercioli, Leonardo 55 Robbins, Michael S 62 Sacamano, James T 71 Quiason, Arturo G 25 Robertson, Michael 1 Sachs, GaryS 8,11,23, 92 Quigley, Rosemary 60 Robin, Authur L 31 Sackeim, Harold A 5,9,81 120 PARTICIPANT INDEX

Sadoffjoan 54 Seidman, Stuart N 2, 34, 47 Smith, Mary Kay 89 Sadoff, Robert L 44, 54 Sellers, Brealyn M 49 Smith, Matthew B 84 Saeed, S. Atezaz 1, 76, 88 Seltzer, Mark F 85 Smoller, Jordan W. 23 Sagan, Meredith L 90 Sengupta, Anjana 97 Snyder, David L 18 Said,Tewfik 39 Sercan, Mustafa 75 Scares, Claudio N 23, 32, 57, 76 Sajatovic, Martha 2 Sernyak, Michael J 3 Sokol, Mae S 2 Sakhrani, Duru 74 Serrant, Donna M 44 Sokoll, Steven 70,73 Salahuddin, Kazi M 18 Sexson, Sandra 19 Solhkhah, Ramon 18 Salomon, Richard 96 Shaffer, David 54, 55 Soloff, Paul H 24 Salone, Anatolia 22 Shah, Manoj R 65 Solomon, Brenda C 58 Salonen, Jukka T 46 Shalev, Arieh Y 17, 57 Soltys, Stephen M 44 Sambrano, Soledad 83 Shanfield, Stephen B 42 Solursh, Lionel P 44 Samsock, Teresa C 74 Shapiro, Edward R 19, 50 Somasundaram, Daya 47 Samuel, Steven E 43 Shapiro, Peter A 41, 67 Somers, Julian 57 Samuels, Jack F 82 Shapshak, Paul 29 Sommers, Frank G 48 Sanacora, Gerard 64 Sharfstein, Steven S ...... 31,82,88 Sonawalla, Shamsah B 49 Sanchez, Herman 32 Sharma, Rajiv P 38 Sonnenreich, Michael R 43 Sanchez-Lacay, J. Arturo 61 Sharon, Estee 33 Sood, Erica 34, 64 Sanchez-Way, Ruth 93 Sharp, Conni 42 Sotsky, Stuart M 51 Sane, Natasha S 34 Shea, M. Tracie 24, 35, 56, 81 Southard, Marvin 89 Sanguineti, Vincenzo R 7 Shea, Shawn C 15 Southwick, Steven M 55 Sanislow, Charles A 24, 55, 56, 81 Shear, M. Katherine 11 Sowers, Wesley 6 Sano, Mary 85 Shedlack, Karen J 91 Speigelman, D 57 Santiago, Rolando 90 Sheehan, David V 8, 13 Spencer, Thomas J 3, 86 Saraceno, Benedetto 17, 79 Sheehejohn 42 Sperry, Leonard T 17 Sartorius, Norman 6, 60 Shellow, Ronald A 89 Spiegel, David 61 Sassani, Andrew A 90 Shelton, Richard C 65, 87, 96 Spiegel, Herbert 56 Satcher, David 68 Shen, Hong 70 Spitz, Deborah 25, 70, 77 Satel, Sally L 39 ShifrenJanL 23,76 Spitz, Henry 1 44 Satmis, Nevzat 75 Shinn, Ann 81 Springer, J. Fred 83 Sautter, FredricJ 55 Sholevar, Ellen H 23, 84 Spritz, Melanie E 19 Savage, Seddon R 62 Sholevar, G. Pirooz 61, 84 Spungen, Deborah 46 Scalco, Monica Z 32 Shrier, Diane K 26 Srinivasaraghavan, Jagannathan 93 Scasta, David L 43, 51 Shrout, Patrick 48 Stabinsky, Harvey 19, 91 Schafer,John 96 Shubert, Duane D 18 Stabinsky, Susan 19, 75 Scharf, Bruce A 57 Shuman, Daniel W 39 Stahl, Stephen M 37, 57 Scharf, Michael A 48 Shwartz, Michael 25 Stange, Judy L 90 Schatzberg, Alan F 9, 28, 67 Siari, Valerie 59 Stangler, Ronnie S 50, 89, 93 Scheiber, Stephen C 69, 77 Siddarth, Prahba 34 Stanley, Richard M 90 Schiffer, Randolph B 5, 26 Siegel, Glenn N 90 Star, Jodi E 70, 91 Schindler, Barbara A 35, 69 Siegel, Patricia 31 Stasko, Robert S 89 Schindler, Shiro 95 Sierles, Frederick S 97 Steadman, Henry 97 Schmidt, La 55 Sierra, Victor 49 Stecher,VeraJ 47 Schmidt, Jr., Chester W 50, 78, 82, 89 Siever, Larry J 65, 74, 84, 87 Stein, Bradley D 33 Schneier, Franklin R 61 Sikich, Linmarie 48 Stein, Dan J 57 Stein, Mark A 47 Schoener, Gary R 51, 71 Silberman, Edward K 38 Stein, Mitchel J 71 Schooler, Nina R 30, 64, 92 Silberstein, Stephen C 22 Stein, Murray B 61 Schottenfeld, Richard S 42, 46 Silk, Kenneth R 24, 31, 50, 74, 81 Stein, Seth P 76 Schouten, Ronald 7 Silver, Alan 60 Steinberg, Karen 43 Schubmehl, James Q 39 Silver, Ann-Louise S 17, 31 Steinberg, Marc 33 Schuh, Leslie M 24 Silver, Stuart B 1 Steinberg, Maurice D 45, 70 Schulman, Julie K 50, 70 Silverman, Jeremy 74 Steiner, Hans 14, 65 Silverman, Samuel M 49 Schulz, S. Charles 13, 87 Stern, Jessica 77 Schuster, James M 43 Simeon, Daphne 84 Stern, Robert G 55 Schuyler, Dean 27 Simkin, Deborah R 83, 84 Stern, Theodore A 69, 72 Schwab-Stone, Mary E 70 Simon, Gregory E 59 Stevenson, Ellen M 48 Schwartz, Alan 18 Simon, Naomi M 10 Stewart, AlthaJ 61, 82, 94 Schwartz, Charles E 20 Simon, Robert 1 39 Stewart, Bette 74 Schwartz, Jonathan 49 Simon, Sara 81 Stewart, Donna E 40, 53, 70 Schwartz, Joseph M 72, 82, 89 Simpatico, Thomas A 1, 32 Stewart, Jonathan W 6, 61 Schwartz, Marc D 75 Simpson, D. Dwayne 26 Stokes, Honorable Louis 42 Scimeca, Michael M 19 Singh, Bruce 25 Stone, Alan A 10, 32, 56, 80 Sciutto, Mary S 66, 88 Sinha, Rajita 83 Stone, Michael H 31, 58 Scott, C. Paul 27 Siris, Samuel G 30 Stotland, NadaL 7, 49, 69, 80 Scott, Jan L 78 Sisson, Robert 91 Stout, Robert L 24, 56, 81 Scott, Marcia 7 Sivertz, Kristin S 8 Stowe, Zachary N 28 Scott, Nelda F 75 Skiljan, Carol 17 Strain, Eric C 55, 66 Scott, William M.W 90 Skodol II, Andrew E 15, 56, 81 Strakowski, Stephan M 48 Scotton, Bruce W 15 Skudlarski, Pawel 56 Strauss, John S 1 Scully, Paul J 96 Slovenko, Ralph 96 Strotmeyer, Stephen J 24 Scully, Jr., James H 77 Small, Gary W 34, 86 Stuart, Scott P 1 Sealy, Yvette 44 Smith, Christopher 65 Suchinsky, Richard T 18 Sederer, Lloyd 1 17, 76 Smith, Eric G 90 Sudak, Donna M 18, 89 Segal, Gerald 56 Smith, Eric L 57 Sudders, MaryLou 49 Seidman, Larry J 86 Smith, James 8 Sulfaro, Michelle 60 121 PARTICIPANT INDEX

Sullivan, Ann Marie T 20, 50 TsuangJohnW 52 W Sullivan, Kenneth A 29 Tsuang, Ming T. 30,65 Sullivan, Thomas] 35 Tucker, Bethany J 42,77 Waddington, John L 96 Sultzer, David L 7 Tucker, Phebe M 8 Wade, Terrance J 23,47,75 Sunday, Suzanne R. 30 Tucker, William M 56 Wadhwa,Uttam J 13 Sundelin-Wahlsten, Viveka 61 Tufnell, Guinevere 61 Wagenheim, Helen S 35 Suo-Chan, Shannon T 70 Tuma, Farris 71 Wagner, Karen D 3,5 Suppes, Patricia 8,11,24 Turgay, Atilla 74, 91 Waheed, Rubina 91 Svehlova, Jana H 57 Turkcan, Solmaz 75 Wahl, David S 94 Swann, AlanC 65, 87 Turkel,AnnR 82 Wainberg, Milton L 94 Swartz,Holly A 3,37,96 Turner, Charles W 62 Waldbaum, Marjorie E 42 Swartz, Marvin S 44 Turner, J. Blake 57,91 Waldron, Holly B 62 Swerdlow, Michael 38 Turner, Samuel M 55 Waldron, Jr., Sherwood 17 Sysko.Robyn 59 Turner, Susan A 70 Walker, R. Dale 10,42, 49, 89 Szadoczky, Erika 75 Tyrer, Peter 31 Walker, Sandra C 25,52 Szarek, Bonnie L 47,76 Tyssen, Reidar 31 Wall, Barry W 60, 72 Szuba, Martin P 14 Walsh, B. Timothy 59,86 u Walsh, James K 85 T Wambach,Kate 98 Uddo, Madeline 55 Wang, Jionjiong 94 Tager, Felice A 29 Ukshini, Shqipe 57 Wapenyi, Khakasa H 29,75 Taintor, Zebulon C 61, 89 Ulm,RonaldR 83 Ward, Jannine 9 TalbottJohnA 6,33,59,73 Ulmer, Helen G 55 Ward, Mike 41 Tamminga, Carol A 12, 20 Ulus,Eda 42 Wamock, Julia K ; 65,87 Tandon, Rajiv 38, 85, 93 Ulus,M.Fuat 42 Warshaw, Carole L 76 Tanskanen, Antti 46 Ungerleider, J.Thomas 43 Wasilchak, Deborah 43 Tapert, Susan 93 Unutzer, Jurgen 59 Waslick, Bruce D 54 Taranto, Richard G 76 Upadhya, Gopalakrishna K 16,25 Watkins, Katherine E 42 Targum, Steven D 14 UrbaitisJohnC 33 Watson, Chris 22 Tariot, Pierre N 2,7,86 Urcuyo, Leonel 91 Weaver, Carrie 82 Tarter, Ralph E 96 Ustun, T. Bedirhan 35 Webb, Carmen T 17 Tarverll, Donald E 80 Weiden, Peter J 9, 86, 92 Tasman, Allan 21 V Weihs, Karen L 23 Tavares, Hermano 32 Weinberger, Daniel R. 6, 12,86 Taylor, David H 22 Vaglum,Per 31 Weine, StevanM 57 Taylor, Mark-Allen 43 Valera,E 86 Weiner, Joseph S 60 Tedaldi, Ellen M 89 Valero, Janeth 74 Weiner, Richard D 38 Teicher, Martin H 84 Van Ameringen, Michael A 22 Weinrieb, Robert M 44,66 Telson, Howard W 75 Van Den Brink, Wim 95 Weinstein, Henry C 69 Tenhundfeld,LyndaA 14 Van Dorn, Deborah HA 66 Weinstein, Stephen P 75,92 Terr.LenoreC 15,61,68 VanelleJ.M 59 Weinstock, Robert 96 Terra, Jean-Louis 59 Van Gorp, Wilfred G 23 Weisberg, Risa B 22 Thase, Michael E 6,11, 59, 66 Van Horn, John D 81 Weisman, Henry WJ 49 Theburge, David 23 Van Horn, Patricia 61 Weiss, Francine 26 Thibaut, Florence 83 Van Ommeren, Mark 47 Weiss, Roger D 48 Thompson, Diane S 87 VanReeJan 95 Weissman, Alicia M 75 Thompson, James W 43, 94 Van Reekum, Robert 32 Weissman, Myma M 3, 97 Thompson II, Troy L 94 Vargas, Janeth 74 Weissman, SidneyH 58 Thoret,Yves 33 Vargas, Luis 62 Welch, Thomas P 51 Thornton, Charles C 75, 92 Vaswani, Meera 74 Weller, Elizabeth B 77, 79, 91, 97 Veijola, JuhaM 91, 92 Thurrell, Richard J 40, 50 Weller, Ronald A 97 Veiling, DrewM 54 Tighe,Patti 17 Wells, Karen C 96 Venkataraman, Sanjeev 7 Tignol.JeanL 95 Weiner, Michael M 31, 58, 91 Ventura, Joseph 23 Tillman,Jane G 19 Welsh, Christopher J 42, 93 Vergare, Michael J 18,22 Tinsley, Joyce A 21, 76 Wenk, Gary L 85 Verma, Sumer 6 West, Donald A 42 Tofler.IanR. 54 Vermette, Heidi S 90 Tohen, Mauricio F 24,47,48,95 West, Joyce C. 60,94 Viale, Gonzalo F 77 WestmanJackC 40,50 Toledo, Daniel 88 Vianu,Donca 51 Tonga, Levent 74 Wexler, Bruce E 24, 56 Vickar, Garry M 33 Whitehom, David 13 Toni, Christina 48,75,91 Victor, Bruce S 15 Whiteside-Mansell, Leanne 20 Toprac, Marcia 98 Vieweg, Walter V 3 Whitman, Sarah M 18,71 Torti, Carlo 75 Viguera, Adele C 11,32 Whyte, Heather 72 Trachtenberg, David A 93 Viinamaki, Heimo 46 Widiger, Thomas A 35,82 Tracy, Martin G 18,42,72 Vitiello, Benedetto 98 Wiederhold, Mark D 98 Travierso, Chiara 48 Vivek, Seeth 18,67 Wieduwilt, Kristin M 74 Trestman, Robert L 43,74 Voas, Robert 95 Wiener, Jerry M 25,79 Trimble, Michael R. 15, 81 Vogel-Scibilia, Suzanne E 51 Wiesner, Irving S 67, 76 Trinidad, Anton C 48 Volavka,Jan 30 Wilcox, Richard E 93 Trivedi,MadhukarH 9,60 Volkan, Vamik D 77 Wilens, Timothy E 5,47 Tropnas, Jean B 44 Volpicelli, Joseph R 83 Wiley, Justin 55 Trzepacz, Paula T 39 Von Korff, Michael 60 Wilfley, Denise E 86 Tsao, Daniel 47 Voutilainen, Sari 46 Wilkie, Frances L 29 Tschan, Werner 19,51,71 Vreys,TinaM 74 Wilkins, Jeffrey N 70 Tso, Alice C 52 Vujanovic, Anna 74 Williams, Jill 33

122 PARTICIPANT INDEX

Williams, John 60 Woods, Scott W 95 Young, Nancy 97 Williams, Laurel L 25 Woods, SherwynM 69 Young, Paula R 96 Williams, Mary Beth 71 Woody, George E 18 Young, Richard A 20 Williams, Richard 1 Workeneh, Lishan 42 Yuan Volpp, Serena 70 Williams, Veronica L 20 Worley, Linda L.M 20,51 Yudofsky, Stuart C 13,20, 37, 39 Williams, Wendy 80 Worthen, Mary R 11 Yung, Alison R 9 Williams-Johnson, Denise M 38 Worthington III, John] 17,23 Yuria,Yuval 91 Willick, Martin S 6 Wozniak, Janet 3,38 Wilson, Daniel R 56, 88 Wright, Harry H 58, 74 z Wilson, G. Terrence 59 Wright, Jesse H 18,26,30,66,78 Wilt, Susan 93 Wu, Nancy Sheng-Shih 77 Zajecka, John M 37 Wims,Rosa 32 Wylie, KevanR 49 Zakzanis, Konstantine K 98 Winer, Jerome A 58 Zanarini, Mary C 24, 56,74, 81 WinkelmanJohnW 10,27,86 Y Zapatel, Jorge A 17,89 Winstead, Daniel K 77 Zarate, Jr., Carlos M 24,48 Wint, Dylan P 23, 70 Yager, Joel 7, 26, 30,77 Zavodnick, Jacquelyn M 84 Wirshing, Donna A 3,9 Yang, Jing-Duan 48 Zerbe, KathrynJ 2 Wirshing, William C 9 Yates, Alayne 22, 49 Ziedonis, Douglas M 33 Wise, Thomas N 44,69 Yee, Maria R 49 ZilJohnS 69 Wiseman, Claire V 30 Yehuda, Rachel 8,26,44,71 Zilberman, Monica L 32 Wisner, Katherine L 35, 75 Yen, Shirley 24, 81 Zimbardo, Philip G 51, 67 Wohlford, Paul 32 Yeomans, Frank E 66 Zipursky, Robert B 95 Wolfe, Rosemarie 97 Yeung, Albert 49 Ziskin, Mikhail Y 44 Wolkstein, Eileen C 43 Yeung, Paul P 24, 47 Zito, Julio M 83 Wonderlich, Stephen A 30 Yoast,Bill 54 Zivin,Gail 43 Wong, Frank Y 93 Yonkers, Kimberly A 11, 87 Zonana, Howard V 76 Wong, Marleen 33 Young, Alexanders 25,59 Zubritsky, Cynthia 32 Wood, William G 6 Young, Carolyn M 75 Zweben, Allen 95 Woodley, Hazel 13 Young, Keith W 42, 50, 60, 88

123 THE WIDEST ARRAY Of At Your Annual Meeting Bookstore

APPI BOOKSTORE AT THE 2OO2 The American Psychiatric APA ANNUAL MEETING Publishing Textbook of Grow professionally and increase your knowledge of Consultation-Liaison Psychiatry psychiatric practices through the extensive selection Psychiatry in the Medically III, at the APPI bookstore. Our wide variety of topics Second Edition allows you to pick up the titles you've always wanted Edited by Michael G. Wise, M.D. or find a title to complete series collections and and James R. Rundell, M.D. annual reviews. We look forward to seeing you! Today, nearly 3,000 psychiatrists in the United States work at the Make sure to visit the APPI bookstore when you're in forefront of psychiatry's interaction with other medical specialties, Philadelphia—you won't be disappointed! devoting at least 25% of their professional time to consultation- liaison psychiatry. This second edition, meticulously researched, clearly written, and designed for ease of use, brings together the body of knowledge and skills that defines the subspecialty of con- APPI Bookstore Hours during the sultation-liaison psychiatry. More than 100 clinical and academic .TmiXKm*aMwOL •MinOClI IViBfimlllCC.' ' " '" x> ~ftl!. •^WP^T^^ff•«jwMfc ' *•*W^*9* ^^-^b^iJL^Jfm£^^&^ * ^*W^^W^^VW w -i #t?*v'v"-' leaders share their knowledge, expertise, and research within Saturday, May 18 11 am-5 pm these pages, offering practical guidance based on their firsthand Sunday, May 19 11 am-4:30 pm clinical experience in evaluating and treating psychiatric disorders A%H«% &te? J& > J&'ttw^pji^ >> V ^ §'J". in patients with concomitant medical or surgical illness. c ? %ssd®$ $fa? 21 "1C. ft«^ ^« ; T * £ > ' \* ], -; jpOK** TlaO'pagifc* ^^^8%^^^f»«ra^ Wednesday, May 22 10 am-3 pm $175.00 ? Item #8393 Special Hoipft^far > 1 S The American Psychiatric Members-in-Training ONLY. Publishing Textbook of OnSunday, May 19th from 8:00am to11:00am the Neuropsychiatry and bookstore will be open for members-in-training only. Clinical Neurosciences, 44«4^lf\^ii^'^ie^|^i-J^|^^*^^ Fourth Edition f^fiiioidb^MJtoii^fMkiff^' ,r ^xX^fT^f-^ (1>^ Edited by Stuart C. Yudofsky, M.D., and Robert E. Hales, M.D. Textbook of Anxiety Disorders PRAISE FOR THE PREVIOUS EDITION First published 15 years ago as the only multiauthored, comprehen- Edited by Dan J. Stein, M.B., and sive textbook in the field, the fourth edition of this tremendously Eric Hollander, M.D. successful volume expands its focus on the neurosciences to encom- This "one-stop" resource for both clinicians pass the great strides we've made. To convey this intensified focus, and researchers details not only the rigorous the editors have added "...and Clinical Neurosciences" to the title, diagnostic schemas, sophisticated psychobio- with new and expanded chapters that cover topics such as the epi- logical models, and effective pharmacotherapy and psychotherapy demiology and genetics of neuropsychiatric disorders, the neuropsy- interventions developed during the past few decades but also the chiatric aspects of delirium, the growth in clinical knowledge about latest advances in research, theory, and clinical knowledge in this and clinical relevance of drug-induced delirium and encephalopathies diverse field. In this remarkable collection, 77 U.S. and interna- other than delirium, and educational and certification issues in tional experts cover the phenomenology, etiology, psychotherapy, neuropsychiatry. and pharmacotherapy of every major anxiety disorder. 2002 ? 1420 pages ? ISBN 1- 58562-004-1? hardcover * -$44 pogirf WWitfii^tN* *tawpfc - $219.00 ? Item #62004 $?7j0»n©mtii^ -rvnw.v'* ^s^tni American Psychiatric Association American Psychiatric Publishing, Inc. Practice Guidelines for the Treatment 1400 K Street, NW of Psychiatric Disorders Washington, DC 20005-2403 Compendium 2002 Phone: 202-682-6262 or 1-800-368-5777 American Psychiatric Association Mon.-Fri., 9 am to 5:30 pm, ET 2002 ? 896 pages ? ISBN 0-89042-320-2 ? hardcover Fax: 1-202-789-2648 • Email: [email protected] • Web: www.appi.org $74.95 ? Item #2320 ;" Please reference priority code AH203 when ordering 2002 ? 896 pages ? ISBN 0-89042-323-7 ? paperback $57.95 ? Item #2323 124 I '-J^V^al! I f *\ d -V^ :TVr7T?€^^ A ^ J*l •!

MAY5 IWWOIPSTW^f Brain Circuitry and Signaling in Psychiatry ^^^Sliy Basic Science and Clinical Implications Quality Indicators WUNKif' Edited by Gary B. Kaplan, M.D., and Defining and Measuring Quality in Psychiatric Care Ronald P. Hammer Jr., Ph.D. Emergency Psychiatry for Adults and Children 2002 • 272 pages • ISBN 0-88048-957-X (Keport of the APA Task Force on Quality Indicators and Itel If !$<3iaei R ABea, M»D. hardcover • $45.00 • Item #8957 2002* 224 pages-ISBN 1-58562-070-X Kepon of the APA Task Force on Quality Indicators for papefbock-$31.95'Item #62070 Concise Guide to Geriatric Psychiatry, Children and Adolescents) Third Edition American Psychiatric Association Mentd Health Issues in Lesbian, Gay, James E. Spar, M.D., and 2002 • 240 poges • ISBN 0-89042-291-5 Bisexual, md Transgertder Communities Asenath La Rue, Ph.D. poperbock* $27.95* Item #2291 ky Billy i Jones, HD., &I& 2002 • 400 pages • ISBN 1-58562-064-5 Quick Reference Guide to the American atfM«MfeJ%K' for the Treatment of Psychiatric Disorders Compendium 2002 Cutting-Edge Meefidne Defining Psydtopathology in the 21st Century American Psychiatric Association What Psycliiatrists Need to Know DSM-V and Beyond 2002 • 250 pages • ISBN 0-89042-321-0 Btted % Nada L Stetfaoi M.R, ERft Edited by John E. Helzer, M.D., and paperback* $29.00* Item #2321 2002* 176 pages-ISBN 1-58562-072-6 James J. Hudziak, M.D. papedwA. $31.95-Item #62072 2002 • 288 pages • ISBN 1-58562-063-7 Concise Guide to Managing Behavioral Health paperback* $49.00* Item #62063 Care Within a Managed Care Environment The Many Faces of Depression in Chfldren Michael Isaiah Bennett, M.D. and Adolescents APRIL 2002 • 112 pages • ISBN 0-88048-738-0 paperback* $24.95* Item #8738 Mt^ Jjy Datid Shaffer, ED,, fift.C£f American Psychiatric Association Practice ERjC%db. aal Broce Wtaa, M.D. Guideline for the Treatment of Patients With Concise Guide to Computers hi Clinical 2002-224 pages-ISBN 1-58562-071-8 paperback-$31.95-Item #62071 Bipolar Disorder, Second Edition Psychiatry American Psychiatric Association Carlyle H. Chan, M.D., John S. Luo, M.D., 2002 • 54 pages • ISBN 0-89042-322-9 and Robert S. Kennedy, M.A. yH^ggiMi^jfc-ir paperback • $29.50 • Item #2322 2002* 192 pages* ISBN 1-58562-100-5 ^IBlHPIllllWWsW,,'! paperback* $27.95* Item #62100 Cultural Assessment hi Clinical Psychiatry Concise Guide to Neuropsychiatry and Group for the Advancement of Psychiatry Behavioral Neurology, Second Edition Agitation hi Patients With Dementia 2002 • 208 pages • ISBN 0-87318-144-1 Jeffrey L. Cummings, M.D., and A Practical Guide to Diagnosis and Management paperback • $38.00 • Item #7144 Michael R. Trimble, M.D., F.R.C.P., F.R.C.Psych. Edited by Donald P. Hay, M.D., 2002 • 336 pages • ISBN 1-58562-078-5 David T. Klein, Psy.D, Linda K. Hay, Ph.D., Handbook of Geriatric Psychophormacology paperback* $29.95* Item #62078 and George T. Grossberg, M.D. Sandra A. Jacobson, M.D., Ronald W. Pies, Mastering Forensk Psychiatric Practice 2002 • 288 pages • ISBN 0-88048-843-3 M.D., and David J. Greenblatt, M.D. paperback* $43.95* Item #8843 2002 • 512 pages • ISBN 0-88048-823-9 Advance Strategies for the Expert Witness paperback* $54.00 • Item #8823 Thomas G. Gutheil, M.D., and Medkal Complications of Psychiatric Illness Robert I. Simon, M.D. Claire Pomeroy, M.D., James E. Mitchell, M.D., Handbook of Integrated Short-Term 2002 • 192 pages • ISBN 1-58562-007-6 James Roerig, Pharm.D., B.C.P.P., and Psychotherapy paperback* $29.95* Item #62007 Scott Crow, M.D. Arnold Winston, M.D., and Concise Guide to Evaluation and Management 2002 • 240 pages • ISBN 0-88048-807-7 Beverly Winston, Ph.D. paperback • $29.95 • Item #8807 2002 • 320 pages • ISBN 0-88048-814-X of Sleep Disorders, Third Edition paperback* $45.00* Item #8814 Martin Reite, M.D., John Ruddy, M.D., and Manual of Ginkd Psychopharmocology, Kim Nagel, M.D. Fourth Edition FEBRUARY 2002 • 288 pages • ISBN 1-58562-045-9 Alan F. Schatzberg, M.D., Jonathan Cole, M.D., paperback* $27.95* Item #62045 Molecular Genetics and the Human and Charles DeBattista, M.D. Retrospective Assessment of Mental States 2002 • 736 poges • ISBN 0-88048-865-4 Personofiry poperbock* $59.00* Item #8865 Edited by Jonathan Benjamin, M.D., in Litigation Richard P. Ebstein, Ph.D., and Predicting the Past Psychiatric Illness in Women Robert H. Belmaker, M.D. Edited by Robert I. Simon, M.D., and Emerging Treatments and Research 2002* 288 pages* ISBN 0-88048-755-0 Daniel W. Shuman, J.D. Edited by Freda Lewis-Hall, M.D., hardcover- $49.00 • Item #8755 2002 • 560 poges • ISBN 1-58562-001-7 Teresa S. Williams, B.Sc., Jill A. Panetta, Ph.D., hardcover • $84.00 • Item #62001 Environmental and Chemical Toxins and and John M. Herrera, Ph.D. Treating Trauma Survivors With PTSD 2002 • 688 poges • ISBN 1-58562-003-3 Psychiatric Illness paperback • $65.00 • Item #62003 James S. Brown Jr., M.D. Edited by Rachel Yehuda, Ph.D. 2002 • 320 pages • ISBN 0-88048-954-5 2002 • 240 pages • ISBN 1-58562-010-6 JULY paperback • $45.00 • Item #8954 paperback • $36.95 • Item #62010 Outcome Measurement in Psychiatry Negotiating Managed Core A Critical Review A Manual for Clinicians Edited by Waguih William IsHak, M.D., Michael A. Fauman, Ph.D., M.D. Tal Burt, M.D., and Lloyd I. Sederer, M.D. 2002 • 128 pages* ISBN 1-58562-042-4 2002 • 464 pages • ISBN 0-88048-119-6 paperback- $24.95 • Item #62042 paperback* $69.95* Item #8119 125 AMERICAN PSYCHIATRIC ASSOCIATION - 156TH ANNUAL MEETING - MAY 17-22, 2003 SAN FRANSICO, CA CALL FOR PAPERS

PRESIDENTS THEME: The Promise of Science - The Power of Healing

Paul S. Appelbaum, M.D. President Geetha Jay or am, M.D., Chairperson Scientific Program Committee THE SUBMISSION SCHEDULE

Format Deadline

Industry- Supported Symposium June 3, 2002 Course September 4, 2002 Reports September 4,2002 Symposium September 4,2002 Workshops Issue: September 4, 2002 Component: September 17, 2002 New Research January 3, 2003

Incomplete and/or Incorrect Forms Will Not Be Considered.

For complete submission forms, you may download the forms at www.psych.org, click on the Annual Meeting logo, then click on submission forms. You may also contact theAPA toll free at 1-888-357-7924, and speak directly with an Answer Center Coordinator.

If you want to volunteer to chair a session, please send a letter to the attention of Dr. Jayaram at the American Psychiatric Association. Please indicate your name, address, area of expertise, and the type of session you would like to chair. Please be aware that we receive more requests than available slots. If you are selected as a chairperson, you will be notified by the end of November.

126 INDUSTRY-SUPPORTED SYMPOSIUM 1 Saturday, May 18, 7:00 p.m. -10:00 p.m. Millennium Hall, Second Floor, Loews

INDUSTRY-SUPPORTED SYMPOSIUM 2 Saturday, May 18, 7:00 p.m. -10:00 p.m. Regency Ballrooms A-C, Second Floor, Loews

127 INDUSTRY-SUPPORTED SYMPOSIUM 3 Saturday, May 18, 7:00 p.m. -10:00 p.m. Grand Ballroom Salons E/F, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 4 Saturday, May 18, 7:00 p.m. -10:00 p.m. Grand Ballroom Salons G/H, Level 5, Marriott

128 INDUSTRY-SUPPORTED SYMPOSIUM 5 Saturday, May 18, 7:00 p.m. -10:00 p.m. Wyndham Ballrooms A/B, First Floor, Wyndham

INDUSTRY-SUPPORTED SYMPOSIUM 6 Saturday, May 18, 7:00 p.m. -10:00 p.m. Wyndham Ballrooms C/D, First Floor, Wyndham

129 INDUSTRY-SUPPORTED SYMPOSIUM 7 Sunday, May 19, 8:00 a.m. -11:00 a.m. Millennium Hall, Second Floor, Loews

INDUSTRY-SUPPORTED SYMPOSIUM 8 Sunday, May 19, 8:00 a.m. -11:00 a.m. Regency Ballrooms A-C, Second Floor, Loews

130 INDUSTRY-SUPPORTED SYMPOSIUM 9 Sunday, May 19, 8:00 a.m. -11:00 a.m. Grand Ballroom Salons E/F, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 10 Sunday, May 19, 8:00 a.m. -11:00 a.m. Grand Ballroom Salons G/H, Level 5, Marriott

131 INDUSTRY-SUPPORTED SYMPOSIUM 11 Sunday, May 19, 8:00 a.m. -11:00 a.m. Wyndham Ballrooms A/B, First Floor, Wyndham

INDUSTRY-SUPPORTED SYMPOSIUM 12 Sunday, May 19, 8:00 a.m. -11:00 a.m. Wyndham Ballrooms C/D, First Floor, Wyndham

132 INDUSTRY-SUPPORTED SYMPOSIUM 13 Sunday, May 19, 1:30 p.m. -4:30 p.m. Millennium Hall, Second Floor, Loews

INDUSTRY-SUPPORTED SYMPOSIUM 14 Sunday, May 19, 1:30 p.m. -4:30 p.m. Regency Ballrooms A-C, Second Floor, Loews

133 INDUSTRY-SUPPORTED SYMPOSIUM 15 Sunday, May 19, 1:30 p.m. - 4:30 p.m. Grand Ballroom Salons E/F, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 16 Sunday, May 19, 1:30 p.m. -4:30 p.m. Grand Ballroom Salons G/H, Level 5, Marriott

134 INDUSTRY-SUPPORTED SYMPOSIUM 17 Sunday, May 19, 1:30 p.m. - 4:30 p.m. Wyndham Ballrooms A/B, First Floor, Wyndham

INDUSTRY-SUPPORTED SYMPOSIUM 18 Sunday, May 19, 1:30 p.m. -4:30 p.m. Wyndham Ballrooms C/D, First Floor, Wyndham

135 INDUSTRY-SUPPORTED SYMPOSIUM 19 Sunday, May 19, 7:00 p.m. -10:00 p.m. Millennium Hall, Second Floor, Loews

INDUSTRY-SUPPORTED SYMPOSIUM 20 Sunday, May 19, 7:00 p.m. -10:00 p.m. Regency Ballrooms A-C, Second Floor, Loews

136 INDUSTRY-SUPPORTED SYMPOSIUM 21 Sunday, May 19, 7:00 p.m. -10:00 p.m. Grand Ballroom Salons E/F, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 22 Sunday, May 19, 7:00 p.m. -10:00 p.m. Grand Ballroom Salons G/H, Level 5, Marriott

137 INDUSTRY-SUPPORTED SYMPOSIUM 23 Sunday, May 19, 7:00 p.m. -10:00 p.m. Wyndham Ballrooms A/B, First Floor, Wyndham

INDUSTRY-SUPPORTED SYMPOSIUM 24 Sunday, May 19, 7:00 p.m. -10:00 p.m. Wyndham Ballrooms C/D, First Floor, Wyndham

138 INDUSTRY-SUPPORTED SYMPOSIUM 25 Monday, May 20, and Tuesday, May 21, 7:00 a.m. - 8:30 a.m. Millennium Hall, Second Floor, Loews

INDUSTRY-SUPPORTED SYMPOSIUM 26 Monday, May 20, and Tuesday, May 21, 7:00 a.m. - 8:30 a.m. Regency Ballrooms A-C, Second Floor, Loews

139 INDUSTRY-SUPPORTED SYMPOSIUM 27 Monday, May 20, and Tuesday, May 21, 7:00 a.m. - 8:30 a.m. Grand Ballroom Salons E/F, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 28 Monday, May 20, and Tuesday, May 21, 7:00 a.m. - 8:30 a.m. Grand Ballroom Salons G/H, Level 5, Marriott

140 INDUSTRY-SUPPORTED SYMPOSIUM 29 Monday, May 20, and Tuesday, May 21, 7:00 a.m. - 8:30 a.m. Wyndham Ballrooms A/B, First Floor, Wyndham

INDUSTRY-SUPPORTED SYMPOSIUM 30 Monday, May 20, and Tuesday, May 21, 7:00 a.m. - 8:30 a.m. Wyndham Ballrooms C/D, First Floor, Wyndham

141 INDUSTRY-SUPPORTED SYMPOSIUM 31 Tuesday, May 21, 7:00 p.m. -10:00 p.m. Ballrooms A/B, Ballroom Level, Convention Center

INDUSTRY-SUPPORTED SYMPOSIUM 32 Tuesday, May 21, 7:00 p.m. -10:00 p.m. Millennium Hall, Second Floor, Loews

142 INDUSTRY-SUPPORTED SYMPOSIUM 33 Tuesday, May 21, 7:00 p.m. -10:00 p.m. Regency Ballrooms A-C, Second Floor, Loews

INDUSTRY-SUPPORTED SYMPOSIUM 34 Tuesday, May 21, 7:00 p.m. -10:00 p.m. Grand Ballroom Salons E/F, Level 5, Marriott

143 INDUSTRY-SUPPORTED SYMPOSIUM 35 Tuesday, May 21, 7:00 p.m. -10:00 p.m. Grand Ballroom Salons G/H, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 36 Tuesday, May 21, 7:00 p.m. -10:00 p.m. Wyndham Ballrooms A/B, First Floor, Wyndham

144 INDUSTRY-SUPPORTED SYMPOSIUM 37 Tuesday, May 21, 7:00 p.m. -10:00 p.m. Wyndham Ballrooms C/D, First Floor, Wyndham

INDUSTRY-SUPPORTED SYMPOSIUM 38 Wednesday, May 22, and Thursday, May 23, 7:00 a.m. - 8:30 a.m. Ballrooms A/B, Ballroom Level, Convention Center

145 INDUSTRY-SUPPORTED SYMPOSIUM 39 Wednesday, May 22, and Thursday, May 23, 7:00 a.m. - 8:30 a.m. Millennium Hall, Second Floor, Loews

INDUSTRY-SUPPORTED SYMPOSIUM 40 Wednesday, May 22, and Thursday, May 23, 7:00 a.m. - 8:30 a.m. Regency Ballrooms A-C, Second Floor, Loews

146 INDUSTRY-SUPPORTED SYMPOSIUM 41 Wednesday, May 22, and Thursday, May 23, 7:00 a.m. - 8:30 a.m. Grand Ballroom Salons E/F, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 42 Wednesday, May 22, and Thursday, May 23, 7:00 a.m. - 8:30 a.m. Grand Ballroom Salons G/H, Level 5, Marriott

147 INDUSTRY-SUPPORTED SYMPOSIUM 43 Wednesday, May 22, 7:00 p.m. -10:00 p.m. Ballrooms A/B, Ballroom Level, Convention Center Non-Cholinergic Treatment for Alzheimer's Disease: Present Knowledge, Future Hope

APA 2002 Annual Meeting, Wednesday, May 22, 2002, 7:00 -10:00 p.m., Dinner 6:30 - 7:00 p.m. Ballrooms A/B, Pennsylvania Convention Center Attendees must be registered for the APA Annual Meeting to attend this symposium. Seating is limited and will be based on 7:00 - 7:05 p.m. Introduction first-come, first-served. For more infor- mation about the meeting, please visit the 7:05 7:35 p.m. The Diagnosis and Treatment of Alzheimer's Disease: An Overview APA website at www.psych.org or contact Barry D. Lebowitz, PhD, National Institute of Mental Health the APA toll free at 1-888-357-7924 (within 7:35 8:05 p.m. Current Treatments for Alzheimer's Disease: Cholinesterase Inhibitors the U.S. or Canada) or 202-682-6000. Rachelle Doody, MD, PhD, Baylor College of Medicine This program is sponsored by the American Psychiatric Association. 8:05 - 8:35 p.m. The Neroanatomy of Alzheimer's Disease The American Psychiatric Association Gary L. Wenk, PhD, Graduate Program in Cognition and Neural Systems, University (APA) is accredited by the Accreditation of Arizona Council for Continuing Medical Education to provide continuing medical education 8.35 9:05 p.m. Beyond Acetylcholine: The Search for Better Treatment Options (Part I) for physicians. Jacobo Mintzer, MD, Department of Psychiatry, Medical University of South Carolina The APA designates this educational activ- 9:05 9:30 p.m. Beyond Acetylcholine: The Search for Better Treatment Options (Part II) ity for up to 3 hours in category 1 credit Mary Sano, PhD, Department of Neurology, Columbia Presbyterian Medical Center towards the AMA Physician's Recognition Award and for the CME requirement of 9:30 -10:00 p.m. Questions (five minutes of questions will follow each presentation) the APA. Each physician should claim only those hours of credit that he/she actually spends in the educational activity. At the conclusion of this symposium the participants should be able to: This program is supported by an unre- - Understand existing cholinergic treatments of Alzheimer's disease; stricted educational grant from Forest - Better comprehend the neuroanatomy of Alzheimer's disease; Laboratories. - Recognize alternative options that may be used alone or in combination with existing treatments; and - Consider the future of Alzheimer's disease treatments. Forest Laboratories, Inc.

INDUSTRY-SUPPORTED SYMPOSIUM 44 Wednesday, May 22, 7:00 p.m. -10:00 p.m. Millennium Hall, Second Floor, Loews

148 INDUSTRY-SUPPORTED SYMPOSIUM 45 Wednesday, May 22, 7:00 p.m. -10:00 p.m. Regency Ballrooms A-C, Second Floor, Loews

INDUSTRY-SUPPORTED SYMPOSIUM 46 Wednesday, May 22, 7:00 p.m. -10:00 p.m. Grand Ballroom Salons E/F, Level 5, Marriott

149 INDUSTRY-SUPPORTED SYMPOSIUM 47 Wednesday, May 22, 7:00 p.m. -10:00 p.m. Grand Ballroom Salons G/H, Level 5, Marriott

INDUSTRY-SUPPORTED SYMPOSIUM 48 Wednesday, May 22, 7:00 p.m. -10:00 p.m. Wyndham Ballrooms A/B, First Floor, Wyndham

150 INDUSTRY-SUPPORTED SYMPOSIUM 49 Wednesday, May 22, 7:00 p.m. -10:00 p.m. Wyndham Ballrooms C/D, First Floor, Wyndham

151 American Psychiatric Association "Community Counts: 54th Institute on Psychiatric Services Wednesday, October 9-Simday, October 13,2002 Creating and Chicago, IL Supporting Systems of Care"

• Distinguished Lecturers • INSTITUTE OBJECTIVES: Did you know that...

• CME Courses • At the conclusion of the 2002 Institute P You can earn up to 48 hours of on Psychiatric Services, participants category 1 credit for attending the • Leadership and will: Institute? Career Development Seminars • 1. Acquire new knowledge and skills in IP APA members receive a 40% (for Residents and clinical psychiatry, which can be discount on their cost for Early Career Psychiatrists) utilized to improve patient care; registration?

• Industry-Supported Symposia 2. Better understand how the current IP Industry-Supported Breakfast, health care system affects patient Lunch and Dinner Symposia are • Medical Updates • care; presented each day?

• Symposia • 3. Gain new knowledge and skills IP All scientific sessions will be held useful in public psychiatric settings; in the Palmer House Hilton Hotel • Workshops • and in Chicago?

• Debates • 4. Understand the importance of all IP There are prize drawings, beverages disciplines working together to and receptions held daily in the • Forums • ensure high quality patient care. exhibit hall?

• Full-Day Sessions • (p The 2001 Institute received the highest attendee-rated evaluations? • Poster Sessions •

• Discussion Groups • For further information, please call or write to: • Innovative Programs • Annual Meetings Department American Psychiatric Association • Clinical Consultations • HOOK Street,N.W. Washington, DC 20025 Telephone: 1 (888) 357-7924 (Toll Free) Fax: (202)682-6345 E-Mail: [email protected] Web: http://www.psvch.org

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The APA designates this educational activity for up to 48 hours in category 1 credit to- wards the AMA Physician's Recognition Award and for the CME requirement of the APA. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. 152 As Questions Arise at the APA Annual Meeting, Keep One Place in Mind

Where can I get a copy of the Interesting APA journal article poster session. \ they referenced at Can I get a copy of that symposium? Hmmm... the new research presented here? would my patients benefit if I had a website? My colleagues have always emphasized the importance of APA membership. Is Congress set How do I loin? to vote on this? How can I make my APA voice be heard? How did she get Resource that personalized Center certificate of How will these attendance? new regulations affect my practice?

Answers to all these questions and more APA Resource Center can be found at the APA Resource Center. Exhibit Halls A-C Along with new research abstracts on CD-ROM, Exhibit Hall Level, Convention Center complimentary copies of the latest APA publications, and opportunities to advertise or apply for position openings, Hours of Operation you'll find the latest HIV/AIDS treatment information; Saturday, May 18: 10:00 a.m.-5:00 p.m. Sunday, May 19: 8:00 a.m-4:30 p.m.* fellowship opportunities; how to report, track, and attain Monday, May 20: 10:00 a.m-6:00 p.m. additional CME credits; and other resources of benefit to Tuesday, May 21: 10:00 a.m-6:00 p.m. the 21 st century psychiatrist. Even a place to reconnect to Wednesday, May 22: 10:00 a.m-3:00 p.m. your 21 st century life at the Internet Village. So make the APA Resource Center part of your Annual 'Early closing for Opening Session Meeting experience and find out how the programs and resources of APA equip the 21 st century psychiatrist and specifically how APA membership can work for you.